<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.2.475">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Oncology Adverse Events</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1.6em;
  vertical-align: middle;
}
</style>


<script src="OncologSideEffects_quarto_files/libs/clipboard/clipboard.min.js"></script>
<script src="OncologSideEffects_quarto_files/libs/quarto-html/quarto.js"></script>
<script src="OncologSideEffects_quarto_files/libs/quarto-html/popper.min.js"></script>
<script src="OncologSideEffects_quarto_files/libs/quarto-html/tippy.umd.min.js"></script>
<script src="OncologSideEffects_quarto_files/libs/quarto-html/anchor.min.js"></script>
<link href="OncologSideEffects_quarto_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="OncologSideEffects_quarto_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="OncologSideEffects_quarto_files/libs/bootstrap/bootstrap.min.js"></script>
<link href="OncologSideEffects_quarto_files/libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="OncologSideEffects_quarto_files/libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script src="OncologSideEffects_quarto_files/libs/htmlwidgets-1.6.2/htmlwidgets.js"></script>
<script src="OncologSideEffects_quarto_files/libs/plotly-binding-4.10.1/plotly.js"></script>
<script src="OncologSideEffects_quarto_files/libs/typedarray-0.1/typedarray.min.js"></script>
<script src="OncologSideEffects_quarto_files/libs/jquery-3.5.1/jquery.min.js"></script>
<link href="OncologSideEffects_quarto_files/libs/crosstalk-1.2.0/css/crosstalk.min.css" rel="stylesheet">
<script src="OncologSideEffects_quarto_files/libs/crosstalk-1.2.0/js/crosstalk.min.js"></script>
<link href="OncologSideEffects_quarto_files/libs/plotly-htmlwidgets-css-2.11.1/plotly-htmlwidgets.css" rel="stylesheet">
<script src="OncologSideEffects_quarto_files/libs/plotly-main-2.11.1/plotly-latest.min.js"></script>


</head>

<body>

<div id="quarto-content" class="page-columns page-rows-contents page-layout-full">

<main class="content column-page" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">Oncology Adverse Events</h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  

</header>

<div class="cell">

</div>
<div class="cell">

</div>
<section id="safety" class="level2">
<h2 class="anchored" data-anchor-id="safety">Safety</h2>
<section id="all-adverse-events" class="level4">
<h4 class="anchored" data-anchor-id="all-adverse-events">All Adverse Events</h4>
<p>This section has all adverse events listed in the study, including all levels of stratification.</p>
<section id="difference" class="level6">
<h6 class="anchored" data-anchor-id="difference">|- Difference</h6>
<p>% pts reporting adverse events, control arms vs.&nbsp;experimental. Dividing line is a 1:1 line</p>
<div class="cell">
<div class="cell-output-display">
<div class="plotly html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-3390a1872943934576f9" style="width:100%;height:325px;"></div>
<script type="application/json" data-for="htmlwidget-3390a1872943934576f9">{"x":{"data":[{"x":[-0.01,1.01],"y":[-0.01,1.01],"text":"intercept: 0<br />slope: 1","type":"scatter","mode":"lines","line":{"width":3.77952755905512,"color":"rgba(190,190,190,1)","dash":"solid"},"hoveron":"points","showlegend":false,"xaxis":"x","yaxis":"y","hoverinfo":"text","frame":null},{"x":[0,0.005,0.01,0.01,0,0.015,0,0,0,0.003,0.005,0.6,0.33,0.27,0.54,0.16,0.14,0.29,0.38,0.16,0.24,0.21,0.44,0.42,0.009,0.011,0.005,0,0.009,0.016,0.03,0.016,0.002,0.018,0.005,0,0.009,0.21,0.03,0.02,0,0,0,0.01,0,0,0,0,0.27,0.12,0.01,0,0,0,0.3,0.18,0.33,0.21,0.05,0,0,0.009,0.013,0.018,0,0.19,0.28,0.26,0.2,0.21,0.22,0.14,0.11,0.012,0.11,0.006,0.037,0.13,0,0.009,0,0.24,0.1,0.003,0.021,0.015,0.006,0.015,0.003,0,0,0,0,0.006,0.015,0.009,0.006,0.43,0.36,0,0,0,0,0,0.45,0.24,0.14,0.57,0.18,0.3,0.04,0,0.12,0.003,0.06,0.003,0,0.43,0.18,0.11,0.06,0.018,0.029,0.02,0.018,0,0,0.003,0.006,0.014,0.13,0.23,0.29,0.017,0.006,0,0.047,0,0.05,0.38,0.57,0,0.41,0.29,0.21,0.23,0.16,0.18,0.21,0.12,0.11,0.12,0.11,0.11,0.1,0.12,0.49,0.64,0.03,0.02,0.03,0.03,0,0,0.04,0,0.02,0.02,0.21,0.01,0,0,0.01,0,0,0,0.07,0,0.02,0.03,0.04,0.01,0,0,0.05,0.05,0,0.003,0,0.001,0,0.01,0,0.01,0.01,0.01,0.13,0,0.58,0.44,0.33,0.27,0.26,0.06,0,0.026,0.01,0.013,0.11,0,0,0.05,0.02,0,0.03,0,0,0,0.1,0.15,0.15,0.13,0.23,0.16,0,0.003,0.003,0.009,0.09,0.006,0,0,0,0.003,0.42,0.31,0.003,0.008,0,0.01,0.29,0.2,0.16,0.17,0.16,0.12,0.21,0.12,0.015,0.012,0.035,0.004,0,0.015,0.004,0.008,0,0.4,0.24,0.07,0,0.05,0.05,0.19,0.25,0,0,0.003,0,0,0.49,0.47,0.35,0.23,0.018,0.018,0.032,0.011,0.004,0.007,0.06,0.01,0.01,0.01,0,0.25,0.32,0.18,0.01,0.032,0.021,0.025,0,0.71,0.01,0,0,0,0.01,0.14,0,0,0,0,0.047,0.023,0,0,0,0.023,0,0,0,0.019,0.01,0.01,0.004,0.01,0.004,0.036,0.005,0,0.01,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11,0.01,0.03,0.049,0.003,0,0.003,0,0,0.003,0,0.01,0.003,0.56,0.43,0.35,0.19,0.12,0.11,0.5,0.41,0.13,0.13,0.1,0.11,0.13,0.026,0.01,0.03,0.02,0.03,0.06,0.049,0,0.01,0.003,0,0.003,0,0.16,0.14,0,0,0.011,0.004,0.004,0.005,0,0,0.019,0.006,0.003,0,0.45,0.13,0.23,0.15,0.011,0.011,0.006,0.023,0,0,0,0,0,0.036,0.027,0.009,0.3,0.71,0.46,0.24,0.013,0,0.013,0.08,0.11,0.026,0,0,0,0.001,0,0,0,0,0,0,0,0,0,0,0,0.12,0.15,0.13,0.13,0.02,0.01,0.07,0.02,0,0.01,0.02,0.01,0.26,0.13,0.34,0.14,0.2,0.34,0.32,0.28,0.18,0.43,0.19,0.02,0.1,0.02,0.01,0,0.01,0.01,0,0,0,0.01,0.01,0,0,0.09,0.14,0.43,0.38,0.02,0.04,0,0.01,0.006,0,0,0,0.02,0,0.037,0.042,0.003,0.02,0.001,0.02,0.09,0.02,0.004,0,0.01,0,0.02,0,0,0.004,0,0.004,0,0,0,0,0,0.016,0,0,0,0,0,1,0.54,0.23,0.52,0.41,0.22,0.72,0.11,0.04,0.02,0.02,0.01,0.02,0.15,0.17,0.03,0.18,0.14,0.18,0.39,0.52,0.52,0.3,0.39,0.32,0.14,0.085,0.007,0,0,0.007,0.021,0.007,0.014,0,0.028,0.014,0.014,0.035,0,0.27,0.5,0.26,0.18,0.12,0.015,0.16,0.02,0.05,0.003,0.31,0.21,0.22,0.41,0.46,0.39,0.003,0.08,0.08,0.044,0.14,0.003,0.003,0,0.006,0.003,0.01,0.04,0,0,0.32,0.15,0,0,0.032,0,0,0,0.016,0,0.47,0.09,0.25,0.21,0.15,0.14,0.004,0.023,0.015,0.008,0.015,0,0.03,0,0.023,0.023,0.004,0.008,0.24,0.2,0.13,0.22,0.43,0.11,0.007,0.013,0.007,0.013,0.007,0.007,0.007,0,0.007,0.007,0,0.07,0,0.45,0.43,0.3,0.18,0.25,0.06,0,0.025,0.007,0.021,0.032,0.014,0,0.21,0.22,0.007,0,0.017,0.026,0.006,0.006,0.28,0.35,0.19,0.2,0.26,0.19,0.19,0.27,0.3,0,0.05,0,0.005,0.014,0.09,0.005,0.005,0.048,0.13,0,0.32,0.17,0.49,0.14,0.17,0.16,0.24,0.06,0,0,0,0.026,0.05,0,0,0,0,0.038,0,0,0.41,0.23,0.006,0.006,0.009,0.009,0.57,0.58,0.33,0.44,0.42,0.16,0.11,0.058,0.4,0.48,0.15,0.15,0.2,0.18,0.14,0.23,0.11,0.088,0.19,0.53,0.029,0.029,0.036,0.022,0,0.007,0,0.007,0,0.036,0.029,0.022,0.007,0,0.015,0,0.007,0.007,0,0,0,0,0.022,0.029,0.007,0.05,0.01,0,0.34,0.22,0.12,0.34,0.19,0.019,0.008,0.042,0.004,0.42,0.27,0.18,0.005,0.025,0.005,0.023,0.007,0,0.27,0.64,0.28,0.32,0.2,0.19,0.03,0.01,0.01,0.01,0,0.05,0.01,0.01,0.01,0.01,0,0.02,0.01,0.01,0.01,0.41,0.48,0.32,0.29,0.18,0.27,0.43,0.26,0.08,0.01,0.01,0.1,0.05,0.03,0.01,0.03,0,0.03,0.02,0,0,0.01,0,0,0.34,0.19,0.17,0.11,0.34,0.32,0.019,0.011,0.011,0,0,0.008,0,0,0,0,0,0,0.006,0.003,0,0.003,0.003,0.01,0,0.006,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003,0,0.27,0.17,0.07,0.11,0.09,0.08,0.08,0.07,0.06,0.06,0.05,0.06,0.02,0.01,0.01,0.01,0.01,0.06,0.01,0,0,0.01,0.01,0.01,0.01,0.01,0,0,0,0,0,0.01,0.01,0,0.01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.52,0.54,0.69,0.6,0.29,0.25,0.35,0.33,0.27,0.08,0.03,0.39,0.04,0.05,0.57,0.07,0.04,0.01,0,0.01,0.27,0.44,0.319,0.282,0.245,0.171,0.162,0.148,0.144,0.162,0.116,0.083,0.056,0.093,0.042,0.074,0.005,0.009,0.051,0.023,0.065,0.005,0.019,0.023,0.009,0.019,0.037,0.62,0.5,0.59,0.29,0.41,0.37,0.22,0.17,0.31,0.19,0.15,0.22,0.11,0.17,0.2,0.3,0.11,0.19,0.12,0.22,0.23,0.21,0.16,0.19,0.17,0.12,0.11,0.09,0.04,0.06,0.05,0.05,0.1,0.01,0.01,0,0,0,0,0.01,0.01,0,0.04,0,0,0.01,0.01,0,0,0.03,0.06,0,0.04,0,0.01,0.01,0.02,0.17,0.15,0,0.01,0.01,0.04],"y":[0,0,0.01,0,0,0.015,0,0,0,0.003,0,0.6,0.32,0.25,0.53,0.14,0.13,0.29,0.37,0.13,0.24,0.19,0.44,0.39,0.007,0.007,0,0,0.002,0.011,0.025,0.011,0,0.005,0.005,0,0.009,0.21,0.01,0.01,0,0,0,0.01,0,0,0,0,0.26,0.12,0,0,0,0,0.24,0.1,0.1,0.14,0.013,0,0,0.008,0,0.013,0,0.18,0.26,0.24,0.19,0.2,0.14,0.13,0.11,0.012,0.09,0.006,0.025,0.13,0,0.009,0,0.19,0.1,0,0.018,0.015,0,0.012,0,0,0,0,0,0,0.006,0.006,0,0.37,0.3,0,0,0,0,0,0.27,0.2,0.12,0.32,0.17,0.26,0.018,0,0.028,0,0.039,0.003,0,0.42,0.18,0.1,0.06,0.015,0.006,0.015,0.012,0,0,0.003,0.002,0.014,0.12,0.13,0.13,0.013,0.003,0,0,0,0,0.33,0.53,0,0.25,0.23,0.17,0.2,0.15,0.16,0.14,0.12,0.1,0.08,0.07,0.05,0.05,0.04,0.49,0.49,0.03,0,0,0.01,0,0,0.04,0,0.01,0.01,0.12,0,0,0,0.01,0,0,0,0.03,0,0,0,0.03,0,0,0,0.04,0.03,0,0.003,0,0.001,0,0.01,0,0.01,0.01,0.01,0.11,0,0.56,0.4,0.28,0.26,0.24,0.042,0,0.02,0.003,0.007,0.09,0,0,0.03,0.02,0,0.02,0,0,0,0.1,0.15,0.13,0.11,0.22,0.16,0,0.003,0.003,0.006,0.06,0.003,0,0,0,0.003,0.41,0.29,0,0.005,0,0.005,0.29,0.17,0.15,0.13,0.12,0.11,0.2,0.12,0.008,0.006,0.008,0.002,0,0.013,0.002,0.006,0,0.4,0.24,0.07,0,0.041,0.03,0.19,0.18,0,0,0.003,0,0,0.48,0.44,0.34,0.2,0.017,0.018,0.027,0.008,0,0.007,0.06,0.01,0.01,0.01,0,0.21,0.3,0.17,0.01,0.01,0.017,0.01,0,0.7,0.01,0,0,0,0.01,0.13,0,0,0,0,0.012,0.012,0,0,0,0.012,0,0,0,0.017,0.01,0.01,0,0.004,0,0.03,0.005,0,0.005,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.01,0.023,0.035,0.003,0,0,0,0,0.003,0,0.006,0.003,0.22,0.2,0.11,0.15,0.12,0.1,0.17,0.28,0.07,0.028,0.08,0,0.13,0.006,0.003,0.006,0.019,0.016,0.04,0.025,0,0,0,0,0.003,0,0.11,0.13,0,0,0.008,0,0.004,0.004,0,0,0.014,0,0.003,0,0.38,0.11,0.2,0.11,0.006,0,0.006,0.011,0,0,0,0,0,0.029,0.012,0.004,0.17,0.12,0.12,0.1,0.006,0,0.006,0.006,0,0,0,0,0,0.001,0,0,0,0,0,0,0,0,0,0,0,0.1,0.12,0.12,0.1,0.01,0.01,0.05,0.02,0,0.01,0,0.01,0.12,0.11,0.22,0.12,0.12,0.2,0.29,0.1,0.16,0.42,0.14,0,0.04,0,0,0,0,0.01,0,0,0,0,0.01,0,0,0.04,0.09,0.43,0.29,0.02,0.04,0,0.01,0,0,0,0,0.01,0,0.032,0.042,0.003,0.013,0.001,0.02,0.06,0.004,0.004,0,0.01,0,0.01,0,0,0,0,0.004,0,0,0,0,0,0.006,0,0,0,0,0,0.99,0.43,0.21,0.18,0.16,0.17,0.67,0.02,0,0.02,0.01,0,0.02,0.01,0.01,0.03,0.17,0.11,0.16,0.18,0.21,0.15,0.17,0.13,0.19,0.11,0.074,0,0,0,0,0.007,0,0.007,0,0.013,0.013,0.007,0.02,0,0.26,0.15,0.14,0.12,0.11,0.006,0.034,0.011,0.05,0,0.27,0.17,0.15,0.4,0.37,0.36,0,0.08,0.08,0.034,0.13,0.003,0.003,0,0,0.003,0.01,0.04,0,0,0.32,0.14,0,0,0.008,0,0,0,0.011,0,0.32,0.046,0.25,0.17,0.13,0.14,0.004,0.023,0.008,0.008,0.015,0,0,0,0.011,0.011,0.004,0.004,0.14,0.14,0.11,0.2,0.11,0.11,0,0,0,0.007,0.007,0,0,0,0.007,0.007,0,0.007,0,0.43,0.24,0.19,0.14,0.24,0.043,0,0.007,0.003,0,0.023,0.01,0,0.21,0.2,0,0,0.017,0.012,0.003,0.003,0.22,0.21,0.17,0.11,0.17,0.13,0.16,0.12,0.13,0,0.019,0,0,0,0.05,0,0.005,0.014,0.08,0,0.26,0.12,0.19,0.13,0.12,0.12,0.18,0.02,0,0,0,0,0.018,0,0,0,0,0.012,0,0,0.32,0.21,0.006,0.006,0.006,0.006,0.53,0.3,0.24,0.21,0.18,0.08,0.007,0.022,0.32,0.18,0.15,0.051,0.15,0.11,0.029,0.12,0.08,0.059,0.088,0.074,0.022,0.022,0.007,0.007,0,0,0,0.007,0,0.029,0.022,0.015,0.007,0,0.007,0,0,0.007,0,0,0,0,0.007,0.007,0,0.03,0.01,0,0.14,0.12,0.11,0.25,0.15,0.003,0,0.014,0,0.21,0.18,0.13,0.002,0.01,0.003,0.01,0.002,0,0.27,0.4,0.18,0.17,0.15,0.16,0.02,0.01,0.01,0.01,0,0.04,0.01,0.01,0.01,0.01,0,0.01,0.01,0,0.01,0.34,0.33,0.3,0.21,0.15,0.27,0.32,0.26,0.07,0.01,0.01,0.02,0.04,0.01,0,0.01,0,0.01,0,0,0,0,0,0,0.34,0.17,0.15,0.1,0.31,0.32,0.004,0,0.011,0,0,0.008,0,0,0,0,0,0,0.003,0,0,0.003,0.003,0,0,0.003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003,0,0.22,0.15,0.06,0.1,0.09,0.08,0.07,0.06,0.06,0.05,0.03,0.03,0.01,0.01,0.01,0.01,0.01,0.06,0.01,0,0,0.01,0.01,0.01,0.01,0.01,0,0,0,0,0,0.01,0.01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.42,0.42,0.41,0.29,0.26,0.25,0.2,0.19,0.02,0.05,0.02,0.3,0.02,0.02,0.15,0.06,0.04,0.01,0,0,0.02,0.41,0.309,0.244,0.235,0.152,0.152,0.138,0.124,0.101,0.092,0.074,0.046,0.088,0.023,0.074,0.005,0.005,0.051,0.014,0.051,0.005,0,0.018,0.005,0.009,0.023,0.44,0.38,0.31,0.24,0.24,0.22,0.18,0.17,0.17,0.16,0.14,0.12,0.09,0.08,0.07,0.07,0.06,0.05,0.05,0.02,0.01,0.02,0.01,0.01,0.01,0.01,0.06,0.04,0.03,0.05,0,0.01,0.05,0,0.01,0,0,0,0,0.01,0.01,0,0.02,0,0,0,0,0,0,0.01,0.01,0,0,0,0,0.01,0,0,0,0,0,0,0],"text":["Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TALAPRO-2, Fatigue/Asthenia, Grade 4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />info: TALAPRO-2, Nausea, Grade 4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: TALAPRO-2, Decreased appetite, Grade 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: TALAPRO-2, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TALAPRO-2, Fractures, Grade 4","Control: 0.015<br />Experimental: 0.015<br />greater: control<br />info: TALAPRO-2, Dizziness, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TALAPRO-2, Dizziness, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TALAPRO-2, Dysgeusia, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TALAPRO-2, Dysgeusia, Grade 4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: PROpel, Nausea, Grade 3-4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />info: PROpel, Abdominal pain, Grade 3-4","Control: 0.600<br />Experimental: 0.600<br />greater: control<br />info: POLARIX, Neutropenia, All grades","Control: 0.330<br />Experimental: 0.320<br />greater: control<br />info: POLARIX, Thrombocytopenia, All grades","Control: 0.270<br />Experimental: 0.250<br />greater: control<br />info: POLARIX, Alanine aminotransferase increased, All grades","Control: 0.540<br />Experimental: 0.530<br />greater: control<br />info: POLARIX, Peripheral neuropathy, All grades","Control: 0.160<br />Experimental: 0.140<br />greater: control<br />info: POLARIX, Altered taste, All grades","Control: 0.140<br />Experimental: 0.130<br />greater: control<br />info: POLARIX, Headache, All grades","Control: 0.290<br />Experimental: 0.290<br />greater: control<br />info: POLARIX, Constipation, All grades","Control: 0.380<br />Experimental: 0.370<br />greater: control<br />info: POLARIX, Fatigue/Asthenia, All grades","Control: 0.160<br />Experimental: 0.130<br />greater: control<br />info: POLARIX, Infusion-related reaction, All grades","Control: 0.240<br />Experimental: 0.240<br />greater: control<br />info: POLARIX, Alopecia, All grades","Control: 0.210<br />Experimental: 0.190<br />greater: control<br />info: POLARIX, Musculoskeletal pain, All grades","Control: 0.440<br />Experimental: 0.440<br />greater: control<br />info: POLARIX, Lymphopenia, Grade 3-4","Control: 0.420<br />Experimental: 0.390<br />greater: control<br />info: POLARIX, Neutropenia, Grade 3-4","Control: 0.009<br />Experimental: 0.007<br />greater: control<br />info: POLARIX, Increased blood creatinine, Grade 3-4","Control: 0.011<br />Experimental: 0.007<br />greater: control<br />info: POLARIX, Aspartate aminotransferase increased, Grade 3-4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />info: POLARIX, Alkaline phosphatase increased, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: POLARIX, Altered taste, Grade 3-4","Control: 0.009<br />Experimental: 0.002<br />greater: control<br />info: POLARIX, Headache, Grade 3-4","Control: 0.016<br />Experimental: 0.011<br />greater: control<br />info: POLARIX, Abdominal pain, Grade 3-4","Control: 0.030<br />Experimental: 0.025<br />greater: control<br />info: POLARIX, Fatigue/Asthenia, Grade 3-4","Control: 0.016<br />Experimental: 0.011<br />greater: control<br />info: POLARIX, Infusion-related reaction, Grade 3-4","Control: 0.002<br />Experimental: 0.000<br />greater: control<br />info: POLARIX, Alopecia, Grade 3-4","Control: 0.018<br />Experimental: 0.005<br />greater: control<br />info: POLARIX, Musculoskeletal pain, Grade 3-4","Control: 0.005<br />Experimental: 0.005<br />greater: control<br />info: POLARIX, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: POLARIX, Cough, Grade 3-4","Control: 0.009<br />Experimental: 0.009<br />greater: control<br />info: POLARIX, Dyspnea, Grade 3-4","Control: 0.210<br />Experimental: 0.210<br />greater: control<br />info: TROPiCS-02, Decreased appetite, All grades","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />info: TROPiCS-02, Nausea, Grade 3-4","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />info: TROPiCS-02, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TROPiCS-02, Abdominal Pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TROPiCS-02, Dyspepsia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TROPiCS-02, Arthralgia, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: TROPiCS-02, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TROPiCS-02, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TROPiCS-02, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TROPiCS-02, Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TROPiCS-02, Pruritus, Grade 3-4","Control: 0.270<br />Experimental: 0.260<br />greater: control<br />info: EMERALD, Fatigue/Asthenia, All grades","Control: 0.120<br />Experimental: 0.120<br />greater: control<br />info: EMERALD, Headache, All grades","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: EMERALD, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: EMERALD, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: EMERALD, Dyspepsia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: EMERALD, Hot flush , Grade 3-4","Control: 0.300<br />Experimental: 0.240<br />greater: control<br />info: SEQUOIA, Rash, All grades","Control: 0.180<br />Experimental: 0.100<br />greater: control<br />info: SEQUOIA, Constipation, All grades","Control: 0.330<br />Experimental: 0.100<br />greater: control<br />info: SEQUOIA, Nausea, All grades","Control: 0.210<br />Experimental: 0.140<br />greater: control<br />info: SEQUOIA, Fatigue/Asthenia, All grades","Control: 0.050<br />Experimental: 0.013<br />greater: control<br />info: SEQUOIA, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: SEQUOIA, Bruising, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: SEQUOIA, Cough, Grade 3-4","Control: 0.009<br />Experimental: 0.008<br />greater: control<br />info: SEQUOIA, Diarrhea, Grade 3-4","Control: 0.013<br />Experimental: 0.000<br />greater: control<br />info: SEQUOIA, Nausea, Grade 3-4","Control: 0.018<br />Experimental: 0.013<br />greater: control<br />info: SEQUOIA, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: SEQUOIA, Headache, Grade 3-4","Control: 0.190<br />Experimental: 0.180<br />greater: control<br />info: ALPINE, Pneumonia, All grades","Control: 0.280<br />Experimental: 0.260<br />greater: control<br />info: ALPINE, Musculoskeletal pain, All grades","Control: 0.260<br />Experimental: 0.240<br />greater: control<br />info: ALPINE, Hemorrhage, All grades","Control: 0.200<br />Experimental: 0.190<br />greater: control<br />info: ALPINE, Hypertension, All grades","Control: 0.210<br />Experimental: 0.200<br />greater: control<br />info: ALPINE, Rash, All grades","Control: 0.220<br />Experimental: 0.140<br />greater: control<br />info: ALPINE, Diarrhea, All grades","Control: 0.140<br />Experimental: 0.130<br />greater: control<br />info: ALPINE, Fatigue/Asthenia, All grades","Control: 0.110<br />Experimental: 0.110<br />greater: control<br />info: ALPINE, Cough, All grades","Control: 0.012<br />Experimental: 0.012<br />greater: control<br />info: ALPINE, Upper respiratory tract infection, Grade 3-4","Control: 0.110<br />Experimental: 0.090<br />greater: control<br />info: ALPINE, Pneumonia, Grade 3-4","Control: 0.006<br />Experimental: 0.006<br />greater: control<br />info: ALPINE, Musculoskeletal pain, Grade 3-4","Control: 0.037<br />Experimental: 0.025<br />greater: control<br />info: ALPINE, Hemorrhage, Grade 3-4","Control: 0.130<br />Experimental: 0.130<br />greater: control<br />info: ALPINE, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALPINE, Bruising, Grade 3-4","Control: 0.009<br />Experimental: 0.009<br />greater: control<br />info: ALPINE, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALPINE, Dizziness, Grade 3-4","Control: 0.240<br />Experimental: 0.190<br />greater: control<br />info: POSEIDON, Constipation, All grades","Control: 0.100<br />Experimental: 0.100<br />greater: control<br />info: POSEIDON, Edema, All grades","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />info: POSEIDON, Cough/Productive Cough, Grade 3-4","Control: 0.021<br />Experimental: 0.018<br />greater: control<br />info: POSEIDON, Nausea, Grade 3-4","Control: 0.015<br />Experimental: 0.015<br />greater: control<br />info: POSEIDON, Diarrhea, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />info: POSEIDON, Constipation, Grade 3-4","Control: 0.015<br />Experimental: 0.012<br />greater: control<br />info: POSEIDON, Vomiting, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />info: POSEIDON, Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: POSEIDON, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: POSEIDON, Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: POSEIDON, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: POSEIDON, Pyrexia, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />info: POSEIDON, Edema, Grade 3-4","Control: 0.015<br />Experimental: 0.006<br />greater: control<br />info: POSEIDON, Musculoskeletal Pain, Grade 3-4","Control: 0.009<br />Experimental: 0.006<br />greater: control<br />info: POSEIDON, Upper respiratory tract infection, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />info: POSEIDON, Headache, Grade 3-4","Control: 0.430<br />Experimental: 0.370<br />greater: control<br />info: Study 16113, Alopecia, All grades","Control: 0.360<br />Experimental: 0.300<br />greater: control<br />info: Study 16113, Musculoskeletal pain, All grades","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study 16113, Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study 16113, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study 16113, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study 16113, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study 16113, Insomnia, Grade 3-4","Control: 0.450<br />Experimental: 0.270<br />greater: control<br />info: HIMALAYA, Diarrhea, All grades","Control: 0.240<br />Experimental: 0.200<br />greater: control<br />info: HIMALAYA, Abdominal pain, All grades","Control: 0.140<br />Experimental: 0.120<br />greater: control<br />info: HIMALAYA, Nausea, All grades","Control: 0.570<br />Experimental: 0.320<br />greater: control<br />info: HIMALAYA, Rash, All grades","Control: 0.180<br />Experimental: 0.170<br />greater: control<br />info: HIMALAYA, Decreased appetite, All grades","Control: 0.300<br />Experimental: 0.260<br />greater: control<br />info: HIMALAYA, Fatigue/Asthenia, All grades","Control: 0.040<br />Experimental: 0.018<br />greater: control<br />info: HIMALAYA, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HIMALAYA, Nausea, Grade 3-4","Control: 0.120<br />Experimental: 0.028<br />greater: control<br />info: HIMALAYA, Rash, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />info: HIMALAYA, Pruritus, Grade 3-4","Control: 0.060<br />Experimental: 0.039<br />greater: control<br />info: HIMALAYA, Fatigue/Asthenia, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: HIMALAYA, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HIMALAYA, Hypothyroidism, Grade 3-4","Control: 0.430<br />Experimental: 0.420<br />greater: control<br />info: TOPAZ-1, Fatigue/Asthenia, All grades","Control: 0.180<br />Experimental: 0.180<br />greater: control<br />info: TOPAZ-1, Vomiting, All grades","Control: 0.110<br />Experimental: 0.100<br />greater: control<br />info: TOPAZ-1, Insomnia, All grades","Control: 0.060<br />Experimental: 0.060<br />greater: control<br />info: TOPAZ-1, Fatigue/Asthenia, Grade 3-4","Control: 0.018<br />Experimental: 0.015<br />greater: control<br />info: TOPAZ-1, Nausea, Grade 3-4","Control: 0.029<br />Experimental: 0.006<br />greater: control<br />info: TOPAZ-1, Abdominal pain, Grade 3-4","Control: 0.020<br />Experimental: 0.015<br />greater: control<br />info: TOPAZ-1, Vomiting, Grade 3-4","Control: 0.018<br />Experimental: 0.012<br />greater: control<br />info: TOPAZ-1, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TOPAZ-1, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TOPAZ-1, Insomnia, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: ARASENS, Constipation, Grade 3-4","Control: 0.006<br />Experimental: 0.002<br />greater: control<br />info: ARASENS, Decreased Appetite, Grade 3-4","Control: 0.014<br />Experimental: 0.014<br />greater: control<br />info: ARASENS, Hemorrhage, Grade 3-4","Control: 0.130<br />Experimental: 0.120<br />greater: control<br />info: DESTINY-Breast04, Pyrexia, All grades","Control: 0.230<br />Experimental: 0.130<br />greater: control<br />info: DESTINY-Breast04, Rash, All grades","Control: 0.290<br />Experimental: 0.130<br />greater: control<br />info: DESTINY-Breast04, Peripheral neuropathy, All grades","Control: 0.017<br />Experimental: 0.013<br />greater: control<br />info: DESTINY-Breast04, Diarrhea, Grade 3-4","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />info: DESTINY-Breast04, Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Breast04, Alopecia, Grade 3-4","Control: 0.047<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Breast04, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Breast04, Hemorrhage, Grade 3-4","Control: 0.050<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Breast04, Peripheral neuropathy, Grade 3-4","Control: 0.380<br />Experimental: 0.330<br />greater: control<br />info: TRANSFORM, Thrombocytopenia, Grade 1–2","Control: 0.570<br />Experimental: 0.530<br />greater: control<br />info: TRANSFORM, Nausea, Grade 1–2","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Prolonged cytopeniat, Grade 1–2","Control: 0.410<br />Experimental: 0.250<br />greater: control<br />info: TRANSFORM, Diarrhea, Grade 1–2","Control: 0.290<br />Experimental: 0.230<br />greater: control<br />info: TRANSFORM, Decreased appetite, Grade 1–2","Control: 0.210<br />Experimental: 0.170<br />greater: control<br />info: TRANSFORM, Hypokalemia, Grade 1–2","Control: 0.230<br />Experimental: 0.200<br />greater: control<br />info: TRANSFORM, Vomiting, Grade 1–2","Control: 0.160<br />Experimental: 0.150<br />greater: control<br />info: TRANSFORM, Back pain, Grade 1–2","Control: 0.180<br />Experimental: 0.160<br />greater: control<br />info: TRANSFORM, Peripheral edema, Grade 1–2","Control: 0.210<br />Experimental: 0.140<br />greater: control<br />info: TRANSFORM, Hypomagnesaemia, Grade 1–2","Control: 0.120<br />Experimental: 0.120<br />greater: control<br />info: TRANSFORM, Abdominal pain, Grade 1–2","Control: 0.110<br />Experimental: 0.100<br />greater: control<br />info: TRANSFORM, Tachycardia, Grade 1–2","Control: 0.120<br />Experimental: 0.080<br />greater: control<br />info: TRANSFORM, Peripheral sensory neuropathy, Grade 1–2","Control: 0.110<br />Experimental: 0.070<br />greater: control<br />info: TRANSFORM, Hypophosphatemia, Grade 1–2","Control: 0.110<br />Experimental: 0.050<br />greater: control<br />info: TRANSFORM, Dyspepsia, Grade 1–2","Control: 0.100<br />Experimental: 0.050<br />greater: control<br />info: TRANSFORM, Stomatitis, Grade 1–2","Control: 0.120<br />Experimental: 0.040<br />greater: control<br />info: TRANSFORM, Mucosal inflammation, Grade 1–2","Control: 0.490<br />Experimental: 0.490<br />greater: control<br />info: TRANSFORM, Anemia, Grade ≥ 3","Control: 0.640<br />Experimental: 0.490<br />greater: control<br />info: TRANSFORM, Thrombocytopenia, Grade ≥ 3","Control: 0.030<br />Experimental: 0.030<br />greater: control<br />info: TRANSFORM, Nausea, Grade ≥ 3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Fatigue/Asthenia, Grade ≥ 3","Control: 0.030<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Diarrhea, Grade ≥ 3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />info: TRANSFORM, Decreased appetite, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Pyrexia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Dizziness, Grade ≥ 3","Control: 0.040<br />Experimental: 0.040<br />greater: control<br />info: TRANSFORM, Hypokalemia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Insomnia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />info: TRANSFORM, Vomiting, Grade ≥ 3","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />info: TRANSFORM, Back pain, Grade ≥ 3","Control: 0.210<br />Experimental: 0.120<br />greater: control<br />info: TRANSFORM, Febrile neutropenia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Hypomagnesaemia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Arthralgia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Cough, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: TRANSFORM, Dyspnea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Bone pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Tachycardia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Peripheral sensory neuropathy, Grade ≥ 3","Control: 0.070<br />Experimental: 0.030<br />greater: control<br />info: TRANSFORM, Hypophosphatemia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Dyspepsia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Stomatitis, Grade ≥ 3","Control: 0.030<br />Experimental: 0.000<br />greater: control<br />info: TRANSFORM, Mucosal inflammation, Grade ≥ 3","Control: 0.040<br />Experimental: 0.030<br />greater: control<br />info: AG120-C-009, Nausea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: AG120-C-009, Vomiting, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: AG120-C-009, Leukocytosis, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: AG120-C-009, Hematoma, Grade ≥ 3","Control: 0.050<br />Experimental: 0.040<br />greater: control<br />info: AG120-C-009, Hypertension, Grade ≥ 3","Control: 0.050<br />Experimental: 0.030<br />greater: control<br />info: AG120-C-009, Dyspnea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: AG120-C-009, Headache, Grade ≥ 3","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: OlympiA, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: OlympiA, Dysgeusia, Grade 3-4","Control: 0.001<br />Experimental: 0.001<br />greater: control<br />info: OlympiA, Dizziness, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-716, Hypothyroidism, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-716, Diarrhea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-716, Nausea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-716, Increased alanine aminotransferase, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-716, Aspartate aminotransferase increased, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-716, Rash, Grade ≥ 3","Control: 0.130<br />Experimental: 0.110<br />greater: control<br />info: KEYNOTE-564, Abdominal pain, All grades","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-564, Cough, Grade 3-4","Control: 0.580<br />Experimental: 0.560<br />greater: control<br />info: KEYNOTE-826, Alopecia, All grades","Control: 0.440<br />Experimental: 0.400<br />greater: control<br />info: KEYNOTE-826, Nausea, All grades","Control: 0.330<br />Experimental: 0.280<br />greater: control<br />info: KEYNOTE-826, Constipation, All grades","Control: 0.270<br />Experimental: 0.260<br />greater: control<br />info: KEYNOTE-826, Vomiting, All grades","Control: 0.260<br />Experimental: 0.240<br />greater: control<br />info: KEYNOTE-826, Urinary tract infection, All grades","Control: 0.060<br />Experimental: 0.042<br />greater: control<br />info: KEYNOTE-826, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-826, Alopecia, Grade 3-4","Control: 0.026<br />Experimental: 0.020<br />greater: control<br />info: KEYNOTE-826, Diarrhea, Grade 3-4","Control: 0.010<br />Experimental: 0.003<br />greater: control<br />info: KEYNOTE-826, Constipation, Grade 3-4","Control: 0.013<br />Experimental: 0.007<br />greater: control<br />info: KEYNOTE-826, Arthralgia, Grade 3-4","Control: 0.110<br />Experimental: 0.090<br />greater: control<br />info: KEYNOTE-826, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: COSMIC-311, Dysgeusia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: COSMIC-311, Dysphonia, Grade 3-4","Control: 0.050<br />Experimental: 0.030<br />greater: control<br />info: Study AG120-C-005, Fatigue/Asthenia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />info: Study AG120-C-005, Nausea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study AG120-C-005, Diarrhea, Grade ≥ 3","Control: 0.030<br />Experimental: 0.020<br />greater: control<br />info: Study AG120-C-005, Abdominal pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study AG120-C-005, Cough, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study AG120-C-005, Headache, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study AG120-C-005, Neuropathy, Grade ≥ 3","Control: 0.100<br />Experimental: 0.100<br />greater: control<br />info: CHECKMATE-274, Pyrexia, All grades","Control: 0.150<br />Experimental: 0.150<br />greater: control<br />info: CHECKMATE-274, Abdominal pain, All grades","Control: 0.150<br />Experimental: 0.130<br />greater: control<br />info: CHECKMATE-274, Constipation, All grades","Control: 0.130<br />Experimental: 0.110<br />greater: control<br />info: CHECKMATE-274, Arthralgia, All grades","Control: 0.230<br />Experimental: 0.220<br />greater: control<br />info: CHECKMATE-274, Urinary tract infection, All grades","Control: 0.160<br />Experimental: 0.160<br />greater: control<br />info: CHECKMATE-274, Upper respiratory tract infection, All grades","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-274, Pruritus, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-274, Pyrexia, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-274, Constipation, Grade 3-4","Control: 0.009<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-274, Musculoskeletal pain, Grade 3-4","Control: 0.090<br />Experimental: 0.060<br />greater: control<br />info: CHECKMATE-274, Urinary tract infection, Grade 3-4","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-274, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-274, Hyperthyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-274, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-274, Cough, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-274, Dyspnea, Grade 3-4","Control: 0.420<br />Experimental: 0.410<br />greater: control<br />info: KEYNOTE-522, Peripheral neuropathy, All grades","Control: 0.310<br />Experimental: 0.290<br />greater: control<br />info: KEYNOTE-522, Arthralgia, All grades","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-522, Constipation, Grade 3-4","Control: 0.008<br />Experimental: 0.005<br />greater: control<br />info: KEYNOTE-522, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-522, Alopecia, Grade 3-4","Control: 0.010<br />Experimental: 0.005<br />greater: control<br />info: KEYNOTE-522, Headache, Grade 3-4","Control: 0.290<br />Experimental: 0.290<br />greater: control<br />info: CHECKMATE-577, Diarrhea, All grades","Control: 0.200<br />Experimental: 0.170<br />greater: control<br />info: CHECKMATE-577, Abdominal Pain, All grades","Control: 0.160<br />Experimental: 0.150<br />greater: control<br />info: CHECKMATE-577, Vomiting, All grades","Control: 0.170<br />Experimental: 0.130<br />greater: control<br />info: CHECKMATE-577, Dysphagia, All grades","Control: 0.160<br />Experimental: 0.120<br />greater: control<br />info: CHECKMATE-577, Dyspepsia, All grades","Control: 0.120<br />Experimental: 0.110<br />greater: control<br />info: CHECKMATE-577, Constipation, All grades","Control: 0.210<br />Experimental: 0.200<br />greater: control<br />info: CHECKMATE-577, Cough, All grades","Control: 0.120<br />Experimental: 0.120<br />greater: control<br />info: CHECKMATE-577, Dyspnea, All grades","Control: 0.015<br />Experimental: 0.008<br />greater: control<br />info: CHECKMATE-577, Abdominal Pain, Grade 3-4","Control: 0.012<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-577, Vomiting, Grade 3-4","Control: 0.035<br />Experimental: 0.008<br />greater: control<br />info: CHECKMATE-577, Dysphagia, Grade 3-4","Control: 0.004<br />Experimental: 0.002<br />greater: control<br />info: CHECKMATE-577, Dyspepsia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-577, Constipation, Grade 3-4","Control: 0.015<br />Experimental: 0.013<br />greater: control<br />info: CHECKMATE-577, Fatigue/Asthenia, Grade 3-4","Control: 0.004<br />Experimental: 0.002<br />greater: control<br />info: CHECKMATE-577, Cough, Grade 3-4","Control: 0.008<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-577, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-577, Hypothyroidism, Grade 3-4","Control: 0.400<br />Experimental: 0.400<br />greater: control<br />info: KEYNOTE-590, Constipation, All grades","Control: 0.240<br />Experimental: 0.240<br />greater: control<br />info: KEYNOTE-590, Weight decreased , All grades","Control: 0.070<br />Experimental: 0.070<br />greater: control<br />info: KEYNOTE-590, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-590, Constipation, Grade 3-4","Control: 0.050<br />Experimental: 0.041<br />greater: control<br />info: KEYNOTE-590, Decreased appetite, Grade 3-4","Control: 0.050<br />Experimental: 0.030<br />greater: control<br />info: KEYNOTE-590, Weight decreased , Grade 3-4","Control: 0.190<br />Experimental: 0.190<br />greater: control<br />info: ADAURA, Cough, All grades","Control: 0.250<br />Experimental: 0.180<br />greater: control<br />info: ADAURA, Musculoskeletal Pain, All grades","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ADAURA, Pruritus, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ADAURA, Cough, Grade ≥ 3","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: ADAURA, Musculoskeletal Pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ADAURA, Nasopharyngitis, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ADAURA, Dizziness, Grade ≥ 3","Control: 0.490<br />Experimental: 0.480<br />greater: control<br />info: KEYNOTE-355, Fatigue/Asthenia, All grades","Control: 0.470<br />Experimental: 0.440<br />greater: control<br />info: KEYNOTE-355, Nausea, All grades","Control: 0.350<br />Experimental: 0.340<br />greater: control<br />info: KEYNOTE-355, Alopecia, All grades","Control: 0.230<br />Experimental: 0.200<br />greater: control<br />info: KEYNOTE-355, Headache, All grades","Control: 0.018<br />Experimental: 0.017<br />greater: control<br />info: KEYNOTE-355, Nausea, Grade 3-4","Control: 0.018<br />Experimental: 0.018<br />greater: control<br />info: KEYNOTE-355, Diarrhea, Grade 3-4","Control: 0.032<br />Experimental: 0.027<br />greater: control<br />info: KEYNOTE-355, Vomiting, Grade 3-4","Control: 0.011<br />Experimental: 0.008<br />greater: control<br />info: KEYNOTE-355, Alopecia, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-355, Cough, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />info: KEYNOTE-355, Headache, Grade 3-4","Control: 0.060<br />Experimental: 0.060<br />greater: control<br />info: VIALE-A , Urinary tract infection, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: VIALE-A , Dizziness, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: QUAZAR, Arthralgia, TYPO","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: QUAZAR, Decreased appetite, TYPO","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: QUAZAR, Dizziness, TYPO","Control: 0.250<br />Experimental: 0.210<br />greater: control<br />info: IMspire150, Photosensitivity reaction, All grades","Control: 0.320<br />Experimental: 0.300<br />greater: control<br />info: IMspire150, Nausea, All grades","Control: 0.180<br />Experimental: 0.170<br />greater: control<br />info: IMspire150, Hypertension, All grades","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: IMspire150, Pruritus, Grade 3-4","Control: 0.032<br />Experimental: 0.010<br />greater: control<br />info: IMspire150, Photosensitivity reaction, Grade 3-4","Control: 0.021<br />Experimental: 0.017<br />greater: control<br />info: IMspire150, Pyrexia, Grade 3-4","Control: 0.025<br />Experimental: 0.010<br />greater: control<br />info: IMspire150, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMspire150, Hypothyroidism, Grade 3-4","Control: 0.710<br />Experimental: 0.700<br />greater: control<br />info: RELAY, Diarrhea, All grades","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: RELAY, Gastrointestinal hemorrhage, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: RELAY, Gingival bleeding, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: RELAY, Alopecia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: RELAY, Epistaxis, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: RELAY, Pulmonary hemorrhage, Grade ≥ 3","Control: 0.140<br />Experimental: 0.130<br />greater: control<br />info: INVICTUS , Asthenia, Grades 1-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Dry skin, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Pruritus, Grade 3-4","Control: 0.047<br />Experimental: 0.012<br />greater: control<br />info: INVICTUS , Asthenia, Grade 3-4","Control: 0.023<br />Experimental: 0.012<br />greater: control<br />info: INVICTUS , Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Muscle spasms, Grade 3-4","Control: 0.023<br />Experimental: 0.012<br />greater: control<br />info: INVICTUS , Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: INVICTUS , Dyspnea, Grade 3-4","Control: 0.019<br />Experimental: 0.017<br />greater: control<br />info: PAOLA-1, Vomiting, TYPO","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: PRIMA, Nausea, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: PRIMA, Vomiting, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />info: PRIMA, Dizziness, Grade 3-4","Control: 0.010<br />Experimental: 0.004<br />greater: control<br />info: PRIMA, Dyspnea, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />info: PRIMA, Cough, Grade 3-4","Control: 0.036<br />Experimental: 0.030<br />greater: control<br />info: HER2CLIMB, Vomiting, Grade 3","Control: 0.005<br />Experimental: 0.005<br />greater: control<br />info: HER2CLIMB, Arthralgia, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Increased blood creatinine, Grade 3","Control: 0.010<br />Experimental: 0.005<br />greater: control<br />info: HER2CLIMB, Peripheral neuropathy, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Epistaxis, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Vomiting, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Stomatitis, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Palmar-plantar erythrodysesthesia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Rash, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Anemia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Arthralgia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Increased blood creatinine, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Weight decreased , Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Peripheral neuropathy, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HER2CLIMB, Epistaxis, Grade 4","Control: 0.110<br />Experimental: 0.100<br />greater: control<br />info: CHECKMATE-648, Alopecia, All grades","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: CHECKMATE-648, Constipation, Grade 3-4","Control: 0.030<br />Experimental: 0.023<br />greater: control<br />info: CHECKMATE-648, Vomiting, Grade 3-4","Control: 0.049<br />Experimental: 0.035<br />greater: control<br />info: CHECKMATE-648, Fatigue/Asthenia, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-648, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Edema, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Insomnia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Alopecia, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-648, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Hypothyroidism, Grade 3-4","Control: 0.010<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-648, Weight decreased , Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-648, Musculoskeletal pain, Grade 3-4","Control: 0.560<br />Experimental: 0.220<br />greater: control<br />info: CHECKMATE-648, Nausea, All grades","Control: 0.430<br />Experimental: 0.200<br />greater: control<br />info: CHECKMATE-648, Constipation, All grades","Control: 0.350<br />Experimental: 0.110<br />greater: control<br />info: CHECKMATE-648, Stomatitis, All grades","Control: 0.190<br />Experimental: 0.150<br />greater: control<br />info: CHECKMATE-648, Vomiting, All grades","Control: 0.120<br />Experimental: 0.120<br />greater: control<br />info: CHECKMATE-648, Dysphagia, All grades","Control: 0.110<br />Experimental: 0.100<br />greater: control<br />info: CHECKMATE-648, Abdominal pain, All grades","Control: 0.500<br />Experimental: 0.170<br />greater: control<br />info: CHECKMATE-648, Decreased appetite, All grades","Control: 0.410<br />Experimental: 0.280<br />greater: control<br />info: CHECKMATE-648, Fatigue/Asthenia, All grades","Control: 0.130<br />Experimental: 0.070<br />greater: control<br />info: CHECKMATE-648, Edema, All grades","Control: 0.130<br />Experimental: 0.028<br />greater: control<br />info: CHECKMATE-648, Peripheral neuropathy, All grades","Control: 0.100<br />Experimental: 0.080<br />greater: control<br />info: CHECKMATE-648, Insomnia, All grades","Control: 0.110<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Alopecia, All grades","Control: 0.130<br />Experimental: 0.130<br />greater: control<br />info: CHECKMATE-648, Cough, All grades","Control: 0.026<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-648, Nausea, Grade 3-4","Control: 0.010<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-648, Constipation, Grade 3-4","Control: 0.030<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-648, Stomatitis, Grade 3-4","Control: 0.020<br />Experimental: 0.019<br />greater: control<br />info: CHECKMATE-648, Diarrhea, Grade 3-4","Control: 0.030<br />Experimental: 0.016<br />greater: control<br />info: CHECKMATE-648, Vomiting, Grade 3-4","Control: 0.060<br />Experimental: 0.040<br />greater: control<br />info: CHECKMATE-648, Decreased appetite, Grade 3-4","Control: 0.049<br />Experimental: 0.025<br />greater: control<br />info: CHECKMATE-648, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Edema, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Peripheral neuropathy, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Insomnia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Alopecia, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-648, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-648, Hypothyroidism, Grade 3-4","Control: 0.160<br />Experimental: 0.110<br />greater: control<br />info: DESTINY-Breast03, Epistaxis, All grades","Control: 0.140<br />Experimental: 0.130<br />greater: control<br />info: DESTINY-Breast03, Peripheral neuropathy, All grades","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Breast03, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Breast03, Dyspepsia, Grade 3-4","Control: 0.011<br />Experimental: 0.008<br />greater: control<br />info: DESTINY-Breast03, Respiratory infection, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Breast03, Epistaxis, Grade 3-4","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />info: DESTINY-Breast03, Peripheral neuropathy, Grade 3-4","Control: 0.005<br />Experimental: 0.004<br />greater: control<br />info: VISION, Peripheral edema, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: VISION, Dry mouth, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: VISION, Dysgeusia, Grade 3-4","Control: 0.019<br />Experimental: 0.014<br />greater: control<br />info: RELATIVITY-047, Rash, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />info: RELATIVITY-047, Pruritus, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: RELATIVITY-047, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: RELATIVITY-047, Hypothyroidism, Grade 3-4","Control: 0.450<br />Experimental: 0.380<br />greater: control<br />info: CHECKMATE-816, Nausea, All grades","Control: 0.130<br />Experimental: 0.110<br />greater: control<br />info: CHECKMATE-816, Vomiting, All grades","Control: 0.230<br />Experimental: 0.200<br />greater: control<br />info: CHECKMATE-816, Decreased appetite, All grades","Control: 0.150<br />Experimental: 0.110<br />greater: control<br />info: CHECKMATE-816, Alopecia, All grades","Control: 0.011<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-816, Nausea, Grade 3-4","Control: 0.011<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-816, Constipation, Grade 3-4","Control: 0.006<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-816, Malaise, Grade 3-4","Control: 0.023<br />Experimental: 0.011<br />greater: control<br />info: CHECKMATE-816, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-816, Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-816, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMCgp100-202, Dry skin, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMCgp100-202, Erythema, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMCgp100-202, Edema, Grade 3-4","Control: 0.036<br />Experimental: 0.029<br />greater: control<br />info: IMCgp100-202, Abdominal pain, Grade 3-4","Control: 0.027<br />Experimental: 0.012<br />greater: control<br />info: IMCgp100-202, Diarrhea, Grade 3-4","Control: 0.009<br />Experimental: 0.004<br />greater: control<br />info: IMCgp100-202, Headache, Grade 3-4","Control: 0.300<br />Experimental: 0.170<br />greater: control<br />info: ASCEMBL, Rash, All grades","Control: 0.710<br />Experimental: 0.120<br />greater: control<br />info: ASCEMBL, Diarrhea, All grades","Control: 0.460<br />Experimental: 0.120<br />greater: control<br />info: ASCEMBL, Nausea, All grades","Control: 0.240<br />Experimental: 0.100<br />greater: control<br />info: ASCEMBL, Abdominal pain, All grades","Control: 0.013<br />Experimental: 0.006<br />greater: control<br />info: ASCEMBL, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASCEMBL, Arthralgia, Grade 3-4","Control: 0.013<br />Experimental: 0.006<br />greater: control<br />info: ASCEMBL, Fatigue/Asthenia, Grade 3-4","Control: 0.080<br />Experimental: 0.006<br />greater: control<br />info: ASCEMBL, Rash, Grade 3-4","Control: 0.110<br />Experimental: 0.000<br />greater: control<br />info: ASCEMBL, Diarrhea, Grade 3-4","Control: 0.026<br />Experimental: 0.000<br />greater: control<br />info: ASCEMBL, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMpower010, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMpower010, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMpower010, Cough, Grade 3-4","Control: 0.001<br />Experimental: 0.001<br />greater: control<br />info: monarchE, Dizziness, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Alopecia, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Vomiting, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Stomatitis, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Fatigue/Asthenia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Headache, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Dizziness, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Rash, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: monarchE, Alopecia, Grade 4","Control: 0.120<br />Experimental: 0.100<br />greater: control<br />info: REACH-3, Edema, All grades","Control: 0.150<br />Experimental: 0.120<br />greater: control<br />info: REACH-3, Hemorrhage, All grades","Control: 0.130<br />Experimental: 0.120<br />greater: control<br />info: REACH-3, Nausea, All grades","Control: 0.130<br />Experimental: 0.100<br />greater: control<br />info: REACH-3, Diarrhea, All grades","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />info: REACH-3, Fatigue/Asthenia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: REACH-3, Edema, Grade ≥ 3","Control: 0.070<br />Experimental: 0.050<br />greater: control<br />info: REACH-3, Hypertension, Grade ≥ 3","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />info: REACH-3, Hemorrhage, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: REACH-3, Cough, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: REACH-3, Dyspnea, Grade ≥ 3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />info: REACH-3, Nausea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: REACH-3, Diarrhea, Grade ≥ 3","Control: 0.260<br />Experimental: 0.120<br />greater: control<br />info: ASPEN, Pneumonia, All grades","Control: 0.130<br />Experimental: 0.110<br />greater: control<br />info: ASPEN, Urinary tract infection, All grades","Control: 0.340<br />Experimental: 0.220<br />greater: control<br />info: ASPEN, Diarrhea, All grades","Control: 0.140<br />Experimental: 0.120<br />greater: control<br />info: ASPEN, Vomiting, All grades","Control: 0.200<br />Experimental: 0.120<br />greater: control<br />info: ASPEN, Edema peripheral, All grades","Control: 0.340<br />Experimental: 0.200<br />greater: control<br />info: ASPEN, Bruising, All grades","Control: 0.320<br />Experimental: 0.290<br />greater: control<br />info: ASPEN, Rash, All grades","Control: 0.280<br />Experimental: 0.100<br />greater: control<br />info: ASPEN, Muscle spasms, All grades","Control: 0.180<br />Experimental: 0.160<br />greater: control<br />info: ASPEN, Cough, All grades","Control: 0.430<br />Experimental: 0.420<br />greater: control<br />info: ASPEN, Hemorrhage, All grades","Control: 0.190<br />Experimental: 0.140<br />greater: control<br />info: ASPEN, Hypertension, All grades","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Upper respiratory tract infection, Grade 3-4","Control: 0.100<br />Experimental: 0.040<br />greater: control<br />info: ASPEN, Pneumonia, Grade 3-4","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Urinary tract infection, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Constipation, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Vomiting, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: ASPEN, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Edema peripheral, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Bruising, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Rash, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Muscle spasms, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: ASPEN, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASPEN, Dyspnea, Grade 3-4","Control: 0.090<br />Experimental: 0.040<br />greater: control<br />info: ASPEN, Hemorrhage, Grade 3-4","Control: 0.140<br />Experimental: 0.090<br />greater: control<br />info: ASPEN, Hypertension, Grade 3-4","Control: 0.430<br />Experimental: 0.430<br />greater: control<br />info: CLEAR, Stomatitis, All Grades","Control: 0.380<br />Experimental: 0.290<br />greater: control<br />info: CLEAR, Palmar-plantar erythrodysesthesia, All Grades","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />info: CLEAR, Stomatitis, Grade 3-4","Control: 0.040<br />Experimental: 0.040<br />greater: control<br />info: CLEAR, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CLEAR, Dysphonia, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: CLEAR, Headache, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />info: Study 309, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study 309, Dysphonia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: APOLLO, Pyrexia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: APOLLO, Edema peripheral, Grade ≥ 3","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />info: APOLLO, Upper respiratory tract infection, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: APOLLO, Cough, Grade ≥ 3","Control: 0.037<br />Experimental: 0.032<br />greater: control<br />info: CHECKMATE-649, Nausea, Grade 3-4","Control: 0.042<br />Experimental: 0.042<br />greater: control<br />info: CHECKMATE-649, Vomiting, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-649, Hypoalbuminemia, Grade 3-4","Control: 0.020<br />Experimental: 0.013<br />greater: control<br />info: CHECKMATE-649, Musculoskeletal pain, Grade 3-4","Control: 0.001<br />Experimental: 0.001<br />greater: control<br />info: CHECKMATE-649, Upper respiratory tract infection, Grade 3-4","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />info: ASCENT, Lymphopenia, Grade 3-4","Control: 0.090<br />Experimental: 0.060<br />greater: control<br />info: ASCENT, Fatigue/Asthenia, Grade 3-4","Control: 0.020<br />Experimental: 0.004<br />greater: control<br />info: ASCENT, Pyrexia, Grade 3-4","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />info: ASCENT, Urinary tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASCENT, Upper respiratory tract infection, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: ASCENT, Alanine aminotransferase increased, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASCENT, Hypomagnesaemia, Grade 3-4","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />info: ASCENT, Back pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASCENT, Dizziness, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASCENT, Insomnia, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />info: ASCENT, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASCENT, Alopecia, Grade 3-4","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />info: ASCENT, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ASCENT, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IKEMA, Cough, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IKEMA, Infusion-related reaction, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IKEMA, Upper respiratory tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IKEMA, Bronchitis, Grade 4","Control: 0.016<br />Experimental: 0.006<br />greater: control<br />info: IKEMA, Hypertension, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IKEMA, Dyspnea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IKEMA, Cough, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IKEMA, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IKEMA, Vomiting, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IKEMA, Fatigue/Asthenia, Grade 4","Control: 1.000<br />Experimental: 0.990<br />greater: control<br />info: TIVO-3, Any, All Grades","Control: 0.540<br />Experimental: 0.430<br />greater: control<br />info: TIVO-3, Diarrhea, All Grades","Control: 0.230<br />Experimental: 0.210<br />greater: control<br />info: TIVO-3, Stomatitis, All Grades","Control: 0.520<br />Experimental: 0.180<br />greater: control<br />info: TIVO-3, Rash, All Grades","Control: 0.410<br />Experimental: 0.160<br />greater: control<br />info: TIVO-3, Palmar-plantar erythrodysesthesia, All Grades","Control: 0.220<br />Experimental: 0.170<br />greater: control<br />info: TIVO-3, Weight decreased , All Grades","Control: 0.720<br />Experimental: 0.670<br />greater: control<br />info: TIVO-3, Any, Grade 3-4","Control: 0.110<br />Experimental: 0.020<br />greater: control<br />info: TIVO-3, Diarrhea, Grade 3-4","Control: 0.040<br />Experimental: 0.000<br />greater: control<br />info: TIVO-3, Nausea, Grade 3-4","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />info: TIVO-3, Stomatitis, Grade 3-4","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />info: TIVO-3, Vomiting, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: TIVO-3, Cough, Grade 3-4","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />info: TIVO-3, Back pain, Grade 3-4","Control: 0.150<br />Experimental: 0.010<br />greater: control<br />info: TIVO-3, Rash, Grade 3-4","Control: 0.170<br />Experimental: 0.010<br />greater: control<br />info: TIVO-3, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.030<br />Experimental: 0.030<br />greater: control<br />info: TIVO-3, Weight decreased , Grade 3-4","Control: 0.180<br />Experimental: 0.170<br />greater: control<br />info: Study B7461006, Headache, All Grades","Control: 0.140<br />Experimental: 0.110<br />greater: control<br />info: Study B7461006, Dizziness, All Grades","Control: 0.180<br />Experimental: 0.160<br />greater: control<br />info: Study B7461006, Cough, All Grades","Control: 0.390<br />Experimental: 0.180<br />greater: control<br />info: Study B7461006, Vision disorder, All Grades","Control: 0.520<br />Experimental: 0.210<br />greater: control<br />info: Study B7461006, Diarrhea, All Grades","Control: 0.520<br />Experimental: 0.150<br />greater: control<br />info: Study B7461006, Nausea, All Grades","Control: 0.300<br />Experimental: 0.170<br />greater: control<br />info: Study B7461006, Constipation, All Grades","Control: 0.390<br />Experimental: 0.130<br />greater: control<br />info: Study B7461006, Vomiting, All Grades","Control: 0.320<br />Experimental: 0.190<br />greater: control<br />info: Study B7461006, Fatigue/Asthenia, All Grades","Control: 0.140<br />Experimental: 0.110<br />greater: control<br />info: Study B7461006, Chest pain, All Grades","Control: 0.085<br />Experimental: 0.074<br />greater: control<br />info: Study B7461006, Pneumonia, All Grades","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: Study B7461006, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study B7461006, Dizziness, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study B7461006, Cough, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: Study B7461006, Vision disorder, Grade 3-4","Control: 0.021<br />Experimental: 0.007<br />greater: control<br />info: Study B7461006, Nausea, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: Study B7461006, Constipation, Grade 3-4","Control: 0.014<br />Experimental: 0.007<br />greater: control<br />info: Study B7461006, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study B7461006, Pain in extremity, Grade 3-4","Control: 0.028<br />Experimental: 0.013<br />greater: control<br />info: Study B7461006, Fatigue/Asthenia, Grade 3-4","Control: 0.014<br />Experimental: 0.013<br />greater: control<br />info: Study B7461006, Pyrexia, Grade 3-4","Control: 0.014<br />Experimental: 0.007<br />greater: control<br />info: Study B7461006, Upper respiratory tract infection, Grade 3-4","Control: 0.035<br />Experimental: 0.020<br />greater: control<br />info: Study B7461006, Pneumonia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: Study B7461006, Rash, Grade 3-4","Control: 0.270<br />Experimental: 0.260<br />greater: control<br />info: Study 1624, Musculoskeletal pain, All Grades","Control: 0.500<br />Experimental: 0.150<br />greater: control<br />info: Study 1624, Anemia, All Grades","Control: 0.260<br />Experimental: 0.140<br />greater: control<br />info: Study 1624, Fatigue/Asthenia, All Grades","Control: 0.180<br />Experimental: 0.120<br />greater: control<br />info: Study 1624, Decreased appetite, All Grades","Control: 0.120<br />Experimental: 0.110<br />greater: control<br />info: Study 1624, Pneumonia, All Grades","Control: 0.015<br />Experimental: 0.006<br />greater: control<br />info: Study 1624, Musculoskeletal pain, Grade 3-4","Control: 0.160<br />Experimental: 0.034<br />greater: control<br />info: Study 1624, Anemia, Grade 3-4","Control: 0.020<br />Experimental: 0.011<br />greater: control<br />info: Study 1624, Fatigue/Asthenia, Grade 3-4","Control: 0.050<br />Experimental: 0.050<br />greater: control<br />info: Study 1624, Pneumonia, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />info: Study 1624, Cough, Grade 3-4","Control: 0.310<br />Experimental: 0.270<br />greater: control<br />info: CHECKMATE-9ER, Nausea, Grades 1-4","Control: 0.210<br />Experimental: 0.170<br />greater: control<br />info: CHECKMATE-9ER, Vomiting, Grades 1-4","Control: 0.220<br />Experimental: 0.150<br />greater: control<br />info: CHECKMATE-9ER, Dyspepsia, Grades 1-4","Control: 0.410<br />Experimental: 0.400<br />greater: control<br />info: CHECKMATE-9ER, Palmar-plantar erythrodysesthesia, Grades 1-4","Control: 0.460<br />Experimental: 0.370<br />greater: control<br />info: CHECKMATE-9ER, Stomatitis, Grades 1-4","Control: 0.390<br />Experimental: 0.360<br />greater: control<br />info: CHECKMATE-9ER, Hypertension, Grades 1-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-9ER, Dyspepsia, Grade 3-4","Control: 0.080<br />Experimental: 0.080<br />greater: control<br />info: CHECKMATE-9ER, Fatigue/Asthenia, Grade 3-4","Control: 0.080<br />Experimental: 0.080<br />greater: control<br />info: CHECKMATE-9ER, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.044<br />Experimental: 0.034<br />greater: control<br />info: CHECKMATE-9ER, Stomatitis, Grade 3-4","Control: 0.140<br />Experimental: 0.130<br />greater: control<br />info: CHECKMATE-9ER, Hypertension, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-9ER, Hypothyroidism, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-9ER, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-9ER, Dysgeusia, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-9ER, Headache, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-9ER, Upper respiratory tract infection, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: ANDROMEDA, Upper respiratory tract infection, Grade 3-4","Control: 0.040<br />Experimental: 0.040<br />greater: control<br />info: ANDROMEDA, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ANDROMEDA, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ANDROMEDA, Injection site reactions, Grade 3-4","Control: 0.320<br />Experimental: 0.320<br />greater: control<br />info: DESTINY-Gastric01, Diarrhea, All Grades","Control: 0.150<br />Experimental: 0.140<br />greater: control<br />info: DESTINY-Gastric01, Abdominal pain, All Grades","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Gastric01, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Gastric01, Constipation, Grade 3-4","Control: 0.032<br />Experimental: 0.008<br />greater: control<br />info: DESTINY-Gastric01, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Gastric01, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Gastric01, Edema peripheral, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: DESTINY-Gastric01, Alopecia, Grade 3-4","Control: 0.016<br />Experimental: 0.011<br />greater: control<br />info: HERO, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: HERO, Constipation, Grade 3-4","Control: 0.470<br />Experimental: 0.320<br />greater: control<br />info: BOSTON, Peripheral neuropathy, All Grades","Control: 0.090<br />Experimental: 0.046<br />greater: control<br />info: BOSTON, Peripheral neuropathy, Grade 3-4","Control: 0.250<br />Experimental: 0.250<br />greater: control<br />info: SOPHIA, Diarrhea, All Grades","Control: 0.210<br />Experimental: 0.170<br />greater: control<br />info: SOPHIA, Abdominal pain, All Grades","Control: 0.150<br />Experimental: 0.130<br />greater: control<br />info: SOPHIA, Palmar-plantar erythrodysesthesia, All Grades","Control: 0.140<br />Experimental: 0.140<br />greater: control<br />info: SOPHIA, Decreased appetite, All Grades","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />info: SOPHIA, Pyrexia, Grade 3-4","Control: 0.023<br />Experimental: 0.023<br />greater: control<br />info: SOPHIA, Diarrhea, Grade 3-4","Control: 0.015<br />Experimental: 0.008<br />greater: control<br />info: SOPHIA, Vomiting, Grade 3-4","Control: 0.008<br />Experimental: 0.008<br />greater: control<br />info: SOPHIA, Constipation, Grade 3-4","Control: 0.015<br />Experimental: 0.015<br />greater: control<br />info: SOPHIA, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: SOPHIA, Alopecia, Grade 3-4","Control: 0.030<br />Experimental: 0.000<br />greater: control<br />info: SOPHIA, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: SOPHIA, Headache, Grade 3-4","Control: 0.023<br />Experimental: 0.011<br />greater: control<br />info: SOPHIA, Peripheral neuropathy, Grade 3-4","Control: 0.023<br />Experimental: 0.011<br />greater: control<br />info: SOPHIA, Dyspnea, Grade 3-4","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />info: SOPHIA, Decreased appetite, Grade 3-4","Control: 0.008<br />Experimental: 0.004<br />greater: control<br />info: SOPHIA, Arthralgia/Myalgia, Grade 3-4","Control: 0.240<br />Experimental: 0.140<br />greater: control<br />info: KEYNOTE-204, Nausea, All Grades","Control: 0.200<br />Experimental: 0.140<br />greater: control<br />info: KEYNOTE-204, Vomiting, All Grades","Control: 0.130<br />Experimental: 0.110<br />greater: control<br />info: KEYNOTE-204, Abdominal pain, All Grades","Control: 0.220<br />Experimental: 0.200<br />greater: control<br />info: KEYNOTE-204, Fatigue/Asthenia, All Grades","Control: 0.430<br />Experimental: 0.110<br />greater: control<br />info: KEYNOTE-204, Peripheral neuropathy, All Grades","Control: 0.110<br />Experimental: 0.110<br />greater: control<br />info: KEYNOTE-204, Headache, All Grades","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-204, Urinary tract infection, Grade 3-4","Control: 0.013<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-204, Musculoskeletal pain, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-204, Nausea, Grade 3-4","Control: 0.013<br />Experimental: 0.007<br />greater: control<br />info: KEYNOTE-204, Abdominal pain, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />info: KEYNOTE-204, pyrexia, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-204, Fatigue/Asthenia, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-204, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-204, Pruritus, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />info: KEYNOTE-204, Cough, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />info: KEYNOTE-204, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-204, Hypothyroidism, Grade 3-4","Control: 0.070<br />Experimental: 0.007<br />greater: control<br />info: KEYNOTE-204, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-204, Headache, Grade 3-4","Control: 0.450<br />Experimental: 0.430<br />greater: control<br />info: CHECKMATE-743, Fatigue/Asthenia, All Grades","Control: 0.430<br />Experimental: 0.240<br />greater: control<br />info: CHECKMATE-743, Nausea, All Grades","Control: 0.300<br />Experimental: 0.190<br />greater: control<br />info: CHECKMATE-743, Constipation, All Grades","Control: 0.180<br />Experimental: 0.140<br />greater: control<br />info: CHECKMATE-743, Vomiting, All Grades","Control: 0.250<br />Experimental: 0.240<br />greater: control<br />info: CHECKMATE-743, Decreased appetite, All Grades","Control: 0.060<br />Experimental: 0.043<br />greater: control<br />info: CHECKMATE-743, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-743, Edema, Grade 3-4","Control: 0.025<br />Experimental: 0.007<br />greater: control<br />info: CHECKMATE-743, Nausea, Grade 3-4","Control: 0.007<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-743, Constipation, Grade 3-4","Control: 0.021<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-743, Vomiting, Grade 3-4","Control: 0.032<br />Experimental: 0.023<br />greater: control<br />info: CHECKMATE-743, Dyspnea, Grade 3-4","Control: 0.014<br />Experimental: 0.010<br />greater: control<br />info: CHECKMATE-743, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-743, Hypothyroidism, Grade 3-4","Control: 0.210<br />Experimental: 0.210<br />greater: control<br />info: CANDOR, Cough, All Grades","Control: 0.220<br />Experimental: 0.200<br />greater: control<br />info: CANDOR, Dyspnea, All Grades","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: CANDOR, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CANDOR, Cough, Grade 3-4","Control: 0.017<br />Experimental: 0.017<br />greater: control<br />info: JAVELIN Bladder 100, Fatigue/Asthenia, Grade 3-4","Control: 0.026<br />Experimental: 0.012<br />greater: control<br />info: JAVELIN Bladder 100, Musculoskeletal pain, Grade 3-4","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />info: JAVELIN Bladder 100, Nausea, Grade 3-4","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />info: JAVELIN Bladder 100, Decreased appetite, Grade 3-4","Control: 0.280<br />Experimental: 0.220<br />greater: control<br />info: ATTRACTION-3, Rash, All Grades","Control: 0.350<br />Experimental: 0.210<br />greater: control<br />info: ATTRACTION-3, Decreased appetite, All Grades","Control: 0.190<br />Experimental: 0.170<br />greater: control<br />info: ATTRACTION-3, Constipation, All Grades","Control: 0.200<br />Experimental: 0.110<br />greater: control<br />info: ATTRACTION-3, Nausea, All Grades","Control: 0.260<br />Experimental: 0.170<br />greater: control<br />info: ATTRACTION-3, Musculoskeletal pain, All Grades","Control: 0.190<br />Experimental: 0.130<br />greater: control<br />info: ATTRACTION-3, Pneumonia, All Grades","Control: 0.190<br />Experimental: 0.160<br />greater: control<br />info: ATTRACTION-3, Pyrexia, All Grades","Control: 0.270<br />Experimental: 0.120<br />greater: control<br />info: ATTRACTION-3, Fatigue/Asthenia, All Grades","Control: 0.300<br />Experimental: 0.130<br />greater: control<br />info: ATTRACTION-3, Anemia, All Grades","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ATTRACTION-3, Pruritus, Grade 3-4","Control: 0.050<br />Experimental: 0.019<br />greater: control<br />info: ATTRACTION-3, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ATTRACTION-3, Constipation, Grade 3-4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />info: ATTRACTION-3, Nausea, Grade 3-4","Control: 0.014<br />Experimental: 0.000<br />greater: control<br />info: ATTRACTION-3, Musculoskeletal pain, Grade 3-4","Control: 0.090<br />Experimental: 0.050<br />greater: control<br />info: ATTRACTION-3, Pneumonia, Grade 3-4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />info: ATTRACTION-3, Cough, Grade 3-4","Control: 0.005<br />Experimental: 0.005<br />greater: control<br />info: ATTRACTION-3, Pyrexia, Grade 3-4","Control: 0.048<br />Experimental: 0.014<br />greater: control<br />info: ATTRACTION-3, Fatigue/Asthenia, Grade 3-4","Control: 0.130<br />Experimental: 0.080<br />greater: control<br />info: ATTRACTION-3, Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ATTRACTION-3, Hypothyroidism, Grade 3-4","Control: 0.320<br />Experimental: 0.260<br />greater: control<br />info: IMbrave150, Fatigue/Asthenia, All Grades","Control: 0.170<br />Experimental: 0.120<br />greater: control<br />info: IMbrave150, Rash, All Grades","Control: 0.490<br />Experimental: 0.190<br />greater: control<br />info: IMbrave150, Diarrhea, All Grades","Control: 0.140<br />Experimental: 0.130<br />greater: control<br />info: IMbrave150, Constipation, All Grades","Control: 0.170<br />Experimental: 0.120<br />greater: control<br />info: IMbrave150, Abdominal Pain, All Grades","Control: 0.160<br />Experimental: 0.120<br />greater: control<br />info: IMbrave150, Nausea, All Grades","Control: 0.240<br />Experimental: 0.180<br />greater: control<br />info: IMbrave150, Decreased Appetite, All Grades","Control: 0.060<br />Experimental: 0.020<br />greater: control<br />info: IMbrave150, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Pruritus, Grade 3-4","Control: 0.026<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Rash, Grade 3-4","Control: 0.050<br />Experimental: 0.018<br />greater: control<br />info: IMbrave150, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Abdominal Pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Vomiting, Grade 3-4","Control: 0.038<br />Experimental: 0.012<br />greater: control<br />info: IMbrave150, Decreased Appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: IMbrave150, Epistaxis, Grade 3-4","Control: 0.410<br />Experimental: 0.320<br />greater: control<br />info: CHECKMATE-9LA, Nausea, All Grades","Control: 0.230<br />Experimental: 0.210<br />greater: control<br />info: CHECKMATE-9LA, Constipation, All Grades","Control: 0.006<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-9LA, Pyrexia, Grade 3-4","Control: 0.006<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-9LA, Constipation, Grade 3-4","Control: 0.009<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-9LA, Abdominal pain, Grade 3-4","Control: 0.009<br />Experimental: 0.006<br />greater: control<br />info: CHECKMATE-9LA, Cough, Grade 3-4","Control: 0.570<br />Experimental: 0.530<br />greater: control<br />info: ALTA 1L, Diarrhea, All Grades","Control: 0.580<br />Experimental: 0.300<br />greater: control<br />info: ALTA 1L, Nausea, All Grades","Control: 0.330<br />Experimental: 0.240<br />greater: control<br />info: ALTA 1L, Abdominal pain, All Grades","Control: 0.440<br />Experimental: 0.210<br />greater: control<br />info: ALTA 1L, Vomiting, All Grades","Control: 0.420<br />Experimental: 0.180<br />greater: control<br />info: ALTA 1L, Constipation, All Grades","Control: 0.160<br />Experimental: 0.080<br />greater: control<br />info: ALTA 1L, Dyspepsia, All Grades","Control: 0.110<br />Experimental: 0.007<br />greater: control<br />info: ALTA 1L, Gastroesophageal reflux disease, All Grades","Control: 0.058<br />Experimental: 0.022<br />greater: control<br />info: ALTA 1L, Pulmonary embolism, All Grades","Control: 0.400<br />Experimental: 0.320<br />greater: control<br />info: ALTA 1L, Fatigue/Asthenia, All Grades","Control: 0.480<br />Experimental: 0.180<br />greater: control<br />info: ALTA 1L, Edema, All Grades","Control: 0.150<br />Experimental: 0.150<br />greater: control<br />info: ALTA 1L, Pyrexia, All Grades","Control: 0.150<br />Experimental: 0.051<br />greater: control<br />info: ALTA 1L, Pain in extremity, All Grades","Control: 0.200<br />Experimental: 0.150<br />greater: control<br />info: ALTA 1L, Dizziness, All Grades","Control: 0.180<br />Experimental: 0.110<br />greater: control<br />info: ALTA 1L, Peripheral neuropathy, All Grades","Control: 0.140<br />Experimental: 0.029<br />greater: control<br />info: ALTA 1L, Dysgeusia, All Grades","Control: 0.230<br />Experimental: 0.120<br />greater: control<br />info: ALTA 1L, Bradycardia, All Grades","Control: 0.110<br />Experimental: 0.080<br />greater: control<br />info: ALTA 1L, Nasopharyngitis, All Grades","Control: 0.088<br />Experimental: 0.059<br />greater: control<br />info: ALTA 1L, Urinary tract infection, All Grades","Control: 0.190<br />Experimental: 0.088<br />greater: control<br />info: ALTA 1L, Decreased Appetite, All Grades","Control: 0.530<br />Experimental: 0.074<br />greater: control<br />info: ALTA 1L, Visual Disturbance0e, All Grades","Control: 0.029<br />Experimental: 0.022<br />greater: control<br />info: ALTA 1L, Diarrhea, Grade 3-4","Control: 0.029<br />Experimental: 0.022<br />greater: control<br />info: ALTA 1L, Nausea, Grade 3-4","Control: 0.036<br />Experimental: 0.007<br />greater: control<br />info: ALTA 1L, Abdominal pain, Grade 3-4","Control: 0.022<br />Experimental: 0.007<br />greater: control<br />info: ALTA 1L, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Constipation, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Dyspepsia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Gastroesophageal reflux disease, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />info: ALTA 1L, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Cough, Grade 3-4","Control: 0.036<br />Experimental: 0.029<br />greater: control<br />info: ALTA 1L, Dyspnea, Grade 3-4","Control: 0.029<br />Experimental: 0.022<br />greater: control<br />info: ALTA 1L, Pulmonary embolism, Grade 3-4","Control: 0.022<br />Experimental: 0.015<br />greater: control<br />info: ALTA 1L, Fatigue/Asthenia, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />info: ALTA 1L, Edema, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Myalgia, Grade 3-4","Control: 0.015<br />Experimental: 0.007<br />greater: control<br />info: ALTA 1L, Back pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Arthralgia, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Pain in extremity, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />info: ALTA 1L, Dizziness, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Dysgeusia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Increased Blood cholesterol, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Nasopharyngitis, Grade 3-4","Control: 0.022<br />Experimental: 0.007<br />greater: control<br />info: ALTA 1L, Urinary tract infection, Grade 3-4","Control: 0.029<br />Experimental: 0.007<br />greater: control<br />info: ALTA 1L, Decreased Appetite, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />info: ALTA 1L, Visual Disturbance0e, Grade 3-4","Control: 0.050<br />Experimental: 0.030<br />greater: control<br />info: PROfound, Fatigue/Asthenia, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: PROfound, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: PROfound, Cough, Grade 3-4","Control: 0.340<br />Experimental: 0.140<br />greater: control<br />info: IMpower110, Nausea, All Grades","Control: 0.220<br />Experimental: 0.120<br />greater: control<br />info: IMpower110, Constipation, All Grades","Control: 0.120<br />Experimental: 0.110<br />greater: control<br />info: IMpower110, Diarrhea, All Grades","Control: 0.340<br />Experimental: 0.250<br />greater: control<br />info: IMpower110, Fatigue/Asthenia, All Grades","Control: 0.190<br />Experimental: 0.150<br />greater: control<br />info: IMpower110, Decreased appetite, All Grades","Control: 0.019<br />Experimental: 0.003<br />greater: control<br />info: IMpower110, Nausea, Grade 3-4","Control: 0.008<br />Experimental: 0.000<br />greater: control<br />info: IMpower110, Diarrhea, Grade 3-4","Control: 0.042<br />Experimental: 0.014<br />greater: control<br />info: IMpower110, Fatigue/Asthenia, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />info: IMpower110, Pyrexia, Grade 3-4","Control: 0.420<br />Experimental: 0.210<br />greater: control<br />info: CHECKMATE-227, Nausea, All Grades","Control: 0.270<br />Experimental: 0.180<br />greater: control<br />info: CHECKMATE-227, Constipation, All Grades","Control: 0.180<br />Experimental: 0.130<br />greater: control<br />info: CHECKMATE-227, Vomiting, All Grades","Control: 0.005<br />Experimental: 0.002<br />greater: control<br />info: CHECKMATE-227, Edema, Grade 3-4","Control: 0.025<br />Experimental: 0.010<br />greater: control<br />info: CHECKMATE-227, Nausea, Grade 3-4","Control: 0.005<br />Experimental: 0.003<br />greater: control<br />info: CHECKMATE-227, Constipation, Grade 3-4","Control: 0.023<br />Experimental: 0.010<br />greater: control<br />info: CHECKMATE-227, Vomiting, Grade 3-4","Control: 0.007<br />Experimental: 0.002<br />greater: control<br />info: CHECKMATE-227, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CHECKMATE-227, Hyperthyroidism, Grade 3-4","Control: 0.270<br />Experimental: 0.270<br />greater: control<br />info: E1912, Pyrexia, All Grades","Control: 0.640<br />Experimental: 0.400<br />greater: control<br />info: E1912, Nausea, All Grades","Control: 0.280<br />Experimental: 0.180<br />greater: control<br />info: E1912, Vomiting, All Grades","Control: 0.320<br />Experimental: 0.170<br />greater: control<br />info: E1912, Constipation, All Grades","Control: 0.200<br />Experimental: 0.150<br />greater: control<br />info: E1912, Decreased appetite, All Grades","Control: 0.190<br />Experimental: 0.160<br />greater: control<br />info: E1912, Insomnia, All Grades","Control: 0.030<br />Experimental: 0.020<br />greater: control<br />info: E1912, Fatigue/Asthenia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: E1912, Pyrexia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: E1912, Nausea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: E1912, Stomatitis, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: E1912, Constipation, Grade ≥ 3","Control: 0.050<br />Experimental: 0.040<br />greater: control<br />info: E1912, Rash, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: E1912, Bruising, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: E1912, Headache, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: E1912, Dizziness, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: E1912, Peripheral neuropathy, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: E1912, Cough, Grade ≥ 3","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />info: E1912, Upper respiratory tract infection, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: E1912, Skin infection, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: E1912, Decreased appetite, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: E1912, Insomnia, Grade ≥ 3","Control: 0.410<br />Experimental: 0.340<br />greater: control<br />info: BEACON CRC, Nausea, All Grades","Control: 0.480<br />Experimental: 0.330<br />greater: control<br />info: BEACON CRC, Diarrhea, All Grades","Control: 0.320<br />Experimental: 0.300<br />greater: control<br />info: BEACON CRC, Abdominal pain, All Grades","Control: 0.290<br />Experimental: 0.210<br />greater: control<br />info: BEACON CRC, Vomiting, All Grades","Control: 0.180<br />Experimental: 0.150<br />greater: control<br />info: BEACON CRC, Constipation, All Grades","Control: 0.270<br />Experimental: 0.270<br />greater: control<br />info: BEACON CRC, Decreased appetite, All Grades","Control: 0.430<br />Experimental: 0.320<br />greater: control<br />info: BEACON CRC, Dermatitis acneiform, All Grades","Control: 0.260<br />Experimental: 0.260<br />greater: control<br />info: BEACON CRC, Rash, All Grades","Control: 0.080<br />Experimental: 0.070<br />greater: control<br />info: BEACON CRC, Fatigue/Asthenia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: BEACON CRC, Pyrexia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: BEACON CRC, Nausea, Grade ≥ 3","Control: 0.100<br />Experimental: 0.020<br />greater: control<br />info: BEACON CRC, Diarrhea, Grade ≥ 3","Control: 0.050<br />Experimental: 0.040<br />greater: control<br />info: BEACON CRC, Abdominal pain, Grade ≥ 3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />info: BEACON CRC, Vomiting, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: BEACON CRC, Constipation, Grade ≥ 3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />info: BEACON CRC, Decreased appetite, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: BEACON CRC, Pain in extremity, Grade ≥ 3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />info: BEACON CRC, Dermatitis acneiform, Grade ≥ 3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />info: BEACON CRC, Rash, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: BEACON CRC, Pruritus, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: BEACON CRC, Melanocytic nevus, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: BEACON CRC, Dry skin, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: BEACON CRC, Headache, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: BEACON CRC, Insomnia, Grade ≥ 3","Control: 0.340<br />Experimental: 0.340<br />greater: control<br />info: CASPIAN , Nausea, All Grades","Control: 0.190<br />Experimental: 0.170<br />greater: control<br />info: CASPIAN , Constipation, All Grades","Control: 0.170<br />Experimental: 0.150<br />greater: control<br />info: CASPIAN , Vomiting, All Grades","Control: 0.110<br />Experimental: 0.100<br />greater: control<br />info: CASPIAN , Diarrhea, All Grades","Control: 0.340<br />Experimental: 0.310<br />greater: control<br />info: CASPIAN , Alopecia, All Grades","Control: 0.320<br />Experimental: 0.320<br />greater: control<br />info: CASPIAN , Fatigue/Asthenia, All Grades","Control: 0.019<br />Experimental: 0.004<br />greater: control<br />info: CASPIAN , Nausea, Grade 3-4","Control: 0.011<br />Experimental: 0.000<br />greater: control<br />info: CASPIAN , Vomiting, Grade 3-4","Control: 0.011<br />Experimental: 0.011<br />greater: control<br />info: CASPIAN , Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CASPIAN , Hyperthyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: CASPIAN , Rash, Grade 3-4","Control: 0.008<br />Experimental: 0.008<br />greater: control<br />info: CASPIAN , Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ICARIA-MM, Nausea, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ICARIA-MM, Upper respiratory tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ICARIA-MM, Dyspnea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ICARIA-MM, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ICARIA-MM, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ICARIA-MM, Vomiting, Grade 4","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />info: NALA, Abdominal distension, Grade 3","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />info: NALA, Malaise, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Influenza-like illness, Grade 3","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: NALA, Upper respiratory tract infection, Grade 3","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: NALA, Back Pain, Grade 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: NALA, Arthralgia, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Muscle spasms, Grade 3","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />info: NALA, Dizziness, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Dysuria, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Vomiting, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Constipation, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Abdominal distension, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Fatigue/Asthenia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Malaise, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Influenza-like illness, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Urinary tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Upper respiratory tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Back Pain, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Arthralgia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Muscle spasms, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Dizziness, Grade 4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />info: NALA, Renal impairment, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: NALA, Dysuria, Grade 4","Control: 0.270<br />Experimental: 0.220<br />greater: control<br />info: KEYNOTE-091, Weight Increased, Grade 1–2","Control: 0.170<br />Experimental: 0.150<br />greater: control<br />info: KEYNOTE-091, Cough, Grade 1–2","Control: 0.070<br />Experimental: 0.060<br />greater: control<br />info: KEYNOTE-091, Hypertension, Grade 1–2","Control: 0.110<br />Experimental: 0.100<br />greater: control<br />info: KEYNOTE-091, Dyspnea, Grade 1–2","Control: 0.090<br />Experimental: 0.090<br />greater: control<br />info: KEYNOTE-091, Upper respiratory tract infection, Grade 1–2","Control: 0.080<br />Experimental: 0.080<br />greater: control<br />info: KEYNOTE-091, Back pain, Grade 1–2","Control: 0.080<br />Experimental: 0.070<br />greater: control<br />info: KEYNOTE-091, Headache, Grade 1–2","Control: 0.070<br />Experimental: 0.060<br />greater: control<br />info: KEYNOTE-091, Constipation, Grade 1–2","Control: 0.060<br />Experimental: 0.060<br />greater: control<br />info: KEYNOTE-091, Influenza-like illness, Grade 1–2","Control: 0.060<br />Experimental: 0.050<br />greater: control<br />info: KEYNOTE-091, Pyrexia, Grade 1–2","Control: 0.050<br />Experimental: 0.030<br />greater: control<br />info: KEYNOTE-091, Pain in extremity, Grade 1–2","Control: 0.060<br />Experimental: 0.030<br />greater: control<br />info: KEYNOTE-091, Paresthesia, Grade 1–2","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Weight Increased, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Pruritus, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Arthralgia, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Diarrhea, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Fatigue/Asthenia, Grade 3","Control: 0.060<br />Experimental: 0.060<br />greater: control<br />info: KEYNOTE-091, Hypertension, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Dyspnea, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Upper respiratory tract infection, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Nasopharyngitis, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Increased alanine aminotransferase, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Headache, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Asthenia, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Aspartate aminotransferase increased, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Decreased appetite, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Weight decreased , Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Increased blood creatinine, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Productive cough, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Constipation, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Influenza-like illness, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Pneumonitis, Grade 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE-091, Pyrexia, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Dry skin, Grade 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Pain in extremity, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Paresthesia, Grade 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Weight Increased, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Pruritus, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Hypothyroidism, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Arthralgia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Fatigue/Asthenia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Cough, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Hypertension, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Dyspnea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Hyperthyroidism, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Upper respiratory tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Nasopharyngitis, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Rash, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Increased alanine aminotransferase, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Back pain, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Headache, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Asthenia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Maculopapular rash, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Aspartate aminotransferase increased, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Weight decreased , Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Increased blood creatinine, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Myalgia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Productive cough, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Constipation, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Influenza-like illness, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Pyrexia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Dry skin, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Pain in extremity, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-091, Paresthesia, Grade 4","Control: 0.520<br />Experimental: 0.420<br />greater: control<br />info: ZUMA-7, Fatigue/Asthenia, Any Grade","Control: 0.540<br />Experimental: 0.420<br />greater: control<br />info: ZUMA-7, Anemia, Any Grade","Control: 0.690<br />Experimental: 0.410<br />greater: control<br />info: ZUMA-7, Nausea, Any Grade","Control: 0.600<br />Experimental: 0.290<br />greater: control<br />info: ZUMA-7, Thrombocytopenia, Any Grade","Control: 0.290<br />Experimental: 0.260<br />greater: control<br />info: ZUMA-7, Hypokalemia, Any Grade","Control: 0.250<br />Experimental: 0.250<br />greater: control<br />info: ZUMA-7, Decreased appetite, Any Grade","Control: 0.350<br />Experimental: 0.200<br />greater: control<br />info: ZUMA-7, Constipation, Any Grade","Control: 0.330<br />Experimental: 0.190<br />greater: control<br />info: ZUMA-7, Vomiting, Any Grade","Control: 0.270<br />Experimental: 0.020<br />greater: control<br />info: ZUMA-7, Febrile neutropenia, Any Grade","Control: 0.080<br />Experimental: 0.050<br />greater: control<br />info: ZUMA-7, Paresthesia, Any Grade","Control: 0.030<br />Experimental: 0.020<br />greater: control<br />info: ZUMA-7, Delirium, Any Grade","Control: 0.390<br />Experimental: 0.300<br />greater: control<br />info: ZUMA-7, Anemia, Grade ≥3","Control: 0.040<br />Experimental: 0.020<br />greater: control<br />info: ZUMA-7, Diarrhea, Grade ≥3","Control: 0.050<br />Experimental: 0.020<br />greater: control<br />info: ZUMA-7, Nausea, Grade ≥3","Control: 0.570<br />Experimental: 0.150<br />greater: control<br />info: ZUMA-7, Thrombocytopenia, Grade ≥3","Control: 0.070<br />Experimental: 0.060<br />greater: control<br />info: ZUMA-7, Hypokalemia, Grade ≥3","Control: 0.040<br />Experimental: 0.040<br />greater: control<br />info: ZUMA-7, Decreased appetite, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: ZUMA-7, Dizziness, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: ZUMA-7, Constipation, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: ZUMA-7, Vomiting, Grade ≥3","Control: 0.270<br />Experimental: 0.020<br />greater: control<br />info: ZUMA-7, Febrile neutropenia, Grade ≥3","Control: 0.440<br />Experimental: 0.410<br />greater: control<br />info: KEYNOTE-811, Anemia, Any grade","Control: 0.319<br />Experimental: 0.309<br />greater: control<br />info: KEYNOTE-811, Decreased appetite, Any grade","Control: 0.282<br />Experimental: 0.244<br />greater: control<br />info: KEYNOTE-811, Platelet count decreased, Any grade","Control: 0.245<br />Experimental: 0.235<br />greater: control<br />info: KEYNOTE-811, Neutrophil count decreased, Any grade","Control: 0.171<br />Experimental: 0.152<br />greater: control<br />info: KEYNOTE-811, Constipation, Any grade","Control: 0.162<br />Experimental: 0.152<br />greater: control<br />info: KEYNOTE-811, Neuropathy peripheral, Any grade","Control: 0.148<br />Experimental: 0.138<br />greater: control<br />info: KEYNOTE-811, Hypoalbuminemia, Any grade","Control: 0.144<br />Experimental: 0.124<br />greater: control<br />info: KEYNOTE-811, White-cell count decreased, Any grade","Control: 0.162<br />Experimental: 0.101<br />greater: control<br />info: KEYNOTE-811, Asthenia, Any grade","Control: 0.116<br />Experimental: 0.092<br />greater: control<br />info: KEYNOTE-811, Thrombocytopenia, Any grade","Control: 0.083<br />Experimental: 0.074<br />greater: control<br />info: KEYNOTE-811, Diarrhea, Grade 3-5","Control: 0.056<br />Experimental: 0.046<br />greater: control<br />info: KEYNOTE-811, Nausea, Grade 3-5","Control: 0.093<br />Experimental: 0.088<br />greater: control<br />info: KEYNOTE-811, Anemia, Grade 3-5","Control: 0.042<br />Experimental: 0.023<br />greater: control<br />info: KEYNOTE-811, Decreased appetite, Grade 3-5","Control: 0.074<br />Experimental: 0.074<br />greater: control<br />info: KEYNOTE-811, Neutrophil count decreased, Grade 3-5","Control: 0.005<br />Experimental: 0.005<br />greater: control<br />info: KEYNOTE-811, Aspartate aminotransferase increased, Grade 3-5","Control: 0.009<br />Experimental: 0.005<br />greater: control<br />info: KEYNOTE-811, Palmar-plantar erythrodysesthesia, Grade 3-5","Control: 0.051<br />Experimental: 0.051<br />greater: control<br />info: KEYNOTE-811, Neutropenia, Grade 3-5","Control: 0.023<br />Experimental: 0.014<br />greater: control<br />info: KEYNOTE-811, Neuropathy peripheral, Grade 3-5","Control: 0.065<br />Experimental: 0.051<br />greater: control<br />info: KEYNOTE-811, Hypokalemia, Grade 3-5","Control: 0.005<br />Experimental: 0.005<br />greater: control<br />info: KEYNOTE-811, Alanine aminotransferase increased, Grade 3-5","Control: 0.019<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE-811, Hypoalbuminemia, Grade 3-5","Control: 0.023<br />Experimental: 0.018<br />greater: control<br />info: KEYNOTE-811, White-cell count decreased, Grade 3-5","Control: 0.009<br />Experimental: 0.005<br />greater: control<br />info: KEYNOTE-811, Malaise, Grade 3-5","Control: 0.019<br />Experimental: 0.009<br />greater: control<br />info: KEYNOTE-811, Stomatitis, Grade 3-5","Control: 0.037<br />Experimental: 0.023<br />greater: control<br />info: KEYNOTE-811, Asthenia, Grade 3-5","Control: 0.620<br />Experimental: 0.440<br />greater: control<br />info: KEYNOTE‑177, Diarrhea, Any grade","Control: 0.500<br />Experimental: 0.380<br />greater: control<br />info: KEYNOTE‑177, Fatigue/Asthenia, Any grade","Control: 0.590<br />Experimental: 0.310<br />greater: control<br />info: KEYNOTE‑177, Nausea, Any grade","Control: 0.290<br />Experimental: 0.240<br />greater: control<br />info: KEYNOTE‑177, Abdominal pain, Any grade","Control: 0.410<br />Experimental: 0.240<br />greater: control<br />info: KEYNOTE‑177, Decreased appetite, Any grade","Control: 0.370<br />Experimental: 0.220<br />greater: control<br />info: KEYNOTE‑177, Vomiting, Any grade","Control: 0.220<br />Experimental: 0.180<br />greater: control<br />info: KEYNOTE‑177, Anemia, Any grade","Control: 0.170<br />Experimental: 0.170<br />greater: control<br />info: KEYNOTE‑177, Back pain, Any grade","Control: 0.310<br />Experimental: 0.170<br />greater: control<br />info: KEYNOTE‑177, Constipation, Any grade","Control: 0.190<br />Experimental: 0.160<br />greater: control<br />info: KEYNOTE‑177, Dizziness, Any grade","Control: 0.150<br />Experimental: 0.140<br />greater: control<br />info: KEYNOTE‑177, Headache, Any grade","Control: 0.220<br />Experimental: 0.120<br />greater: control<br />info: KEYNOTE‑177, Asthenia, Any grade","Control: 0.110<br />Experimental: 0.090<br />greater: control<br />info: KEYNOTE‑177, Urinary tract infection, Any grade","Control: 0.170<br />Experimental: 0.080<br />greater: control<br />info: KEYNOTE‑177, Hypokalemia, Any grade","Control: 0.200<br />Experimental: 0.070<br />greater: control<br />info: KEYNOTE‑177, Alopecia, Any grade","Control: 0.300<br />Experimental: 0.070<br />greater: control<br />info: KEYNOTE‑177, Stomatitis, Any grade","Control: 0.110<br />Experimental: 0.060<br />greater: control<br />info: KEYNOTE‑177, Dyspepsia, Any grade","Control: 0.190<br />Experimental: 0.050<br />greater: control<br />info: KEYNOTE‑177, Mucosal inflammation, Any grade","Control: 0.120<br />Experimental: 0.050<br />greater: control<br />info: KEYNOTE‑177, Weight decreased , Any grade","Control: 0.220<br />Experimental: 0.020<br />greater: control<br />info: KEYNOTE‑177, Peripheral sensory neuropathy, Any grade","Control: 0.230<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Neutrophil count decreased, Any grade","Control: 0.210<br />Experimental: 0.020<br />greater: control<br />info: KEYNOTE‑177, Neutropenia, Any grade","Control: 0.160<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Epistaxis, Any grade","Control: 0.190<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Peripheral neuropathy, Any grade","Control: 0.170<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, PPE syndrome, Any grade","Control: 0.120<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, White-cell count decrease, Any grade","Control: 0.110<br />Experimental: 0.060<br />greater: control<br />info: KEYNOTE‑177, Diarrhea, Grade ≥3","Control: 0.090<br />Experimental: 0.040<br />greater: control<br />info: KEYNOTE‑177, Fatigue/Asthenia, Grade ≥3","Control: 0.040<br />Experimental: 0.030<br />greater: control<br />info: KEYNOTE‑177, Nausea, Grade ≥3","Control: 0.060<br />Experimental: 0.050<br />greater: control<br />info: KEYNOTE‑177, Abdominal pain, Grade ≥3","Control: 0.050<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Decreased appetite, Grade ≥3","Control: 0.050<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Vomiting, Grade ≥3","Control: 0.100<br />Experimental: 0.050<br />greater: control<br />info: KEYNOTE‑177, Anemia, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Pruritus, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Back pain, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Constipation, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Cough, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Dizziness, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Headache, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Rash, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Upper abdominal pain, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Nasopharyngitis, Grade ≥3","Control: 0.040<br />Experimental: 0.020<br />greater: control<br />info: KEYNOTE‑177, Asthenia, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Dry skin, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Hypothyroidism, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Pain in extremity, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Peripheral edema, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Dry mouth, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Upper respiratory tract infection, Grade ≥3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Urinary tract infection, Grade ≥3","Control: 0.060<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Hypokalemia, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Alopecia, Grade ≥3","Control: 0.040<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Stomatitis, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Dyspepsia, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Mucosal inflammation, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />info: KEYNOTE‑177, Weight decreased , Grade ≥3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Peripheral sensory neuropathy, Grade ≥3","Control: 0.170<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Neutrophil count decreased, Grade ≥3","Control: 0.150<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Neutropenia, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Epistaxis, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, Peripheral neuropathy, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, PPE syndrome, Grade ≥3","Control: 0.040<br />Experimental: 0.000<br />greater: control<br />info: KEYNOTE‑177, White-cell count decrease, Grade ≥3"],"key":["TALAPRO-2, Fatigue/Asthenia, Grade 4","TALAPRO-2, Nausea, Grade 4","TALAPRO-2, Decreased appetite, Grade 3","TALAPRO-2, Decreased appetite, Grade 4","TALAPRO-2, Fractures, Grade 4","TALAPRO-2, Dizziness, Grade 3","TALAPRO-2, Dizziness, Grade 4","TALAPRO-2, Dysgeusia, Grade 3","TALAPRO-2, Dysgeusia, Grade 4","PROpel, Nausea, Grade 3-4","PROpel, Abdominal pain, Grade 3-4","POLARIX, Neutropenia, All grades","POLARIX, Thrombocytopenia, All grades","POLARIX, Alanine aminotransferase increased, All grades","POLARIX, Peripheral neuropathy, All grades","POLARIX, Altered taste, All grades","POLARIX, Headache, All grades","POLARIX, Constipation, All grades","POLARIX, Fatigue/Asthenia, All grades","POLARIX, Infusion-related reaction, All grades","POLARIX, Alopecia, All grades","POLARIX, Musculoskeletal pain, All grades","POLARIX, Lymphopenia, Grade 3-4","POLARIX, Neutropenia, Grade 3-4","POLARIX, Increased blood creatinine, Grade 3-4","POLARIX, Aspartate aminotransferase increased, Grade 3-4","POLARIX, Alkaline phosphatase increased, Grade 3-4","POLARIX, Altered taste, Grade 3-4","POLARIX, Headache, Grade 3-4","POLARIX, Abdominal pain, Grade 3-4","POLARIX, Fatigue/Asthenia, Grade 3-4","POLARIX, Infusion-related reaction, Grade 3-4","POLARIX, Alopecia, Grade 3-4","POLARIX, Musculoskeletal pain, Grade 3-4","POLARIX, Upper respiratory tract infection, Grade 3-4","POLARIX, Cough, Grade 3-4","POLARIX, Dyspnea, Grade 3-4","TROPiCS-02, Decreased appetite, All grades","TROPiCS-02, Nausea, Grade 3-4","TROPiCS-02, Vomiting, Grade 3-4","TROPiCS-02, Abdominal Pain, Grade 3-4","TROPiCS-02, Dyspepsia, Grade 3-4","TROPiCS-02, Arthralgia, Grade 3-4","TROPiCS-02, Headache, Grade 3-4","TROPiCS-02, Dyspnea, Grade 3-4","TROPiCS-02, Cough, Grade 3-4","TROPiCS-02, Alopecia, Grade 3-4","TROPiCS-02, Pruritus, Grade 3-4","EMERALD, Fatigue/Asthenia, All grades","EMERALD, Headache, All grades","EMERALD, Diarrhea, Grade 3-4","EMERALD, Constipation, Grade 3-4","EMERALD, Dyspepsia, Grade 3-4","EMERALD, Hot flush , Grade 3-4","SEQUOIA, Rash, All grades","SEQUOIA, Constipation, All grades","SEQUOIA, Nausea, All grades","SEQUOIA, Fatigue/Asthenia, All grades","SEQUOIA, Rash, Grade 3-4","SEQUOIA, Bruising, Grade 3-4","SEQUOIA, Cough, Grade 3-4","SEQUOIA, Diarrhea, Grade 3-4","SEQUOIA, Nausea, Grade 3-4","SEQUOIA, Fatigue/Asthenia, Grade 3-4","SEQUOIA, Headache, Grade 3-4","ALPINE, Pneumonia, All grades","ALPINE, Musculoskeletal pain, All grades","ALPINE, Hemorrhage, All grades","ALPINE, Hypertension, All grades","ALPINE, Rash, All grades","ALPINE, Diarrhea, All grades","ALPINE, Fatigue/Asthenia, All grades","ALPINE, Cough, All grades","ALPINE, Upper respiratory tract infection, Grade 3-4","ALPINE, Pneumonia, Grade 3-4","ALPINE, Musculoskeletal pain, Grade 3-4","ALPINE, Hemorrhage, Grade 3-4","ALPINE, Hypertension, Grade 3-4","ALPINE, Bruising, Grade 3-4","ALPINE, Fatigue/Asthenia, Grade 3-4","ALPINE, Dizziness, Grade 3-4","POSEIDON, Constipation, All grades","POSEIDON, Edema, All grades","POSEIDON, Cough/Productive Cough, Grade 3-4","POSEIDON, Nausea, Grade 3-4","POSEIDON, Diarrhea, Grade 3-4","POSEIDON, Constipation, Grade 3-4","POSEIDON, Vomiting, Grade 3-4","POSEIDON, Stomatitis, Grade 3-4","POSEIDON, Hypothyroidism, Grade 3-4","POSEIDON, Alopecia, Grade 3-4","POSEIDON, Pruritus, Grade 3-4","POSEIDON, Pyrexia, Grade 3-4","POSEIDON, Edema, Grade 3-4","POSEIDON, Musculoskeletal Pain, Grade 3-4","POSEIDON, Upper respiratory tract infection, Grade 3-4","POSEIDON, Headache, Grade 3-4","Study 16113, Alopecia, All grades","Study 16113, Musculoskeletal pain, All grades","Study 16113, Alopecia, Grade 3-4","Study 16113, Nausea, Grade 3-4","Study 16113, Vomiting, Grade 3-4","Study 16113, Peripheral neuropathy, Grade 3-4","Study 16113, Insomnia, Grade 3-4","HIMALAYA, Diarrhea, All grades","HIMALAYA, Abdominal pain, All grades","HIMALAYA, Nausea, All grades","HIMALAYA, Rash, All grades","HIMALAYA, Decreased appetite, All grades","HIMALAYA, Fatigue/Asthenia, All grades","HIMALAYA, Abdominal pain, Grade 3-4","HIMALAYA, Nausea, Grade 3-4","HIMALAYA, Rash, Grade 3-4","HIMALAYA, Pruritus, Grade 3-4","HIMALAYA, Fatigue/Asthenia, Grade 3-4","HIMALAYA, Pyrexia, Grade 3-4","HIMALAYA, Hypothyroidism, Grade 3-4","TOPAZ-1, Fatigue/Asthenia, All grades","TOPAZ-1, Vomiting, All grades","TOPAZ-1, Insomnia, All grades","TOPAZ-1, Fatigue/Asthenia, Grade 3-4","TOPAZ-1, Nausea, Grade 3-4","TOPAZ-1, Abdominal pain, Grade 3-4","TOPAZ-1, Vomiting, Grade 3-4","TOPAZ-1, Diarrhea, Grade 3-4","TOPAZ-1, Pruritus, Grade 3-4","TOPAZ-1, Insomnia, Grade 3-4","ARASENS, Constipation, Grade 3-4","ARASENS, Decreased Appetite, Grade 3-4","ARASENS, Hemorrhage, Grade 3-4","DESTINY-Breast04, Pyrexia, All grades","DESTINY-Breast04, Rash, All grades","DESTINY-Breast04, Peripheral neuropathy, All grades","DESTINY-Breast04, Diarrhea, Grade 3-4","DESTINY-Breast04, Stomatitis, Grade 3-4","DESTINY-Breast04, Alopecia, Grade 3-4","DESTINY-Breast04, Rash, Grade 3-4","DESTINY-Breast04, Hemorrhage, Grade 3-4","DESTINY-Breast04, Peripheral neuropathy, Grade 3-4","TRANSFORM, Thrombocytopenia, Grade 1–2","TRANSFORM, Nausea, Grade 1–2","TRANSFORM, Prolonged cytopeniat, Grade 1–2","TRANSFORM, Diarrhea, Grade 1–2","TRANSFORM, Decreased appetite, Grade 1–2","TRANSFORM, Hypokalemia, Grade 1–2","TRANSFORM, Vomiting, Grade 1–2","TRANSFORM, Back pain, Grade 1–2","TRANSFORM, Peripheral edema, Grade 1–2","TRANSFORM, Hypomagnesaemia, Grade 1–2","TRANSFORM, Abdominal pain, Grade 1–2","TRANSFORM, Tachycardia, Grade 1–2","TRANSFORM, Peripheral sensory neuropathy, Grade 1–2","TRANSFORM, Hypophosphatemia, Grade 1–2","TRANSFORM, Dyspepsia, Grade 1–2","TRANSFORM, Stomatitis, Grade 1–2","TRANSFORM, Mucosal inflammation, Grade 1–2","TRANSFORM, Anemia, Grade ≥ 3","TRANSFORM, Thrombocytopenia, Grade ≥ 3","TRANSFORM, Nausea, Grade ≥ 3","TRANSFORM, Fatigue/Asthenia, Grade ≥ 3","TRANSFORM, Diarrhea, Grade ≥ 3","TRANSFORM, Decreased appetite, Grade ≥ 3","TRANSFORM, Pyrexia, Grade ≥ 3","TRANSFORM, Dizziness, Grade ≥ 3","TRANSFORM, Hypokalemia, Grade ≥ 3","TRANSFORM, Insomnia, Grade ≥ 3","TRANSFORM, Vomiting, Grade ≥ 3","TRANSFORM, Back pain, Grade ≥ 3","TRANSFORM, Febrile neutropenia, Grade ≥ 3","TRANSFORM, Hypomagnesaemia, Grade ≥ 3","TRANSFORM, Arthralgia, Grade ≥ 3","TRANSFORM, Cough, Grade ≥ 3","TRANSFORM, Dyspnea, Grade ≥ 3","TRANSFORM, Bone pain, Grade ≥ 3","TRANSFORM, Tachycardia, Grade ≥ 3","TRANSFORM, Peripheral sensory neuropathy, Grade ≥ 3","TRANSFORM, Hypophosphatemia, Grade ≥ 3","TRANSFORM, Dyspepsia, Grade ≥ 3","TRANSFORM, Stomatitis, Grade ≥ 3","TRANSFORM, Mucosal inflammation, Grade ≥ 3","AG120-C-009, Nausea, Grade ≥ 3","AG120-C-009, Vomiting, Grade ≥ 3","AG120-C-009, Leukocytosis, Grade ≥ 3","AG120-C-009, Hematoma, Grade ≥ 3","AG120-C-009, Hypertension, Grade ≥ 3","AG120-C-009, Dyspnea, Grade ≥ 3","AG120-C-009, Headache, Grade ≥ 3","OlympiA, Diarrhea, Grade 3-4","OlympiA, Dysgeusia, Grade 3-4","OlympiA, Dizziness, Grade 3-4","KEYNOTE-716, Hypothyroidism, Grade ≥ 3","KEYNOTE-716, Diarrhea, Grade ≥ 3","KEYNOTE-716, Nausea, Grade ≥ 3","KEYNOTE-716, Increased alanine aminotransferase, Grade ≥ 3","KEYNOTE-716, Aspartate aminotransferase increased, Grade ≥ 3","KEYNOTE-716, Rash, Grade ≥ 3","KEYNOTE-564, Abdominal pain, All grades","KEYNOTE-564, Cough, Grade 3-4","KEYNOTE-826, Alopecia, All grades","KEYNOTE-826, Nausea, All grades","KEYNOTE-826, Constipation, All grades","KEYNOTE-826, Vomiting, All grades","KEYNOTE-826, Urinary tract infection, All grades","KEYNOTE-826, Peripheral neuropathy, Grade 3-4","KEYNOTE-826, Alopecia, Grade 3-4","KEYNOTE-826, Diarrhea, Grade 3-4","KEYNOTE-826, Constipation, Grade 3-4","KEYNOTE-826, Arthralgia, Grade 3-4","KEYNOTE-826, Hypertension, Grade 3-4","COSMIC-311, Dysgeusia, Grade 3-4","COSMIC-311, Dysphonia, Grade 3-4","Study AG120-C-005, Fatigue/Asthenia, Grade ≥ 3","Study AG120-C-005, Nausea, Grade ≥ 3","Study AG120-C-005, Diarrhea, Grade ≥ 3","Study AG120-C-005, Abdominal pain, Grade ≥ 3","Study AG120-C-005, Cough, Grade ≥ 3","Study AG120-C-005, Headache, Grade ≥ 3","Study AG120-C-005, Neuropathy, Grade ≥ 3","CHECKMATE-274, Pyrexia, All grades","CHECKMATE-274, Abdominal pain, All grades","CHECKMATE-274, Constipation, All grades","CHECKMATE-274, Arthralgia, All grades","CHECKMATE-274, Urinary tract infection, All grades","CHECKMATE-274, Upper respiratory tract infection, All grades","CHECKMATE-274, Pruritus, Grade 3-4","CHECKMATE-274, Pyrexia, Grade 3-4","CHECKMATE-274, Constipation, Grade 3-4","CHECKMATE-274, Musculoskeletal pain, Grade 3-4","CHECKMATE-274, Urinary tract infection, Grade 3-4","CHECKMATE-274, Upper respiratory tract infection, Grade 3-4","CHECKMATE-274, Hyperthyroidism, Grade 3-4","CHECKMATE-274, Hypothyroidism, Grade 3-4","CHECKMATE-274, Cough, Grade 3-4","CHECKMATE-274, Dyspnea, Grade 3-4","KEYNOTE-522, Peripheral neuropathy, All grades","KEYNOTE-522, Arthralgia, All grades","KEYNOTE-522, Constipation, Grade 3-4","KEYNOTE-522, Abdominal pain, Grade 3-4","KEYNOTE-522, Alopecia, Grade 3-4","KEYNOTE-522, Headache, Grade 3-4","CHECKMATE-577, Diarrhea, All grades","CHECKMATE-577, Abdominal Pain, All grades","CHECKMATE-577, Vomiting, All grades","CHECKMATE-577, Dysphagia, All grades","CHECKMATE-577, Dyspepsia, All grades","CHECKMATE-577, Constipation, All grades","CHECKMATE-577, Cough, All grades","CHECKMATE-577, Dyspnea, All grades","CHECKMATE-577, Abdominal Pain, Grade 3-4","CHECKMATE-577, Vomiting, Grade 3-4","CHECKMATE-577, Dysphagia, Grade 3-4","CHECKMATE-577, Dyspepsia, Grade 3-4","CHECKMATE-577, Constipation, Grade 3-4","CHECKMATE-577, Fatigue/Asthenia, Grade 3-4","CHECKMATE-577, Cough, Grade 3-4","CHECKMATE-577, Musculoskeletal pain, Grade 3-4","CHECKMATE-577, Hypothyroidism, Grade 3-4","KEYNOTE-590, Constipation, All grades","KEYNOTE-590, Weight decreased , All grades","KEYNOTE-590, Nausea, Grade 3-4","KEYNOTE-590, Constipation, Grade 3-4","KEYNOTE-590, Decreased appetite, Grade 3-4","KEYNOTE-590, Weight decreased , Grade 3-4","ADAURA, Cough, All grades","ADAURA, Musculoskeletal Pain, All grades","ADAURA, Pruritus, Grade ≥ 3","ADAURA, Cough, Grade ≥ 3","ADAURA, Musculoskeletal Pain, Grade ≥ 3","ADAURA, Nasopharyngitis, Grade ≥ 3","ADAURA, Dizziness, Grade ≥ 3","KEYNOTE-355, Fatigue/Asthenia, All grades","KEYNOTE-355, Nausea, All grades","KEYNOTE-355, Alopecia, All grades","KEYNOTE-355, Headache, All grades","KEYNOTE-355, Nausea, Grade 3-4","KEYNOTE-355, Diarrhea, Grade 3-4","KEYNOTE-355, Vomiting, Grade 3-4","KEYNOTE-355, Alopecia, Grade 3-4","KEYNOTE-355, Cough, Grade 3-4","KEYNOTE-355, Headache, Grade 3-4","VIALE-A , Urinary tract infection, Grade 3-4","VIALE-A , Dizziness, Grade 3-4","QUAZAR, Arthralgia, TYPO","QUAZAR, Decreased appetite, TYPO","QUAZAR, Dizziness, TYPO","IMspire150, Photosensitivity reaction, All grades","IMspire150, Nausea, All grades","IMspire150, Hypertension, All grades","IMspire150, Pruritus, Grade 3-4","IMspire150, Photosensitivity reaction, Grade 3-4","IMspire150, Pyrexia, Grade 3-4","IMspire150, Nausea, Grade 3-4","IMspire150, Hypothyroidism, Grade 3-4","RELAY, Diarrhea, All grades","RELAY, Gastrointestinal hemorrhage, Grade ≥ 3","RELAY, Gingival bleeding, Grade ≥ 3","RELAY, Alopecia, Grade ≥ 3","RELAY, Epistaxis, Grade ≥ 3","RELAY, Pulmonary hemorrhage, Grade ≥ 3","INVICTUS , Asthenia, Grades 1-4","INVICTUS , Alopecia, Grade 3-4","INVICTUS , Palmar-plantar erythrodysesthesia, Grade 3-4","INVICTUS , Dry skin, Grade 3-4","INVICTUS , Pruritus, Grade 3-4","INVICTUS , Asthenia, Grade 3-4","INVICTUS , Diarrhea, Grade 3-4","INVICTUS , Stomatitis, Grade 3-4","INVICTUS , Arthralgia, Grade 3-4","INVICTUS , Muscle spasms, Grade 3-4","INVICTUS , Decreased appetite, Grade 3-4","INVICTUS , Weight decreased , Grade 3-4","INVICTUS , Headache, Grade 3-4","INVICTUS , Dyspnea, Grade 3-4","PAOLA-1, Vomiting, TYPO","PRIMA, Nausea, Grade 3-4","PRIMA, Vomiting, Grade 3-4","PRIMA, Dizziness, Grade 3-4","PRIMA, Dyspnea, Grade 3-4","PRIMA, Cough, Grade 3-4","HER2CLIMB, Vomiting, Grade 3","HER2CLIMB, Arthralgia, Grade 3","HER2CLIMB, Increased blood creatinine, Grade 3","HER2CLIMB, Peripheral neuropathy, Grade 3","HER2CLIMB, Epistaxis, Grade 3","HER2CLIMB, Nausea, Grade 4","HER2CLIMB, Vomiting, Grade 4","HER2CLIMB, Stomatitis, Grade 4","HER2CLIMB, Palmar-plantar erythrodysesthesia, Grade 4","HER2CLIMB, Rash, Grade 4","HER2CLIMB, Decreased appetite, Grade 4","HER2CLIMB, Anemia, Grade 4","HER2CLIMB, Arthralgia, Grade 4","HER2CLIMB, Increased blood creatinine, Grade 4","HER2CLIMB, Weight decreased , Grade 4","HER2CLIMB, Peripheral neuropathy, Grade 4","HER2CLIMB, Epistaxis, Grade 4","CHECKMATE-648, Alopecia, All grades","CHECKMATE-648, Constipation, Grade 3-4","CHECKMATE-648, Vomiting, Grade 3-4","CHECKMATE-648, Fatigue/Asthenia, Grade 3-4","CHECKMATE-648, Pyrexia, Grade 3-4","CHECKMATE-648, Edema, Grade 3-4","CHECKMATE-648, Insomnia, Grade 3-4","CHECKMATE-648, Pruritus, Grade 3-4","CHECKMATE-648, Alopecia, Grade 3-4","CHECKMATE-648, Cough, Grade 3-4","CHECKMATE-648, Hypothyroidism, Grade 3-4","CHECKMATE-648, Weight decreased , Grade 3-4","CHECKMATE-648, Musculoskeletal pain, Grade 3-4","CHECKMATE-648, Nausea, All grades","CHECKMATE-648, Constipation, All grades","CHECKMATE-648, Stomatitis, All grades","CHECKMATE-648, Vomiting, All grades","CHECKMATE-648, Dysphagia, All grades","CHECKMATE-648, Abdominal pain, All grades","CHECKMATE-648, Decreased appetite, All grades","CHECKMATE-648, Fatigue/Asthenia, All grades","CHECKMATE-648, Edema, All grades","CHECKMATE-648, Peripheral neuropathy, All grades","CHECKMATE-648, Insomnia, All grades","CHECKMATE-648, Alopecia, All grades","CHECKMATE-648, Cough, All grades","CHECKMATE-648, Nausea, Grade 3-4","CHECKMATE-648, Constipation, Grade 3-4","CHECKMATE-648, Stomatitis, Grade 3-4","CHECKMATE-648, Diarrhea, Grade 3-4","CHECKMATE-648, Vomiting, Grade 3-4","CHECKMATE-648, Decreased appetite, Grade 3-4","CHECKMATE-648, Fatigue/Asthenia, Grade 3-4","CHECKMATE-648, Edema, Grade 3-4","CHECKMATE-648, Peripheral neuropathy, Grade 3-4","CHECKMATE-648, Insomnia, Grade 3-4","CHECKMATE-648, Alopecia, Grade 3-4","CHECKMATE-648, Cough, Grade 3-4","CHECKMATE-648, Hypothyroidism, Grade 3-4","DESTINY-Breast03, Epistaxis, All grades","DESTINY-Breast03, Peripheral neuropathy, All grades","DESTINY-Breast03, Constipation, Grade 3-4","DESTINY-Breast03, Dyspepsia, Grade 3-4","DESTINY-Breast03, Respiratory infection, Grade 3-4","DESTINY-Breast03, Epistaxis, Grade 3-4","DESTINY-Breast03, Peripheral neuropathy, Grade 3-4","VISION, Peripheral edema, Grade 3-4","VISION, Dry mouth, Grade 3-4","VISION, Dysgeusia, Grade 3-4","RELATIVITY-047, Rash, Grade 3-4","RELATIVITY-047, Pruritus, Grade 3-4","RELATIVITY-047, Headache, Grade 3-4","RELATIVITY-047, Hypothyroidism, Grade 3-4","CHECKMATE-816, Nausea, All grades","CHECKMATE-816, Vomiting, All grades","CHECKMATE-816, Decreased appetite, All grades","CHECKMATE-816, Alopecia, All grades","CHECKMATE-816, Nausea, Grade 3-4","CHECKMATE-816, Constipation, Grade 3-4","CHECKMATE-816, Malaise, Grade 3-4","CHECKMATE-816, Decreased appetite, Grade 3-4","CHECKMATE-816, Alopecia, Grade 3-4","CHECKMATE-816, Peripheral neuropathy, Grade 3-4","IMCgp100-202, Dry skin, Grade 3-4","IMCgp100-202, Erythema, Grade 3-4","IMCgp100-202, Edema, Grade 3-4","IMCgp100-202, Abdominal pain, Grade 3-4","IMCgp100-202, Diarrhea, Grade 3-4","IMCgp100-202, Headache, Grade 3-4","ASCEMBL, Rash, All grades","ASCEMBL, Diarrhea, All grades","ASCEMBL, Nausea, All grades","ASCEMBL, Abdominal pain, All grades","ASCEMBL, Upper respiratory tract infection, Grade 3-4","ASCEMBL, Arthralgia, Grade 3-4","ASCEMBL, Fatigue/Asthenia, Grade 3-4","ASCEMBL, Rash, Grade 3-4","ASCEMBL, Diarrhea, Grade 3-4","ASCEMBL, Abdominal pain, Grade 3-4","IMpower010, Pruritus, Grade 3-4","IMpower010, Hypothyroidism, Grade 3-4","IMpower010, Cough, Grade 3-4","monarchE, Dizziness, Grade 3","monarchE, Alopecia, Grade 3","monarchE, Diarrhea, Grade 4","monarchE, Nausea, Grade 4","monarchE, Vomiting, Grade 4","monarchE, Stomatitis, Grade 4","monarchE, Fatigue/Asthenia, Grade 4","monarchE, Headache, Grade 4","monarchE, Dizziness, Grade 4","monarchE, Decreased appetite, Grade 4","monarchE, Rash, Grade 4","monarchE, Alopecia, Grade 4","REACH-3, Edema, All grades","REACH-3, Hemorrhage, All grades","REACH-3, Nausea, All grades","REACH-3, Diarrhea, All grades","REACH-3, Fatigue/Asthenia, Grade ≥ 3","REACH-3, Edema, Grade ≥ 3","REACH-3, Hypertension, Grade ≥ 3","REACH-3, Hemorrhage, Grade ≥ 3","REACH-3, Cough, Grade ≥ 3","REACH-3, Dyspnea, Grade ≥ 3","REACH-3, Nausea, Grade ≥ 3","REACH-3, Diarrhea, Grade ≥ 3","ASPEN, Pneumonia, All grades","ASPEN, Urinary tract infection, All grades","ASPEN, Diarrhea, All grades","ASPEN, Vomiting, All grades","ASPEN, Edema peripheral, All grades","ASPEN, Bruising, All grades","ASPEN, Rash, All grades","ASPEN, Muscle spasms, All grades","ASPEN, Cough, All grades","ASPEN, Hemorrhage, All grades","ASPEN, Hypertension, All grades","ASPEN, Upper respiratory tract infection, Grade 3-4","ASPEN, Pneumonia, Grade 3-4","ASPEN, Urinary tract infection, Grade 3-4","ASPEN, Nausea, Grade 3-4","ASPEN, Constipation, Grade 3-4","ASPEN, Vomiting, Grade 3-4","ASPEN, Fatigue/Asthenia, Grade 3-4","ASPEN, Edema peripheral, Grade 3-4","ASPEN, Bruising, Grade 3-4","ASPEN, Rash, Grade 3-4","ASPEN, Muscle spasms, Grade 3-4","ASPEN, Headache, Grade 3-4","ASPEN, Cough, Grade 3-4","ASPEN, Dyspnea, Grade 3-4","ASPEN, Hemorrhage, Grade 3-4","ASPEN, Hypertension, Grade 3-4","CLEAR, Stomatitis, All Grades","CLEAR, Palmar-plantar erythrodysesthesia, All Grades","CLEAR, Stomatitis, Grade 3-4","CLEAR, Palmar-plantar erythrodysesthesia, Grade 3-4","CLEAR, Dysphonia, Grade 3-4","CLEAR, Headache, Grade 3-4","Study 309, Constipation, Grade 3-4","Study 309, Dysphonia, Grade 3-4","APOLLO, Pyrexia, Grade ≥ 3","APOLLO, Edema peripheral, Grade ≥ 3","APOLLO, Upper respiratory tract infection, Grade ≥ 3","APOLLO, Cough, Grade ≥ 3","CHECKMATE-649, Nausea, Grade 3-4","CHECKMATE-649, Vomiting, Grade 3-4","CHECKMATE-649, Hypoalbuminemia, Grade 3-4","CHECKMATE-649, Musculoskeletal pain, Grade 3-4","CHECKMATE-649, Upper respiratory tract infection, Grade 3-4","ASCENT, Lymphopenia, Grade 3-4","ASCENT, Fatigue/Asthenia, Grade 3-4","ASCENT, Pyrexia, Grade 3-4","ASCENT, Urinary tract infection, Grade 3-4","ASCENT, Upper respiratory tract infection, Grade 3-4","ASCENT, Alanine aminotransferase increased, Grade 3-4","ASCENT, Hypomagnesaemia, Grade 3-4","ASCENT, Back pain, Grade 3-4","ASCENT, Dizziness, Grade 3-4","ASCENT, Insomnia, Grade 3-4","ASCENT, Cough, Grade 3-4","ASCENT, Alopecia, Grade 3-4","ASCENT, Rash, Grade 3-4","ASCENT, Pruritus, Grade 3-4","IKEMA, Cough, Grade 3","IKEMA, Infusion-related reaction, Grade 4","IKEMA, Upper respiratory tract infection, Grade 4","IKEMA, Bronchitis, Grade 4","IKEMA, Hypertension, Grade 4","IKEMA, Dyspnea, Grade 4","IKEMA, Cough, Grade 4","IKEMA, Diarrhea, Grade 4","IKEMA, Vomiting, Grade 4","IKEMA, Fatigue/Asthenia, Grade 4","TIVO-3, Any, All Grades","TIVO-3, Diarrhea, All Grades","TIVO-3, Stomatitis, All Grades","TIVO-3, Rash, All Grades","TIVO-3, Palmar-plantar erythrodysesthesia, All Grades","TIVO-3, Weight decreased , All Grades","TIVO-3, Any, Grade 3-4","TIVO-3, Diarrhea, Grade 3-4","TIVO-3, Nausea, Grade 3-4","TIVO-3, Stomatitis, Grade 3-4","TIVO-3, Vomiting, Grade 3-4","TIVO-3, Cough, Grade 3-4","TIVO-3, Back pain, Grade 3-4","TIVO-3, Rash, Grade 3-4","TIVO-3, Palmar-plantar erythrodysesthesia, Grade 3-4","TIVO-3, Weight decreased , Grade 3-4","Study B7461006, Headache, All Grades","Study B7461006, Dizziness, All Grades","Study B7461006, Cough, All Grades","Study B7461006, Vision disorder, All Grades","Study B7461006, Diarrhea, All Grades","Study B7461006, Nausea, All Grades","Study B7461006, Constipation, All Grades","Study B7461006, Vomiting, All Grades","Study B7461006, Fatigue/Asthenia, All Grades","Study B7461006, Chest pain, All Grades","Study B7461006, Pneumonia, All Grades","Study B7461006, Headache, Grade 3-4","Study B7461006, Dizziness, Grade 3-4","Study B7461006, Cough, Grade 3-4","Study B7461006, Vision disorder, Grade 3-4","Study B7461006, Nausea, Grade 3-4","Study B7461006, Constipation, Grade 3-4","Study B7461006, Vomiting, Grade 3-4","Study B7461006, Pain in extremity, Grade 3-4","Study B7461006, Fatigue/Asthenia, Grade 3-4","Study B7461006, Pyrexia, Grade 3-4","Study B7461006, Upper respiratory tract infection, Grade 3-4","Study B7461006, Pneumonia, Grade 3-4","Study B7461006, Rash, Grade 3-4","Study 1624, Musculoskeletal pain, All Grades","Study 1624, Anemia, All Grades","Study 1624, Fatigue/Asthenia, All Grades","Study 1624, Decreased appetite, All Grades","Study 1624, Pneumonia, All Grades","Study 1624, Musculoskeletal pain, Grade 3-4","Study 1624, Anemia, Grade 3-4","Study 1624, Fatigue/Asthenia, Grade 3-4","Study 1624, Pneumonia, Grade 3-4","Study 1624, Cough, Grade 3-4","CHECKMATE-9ER, Nausea, Grades 1-4","CHECKMATE-9ER, Vomiting, Grades 1-4","CHECKMATE-9ER, Dyspepsia, Grades 1-4","CHECKMATE-9ER, Palmar-plantar erythrodysesthesia, Grades 1-4","CHECKMATE-9ER, Stomatitis, Grades 1-4","CHECKMATE-9ER, Hypertension, Grades 1-4","CHECKMATE-9ER, Dyspepsia, Grade 3-4","CHECKMATE-9ER, Fatigue/Asthenia, Grade 3-4","CHECKMATE-9ER, Palmar-plantar erythrodysesthesia, Grade 3-4","CHECKMATE-9ER, Stomatitis, Grade 3-4","CHECKMATE-9ER, Hypertension, Grade 3-4","CHECKMATE-9ER, Hypothyroidism, Grade 3-4","CHECKMATE-9ER, Arthralgia, Grade 3-4","CHECKMATE-9ER, Dysgeusia, Grade 3-4","CHECKMATE-9ER, Headache, Grade 3-4","CHECKMATE-9ER, Upper respiratory tract infection, Grade 3-4","ANDROMEDA, Upper respiratory tract infection, Grade 3-4","ANDROMEDA, Dyspnea, Grade 3-4","ANDROMEDA, Arthralgia, Grade 3-4","ANDROMEDA, Injection site reactions, Grade 3-4","DESTINY-Gastric01, Diarrhea, All Grades","DESTINY-Gastric01, Abdominal pain, All Grades","DESTINY-Gastric01, Vomiting, Grade 3-4","DESTINY-Gastric01, Constipation, Grade 3-4","DESTINY-Gastric01, Abdominal pain, Grade 3-4","DESTINY-Gastric01, Pyrexia, Grade 3-4","DESTINY-Gastric01, Edema peripheral, Grade 3-4","DESTINY-Gastric01, Alopecia, Grade 3-4","HERO, Musculoskeletal pain, Grade 3-4","HERO, Constipation, Grade 3-4","BOSTON, Peripheral neuropathy, All Grades","BOSTON, Peripheral neuropathy, Grade 3-4","SOPHIA, Diarrhea, All Grades","SOPHIA, Abdominal pain, All Grades","SOPHIA, Palmar-plantar erythrodysesthesia, All Grades","SOPHIA, Decreased appetite, All Grades","SOPHIA, Pyrexia, Grade 3-4","SOPHIA, Diarrhea, Grade 3-4","SOPHIA, Vomiting, Grade 3-4","SOPHIA, Constipation, Grade 3-4","SOPHIA, Abdominal pain, Grade 3-4","SOPHIA, Alopecia, Grade 3-4","SOPHIA, Palmar-plantar erythrodysesthesia, Grade 3-4","SOPHIA, Headache, Grade 3-4","SOPHIA, Peripheral neuropathy, Grade 3-4","SOPHIA, Dyspnea, Grade 3-4","SOPHIA, Decreased appetite, Grade 3-4","SOPHIA, Arthralgia/Myalgia, Grade 3-4","KEYNOTE-204, Nausea, All Grades","KEYNOTE-204, Vomiting, All Grades","KEYNOTE-204, Abdominal pain, All Grades","KEYNOTE-204, Fatigue/Asthenia, All Grades","KEYNOTE-204, Peripheral neuropathy, All Grades","KEYNOTE-204, Headache, All Grades","KEYNOTE-204, Urinary tract infection, Grade 3-4","KEYNOTE-204, Musculoskeletal pain, Grade 3-4","KEYNOTE-204, Nausea, Grade 3-4","KEYNOTE-204, Abdominal pain, Grade 3-4","KEYNOTE-204, pyrexia, Grade 3-4","KEYNOTE-204, Fatigue/Asthenia, Grade 3-4","KEYNOTE-204, Rash, Grade 3-4","KEYNOTE-204, Pruritus, Grade 3-4","KEYNOTE-204, Cough, Grade 3-4","KEYNOTE-204, Dyspnea, Grade 3-4","KEYNOTE-204, Hypothyroidism, Grade 3-4","KEYNOTE-204, Peripheral neuropathy, Grade 3-4","KEYNOTE-204, Headache, Grade 3-4","CHECKMATE-743, Fatigue/Asthenia, All Grades","CHECKMATE-743, Nausea, All Grades","CHECKMATE-743, Constipation, All Grades","CHECKMATE-743, Vomiting, All Grades","CHECKMATE-743, Decreased appetite, All Grades","CHECKMATE-743, Fatigue/Asthenia, Grade 3-4","CHECKMATE-743, Edema, Grade 3-4","CHECKMATE-743, Nausea, Grade 3-4","CHECKMATE-743, Constipation, Grade 3-4","CHECKMATE-743, Vomiting, Grade 3-4","CHECKMATE-743, Dyspnea, Grade 3-4","CHECKMATE-743, Decreased appetite, Grade 3-4","CHECKMATE-743, Hypothyroidism, Grade 3-4","CANDOR, Cough, All Grades","CANDOR, Dyspnea, All Grades","CANDOR, Nausea, Grade 3-4","CANDOR, Cough, Grade 3-4","JAVELIN Bladder 100, Fatigue/Asthenia, Grade 3-4","JAVELIN Bladder 100, Musculoskeletal pain, Grade 3-4","JAVELIN Bladder 100, Nausea, Grade 3-4","JAVELIN Bladder 100, Decreased appetite, Grade 3-4","ATTRACTION-3, Rash, All Grades","ATTRACTION-3, Decreased appetite, All Grades","ATTRACTION-3, Constipation, All Grades","ATTRACTION-3, Nausea, All Grades","ATTRACTION-3, Musculoskeletal pain, All Grades","ATTRACTION-3, Pneumonia, All Grades","ATTRACTION-3, Pyrexia, All Grades","ATTRACTION-3, Fatigue/Asthenia, All Grades","ATTRACTION-3, Anemia, All Grades","ATTRACTION-3, Pruritus, Grade 3-4","ATTRACTION-3, Decreased appetite, Grade 3-4","ATTRACTION-3, Constipation, Grade 3-4","ATTRACTION-3, Nausea, Grade 3-4","ATTRACTION-3, Musculoskeletal pain, Grade 3-4","ATTRACTION-3, Pneumonia, Grade 3-4","ATTRACTION-3, Cough, Grade 3-4","ATTRACTION-3, Pyrexia, Grade 3-4","ATTRACTION-3, Fatigue/Asthenia, Grade 3-4","ATTRACTION-3, Anemia, Grade 3-4","ATTRACTION-3, Hypothyroidism, Grade 3-4","IMbrave150, Fatigue/Asthenia, All Grades","IMbrave150, Rash, All Grades","IMbrave150, Diarrhea, All Grades","IMbrave150, Constipation, All Grades","IMbrave150, Abdominal Pain, All Grades","IMbrave150, Nausea, All Grades","IMbrave150, Decreased Appetite, All Grades","IMbrave150, Fatigue/Asthenia, Grade 3-4","IMbrave150, Pyrexia, Grade 3-4","IMbrave150, Weight decreased , Grade 3-4","IMbrave150, Pruritus, Grade 3-4","IMbrave150, Rash, Grade 3-4","IMbrave150, Diarrhea, Grade 3-4","IMbrave150, Constipation, Grade 3-4","IMbrave150, Abdominal Pain, Grade 3-4","IMbrave150, Nausea, Grade 3-4","IMbrave150, Vomiting, Grade 3-4","IMbrave150, Decreased Appetite, Grade 3-4","IMbrave150, Cough, Grade 3-4","IMbrave150, Epistaxis, Grade 3-4","CHECKMATE-9LA, Nausea, All Grades","CHECKMATE-9LA, Constipation, All Grades","CHECKMATE-9LA, Pyrexia, Grade 3-4","CHECKMATE-9LA, Constipation, Grade 3-4","CHECKMATE-9LA, Abdominal pain, Grade 3-4","CHECKMATE-9LA, Cough, Grade 3-4","ALTA 1L, Diarrhea, All Grades","ALTA 1L, Nausea, All Grades","ALTA 1L, Abdominal pain, All Grades","ALTA 1L, Vomiting, All Grades","ALTA 1L, Constipation, All Grades","ALTA 1L, Dyspepsia, All Grades","ALTA 1L, Gastroesophageal reflux disease, All Grades","ALTA 1L, Pulmonary embolism, All Grades","ALTA 1L, Fatigue/Asthenia, All Grades","ALTA 1L, Edema, All Grades","ALTA 1L, Pyrexia, All Grades","ALTA 1L, Pain in extremity, All Grades","ALTA 1L, Dizziness, All Grades","ALTA 1L, Peripheral neuropathy, All Grades","ALTA 1L, Dysgeusia, All Grades","ALTA 1L, Bradycardia, All Grades","ALTA 1L, Nasopharyngitis, All Grades","ALTA 1L, Urinary tract infection, All Grades","ALTA 1L, Decreased Appetite, All Grades","ALTA 1L, Visual Disturbance0e, All Grades","ALTA 1L, Diarrhea, Grade 3-4","ALTA 1L, Nausea, Grade 3-4","ALTA 1L, Abdominal pain, Grade 3-4","ALTA 1L, Vomiting, Grade 3-4","ALTA 1L, Constipation, Grade 3-4","ALTA 1L, Dyspepsia, Grade 3-4","ALTA 1L, Gastroesophageal reflux disease, Grade 3-4","ALTA 1L, Pruritus, Grade 3-4","ALTA 1L, Cough, Grade 3-4","ALTA 1L, Dyspnea, Grade 3-4","ALTA 1L, Pulmonary embolism, Grade 3-4","ALTA 1L, Fatigue/Asthenia, Grade 3-4","ALTA 1L, Edema, Grade 3-4","ALTA 1L, Myalgia, Grade 3-4","ALTA 1L, Back pain, Grade 3-4","ALTA 1L, Arthralgia, Grade 3-4","ALTA 1L, Pain in extremity, Grade 3-4","ALTA 1L, Dizziness, Grade 3-4","ALTA 1L, Dysgeusia, Grade 3-4","ALTA 1L, Increased Blood cholesterol, Grade 3-4","ALTA 1L, Upper respiratory tract infection, Grade 3-4","ALTA 1L, Nasopharyngitis, Grade 3-4","ALTA 1L, Urinary tract infection, Grade 3-4","ALTA 1L, Decreased Appetite, Grade 3-4","ALTA 1L, Visual Disturbance0e, Grade 3-4","PROfound, Fatigue/Asthenia, Grade 3-4","PROfound, Decreased appetite, Grade 3-4","PROfound, Cough, Grade 3-4","IMpower110, Nausea, All Grades","IMpower110, Constipation, All Grades","IMpower110, Diarrhea, All Grades","IMpower110, Fatigue/Asthenia, All Grades","IMpower110, Decreased appetite, All Grades","IMpower110, Nausea, Grade 3-4","IMpower110, Diarrhea, Grade 3-4","IMpower110, Fatigue/Asthenia, Grade 3-4","IMpower110, Pyrexia, Grade 3-4","CHECKMATE-227, Nausea, All Grades","CHECKMATE-227, Constipation, All Grades","CHECKMATE-227, Vomiting, All Grades","CHECKMATE-227, Edema, Grade 3-4","CHECKMATE-227, Nausea, Grade 3-4","CHECKMATE-227, Constipation, Grade 3-4","CHECKMATE-227, Vomiting, Grade 3-4","CHECKMATE-227, Abdominal pain, Grade 3-4","CHECKMATE-227, Hyperthyroidism, Grade 3-4","E1912, Pyrexia, All Grades","E1912, Nausea, All Grades","E1912, Vomiting, All Grades","E1912, Constipation, All Grades","E1912, Decreased appetite, All Grades","E1912, Insomnia, All Grades","E1912, Fatigue/Asthenia, Grade ≥ 3","E1912, Pyrexia, Grade ≥ 3","E1912, Nausea, Grade ≥ 3","E1912, Stomatitis, Grade ≥ 3","E1912, Constipation, Grade ≥ 3","E1912, Rash, Grade ≥ 3","E1912, Bruising, Grade ≥ 3","E1912, Headache, Grade ≥ 3","E1912, Dizziness, Grade ≥ 3","E1912, Peripheral neuropathy, Grade ≥ 3","E1912, Cough, Grade ≥ 3","E1912, Upper respiratory tract infection, Grade ≥ 3","E1912, Skin infection, Grade ≥ 3","E1912, Decreased appetite, Grade ≥ 3","E1912, Insomnia, Grade ≥ 3","BEACON CRC, Nausea, All Grades","BEACON CRC, Diarrhea, All Grades","BEACON CRC, Abdominal pain, All Grades","BEACON CRC, Vomiting, All Grades","BEACON CRC, Constipation, All Grades","BEACON CRC, Decreased appetite, All Grades","BEACON CRC, Dermatitis acneiform, All Grades","BEACON CRC, Rash, All Grades","BEACON CRC, Fatigue/Asthenia, Grade ≥ 3","BEACON CRC, Pyrexia, Grade ≥ 3","BEACON CRC, Nausea, Grade ≥ 3","BEACON CRC, Diarrhea, Grade ≥ 3","BEACON CRC, Abdominal pain, Grade ≥ 3","BEACON CRC, Vomiting, Grade ≥ 3","BEACON CRC, Constipation, Grade ≥ 3","BEACON CRC, Decreased appetite, Grade ≥ 3","BEACON CRC, Pain in extremity, Grade ≥ 3","BEACON CRC, Dermatitis acneiform, Grade ≥ 3","BEACON CRC, Rash, Grade ≥ 3","BEACON CRC, Pruritus, Grade ≥ 3","BEACON CRC, Melanocytic nevus, Grade ≥ 3","BEACON CRC, Dry skin, Grade ≥ 3","BEACON CRC, Headache, Grade ≥ 3","BEACON CRC, Insomnia, Grade ≥ 3","CASPIAN , Nausea, All Grades","CASPIAN , Constipation, All Grades","CASPIAN , Vomiting, All Grades","CASPIAN , Diarrhea, All Grades","CASPIAN , Alopecia, All Grades","CASPIAN , Fatigue/Asthenia, All Grades","CASPIAN , Nausea, Grade 3-4","CASPIAN , Vomiting, Grade 3-4","CASPIAN , Diarrhea, Grade 3-4","CASPIAN , Hyperthyroidism, Grade 3-4","CASPIAN , Rash, Grade 3-4","CASPIAN , Decreased appetite, Grade 3-4","ICARIA-MM, Nausea, Grade 3","ICARIA-MM, Upper respiratory tract infection, Grade 4","ICARIA-MM, Dyspnea, Grade 4","ICARIA-MM, Diarrhea, Grade 4","ICARIA-MM, Nausea, Grade 4","ICARIA-MM, Vomiting, Grade 4","NALA, Abdominal distension, Grade 3","NALA, Malaise, Grade 3","NALA, Influenza-like illness, Grade 3","NALA, Upper respiratory tract infection, Grade 3","NALA, Back Pain, Grade 3","NALA, Arthralgia, Grade 3","NALA, Muscle spasms, Grade 3","NALA, Dizziness, Grade 3","NALA, Dysuria, Grade 3","NALA, Diarrhea, Grade 4","NALA, Nausea, Grade 4","NALA, Vomiting, Grade 4","NALA, Constipation, Grade 4","NALA, Abdominal distension, Grade 4","NALA, Fatigue/Asthenia, Grade 4","NALA, Malaise, Grade 4","NALA, Influenza-like illness, Grade 4","NALA, Urinary tract infection, Grade 4","NALA, Upper respiratory tract infection, Grade 4","NALA, Decreased appetite, Grade 4","NALA, Back Pain, Grade 4","NALA, Arthralgia, Grade 4","NALA, Muscle spasms, Grade 4","NALA, Dizziness, Grade 4","NALA, Renal impairment, Grade 4","NALA, Dysuria, Grade 4","KEYNOTE-091, Weight Increased, Grade 1–2","KEYNOTE-091, Cough, Grade 1–2","KEYNOTE-091, Hypertension, Grade 1–2","KEYNOTE-091, Dyspnea, Grade 1–2","KEYNOTE-091, Upper respiratory tract infection, Grade 1–2","KEYNOTE-091, Back pain, Grade 1–2","KEYNOTE-091, Headache, Grade 1–2","KEYNOTE-091, Constipation, Grade 1–2","KEYNOTE-091, Influenza-like illness, Grade 1–2","KEYNOTE-091, Pyrexia, Grade 1–2","KEYNOTE-091, Pain in extremity, Grade 1–2","KEYNOTE-091, Paresthesia, Grade 1–2","KEYNOTE-091, Weight Increased, Grade 3","KEYNOTE-091, Pruritus, Grade 3","KEYNOTE-091, Arthralgia, Grade 3","KEYNOTE-091, Diarrhea, Grade 3","KEYNOTE-091, Fatigue/Asthenia, Grade 3","KEYNOTE-091, Hypertension, Grade 3","KEYNOTE-091, Dyspnea, Grade 3","KEYNOTE-091, Upper respiratory tract infection, Grade 3","KEYNOTE-091, Nasopharyngitis, Grade 3","KEYNOTE-091, Increased alanine aminotransferase, Grade 3","KEYNOTE-091, Headache, Grade 3","KEYNOTE-091, Asthenia, Grade 3","KEYNOTE-091, Aspartate aminotransferase increased, Grade 3","KEYNOTE-091, Decreased appetite, Grade 3","KEYNOTE-091, Weight decreased , Grade 3","KEYNOTE-091, Increased blood creatinine, Grade 3","KEYNOTE-091, Productive cough, Grade 3","KEYNOTE-091, Constipation, Grade 3","KEYNOTE-091, Influenza-like illness, Grade 3","KEYNOTE-091, Pneumonitis, Grade 3","KEYNOTE-091, Pyrexia, Grade 3","KEYNOTE-091, Dry skin, Grade 3","KEYNOTE-091, Pain in extremity, Grade 3","KEYNOTE-091, Paresthesia, Grade 3","KEYNOTE-091, Weight Increased, Grade 4","KEYNOTE-091, Pruritus, Grade 4","KEYNOTE-091, Hypothyroidism, Grade 4","KEYNOTE-091, Arthralgia, Grade 4","KEYNOTE-091, Diarrhea, Grade 4","KEYNOTE-091, Fatigue/Asthenia, Grade 4","KEYNOTE-091, Cough, Grade 4","KEYNOTE-091, Hypertension, Grade 4","KEYNOTE-091, Dyspnea, Grade 4","KEYNOTE-091, Hyperthyroidism, Grade 4","KEYNOTE-091, Upper respiratory tract infection, Grade 4","KEYNOTE-091, Nausea, Grade 4","KEYNOTE-091, Nasopharyngitis, Grade 4","KEYNOTE-091, Rash, Grade 4","KEYNOTE-091, Increased alanine aminotransferase, Grade 4","KEYNOTE-091, Back pain, Grade 4","KEYNOTE-091, Headache, Grade 4","KEYNOTE-091, Asthenia, Grade 4","KEYNOTE-091, Maculopapular rash, Grade 4","KEYNOTE-091, Aspartate aminotransferase increased, Grade 4","KEYNOTE-091, Decreased appetite, Grade 4","KEYNOTE-091, Weight decreased , Grade 4","KEYNOTE-091, Increased blood creatinine, Grade 4","KEYNOTE-091, Myalgia, Grade 4","KEYNOTE-091, Productive cough, Grade 4","KEYNOTE-091, Constipation, Grade 4","KEYNOTE-091, Influenza-like illness, Grade 4","KEYNOTE-091, Pyrexia, Grade 4","KEYNOTE-091, Dry skin, Grade 4","KEYNOTE-091, Pain in extremity, Grade 4","KEYNOTE-091, Paresthesia, Grade 4","ZUMA-7, Fatigue/Asthenia, Any Grade","ZUMA-7, Anemia, Any Grade","ZUMA-7, Nausea, Any Grade","ZUMA-7, Thrombocytopenia, Any Grade","ZUMA-7, Hypokalemia, Any Grade","ZUMA-7, Decreased appetite, Any Grade","ZUMA-7, Constipation, Any Grade","ZUMA-7, Vomiting, Any Grade","ZUMA-7, Febrile neutropenia, Any Grade","ZUMA-7, Paresthesia, Any Grade","ZUMA-7, Delirium, Any Grade","ZUMA-7, Anemia, Grade ≥3","ZUMA-7, Diarrhea, Grade ≥3","ZUMA-7, Nausea, Grade ≥3","ZUMA-7, Thrombocytopenia, Grade ≥3","ZUMA-7, Hypokalemia, Grade ≥3","ZUMA-7, Decreased appetite, Grade ≥3","ZUMA-7, Dizziness, Grade ≥3","ZUMA-7, Constipation, Grade ≥3","ZUMA-7, Vomiting, Grade ≥3","ZUMA-7, Febrile neutropenia, Grade ≥3","KEYNOTE-811, Anemia, Any grade","KEYNOTE-811, Decreased appetite, Any grade","KEYNOTE-811, Platelet count decreased, Any grade","KEYNOTE-811, Neutrophil count decreased, Any grade","KEYNOTE-811, Constipation, Any grade","KEYNOTE-811, Neuropathy peripheral, Any grade","KEYNOTE-811, Hypoalbuminemia, Any grade","KEYNOTE-811, White-cell count decreased, Any grade","KEYNOTE-811, Asthenia, Any grade","KEYNOTE-811, Thrombocytopenia, Any grade","KEYNOTE-811, Diarrhea, Grade 3-5","KEYNOTE-811, Nausea, Grade 3-5","KEYNOTE-811, Anemia, Grade 3-5","KEYNOTE-811, Decreased appetite, Grade 3-5","KEYNOTE-811, Neutrophil count decreased, Grade 3-5","KEYNOTE-811, Aspartate aminotransferase increased, Grade 3-5","KEYNOTE-811, Palmar-plantar erythrodysesthesia, Grade 3-5","KEYNOTE-811, Neutropenia, Grade 3-5","KEYNOTE-811, Neuropathy peripheral, Grade 3-5","KEYNOTE-811, Hypokalemia, Grade 3-5","KEYNOTE-811, Alanine aminotransferase increased, Grade 3-5","KEYNOTE-811, Hypoalbuminemia, Grade 3-5","KEYNOTE-811, White-cell count decreased, Grade 3-5","KEYNOTE-811, Malaise, Grade 3-5","KEYNOTE-811, Stomatitis, Grade 3-5","KEYNOTE-811, Asthenia, Grade 3-5","KEYNOTE‑177, Diarrhea, Any grade","KEYNOTE‑177, Fatigue/Asthenia, Any grade","KEYNOTE‑177, Nausea, Any grade","KEYNOTE‑177, Abdominal pain, Any grade","KEYNOTE‑177, Decreased appetite, Any grade","KEYNOTE‑177, Vomiting, Any grade","KEYNOTE‑177, Anemia, Any grade","KEYNOTE‑177, Back pain, Any grade","KEYNOTE‑177, Constipation, Any grade","KEYNOTE‑177, Dizziness, Any grade","KEYNOTE‑177, Headache, Any grade","KEYNOTE‑177, Asthenia, Any grade","KEYNOTE‑177, Urinary tract infection, Any grade","KEYNOTE‑177, Hypokalemia, Any grade","KEYNOTE‑177, Alopecia, Any grade","KEYNOTE‑177, Stomatitis, Any grade","KEYNOTE‑177, Dyspepsia, Any grade","KEYNOTE‑177, Mucosal inflammation, Any grade","KEYNOTE‑177, Weight decreased , Any grade","KEYNOTE‑177, Peripheral sensory neuropathy, Any grade","KEYNOTE‑177, Neutrophil count decreased, Any grade","KEYNOTE‑177, Neutropenia, Any grade","KEYNOTE‑177, Epistaxis, Any grade","KEYNOTE‑177, Peripheral neuropathy, Any grade","KEYNOTE‑177, PPE syndrome, Any grade","KEYNOTE‑177, White-cell count decrease, Any grade","KEYNOTE‑177, Diarrhea, Grade ≥3","KEYNOTE‑177, Fatigue/Asthenia, Grade ≥3","KEYNOTE‑177, Nausea, Grade ≥3","KEYNOTE‑177, Abdominal pain, Grade ≥3","KEYNOTE‑177, Decreased appetite, Grade ≥3","KEYNOTE‑177, Vomiting, Grade ≥3","KEYNOTE‑177, Anemia, Grade ≥3","KEYNOTE‑177, Pruritus, Grade ≥3","KEYNOTE‑177, Back pain, Grade ≥3","KEYNOTE‑177, Constipation, Grade ≥3","KEYNOTE‑177, Cough, Grade ≥3","KEYNOTE‑177, Dizziness, Grade ≥3","KEYNOTE‑177, Headache, Grade ≥3","KEYNOTE‑177, Rash, Grade ≥3","KEYNOTE‑177, Upper abdominal pain, Grade ≥3","KEYNOTE‑177, Nasopharyngitis, Grade ≥3","KEYNOTE‑177, Asthenia, Grade ≥3","KEYNOTE‑177, Dry skin, Grade ≥3","KEYNOTE‑177, Hypothyroidism, Grade ≥3","KEYNOTE‑177, Pain in extremity, Grade ≥3","KEYNOTE‑177, Peripheral edema, Grade ≥3","KEYNOTE‑177, Dry mouth, Grade ≥3","KEYNOTE‑177, Upper respiratory tract infection, Grade ≥3","KEYNOTE‑177, Urinary tract infection, Grade ≥3","KEYNOTE‑177, Hypokalemia, Grade ≥3","KEYNOTE‑177, Alopecia, Grade ≥3","KEYNOTE‑177, Stomatitis, Grade ≥3","KEYNOTE‑177, Dyspepsia, Grade ≥3","KEYNOTE‑177, Mucosal inflammation, Grade ≥3","KEYNOTE‑177, Weight decreased , Grade ≥3","KEYNOTE‑177, Peripheral sensory neuropathy, Grade ≥3","KEYNOTE‑177, Neutrophil count decreased, Grade ≥3","KEYNOTE‑177, Neutropenia, Grade ≥3","KEYNOTE‑177, Epistaxis, Grade ≥3","KEYNOTE‑177, Peripheral neuropathy, Grade ≥3","KEYNOTE‑177, PPE syndrome, Grade ≥3","KEYNOTE‑177, White-cell count decrease, Grade ≥3"],"type":"scatter","mode":"markers","marker":{"autocolorscale":false,"color":"rgba(48,26,75,1)","opacity":0.55,"size":5.66929133858268,"symbol":"circle","line":{"width":1.88976377952756,"color":"rgba(48,26,75,1)"}},"hoveron":"points","name":"control","legendgroup":"control","showlegend":true,"xaxis":"x","yaxis":"y","hoverinfo":"text","_isNestedKey":false,"frame":null},{"x":[0.4,0.01,0.17,0.01,0.14,0.1,0.015,0.09,0.045,0.18,0.06,0.3,0.14,0.1,0.07,0.07,0.07,0.033,0.018,0.015,0.003,0,0,0.67,0.09,0.64,0.23,0.22,0.17,0.12,0.37,0.2,0.19,0.14,0.14,0.13,0.11,0.11,0.16,0.14,0.14,0.11,0.06,0.09,0.005,0.16,0.002,0.011,0.005,0.018,0.002,0.005,0.007,0,0.002,0,0.007,0.23,0.35,0.25,0.16,0.14,0.06,0.51,0.04,0.12,0.15,0.17,0.07,0.19,0.02,0.01,0,0.04,0,0,0.39,0.19,0.09,0.1,0.06,0.1,0.026,0.1,0.08,0.01,0.009,0,0.009,0.01,0.004,0,0.17,0.15,0.08,0.04,0.05,0.026,0.1,0.12,0.013,0.08,0.05,0.004,0.009,0.04,0.004,0.026,0,0.004,0,0.22,0.1,0.14,0.07,0.046,0.009,0.009,0,0.08,0.37,0.15,0.14,0.06,0.021,0.1,0.06,0.045,0.32,0.08,0.22,0.25,0.12,0.09,0.08,0.006,0.045,0.012,0.042,0.06,0.16,0.11,0.1,0.07,0.18,0.19,0.12,0.08,0.07,0.07,0,0,0,0,0.02,0,0,0.007,0.06,0.09,0.043,0.06,0.17,0.043,0.008,0,0.008,0.16,0.34,0.29,0.23,0.15,0.23,0.14,0.08,0.006,0.003,0.009,0,0.2,0.13,0.15,0.13,0.16,0.09,0.002,0.012,0.037,0.3,0.13,0.22,0.22,0.13,0.12,0.48,0.33,0.27,0.19,0.31,0.08,0.035,0.06,0.06,0.05,0.006,0.09,0,0,0,0,0.047,0,0.05,0.012,0.006,0,0,0,0,0,0.012,0.19,0.37,0,0.21,0.37,0.24,0.23,0.04,0.14,0.12,0.04,0.07,0.03,0.1,0.09,0.08,0.1,0,0.04,0.09,0.07,0.51,0,0.03,0.01,0,0.09,0,0,0.12,0.01,0,0,0,0.01,0.38,0.27,0.07,0.12,0.08,0.01,0.04,0.08,0.08,0.15,0.03,0.03,0,0.08,0.01,0.23,0.08,0.14,0.045,0.28,0.039,0.06,0.07,0.17,0.048,0.07,0.06,0,0,0,0.007,0.003,0.003,0.008,0.001,0,0.02,0.01,0.1,0.06,0.18,0.08,0.07,0.03,0.04,0.02,0.1,0.06,0.02,0,0,0,0,0,0,0,0.36,0.31,0.15,0.13,0.23,0.1,0.036,0.002,0.12,0.13,0.07,0.1,0.006,0.002,0.004,0,0.002,0,0.002,0,0,0,0.006,0.002,0.57,0.15,0.46,0.3,0.26,0.23,0.003,0.06,0.016,0.019,0.08,0.03,0.02,0.08,0.03,0.02,0.23,0.16,0,0.05,0.05,0,0.02,0.02,0,0.03,0,0,0,0,0,0,0,0,0.03,0,0,0,0,0.31,0.29,0.17,0.22,0.15,0.2,0.09,0.19,0.05,0.07,0.07,0,0.07,0,0,0,0,0.19,0.16,0.32,0.27,0.13,0.24,0.011,0.023,0.16,0.11,0.06,0.07,0.09,0.08,0.003,0.003,0.017,0,0.006,0,0.009,0.003,0,0.006,0.66,0.19,0.66,0.39,0.34,0.29,0.28,0.23,0.58,0.41,0.29,0.19,0.24,0.17,0.19,0.039,0.003,0.018,0.018,0.01,0.015,0.005,0.023,0.003,0,0,0.003,0,0.21,0.29,0.1,0.06,0.09,0.2,0.08,0.1,0.015,0.008,0,0.004,0.004,0,0,0,0.008,0.63,0.33,0.32,0.26,0.46,0.38,0.03,0.05,0.038,0.09,0.2,0.07,0.07,0.19,0.038,0.07,0.09,0.1,0.1,0.07,0.09,0.09,0.038,0.003,0,0,0,0,0,0,0,0.003,0,0.23,0.27,0.22,0.16,0.2,0.14,0.043,0.004,0,0.004,0.35,0.33,0.23,0.13,0.13,0.19,0.28,0.23,0.19,0.24,0.08,0.17,0.15,0.16,0.09,0.1,0.08,0.01,0.03,0.01,0,0,0.19,0.01,0.02,0,0.03,0.03,0.01,0,0.14,0.02,0.24,0.1,0.21,0.24,0.13,0.25,0.17,0.1,0.05,0.06,0.08,0.09,0.01,0,0.01,0,0.01,0.01,0.05,0,0.08,0.72,0.17,0.45,0.35,0.21,0.36,0.15,0.48,0.1,0.08,0.08,0.06,0.23,0.018,0,0.13,0.01,0.032,0,0.01,0.01,0.07,0.76,0.12,0.36,0.03,0.01,0.08,0.2,0.12,0.02,0.04,0.07,0.07,0.05,0.01,0.01,0,0,0,0.047,0,0.07,0.047,0.23,0.07,0.12,0.3,0.19,0.14,0.07,0,0.12,0.047,0.047,0.21,0.12,0.047,0.047,0,0.023,0,0,0.047,0,0,0,0,0.32,0.22,0.11,0.1,0.09,0.1,0.015,0.007,0.004,0.011,0.015,0.05,0.18,0.08,0.09,0.28,0.2,0.12,0.41,0.07,0.08,0.38,0.15,0.13,0.15,0.05,0.13,0.15,0.07,0.004,0.02,0.01,0.004,0.004,0.01,0.008,0,0,0,0.004,0,0.01,0.53,0.44,0.25,0.21,0.53,0.15,0.24,0.2,0.13,0.046,0.015,0.06,0.07,0.05,0.09,0.03,0.005,0.09,0.005,0.036,0,0.025,0.005,0,0,0.56,0.43,0.35,0.2,0.19,0.12,0.11,0.5,0.41,0.12,0.13,0.13,0.1,0.07,0.036,0.13,0.1,0.003,0.11,0.08,0.026,0.03,0.02,0.049,0.007,0.06,0.01,0,0.026,0.2,0.12,0.07,0.036,0.1,0.003,0.11,0.08,0.049,0.007,0.003,0,0,0.026,0.01,0.003,0.3,0.1,0.2,0.07,0.08,0.05,0.06,0.35,0.17,0.031,0.25,0.17,0.06,0.12,0.1,0.019,0.16,0.08,0.004,0.008,0.004,0.004,0,0.008,0.06,0,0.004,0.004,0.004,0,0,0,0,0.23,0.15,0.09,0.07,0.034,0.005,0.17,0.11,0.06,0.029,0.06,0.13,0.044,0.01,0.06,0.044,0.02,0.015,0.015,0.005,0,0,0.005,0.005,0.005,0.005,0.005,0.049,0.01,0.005,0.029,0,0,0.31,0.29,0.21,0.17,0.17,0.14,0.12,0.14,0.07,0.11,0.017,0.006,0.014,0,0.003,0,0.32,0.23,0.14,0.07,0.06,0.006,0.011,0,0.027,0.28,0.23,0.036,0.05,0.009,0,0.07,0.42,0.036,0.1,0.26,0.33,0.09,0.2,0.027,0.1,0.16,0,0,0,0.009,0.009,0,0.009,0,0,0,0.12,0.16,0.039,0.15,0.11,0.05,0.013,0,0.039,0,0.014,0.006,0.006,0.11,0.022,0.05,0.07,0.09,0.06,0,0.002,0.002,0.002,0.002,0,0.09,0.09,0.046,0.05,0.39,0.18,0.15,0.07,0.024,0.045,0.027,0.002,0.001,0.001,0,0.027,0.001,0.002,0.001,0,0.001,0.13,0.09,0.1,0.13,0.08,0.08,0,0.01,0.4,0.13,0.07,0.25,0.13,0.06,0.39,0.14,0.12,0.07,0.02,0.02,0,0.01,0,0.56,0.5,0.33,0.18,0.2,0.19,0.41,0.32,0.43,0.26,0.31,0.17,0.04,0.13,0.16,0.09,0.21,0.16,0.08,0.06,0.01,0.01,0.01,0,0.03,0,0.2,0.04,0.01,0.01,0.03,0.02,0,0.05,0.009,0.06,0.15,0.54,0.2,0.47,0.21,0.26,0.21,0.25,0.27,0.21,0.06,0.034,0.13,0.09,0.006,0.009,0.049,0,0.025,0.009,0.06,0.028,0.015,0.022,0.012,0.012,0.006,0,0.003,0.003,0.012,0.003,0,0,0.39,0.14,0.09,0.27,0.22,0.14,0.08,0.05,0.17,0.01,0.46,0.06,0.44,0.34,0.29,0.24,0.21,0.13,0.4,0.11,0.08,0.26,0.09,0.15,0.08,0.05,0.14,0.044,0.12,0.09,0.07,0.048,0.003,0.037,0.026,0.004,0.008,0.05,0.004,0.001,0.025,0.007,0.037,0.004,0.001,0.008,0,0.44,0.28,0.12,0.06,0.17,0.26,0.16,0.23,0.12,0.13,0.5,0.14,0.08,0.03,0.1,0.21,0.13,0.06,0.14,0.07,0.13,0.07,0.05,0.18,0.16,0.05,0.03,0.34,0.06,0.06,0.01,0.004,0.01,0,0.01,0.01,0.01,0.004,0,0.004,0.033,0.57,0.3,0.13,0.32,0.24,0.15,0.29,0.09,0.32,0,0.07,0.15,0.008,0.18,0.008,0.025,0.008,0.033,0.025,0.48,0.31,0.12,0.18,0.17,0.3,0.09,0.15,0.11,0.11,0.16,0.12,0.17,0.01,0.04,0,0.01,0,0.05,0.15,0.06,0.1,0.16,0,0.021,0.11,0.07,0.11,0.08,0.4,0.13,0.13,0.077,0.021,0.085,0,0.007,0,0,0.021,0,0,0.007,0,0,0,0.014,0.021,0.007,0,0.06,0.08,0,0.003,0.47,0.15,0.5,0.26,0.14,0.044,0.3,0.29,0.09,0.2,0.22,0.12,0.17,0.034,0.08,0.044,0.003,0.003,0.003,0.05,0,0,0.031,0.013,0,0,0.21,0.09,0.3,0.29,0.2,0.2,0.11,0.06,0.05,0.05,0.05,0,0.05,0.04,0,0.02,0,0,0,0.02,0.47,0.08,0.23,0.048,0.45,0.032,0.31,0.032,0.44,0.16,0,0.15,0,0.016,0.016,0.016,0,0.13,0.016,0.23,0.032,0.048,0,0.016,0.52,0.29,0.24,0.07,0.1,0,0,0,0.1,0.25,0.044,0.21,0.11,0.05,0.12,0.039,0.22,0.06,0.06,0,0.01,0,0.05,0.01,0,0.01,0,0.015,0.015,0,0.47,0.14,0.32,0.14,0.17,0.15,0.16,0.15,0.12,0.11,0.12,0.09,0.03,0.045,0.004,0,0,0,0.24,0.03,0.29,0.17,0.19,0.12,0.14,0.03,0.07,0.03,0,0.013,0,0.013,0.046,0.08,0.17,0.011,0.11,0.014,0.12,0.1,0.16,0.09,0.014,0.07,0.042,0.007,0.011,0,0.004,0,0.011,0.007,0,0,0.021,0.28,0.28,0.15,0.29,0.12,0.12,0.3,0.31,0.14,0.13,0.28,0.11,0.1,0.05,0.08,0.007,0.033,0.09,0.013,0.16,0.14,0.007,0.13,0.026,0.02,0.013,0.13,0.035,0.15,0.06,0.023,0.017,0.11,0.049,0.09,0.06,0.035,0.046,0.07,0.006,0,0,0,0,0,0.038,0.003,0,0.006,0,0,0,0.07,0.17,0.14,0.14,0.014,0.01,0.014,0,0.24,0.1,0.07,0.1,0.1,0.08,0.1,0.045,0,0.12,0.006,0,0.4,0.1,0.27,0.18,0.17,0.11,0.1,0.029,0.1,0.22,0.15,0.14,0.034,0.07,0.06,0.049,0.02,0.009,0.017,0.014,0.003,0,0.006,0.017,0.032,0,0,0,0.088,0.17,0.058,0.2,0.22,0.022,0.08,0.23,0.17,0.12,0.17,0.007,0.066,0.1,0,0,0.007,0.029,0,0,0,0,0.029,0.15,0.03,0.19,0.07,0.12,0.32,0.18,0.02,0.03,0.05,0,0,0,0.01,0,0.09,0.1,0.1,0.008,0,0,0,0.42,0.11,0.12,0.1,0.033,0.26,0.16,0.025,0.16,0.09,0.16,0.13,0.1,0.012,0.005,0.08,0.06,0.044,0.004,0.004,0,0.014,0.007,0.002,0.009,0.021,0,0.012,0,0.04,0,0.78,0.17,0.08,0.35,0.1,0.27,0.08,0.1,0.29,0.04,0.22,0.08,0.27,0.13,0.13,0.25,0.21,0.19,0.03,0.04,0,0,0.02,0.01,0.01,0.01,0,0.06,0.01,0.01,0,0.5,0.15,0.03,0.04,0.01,0.06,0,0.12,0.03,0.06,0.09,0.06,0,0,0,0,0.09,0.004,0.06,0.17,0,0,0.008,0.023,0,0.23,0.42,0.02,0.12,0.19,0.09,0.034,0,0.16,0.034,0.013,0.013,0.007,0,0,0.027,0.007,0.66,0.42,0.31,0.13,0.032,0.4,0.023,0.013,0.042,0.045,0.22,0.08,0.06,0.019,0.1,0.01,0.019,0.13,0.029,0.019,0,0.045,0.006,0.023,0,0.12,0.05,0.13,0.14,0.15,0.03,0.06,0.06,0.05,0.05,0.05,0.03,0.05,0.04,0.04,0.06,0.03,0.03,0.02,0.04,0,0,0,0,0,0,0,0,0,0.26,0.42,0.15,0.39,0.26,0.1,0.26,0.08,0.17,0.11,0.08,0.12,0.01,0.02,0,0.01,0.01,0.41,0.03,0.02,0.01,0.01,0.22,0,0.12,0,0.04,0,0,0,0,0,0.01,0.444,0.444,0.273,0.199,0.185,0.13,0.171,0.162,0.153,0.116,0.102,0.093,0.12,0.088,0.102,0.056,0.019,0.069,0.028,0.014,0.005,0,0.009,0,0.005,0.009,0.05,0.14,0.08,0.16,0.08,0.11,0.04,0.1,0.11,0.08,0.07,0.09,0.11,0.02,0.08,0.08,0.06,0.06,0,0,0.02,0.02,0.01,0,0.05],"y":[0.49,0.04,0.21,0.02,0.2,0.14,0.03,0.13,0.1,0.48,0.14,0.38,0.3,0.19,0.13,0.16,0.14,0.16,0.05,0.023,0.01,0.01,0.003,0.68,0.15,0.66,0.26,0.23,0.19,0.13,0.42,0.31,0.22,0.16,0.15,0.16,0.14,0.13,0.17,0.17,0.15,0.14,0.08,0.15,0.014,0.18,0.009,0.016,0.011,0.039,0.011,0.014,0.011,0.014,0.005,0.007,0.011,0.62,0.59,0.34,0.23,0.2,0.11,0.6,0.1,0.15,0.16,0.2,0.12,0.48,0.12,0.1,0.01,0.08,0.02,0.02,0.41,0.35,0.19,0.13,0.12,0.11,0.1,0.15,0.11,0.07,0.025,0.008,0.01,0.02,0.008,0.02,0.33,0.28,0.13,0.27,0.14,0.24,0.15,0.14,0.13,0.12,0.11,0.017,0.013,0.05,0.04,0.07,0.004,0.06,0.008,0.27,0.14,0.16,0.1,0.07,0.012,0.015,0.003,0.12,0.42,0.22,0.18,0.1,0.13,0.27,0.1,0.11,0.36,0.19,0.29,0.28,0.17,0.15,0.11,0.024,0.05,0.015,0.08,0.13,0.25,0.14,0.12,0.11,0.23,0.23,0.17,0.11,0.13,0.11,0.013,0.016,0.003,0.013,0.038,0.01,0.013,0.022,0.23,0.13,0.1,0.14,0.22,0.06,0.013,0.003,0.026,0.2,0.4,0.32,0.24,0.17,0.26,0.23,0.11,0.015,0.006,0.021,0.009,0.23,0.19,0.19,0.18,0.18,0.14,0.018,0.021,0.07,0.76,0.4,0.34,0.27,0.18,0.13,0.54,0.4,0.39,0.32,0.32,0.16,0.16,0.15,0.11,0.14,0.12,0.1,0.046,0.016,0.008,0.005,0.09,0.003,0.1,0.024,0.013,0.003,0.003,0.005,0.003,0.013,0.013,0.47,0.39,0.49,0.42,0.39,0.34,0.29,0.09,0.22,0.21,0.2,0.1,0.04,0.14,0.14,0.13,0.13,0.12,0.12,0.1,0.1,0.8,0.01,0.43,0.04,0.02,0.25,0.03,0.01,0.15,0.03,0.01,0.01,0.01,0.04,0.42,0.41,0.2,0.18,0.15,0.13,0.15,0.13,0.3,0.2,0.11,0.1,0.01,0.1,0.04,0.57,0.23,0.18,0.1,0.42,0.24,0.17,0.16,0.2,0.12,0.11,0.13,0.008,0.007,0.001,0.018,0.09,0.03,0.05,0.002,0.002,0.14,0.1,0.18,0.08,0.2,0.09,0.14,0.06,0.07,0.06,0.23,0.16,0.07,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.41,0.4,0.3,0.23,0.27,0.16,0.21,0.12,0.17,0.15,0.14,0.13,0.012,0.012,0.014,0.002,0.027,0.004,0.004,0.002,0.002,0.002,0.037,0.012,0.58,0.22,0.47,0.36,0.27,0.24,0.036,0.07,0.02,0.026,0.09,0.51,0.24,0.14,0.26,0.1,0.42,0.23,0.46,0.3,0.18,0.1,0.1,0.1,0.05,0.15,0.07,0.03,0.01,0.05,0.01,0.1,0.03,0.1,0.1,0.01,0.02,0.02,0.01,0.43,0.41,0.35,0.35,0.23,0.23,0.27,0.24,0.18,0.15,0.13,0.11,0.09,0.02,0.02,0.07,0.01,0.36,0.3,0.36,0.3,0.16,0.28,0.11,0.11,0.17,0.14,0.11,0.13,0.11,0.11,0.017,0.011,0.028,0.006,0.009,0.003,0.017,0.009,0.003,0.04,0.7,0.28,0.67,0.42,0.41,0.34,0.31,0.24,0.61,0.52,0.3,0.2,0.26,0.23,0.21,0.08,0.013,0.037,0.032,0.027,0.027,0.05,0.033,0.005,0.005,0.001,0.009,0.005,0.23,0.34,0.21,0.13,0.13,0.21,0.1,0.15,0.11,0.009,0.008,0.008,0.009,0.004,0.004,0.002,0.009,0.67,0.36,0.34,0.27,0.57,0.44,0.041,0.07,0.06,0.12,0.47,0.32,0.12,0.4,0.37,0.29,0.19,0.14,0.13,0.1,0.13,0.1,0.13,0.024,0.018,0.003,0.006,0.009,0.003,0.006,0.003,0.006,0.006,0.28,0.28,0.26,0.26,0.23,0.21,0.05,0.005,0.02,0.008,0.44,0.43,0.3,0.18,0.18,0.42,0.36,0.31,0.27,0.27,0.12,0.25,0.25,0.22,0.16,0.18,0.17,0.02,0.05,0.02,0.01,0.01,0.42,0.02,0.06,0.01,0.07,0.05,0.04,0.01,0.22,0.04,0.65,0.6,0.5,0.39,0.22,0.44,0.27,0.14,0.11,0.13,0.12,0.11,0.03,0.03,0.05,0.01,0.02,0.04,0.09,0.01,0.11,0.75,0.26,0.51,0.49,0.26,0.5,0.23,0.62,0.22,0.18,0.1,0.12,0.27,0.03,0.01,0.21,0.013,0.043,0.01,0.026,0.013,0.1,0.81,0.45,0.42,0.1,0.09,0.34,0.34,0.34,0.07,0.23,0.15,0.17,0.24,0.07,0.02,0.03,0.01,0.01,0.52,0.21,0.13,0.11,0.42,0.17,0.39,0.36,0.34,0.28,0.21,0.11,0.32,0.18,0.15,0.27,0.19,0.19,0.14,0.13,0.035,0.012,0.035,0.07,0.012,0.035,0.012,0.07,0.53,0.53,0.22,0.41,0.24,0.18,0.05,0.024,0.17,0.07,0.019,0.66,0.64,0.42,0.28,0.57,0.4,0.22,0.51,0.14,0.19,0.39,0.26,0.19,0.25,0.12,0.22,0.18,0.18,0.39,0.31,0.21,0.05,0.01,0.03,0.03,0.01,0.01,0.004,0.01,0.002,0.06,0.81,0.58,0.36,0.32,0.63,0.2,0.42,0.25,0.21,0.15,0.14,0.13,0.13,0.12,0.12,0.037,0.025,0.13,0.007,0.09,0.005,0.037,0.01,0.005,0.002,0.65,0.44,0.44,0.29,0.23,0.14,0.13,0.51,0.47,0.19,0.16,0.18,0.16,0.16,0.11,0.16,0.13,0.07,0.12,0.11,0.042,0.09,0.029,0.07,0.019,0.07,0.013,0.006,0.05,0.22,0.23,0.31,0.17,0.14,0.14,0.12,0.14,0.05,0.009,0.009,0.031,0.009,0.08,0.019,0.006,0.76,0.49,0.34,0.29,0.21,0.2,0.11,0.49,0.33,0.37,0.31,0.29,0.17,0.22,0.11,0.11,0.22,0.13,0.07,0.016,0.012,0.008,0.008,0.06,0.07,0.004,0.012,0.016,0.012,0.004,0.008,0.004,0.004,0.43,0.21,0.11,0.1,0.07,0.39,0.35,0.2,0.19,0.19,0.11,0.32,0.17,0.12,0.09,0.08,0.07,0.07,0.06,0.019,0.004,0.004,0.013,0.011,0.009,0.008,0.011,0.13,0.08,0.038,0.032,0.009,0.008,0.45,0.39,0.28,0.25,0.24,0.17,0.18,0.17,0.15,0.15,0.042,0.02,0.02,0.006,0.006,0.003,0.34,0.26,0.15,0.2,0.13,0.011,0.023,0.023,0.89,0.83,0.69,0.31,0.28,0.24,0.2,0.76,0.64,0.48,0.45,0.49,0.45,0.3,0.25,0.39,0.31,0.22,0.008,0.18,0.045,0.037,0.06,0.004,0.02,0.012,0.033,0.008,0.26,0.22,0.12,0.19,0.17,0.13,0.026,0.019,0.06,0.006,0.17,0.1,0.14,0.16,0.14,0.14,0.12,0.14,0.11,0.012,0.008,0.006,0.004,0.008,0.006,0.84,0.3,0.18,0.14,0.51,0.41,0.2,0.11,0.12,0.11,0.11,0.08,0.005,0.005,0.001,0.049,0.029,0.003,0.006,0.004,0.006,0.18,0.16,0.13,0.16,0.13,0.11,0.01,0.02,0.44,0.18,0.16,0.31,0.16,0.11,0.45,0.18,0.13,0.14,0.03,0.04,0.01,0.09,0.01,0.63,0.62,0.36,0.27,0.26,0.25,0.58,0.57,0.56,0.27,0.41,0.37,0.3,0.3,0.21,0.3,0.25,0.23,0.09,0.1,0.03,0.02,0.03,0.01,0.04,0.01,0.29,0.05,0.04,0.05,0.08,0.05,0.08,0.09,0.67,0.67,0.25,0.58,0.55,0.49,0.37,0.35,0.34,0.27,0.53,0.44,0.34,0.29,0.31,0.26,0.22,0.23,0.2,0.009,0.39,0.026,0.11,0.08,0.029,0.023,0.026,0.026,0.05,0.07,0.1,0.06,0.05,0.006,0.029,0.023,0.46,0.19,0.15,0.38,0.36,0.22,0.13,0.13,0.23,0.05,0.53,0.11,0.48,0.39,0.31,0.27,0.25,0.17,0.44,0.19,0.12,0.29,0.14,0.17,0.14,0.12,0.2,0.18,0.13,0.13,0.1,0.07,0.008,0.05,0.028,0.006,0.018,0.07,0.01,0.005,0.036,0.013,0.07,0.031,0.017,0.015,0.001,0.64,0.4,0.17,0.1,0.59,0.57,0.33,0.37,0.3,0.17,0.65,0.15,0.13,0.12,0.11,0.28,0.16,0.12,0.16,0.12,0.18,0.1,0.11,0.24,0.47,0.12,0.1,0.52,0.09,0.11,0.11,0.03,0.02,0.004,0.03,0.02,0.02,0.03,0.004,0.008,0.46,0.67,0.36,0.24,0.37,0.29,0.23,0.36,0.15,0.42,0.006,0.09,0.19,0.023,0.2,0.05,0.028,0.011,0.05,0.034,0.67,0.44,0.17,0.3,0.18,0.39,0.27,0.22,0.15,0.24,0.19,0.13,0.24,0.03,0.05,0.01,0.03,0.01,0.16,0.34,0.21,0.11,0.2,0.027,0.18,0.19,0.15,0.15,0.17,0.56,0.38,0.17,0.11,0.067,0.11,0.02,0.02,0.02,0.013,0.027,0.02,0.1,0.013,0.007,0.007,0.007,0.04,0.17,0.013,0.02,0.15,0.11,0.014,0.006,0.64,0.22,0.51,0.44,0.36,0.19,0.34,0.33,0.18,0.28,0.24,0.16,0.2,0.17,0.2,0.07,0.006,0.019,0.019,0.11,0.031,0.003,0.038,0.019,0.003,0.003,0.4,0.15,0.36,0.34,0.31,0.26,0.2,0.12,0.1,0.1,0.11,0.11,0.1,0.06,0.02,0.03,0.01,0.02,0.01,0.04,0.63,0.26,0.24,0.11,0.6,0.06,0.58,0.048,0.55,0.24,0.1,0.22,0.1,0.08,0.048,0.024,0.016,0.17,0.024,0.38,0.048,0.09,0.024,0.032,0.54,0.3,0.26,0.12,0.12,0.006,0.003,0.002,0.5,0.32,0.21,0.59,0.15,0.35,0.26,0.12,0.29,0.22,0.13,0.08,0.06,0.041,0.28,0.015,0.036,0.021,0.01,0.036,0.09,0.01,0.57,0.19,0.33,0.21,0.19,0.18,0.19,0.16,0.14,0.13,0.14,0.11,0.13,0.07,0.011,0.004,0.008,0.015,0.41,0.11,0.32,0.22,0.2,0.18,0.2,0.11,0.11,0.19,0.014,0.027,0.014,0.05,0.18,0.17,0.38,0.13,0.34,0.21,0.32,0.15,0.27,0.23,0.15,0.12,0.1,0.013,0.033,0.01,0.027,0.01,0.06,0.01,0.007,0.003,0.04,0.41,0.32,0.2,0.4,0.18,0.17,0.37,0.33,0.32,0.18,0.31,0.18,0.16,0.12,0.11,0.019,0.07,0.13,0.026,0.25,0.17,0.039,0.18,0.039,0.039,0.019,0.35,0.15,0.24,0.16,0.2,0.17,0.2,0.17,0.16,0.16,0.13,0.14,0.14,0.12,0.1,0.003,0.006,0.012,0.003,0.06,0.006,0.006,0.012,0.003,0.003,0.009,0.12,0.18,0.17,0.16,0.11,0.019,0.019,0.01,0.3,0.18,0.2,0.11,0.19,0.1,0.12,0.1,0.11,0.15,0.03,0.024,0.49,0.14,0.39,0.31,0.18,0.12,0.3,0.21,0.11,0.28,0.19,0.18,0.19,0.11,0.11,0.05,0.045,0.017,0.06,0.02,0.047,0.008,0.008,0.02,0.047,0.003,0.006,0.006,0.13,0.4,0.2,0.35,0.25,0.051,0.32,0.28,0.21,0.14,0.22,0.13,0.15,0.12,0.007,0.029,0.029,0.13,0.007,0.022,0.007,0.007,0.051,0.46,0.12,0.41,0.21,0.18,0.41,0.3,0.11,0.1,0.21,0.04,0.01,0.01,0.02,0.02,0.14,0.14,0.12,0.01,0.007,0.007,0.003,0.44,0.18,0.14,0.34,0.21,0.31,0.27,0.13,0.26,0.1,0.26,0.23,0.21,0.16,0.1,0.13,0.11,0.06,0.005,0.047,0.005,0.023,0.019,0.009,0.036,0.043,0.002,0.09,0.005,0.07,0.005,0.8,0.28,0.23,0.61,0.41,0.53,0.22,0.19,0.49,0.36,0.42,0.31,0.4,0.21,0.19,0.32,0.22,0.29,0.16,0.19,0.01,0.02,0.05,0.05,0.04,0.02,0.02,0.19,0.02,0.02,0.01,0.51,0.17,0.27,0.15,0.1,0.14,0.14,0.13,0.2,0.12,0.19,0.13,0.01,0.01,0.01,0.02,0.15,0.1,0.11,0.18,0.008,0.008,0.011,0.034,0.38,0.31,0.57,0.12,0.17,0.26,0.15,0.12,0.013,0.22,0.09,0.11,0.05,0.02,0.013,0.013,0.033,0.013,0.83,0.53,0.46,0.31,0.08,0.45,0.043,0.04,0.09,0.08,0.35,0.1,0.1,0.05,0.14,0.07,0.046,0.25,0.043,0.04,0.01,0.06,0.007,0.026,0.02,0.21,0.21,0.18,0.17,0.16,0.11,0.09,0.09,0.08,0.07,0.07,0.07,0.07,0.07,0.07,0.07,0.06,0.06,0.05,0.05,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.93,0.71,0.44,0.42,0.41,0.34,0.32,0.28,0.26,0.25,0.22,0.21,0.26,0.24,0.21,0.17,0.09,0.69,0.11,0.06,0.03,0.02,0.29,0.01,0.18,0.01,0.09,0.01,0.05,0.07,0.12,0.01,0.02,0.525,0.488,0.309,0.235,0.23,0.207,0.189,0.184,0.157,0.147,0.143,0.143,0.143,0.111,0.111,0.101,0.046,0.078,0.041,0.028,0.009,0.005,0.018,0.005,0.014,0.032,0.18,0.18,0.16,0.17,0.16,0.14,0.14,0.14,0.13,0.13,0.13,0.12,0.12,0.12,0.12,0.12,0.11,0.1,0.01,0.01,0.03,0.03,0.03,0.01,0.07],"text":["Control: 0.400<br />Experimental: 0.490<br />greater: experi<br />info: TALAPRO-2, Fatigue/Asthenia, Grades 1-4","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />info: TALAPRO-2, Fatigue/Asthenia, Grade 3","Control: 0.170<br />Experimental: 0.210<br />greater: experi<br />info: TALAPRO-2, Nausea, Grades 1-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: TALAPRO-2, Nausea, Grade 3","Control: 0.140<br />Experimental: 0.200<br />greater: experi<br />info: TALAPRO-2, Decreased appetite, Grades 1-4","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: TALAPRO-2, Fractures, Grades 1-4","Control: 0.015<br />Experimental: 0.030<br />greater: experi<br />info: TALAPRO-2, Fractures, Grade 3","Control: 0.090<br />Experimental: 0.130<br />greater: experi<br />info: TALAPRO-2, Dizziness, Grades 1-4","Control: 0.045<br />Experimental: 0.100<br />greater: experi<br />info: TALAPRO-2, Dysgeusia, Grades 1-4","Control: 0.180<br />Experimental: 0.480<br />greater: experi<br />info: PROpel, Anemia, Grades 1-4","Control: 0.060<br />Experimental: 0.140<br />greater: experi<br />info: PROpel, Lymphopenia, Grades 1-4","Control: 0.300<br />Experimental: 0.380<br />greater: experi<br />info: PROpel, Fatigue/Asthenia, Grades 1-4","Control: 0.140<br />Experimental: 0.300<br />greater: experi<br />info: PROpel, Nausea, Grades 1-4","Control: 0.100<br />Experimental: 0.190<br />greater: experi<br />info: PROpel, Diarrhea, Grades 1-4","Control: 0.070<br />Experimental: 0.130<br />greater: experi<br />info: PROpel, Abdominal pain, Grades 1-4","Control: 0.070<br />Experimental: 0.160<br />greater: experi<br />info: PROpel, Decreased appetite, Grades 1-4","Control: 0.070<br />Experimental: 0.140<br />greater: experi<br />info: PROpel, Dizziness, Grades 1-4","Control: 0.033<br />Experimental: 0.160<br />greater: experi<br />info: PROpel, Anemia, Grade 3-4","Control: 0.018<br />Experimental: 0.050<br />greater: experi<br />info: PROpel, Lymphopenia, Grade 3-4","Control: 0.015<br />Experimental: 0.023<br />greater: experi<br />info: PROpel, Fatigue/Asthenia, Grade 3-4","Control: 0.003<br />Experimental: 0.010<br />greater: experi<br />info: PROpel, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: PROpel, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: PROpel, Dizziness, Grade 3-4","Control: 0.670<br />Experimental: 0.680<br />greater: experi<br />info: POLARIX, Anemia, All grades","Control: 0.090<br />Experimental: 0.150<br />greater: experi<br />info: POLARIX, Febrile neutropenia, All grades","Control: 0.640<br />Experimental: 0.660<br />greater: experi<br />info: POLARIX, Increased blood creatinine, All grades","Control: 0.230<br />Experimental: 0.260<br />greater: experi<br />info: POLARIX, Aspartate aminotransferase increased, All grades","Control: 0.220<br />Experimental: 0.230<br />greater: experi<br />info: POLARIX, Alkaline phosphatase increased, All grades","Control: 0.170<br />Experimental: 0.190<br />greater: experi<br />info: POLARIX, Uric acid increased, All grades","Control: 0.120<br />Experimental: 0.130<br />greater: experi<br />info: POLARIX, Weight decreased , All grades","Control: 0.370<br />Experimental: 0.420<br />greater: experi<br />info: POLARIX, Nausea, All grades","Control: 0.200<br />Experimental: 0.310<br />greater: experi<br />info: POLARIX, Diarrhea, All grades","Control: 0.190<br />Experimental: 0.220<br />greater: experi<br />info: POLARIX, Mucositis, All grades","Control: 0.140<br />Experimental: 0.160<br />greater: experi<br />info: POLARIX, Abdominal pain, All grades","Control: 0.140<br />Experimental: 0.150<br />greater: experi<br />info: POLARIX, Vomiting, All grades","Control: 0.130<br />Experimental: 0.160<br />greater: experi<br />info: POLARIX, Pyrexia, All grades","Control: 0.110<br />Experimental: 0.140<br />greater: experi<br />info: POLARIX, Edema, All grades","Control: 0.110<br />Experimental: 0.130<br />greater: experi<br />info: POLARIX, Rash, All grades","Control: 0.160<br />Experimental: 0.170<br />greater: experi<br />info: POLARIX, Upper respiratory tract infection, All grades","Control: 0.140<br />Experimental: 0.170<br />greater: experi<br />info: POLARIX, Decreased appetite, All grades","Control: 0.140<br />Experimental: 0.150<br />greater: experi<br />info: POLARIX, Cough, All grades","Control: 0.110<br />Experimental: 0.140<br />greater: experi<br />info: POLARIX, Anemia, Grade 3-4","Control: 0.060<br />Experimental: 0.080<br />greater: experi<br />info: POLARIX, Thrombocytopenia, Grade 3-4","Control: 0.090<br />Experimental: 0.150<br />greater: experi<br />info: POLARIX, Febrile neutropenia, Grade 3-4","Control: 0.005<br />Experimental: 0.014<br />greater: experi<br />info: POLARIX, Alanine aminotransferase increased, Grade 3-4","Control: 0.160<br />Experimental: 0.180<br />greater: experi<br />info: POLARIX, Uric acid increased, Grade 3-4","Control: 0.002<br />Experimental: 0.009<br />greater: experi<br />info: POLARIX, Weight decreased , Grade 3-4","Control: 0.011<br />Experimental: 0.016<br />greater: experi<br />info: POLARIX, Peripheral neuropathy, Grade 3-4","Control: 0.005<br />Experimental: 0.011<br />greater: experi<br />info: POLARIX, Nausea, Grade 3-4","Control: 0.018<br />Experimental: 0.039<br />greater: experi<br />info: POLARIX, Diarrhea, Grade 3-4","Control: 0.002<br />Experimental: 0.011<br />greater: experi<br />info: POLARIX, Constipation, Grade 3-4","Control: 0.005<br />Experimental: 0.014<br />greater: experi<br />info: POLARIX, Mucositis, Grade 3-4","Control: 0.007<br />Experimental: 0.011<br />greater: experi<br />info: POLARIX, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.014<br />greater: experi<br />info: POLARIX, Pyrexia, Grade 3-4","Control: 0.002<br />Experimental: 0.005<br />greater: experi<br />info: POLARIX, Edema, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: POLARIX, Rash, Grade 3-4","Control: 0.007<br />Experimental: 0.011<br />greater: experi<br />info: POLARIX, Decreased appetite, Grade 3-4","Control: 0.230<br />Experimental: 0.620<br />greater: experi<br />info: TROPiCS-02, Diarrhea, All grades","Control: 0.350<br />Experimental: 0.590<br />greater: experi<br />info: TROPiCS-02, Nausea, All grades","Control: 0.250<br />Experimental: 0.340<br />greater: experi<br />info: TROPiCS-02, Constipation, All grades","Control: 0.160<br />Experimental: 0.230<br />greater: experi<br />info: TROPiCS-02, Vomiting, All grades","Control: 0.140<br />Experimental: 0.200<br />greater: experi<br />info: TROPiCS-02, Abdominal Pain, All grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: TROPiCS-02, Dyspepsia, All grades","Control: 0.510<br />Experimental: 0.600<br />greater: experi<br />info: TROPiCS-02, Fatigue/Asthenia, All grades","Control: 0.040<br />Experimental: 0.100<br />greater: experi<br />info: TROPiCS-02, Hypokalemia, All grades","Control: 0.120<br />Experimental: 0.150<br />greater: experi<br />info: TROPiCS-02, Arthralgia, All grades","Control: 0.150<br />Experimental: 0.160<br />greater: experi<br />info: TROPiCS-02, Headache, All grades","Control: 0.170<br />Experimental: 0.200<br />greater: experi<br />info: TROPiCS-02, Dyspnea, All grades","Control: 0.070<br />Experimental: 0.120<br />greater: experi<br />info: TROPiCS-02, Cough, All grades","Control: 0.190<br />Experimental: 0.480<br />greater: experi<br />info: TROPiCS-02, Alopecia, All grades","Control: 0.020<br />Experimental: 0.120<br />greater: experi<br />info: TROPiCS-02, Pruritus, All grades","Control: 0.010<br />Experimental: 0.100<br />greater: experi<br />info: TROPiCS-02, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: TROPiCS-02, Constipation, Grade 3-4","Control: 0.040<br />Experimental: 0.080<br />greater: experi<br />info: TROPiCS-02, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: TROPiCS-02, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: TROPiCS-02, Hypokalemia, Grade 3-4","Control: 0.390<br />Experimental: 0.410<br />greater: experi<br />info: EMERALD, Musculoskeletal pain, All grades","Control: 0.190<br />Experimental: 0.350<br />greater: experi<br />info: EMERALD, Nausea, All grades","Control: 0.090<br />Experimental: 0.190<br />greater: experi<br />info: EMERALD, Vomiting, All grades","Control: 0.100<br />Experimental: 0.130<br />greater: experi<br />info: EMERALD, Diarrhea, All grades","Control: 0.060<br />Experimental: 0.120<br />greater: experi<br />info: EMERALD, Constipation, All grades","Control: 0.100<br />Experimental: 0.110<br />greater: experi<br />info: EMERALD, Abdominal pain, All grades","Control: 0.026<br />Experimental: 0.100<br />greater: experi<br />info: EMERALD, Dyspepsia, All grades","Control: 0.100<br />Experimental: 0.150<br />greater: experi<br />info: EMERALD, Decreased appetite , All grades","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: EMERALD, Hot flush , All grades","Control: 0.010<br />Experimental: 0.070<br />greater: experi<br />info: EMERALD, Musculoskeletal pain, Grade 3-4","Control: 0.009<br />Experimental: 0.025<br />greater: experi<br />info: EMERALD, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: EMERALD, Vomiting, Grade 3-4","Control: 0.009<br />Experimental: 0.010<br />greater: experi<br />info: EMERALD, Abdominal pain, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: EMERALD, Fatigue/Asthenia, Grade 3-4","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />info: EMERALD, Decreased appetite , Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: EMERALD, Headache, Grade 3-4","Control: 0.170<br />Experimental: 0.330<br />greater: experi<br />info: SEQUOIA, Musculoskeletal pain, All grades","Control: 0.150<br />Experimental: 0.280<br />greater: experi<br />info: SEQUOIA, Upper respiratory tract infection, All grades","Control: 0.080<br />Experimental: 0.130<br />greater: experi<br />info: SEQUOIA, Pneumonia, All grades","Control: 0.040<br />Experimental: 0.270<br />greater: experi<br />info: SEQUOIA, Hemorrhage, All grades","Control: 0.050<br />Experimental: 0.140<br />greater: experi<br />info: SEQUOIA, Hypertension, All grades","Control: 0.026<br />Experimental: 0.240<br />greater: experi<br />info: SEQUOIA, Bruising, All grades","Control: 0.100<br />Experimental: 0.150<br />greater: experi<br />info: SEQUOIA, Cough, All grades","Control: 0.120<br />Experimental: 0.140<br />greater: experi<br />info: SEQUOIA, Diarrhea, All grades","Control: 0.013<br />Experimental: 0.130<br />greater: experi<br />info: SEQUOIA, Second primary malignancyl, All grades","Control: 0.080<br />Experimental: 0.120<br />greater: experi<br />info: SEQUOIA, Headache, All grades","Control: 0.050<br />Experimental: 0.110<br />greater: experi<br />info: SEQUOIA, Dizziness, All grades","Control: 0.004<br />Experimental: 0.017<br />greater: experi<br />info: SEQUOIA, Musculoskeletal pain, Grade 3-4","Control: 0.009<br />Experimental: 0.013<br />greater: experi<br />info: SEQUOIA, Upper respiratory tract infection, Grade 3-4","Control: 0.040<br />Experimental: 0.050<br />greater: experi<br />info: SEQUOIA, Pneumonia, Grade 3-4","Control: 0.004<br />Experimental: 0.040<br />greater: experi<br />info: SEQUOIA, Hemorrhage, Grade 3-4","Control: 0.026<br />Experimental: 0.070<br />greater: experi<br />info: SEQUOIA, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: SEQUOIA, Constipation, Grade 3-4","Control: 0.004<br />Experimental: 0.060<br />greater: experi<br />info: SEQUOIA, Second primary malignancyl, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: SEQUOIA, Dizziness, Grade 3-4","Control: 0.220<br />Experimental: 0.270<br />greater: experi<br />info: ALPINE, Upper respiratory tract infection, All grades","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: ALPINE, COVID-19, All grades","Control: 0.140<br />Experimental: 0.160<br />greater: experi<br />info: ALPINE, Bruising, All grades","Control: 0.070<br />Experimental: 0.100<br />greater: experi<br />info: ALPINE, Dizziness, All grades","Control: 0.046<br />Experimental: 0.070<br />greater: experi<br />info: ALPINE, COVID-19, Grade 3-4","Control: 0.009<br />Experimental: 0.012<br />greater: experi<br />info: ALPINE, Rash, Grade 3-4","Control: 0.009<br />Experimental: 0.015<br />greater: experi<br />info: ALPINE, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: ALPINE, Cough, Grade 3-4","Control: 0.080<br />Experimental: 0.120<br />greater: experi<br />info: POSEIDON, Cough/Productive Cough, All grades","Control: 0.370<br />Experimental: 0.420<br />greater: experi<br />info: POSEIDON, Nausea, All grades","Control: 0.150<br />Experimental: 0.220<br />greater: experi<br />info: POSEIDON, Diarrhea, All grades","Control: 0.140<br />Experimental: 0.180<br />greater: experi<br />info: POSEIDON, Vomiting, All grades","Control: 0.060<br />Experimental: 0.100<br />greater: experi<br />info: POSEIDON, Stomatitis, All grades","Control: 0.021<br />Experimental: 0.130<br />greater: experi<br />info: POSEIDON, Hypothyroidism, All grades","Control: 0.100<br />Experimental: 0.270<br />greater: experi<br />info: POSEIDON, Rash, All grades","Control: 0.060<br />Experimental: 0.100<br />greater: experi<br />info: POSEIDON, Alopecia, All grades","Control: 0.045<br />Experimental: 0.110<br />greater: experi<br />info: POSEIDON, Pruritus, All grades","Control: 0.320<br />Experimental: 0.360<br />greater: experi<br />info: POSEIDON, Fatigue/Asthenia, All grades","Control: 0.080<br />Experimental: 0.190<br />greater: experi<br />info: POSEIDON, Pyrexia, All grades","Control: 0.220<br />Experimental: 0.290<br />greater: experi<br />info: POSEIDON, Musculoskeletal Pain, All grades","Control: 0.250<br />Experimental: 0.280<br />greater: experi<br />info: POSEIDON, Decreased appetite, All grades","Control: 0.120<br />Experimental: 0.170<br />greater: experi<br />info: POSEIDON, Pneumonia, All grades","Control: 0.090<br />Experimental: 0.150<br />greater: experi<br />info: POSEIDON, Upper respiratory tract infection, All grades","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: POSEIDON, Headache, All grades","Control: 0.006<br />Experimental: 0.024<br />greater: experi<br />info: POSEIDON, Rash, Grade 3-4","Control: 0.045<br />Experimental: 0.050<br />greater: experi<br />info: POSEIDON, Fatigue/Asthenia, Grade 3-4","Control: 0.012<br />Experimental: 0.015<br />greater: experi<br />info: POSEIDON, Decreased appetite, Grade 3-4","Control: 0.042<br />Experimental: 0.080<br />greater: experi<br />info: POSEIDON, Pneumonia, Grade 3-4","Control: 0.060<br />Experimental: 0.130<br />greater: experi<br />info: Study 16113, Rash, All grades","Control: 0.160<br />Experimental: 0.250<br />greater: experi<br />info: Study 16113, Nausea, All grades","Control: 0.110<br />Experimental: 0.140<br />greater: experi<br />info: Study 16113, Constipation, All grades","Control: 0.100<br />Experimental: 0.120<br />greater: experi<br />info: Study 16113, Vomiting, All grades","Control: 0.070<br />Experimental: 0.110<br />greater: experi<br />info: Study 16113, Diarrhea, All grades","Control: 0.180<br />Experimental: 0.230<br />greater: experi<br />info: Study 16113, Fatigue/Asthenia, All grades","Control: 0.190<br />Experimental: 0.230<br />greater: experi<br />info: Study 16113, Peripheral neuropathy, All grades","Control: 0.120<br />Experimental: 0.170<br />greater: experi<br />info: Study 16113, Decreased appetite, All grades","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: Study 16113, Weight decreased , All grades","Control: 0.070<br />Experimental: 0.130<br />greater: experi<br />info: Study 16113, Dyspnea, All grades","Control: 0.070<br />Experimental: 0.110<br />greater: experi<br />info: Study 16113, Insomnia, All grades","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />info: Study 16113, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.016<br />greater: experi<br />info: Study 16113, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: Study 16113, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />info: Study 16113, Diarrhea, Grade 3-4","Control: 0.020<br />Experimental: 0.038<br />greater: experi<br />info: Study 16113, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: Study 16113, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />info: Study 16113, Weight decreased , Grade 3-4","Control: 0.007<br />Experimental: 0.022<br />greater: experi<br />info: Study 16113, Dyspnea, Grade 3-4","Control: 0.060<br />Experimental: 0.230<br />greater: experi<br />info: HIMALAYA, Pruritus, All grades","Control: 0.090<br />Experimental: 0.130<br />greater: experi<br />info: HIMALAYA, Pyrexia, All grades","Control: 0.043<br />Experimental: 0.100<br />greater: experi<br />info: HIMALAYA, Insomnia, All grades","Control: 0.060<br />Experimental: 0.140<br />greater: experi<br />info: HIMALAYA, Hypothyroidism, All grades","Control: 0.170<br />Experimental: 0.220<br />greater: experi<br />info: HIMALAYA, Musculoskeletal pain, All grades","Control: 0.043<br />Experimental: 0.060<br />greater: experi<br />info: HIMALAYA, Diarrhea, Grade 3-4","Control: 0.008<br />Experimental: 0.013<br />greater: experi<br />info: HIMALAYA, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: HIMALAYA, Insomnia, Grade 3-4","Control: 0.008<br />Experimental: 0.026<br />greater: experi<br />info: HIMALAYA, Musculoskeletal pain, Grade 3-4","Control: 0.160<br />Experimental: 0.200<br />greater: experi<br />info: TOPAZ-1, Pyrexia, All grades","Control: 0.340<br />Experimental: 0.400<br />greater: experi<br />info: TOPAZ-1, Nausea, All grades","Control: 0.290<br />Experimental: 0.320<br />greater: experi<br />info: TOPAZ-1, Constipation, All grades","Control: 0.230<br />Experimental: 0.240<br />greater: experi<br />info: TOPAZ-1, Abdominal pain, All grades","Control: 0.150<br />Experimental: 0.170<br />greater: experi<br />info: TOPAZ-1, Diarrhea, All grades","Control: 0.230<br />Experimental: 0.260<br />greater: experi<br />info: TOPAZ-1, Decreased appetite, All grades","Control: 0.140<br />Experimental: 0.230<br />greater: experi<br />info: TOPAZ-1, Rash, All grades","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: TOPAZ-1, Pruritus, All grades","Control: 0.006<br />Experimental: 0.015<br />greater: experi<br />info: TOPAZ-1, Pyrexia, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />info: TOPAZ-1, Constipation, Grade 3-4","Control: 0.009<br />Experimental: 0.021<br />greater: experi<br />info: TOPAZ-1, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />info: TOPAZ-1, Rash, Grade 3-4","Control: 0.200<br />Experimental: 0.230<br />greater: experi<br />info: ARASENS, Constipation, All grades","Control: 0.130<br />Experimental: 0.190<br />greater: experi<br />info: ARASENS, Decreased Appetite, All grades","Control: 0.150<br />Experimental: 0.190<br />greater: experi<br />info: ARASENS, Rash, All grades","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: ARASENS, Hemorrhage, All grades","Control: 0.160<br />Experimental: 0.180<br />greater: experi<br />info: ARASENS, Weight Increased, All grades","Control: 0.090<br />Experimental: 0.140<br />greater: experi<br />info: ARASENS, Hypertension, All grades","Control: 0.002<br />Experimental: 0.018<br />greater: experi<br />info: ARASENS, Rash, Grade 3-4","Control: 0.012<br />Experimental: 0.021<br />greater: experi<br />info: ARASENS, Weight Increased, Grade 3-4","Control: 0.037<br />Experimental: 0.070<br />greater: experi<br />info: ARASENS, Hypertension, Grade 3-4","Control: 0.300<br />Experimental: 0.760<br />greater: experi<br />info: DESTINY-Breast04, Nausea, All grades","Control: 0.130<br />Experimental: 0.400<br />greater: experi<br />info: DESTINY-Breast04, Vomiting, All grades","Control: 0.220<br />Experimental: 0.340<br />greater: experi<br />info: DESTINY-Breast04, Constipation, All grades","Control: 0.220<br />Experimental: 0.270<br />greater: experi<br />info: DESTINY-Breast04, Diarrhea, All grades","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: DESTINY-Breast04, Abdominal pain, All grades","Control: 0.120<br />Experimental: 0.130<br />greater: experi<br />info: DESTINY-Breast04, Stomatitis, All grades","Control: 0.480<br />Experimental: 0.540<br />greater: experi<br />info: DESTINY-Breast04, Fatigue/Asthenia, All grades","Control: 0.330<br />Experimental: 0.400<br />greater: experi<br />info: DESTINY-Breast04, Alopecia, All grades","Control: 0.270<br />Experimental: 0.390<br />greater: experi<br />info: DESTINY-Breast04, Anemia, All grades","Control: 0.190<br />Experimental: 0.320<br />greater: experi<br />info: DESTINY-Breast04, Decreased appetite, All grades","Control: 0.310<br />Experimental: 0.320<br />greater: experi<br />info: DESTINY-Breast04, Musculoskeletal pain, All grades","Control: 0.080<br />Experimental: 0.160<br />greater: experi<br />info: DESTINY-Breast04, Weight decreased , All grades","Control: 0.035<br />Experimental: 0.160<br />greater: experi<br />info: DESTINY-Breast04, Hemorrhage, All grades","Control: 0.060<br />Experimental: 0.150<br />greater: experi<br />info: DESTINY-Breast04, Headache, All grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: DESTINY-Breast04, Dizziness, All grades","Control: 0.050<br />Experimental: 0.140<br />greater: experi<br />info: DESTINY-Breast04, Upper respiratory tract infection, All grades","Control: 0.006<br />Experimental: 0.120<br />greater: experi<br />info: DESTINY-Breast04, Interstitial lung disease, All grades","Control: 0.090<br />Experimental: 0.100<br />greater: experi<br />info: DESTINY-Breast04, Dyspnea, All grades","Control: 0.000<br />Experimental: 0.046<br />greater: experi<br />info: DESTINY-Breast04, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.016<br />greater: experi<br />info: DESTINY-Breast04, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: DESTINY-Breast04, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: DESTINY-Breast04, Abdominal pain, Grade 3-4","Control: 0.047<br />Experimental: 0.090<br />greater: experi<br />info: DESTINY-Breast04, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: DESTINY-Breast04, Pyrexia, Grade 3-4","Control: 0.050<br />Experimental: 0.100<br />greater: experi<br />info: DESTINY-Breast04, Anemia, Grade 3-4","Control: 0.012<br />Experimental: 0.024<br />greater: experi<br />info: DESTINY-Breast04, Decreased appetite, Grade 3-4","Control: 0.006<br />Experimental: 0.013<br />greater: experi<br />info: DESTINY-Breast04, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: DESTINY-Breast04, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: DESTINY-Breast04, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: DESTINY-Breast04, Dizziness, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: DESTINY-Breast04, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />info: DESTINY-Breast04, Interstitial lung disease, Grade 3-4","Control: 0.012<br />Experimental: 0.013<br />greater: experi<br />info: DESTINY-Breast04, Dyspnea, Grade 3-4","Control: 0.190<br />Experimental: 0.470<br />greater: experi<br />info: TRANSFORM, Neutropenia, Grade 1–2","Control: 0.370<br />Experimental: 0.390<br />greater: experi<br />info: TRANSFORM, Anemia, Grade 1–2","Control: 0.000<br />Experimental: 0.490<br />greater: experi<br />info: TRANSFORM, Cytokine release syndrome, Grade 1–2","Control: 0.210<br />Experimental: 0.420<br />greater: experi<br />info: TRANSFORM, Headache, Grade 1–2","Control: 0.370<br />Experimental: 0.390<br />greater: experi<br />info: TRANSFORM, Fatigue/Asthenia, Grade 1–2","Control: 0.240<br />Experimental: 0.340<br />greater: experi<br />info: TRANSFORM, Constipation, Grade 1–2","Control: 0.230<br />Experimental: 0.290<br />greater: experi<br />info: TRANSFORM, Pyrexia, Grade 1–2","Control: 0.040<br />Experimental: 0.090<br />greater: experi<br />info: TRANSFORM, Lymphopenia, Grade 1–2","Control: 0.140<br />Experimental: 0.220<br />greater: experi<br />info: TRANSFORM, Dizziness, Grade 1–2","Control: 0.120<br />Experimental: 0.210<br />greater: experi<br />info: TRANSFORM, Insomnia, Grade 1–2","Control: 0.040<br />Experimental: 0.200<br />greater: experi<br />info: TRANSFORM, Hypotension, Grade 1–2","Control: 0.070<br />Experimental: 0.100<br />greater: experi<br />info: TRANSFORM, Leukopenia, Grade 1–2","Control: 0.030<br />Experimental: 0.040<br />greater: experi<br />info: TRANSFORM, Febrile neutropenia, Grade 1–2","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: TRANSFORM, Arthralgia, Grade 1–2","Control: 0.090<br />Experimental: 0.140<br />greater: experi<br />info: TRANSFORM, Cough, Grade 1–2","Control: 0.080<br />Experimental: 0.130<br />greater: experi<br />info: TRANSFORM, Dyspnea, Grade 1–2","Control: 0.100<br />Experimental: 0.130<br />greater: experi<br />info: TRANSFORM, Bone pain, Grade 1–2","Control: 0.000<br />Experimental: 0.120<br />greater: experi<br />info: TRANSFORM, Tremor, Grade 1–2","Control: 0.040<br />Experimental: 0.120<br />greater: experi<br />info: TRANSFORM, Myalgia, Grade 1–2","Control: 0.090<br />Experimental: 0.100<br />greater: experi<br />info: TRANSFORM, Asthenia, Grade 1–2","Control: 0.070<br />Experimental: 0.100<br />greater: experi<br />info: TRANSFORM, Hypertension, Grade 1–2","Control: 0.510<br />Experimental: 0.800<br />greater: experi<br />info: TRANSFORM, Neutropenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: TRANSFORM, Cytokine release syndrome, Grade ≥ 3","Control: 0.030<br />Experimental: 0.430<br />greater: experi<br />info: TRANSFORM, Prolonged cytopeniat, Grade ≥ 3","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />info: TRANSFORM, Headache, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: TRANSFORM, Constipation, Grade ≥ 3","Control: 0.090<br />Experimental: 0.250<br />greater: experi<br />info: TRANSFORM, Lymphopenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />info: TRANSFORM, Hypotension, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: TRANSFORM, Peripheral edema, Grade ≥ 3","Control: 0.120<br />Experimental: 0.150<br />greater: experi<br />info: TRANSFORM, Leukopenia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: TRANSFORM, Abdominal pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: TRANSFORM, Tremor, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: TRANSFORM, Myalgia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: TRANSFORM, Asthenia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />info: TRANSFORM, Hypertension, Grade ≥ 3","Control: 0.380<br />Experimental: 0.420<br />greater: experi<br />info: AG120-C-009, Nausea, All grades","Control: 0.270<br />Experimental: 0.410<br />greater: experi<br />info: AG120-C-009, Vomiting, All grades","Control: 0.070<br />Experimental: 0.200<br />greater: experi<br />info: AG120-C-009, Electrocardiogram QT prolonged, All grades","Control: 0.120<br />Experimental: 0.180<br />greater: experi<br />info: AG120-C-009, Insomnia, All grades","Control: 0.080<br />Experimental: 0.150<br />greater: experi<br />info: AG120-C-009, Differentiation Syndrome, All grades","Control: 0.010<br />Experimental: 0.130<br />greater: experi<br />info: AG120-C-009, Leukocytosis, All grades","Control: 0.040<br />Experimental: 0.150<br />greater: experi<br />info: AG120-C-009, Hematoma, All grades","Control: 0.080<br />Experimental: 0.130<br />greater: experi<br />info: AG120-C-009, Hypertension, All grades","Control: 0.080<br />Experimental: 0.300<br />greater: experi<br />info: AG120-C-009, Arthralgia, All grades","Control: 0.150<br />Experimental: 0.200<br />greater: experi<br />info: AG120-C-009, Dyspnea, All grades","Control: 0.030<br />Experimental: 0.110<br />greater: experi<br />info: AG120-C-009, Headache, All grades","Control: 0.030<br />Experimental: 0.100<br />greater: experi<br />info: AG120-C-009, Electrocardiogram QT prolonged, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: AG120-C-009, Insomnia, Grade ≥ 3","Control: 0.080<br />Experimental: 0.100<br />greater: experi<br />info: AG120-C-009, Differentiation Syndrome, Grade ≥ 3","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />info: AG120-C-009, Arthralgia, Grade ≥ 3","Control: 0.230<br />Experimental: 0.570<br />greater: experi<br />info: OlympiA, Nausea, Grades 1-4","Control: 0.080<br />Experimental: 0.230<br />greater: experi<br />info: OlympiA, Vomiting, Grades 1-4","Control: 0.140<br />Experimental: 0.180<br />greater: experi<br />info: OlympiA, Diarrhea, Grades 1-4","Control: 0.045<br />Experimental: 0.100<br />greater: experi<br />info: OlympiA, Stomatitis, Grades 1-4","Control: 0.280<br />Experimental: 0.420<br />greater: experi<br />info: OlympiA, Fatigue/Asthenia, Grades 1-4","Control: 0.039<br />Experimental: 0.240<br />greater: experi<br />info: OlympiA, Anemia, Grades 1-4","Control: 0.060<br />Experimental: 0.170<br />greater: experi<br />info: OlympiA, Leukopenia, Grades 1-4","Control: 0.070<br />Experimental: 0.160<br />greater: experi<br />info: OlympiA, Neutropenia, Grades 1-4","Control: 0.170<br />Experimental: 0.200<br />greater: experi<br />info: OlympiA, Headache, Grades 1-4","Control: 0.048<br />Experimental: 0.120<br />greater: experi<br />info: OlympiA, Dysgeusia, Grades 1-4","Control: 0.070<br />Experimental: 0.110<br />greater: experi<br />info: OlympiA, Dizziness, Grades 1-4","Control: 0.060<br />Experimental: 0.130<br />greater: experi<br />info: OlympiA, Decreased appetite, Grades 1-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: OlympiA, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: OlympiA, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.001<br />greater: experi<br />info: OlympiA, Stomatitis, Grade 3-4","Control: 0.007<br />Experimental: 0.018<br />greater: experi<br />info: OlympiA, Fatigue/Asthenia, Grade 3-4","Control: 0.003<br />Experimental: 0.090<br />greater: experi<br />info: OlympiA, Anemia, Grade 3-4","Control: 0.003<br />Experimental: 0.030<br />greater: experi<br />info: OlympiA, Leukopenia, Grade 3-4","Control: 0.008<br />Experimental: 0.050<br />greater: experi<br />info: OlympiA, Neutropenia, Grade 3-4","Control: 0.001<br />Experimental: 0.002<br />greater: experi<br />info: OlympiA, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: OlympiA, Decreased appetite, Grade 3-4","Control: 0.020<br />Experimental: 0.140<br />greater: experi<br />info: KEYNOTE-716, Hypothyroidism, All grades","Control: 0.010<br />Experimental: 0.100<br />greater: experi<br />info: KEYNOTE-716, Hyperthyroidism, All grades","Control: 0.100<br />Experimental: 0.180<br />greater: experi<br />info: KEYNOTE-716, Diarrhea, All grades","Control: 0.060<br />Experimental: 0.080<br />greater: experi<br />info: KEYNOTE-716, Nausea, All grades","Control: 0.180<br />Experimental: 0.200<br />greater: experi<br />info: KEYNOTE-716, Fatigue/Asthenia, All grades","Control: 0.080<br />Experimental: 0.090<br />greater: experi<br />info: KEYNOTE-716, Asthenia, All grades","Control: 0.070<br />Experimental: 0.140<br />greater: experi<br />info: KEYNOTE-716, Arthralgia, All grades","Control: 0.030<br />Experimental: 0.060<br />greater: experi<br />info: KEYNOTE-716, Myalgia, All grades","Control: 0.040<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-716, Increased alanine aminotransferase, All grades","Control: 0.020<br />Experimental: 0.060<br />greater: experi<br />info: KEYNOTE-716, Aspartate aminotransferase increased, All grades","Control: 0.100<br />Experimental: 0.230<br />greater: experi<br />info: KEYNOTE-716, Pruritus, All grades","Control: 0.060<br />Experimental: 0.160<br />greater: experi<br />info: KEYNOTE-716, Rash, All grades","Control: 0.020<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-716, Rash maculopapular, All grades","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-716, Hyperthyroidism, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-716, Fatigue/Asthenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-716, Asthenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-716, Arthralgia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-716, Myalgia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-716, Pruritus, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-716, Rash maculopapular, Grade ≥ 3","Control: 0.360<br />Experimental: 0.410<br />greater: experi<br />info: KEYNOTE-564, Musculoskeletal pain, All grades","Control: 0.310<br />Experimental: 0.400<br />greater: experi<br />info: KEYNOTE-564, Fatigue/Asthenia, All grades","Control: 0.150<br />Experimental: 0.300<br />greater: experi<br />info: KEYNOTE-564, Rash, All grades","Control: 0.130<br />Experimental: 0.230<br />greater: experi<br />info: KEYNOTE-564, Pruritus, All grades","Control: 0.230<br />Experimental: 0.270<br />greater: experi<br />info: KEYNOTE-564, Diarrhea, All grades","Control: 0.100<br />Experimental: 0.160<br />greater: experi<br />info: KEYNOTE-564, Nausea, All grades","Control: 0.036<br />Experimental: 0.210<br />greater: experi<br />info: KEYNOTE-564, Hypothyroidism, All grades","Control: 0.002<br />Experimental: 0.120<br />greater: experi<br />info: KEYNOTE-564, Hyperthyroidism , All grades","Control: 0.120<br />Experimental: 0.170<br />greater: experi<br />info: KEYNOTE-564, Cough, All grades","Control: 0.130<br />Experimental: 0.150<br />greater: experi<br />info: KEYNOTE-564, Headache, All grades","Control: 0.070<br />Experimental: 0.140<br />greater: experi<br />info: KEYNOTE-564, Hepatotoxicity, All grades","Control: 0.100<br />Experimental: 0.130<br />greater: experi<br />info: KEYNOTE-564, Acute kidney injury, All grades","Control: 0.006<br />Experimental: 0.012<br />greater: experi<br />info: KEYNOTE-564, Musculoskeletal pain, Grade 3-4","Control: 0.002<br />Experimental: 0.012<br />greater: experi<br />info: KEYNOTE-564, Fatigue/Asthenia, Grade 3-4","Control: 0.004<br />Experimental: 0.014<br />greater: experi<br />info: KEYNOTE-564, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: KEYNOTE-564, Pruritus, Grade 3-4","Control: 0.002<br />Experimental: 0.027<br />greater: experi<br />info: KEYNOTE-564, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: KEYNOTE-564, Nausea, Grade 3-4","Control: 0.002<br />Experimental: 0.004<br />greater: experi<br />info: KEYNOTE-564, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: KEYNOTE-564, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: KEYNOTE-564, Hyperthyroidism , Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: KEYNOTE-564, Headache, Grade 3-4","Control: 0.006<br />Experimental: 0.037<br />greater: experi<br />info: KEYNOTE-564, Hepatotoxicity, Grade 3-4","Control: 0.002<br />Experimental: 0.012<br />greater: experi<br />info: KEYNOTE-564, Acute kidney injury, Grade 3-4","Control: 0.570<br />Experimental: 0.580<br />greater: experi<br />info: KEYNOTE-826, Peripheral neuropathy, All grades","Control: 0.150<br />Experimental: 0.220<br />greater: experi<br />info: KEYNOTE-826, Rash, All grades","Control: 0.460<br />Experimental: 0.470<br />greater: experi<br />info: KEYNOTE-826, Fatigue/Asthenia, All grades","Control: 0.300<br />Experimental: 0.360<br />greater: experi<br />info: KEYNOTE-826, Diarrhea, All grades","Control: 0.260<br />Experimental: 0.270<br />greater: experi<br />info: KEYNOTE-826, Arthralgia, All grades","Control: 0.230<br />Experimental: 0.240<br />greater: experi<br />info: KEYNOTE-826, Hypertension, All grades","Control: 0.003<br />Experimental: 0.036<br />greater: experi<br />info: KEYNOTE-826, Rash, Grade 3-4","Control: 0.060<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-826, Fatigue/Asthenia, Grade 3-4","Control: 0.016<br />Experimental: 0.020<br />greater: experi<br />info: KEYNOTE-826, Nausea, Grade 3-4","Control: 0.019<br />Experimental: 0.026<br />greater: experi<br />info: KEYNOTE-826, Vomiting, Grade 3-4","Control: 0.080<br />Experimental: 0.090<br />greater: experi<br />info: KEYNOTE-826, Urinary tract infection, Grade 3-4","Control: 0.030<br />Experimental: 0.510<br />greater: experi<br />info: COSMIC-311, Diarrhea, All grades","Control: 0.020<br />Experimental: 0.240<br />greater: experi<br />info: COSMIC-311, Nausea, All grades","Control: 0.080<br />Experimental: 0.140<br />greater: experi<br />info: COSMIC-311, Vomiting, All grades","Control: 0.030<br />Experimental: 0.260<br />greater: experi<br />info: COSMIC-311, Stomatitis, All grades","Control: 0.020<br />Experimental: 0.100<br />greater: experi<br />info: COSMIC-311, Dry mouth, All grades","Control: 0.230<br />Experimental: 0.420<br />greater: experi<br />info: COSMIC-311, Fatigue/Asthenia, All grades","Control: 0.160<br />Experimental: 0.230<br />greater: experi<br />info: COSMIC-311, Decreased appetite, All grades","Control: 0.000<br />Experimental: 0.460<br />greater: experi<br />info: COSMIC-311, Palmar-plantar erythrodysesthesia, All grades","Control: 0.050<br />Experimental: 0.300<br />greater: experi<br />info: COSMIC-311, Hypertension, All grades","Control: 0.050<br />Experimental: 0.180<br />greater: experi<br />info: COSMIC-311, Weight decreased , All grades","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />info: COSMIC-311, Dysgeusia, All grades","Control: 0.020<br />Experimental: 0.100<br />greater: experi<br />info: COSMIC-311, Headache, All grades","Control: 0.020<br />Experimental: 0.100<br />greater: experi<br />info: COSMIC-311, Dysphonia, All grades","Control: 0.000<br />Experimental: 0.050<br />greater: experi<br />info: COSMIC-311, Pulmonary embolism, All grades","Control: 0.030<br />Experimental: 0.150<br />greater: experi<br />info: COSMIC-311, Proteinuria, All grades","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />info: COSMIC-311, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />info: COSMIC-311, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: COSMIC-311, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.050<br />greater: experi<br />info: COSMIC-311, Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: COSMIC-311, Dry mouth, Grade 3-4","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />info: COSMIC-311, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />info: COSMIC-311, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />info: COSMIC-311, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.030<br />Experimental: 0.100<br />greater: experi<br />info: COSMIC-311, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: COSMIC-311, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: COSMIC-311, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: COSMIC-311, Pulmonary embolism, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: COSMIC-311, Proteinuria, Grade 3-4","Control: 0.310<br />Experimental: 0.430<br />greater: experi<br />info: Study AG120-C-005, Fatigue/Asthenia, All grades","Control: 0.290<br />Experimental: 0.410<br />greater: experi<br />info: Study AG120-C-005, Nausea, All grades","Control: 0.170<br />Experimental: 0.350<br />greater: experi<br />info: Study AG120-C-005, Diarrhea, All grades","Control: 0.220<br />Experimental: 0.350<br />greater: experi<br />info: Study AG120-C-005, Abdominal pain, All grades","Control: 0.150<br />Experimental: 0.230<br />greater: experi<br />info: Study AG120-C-005, Ascites, All grades","Control: 0.200<br />Experimental: 0.230<br />greater: experi<br />info: Study AG120-C-005, Vomiting, All grades","Control: 0.090<br />Experimental: 0.270<br />greater: experi<br />info: Study AG120-C-005, Cough, All grades","Control: 0.190<br />Experimental: 0.240<br />greater: experi<br />info: Study AG120-C-005, Decreased appetite, All grades","Control: 0.050<br />Experimental: 0.180<br />greater: experi<br />info: Study AG120-C-005, Anemia, All grades","Control: 0.070<br />Experimental: 0.150<br />greater: experi<br />info: Study AG120-C-005, Rash, All grades","Control: 0.070<br />Experimental: 0.130<br />greater: experi<br />info: Study AG120-C-005, Headache, All grades","Control: 0.000<br />Experimental: 0.110<br />greater: experi<br />info: Study AG120-C-005, Neuropathy, All grades","Control: 0.070<br />Experimental: 0.090<br />greater: experi<br />info: Study AG120-C-005, Ascites, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: Study AG120-C-005, Vomiting, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: Study AG120-C-005, Decreased appetite, Grade ≥ 3","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />info: Study AG120-C-005, Anemia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: Study AG120-C-005, Rash, Grade ≥ 3","Control: 0.190<br />Experimental: 0.360<br />greater: experi<br />info: CHECKMATE-274, Rash, All grades","Control: 0.160<br />Experimental: 0.300<br />greater: experi<br />info: CHECKMATE-274, Pruritus, All grades","Control: 0.320<br />Experimental: 0.360<br />greater: experi<br />info: CHECKMATE-274, Fatigue/Asthenia, All grades","Control: 0.270<br />Experimental: 0.300<br />greater: experi<br />info: CHECKMATE-274, Diarrhea, All grades","Control: 0.130<br />Experimental: 0.160<br />greater: experi<br />info: CHECKMATE-274, Nausea, All grades","Control: 0.240<br />Experimental: 0.280<br />greater: experi<br />info: CHECKMATE-274, Musculoskeletal pain, All grades","Control: 0.011<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-274, Hyperthyroidism, All grades","Control: 0.023<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-274, Hypothyroidism, All grades","Control: 0.160<br />Experimental: 0.170<br />greater: experi<br />info: CHECKMATE-274, Renal dysfunction, All grades","Control: 0.110<br />Experimental: 0.140<br />greater: experi<br />info: CHECKMATE-274, Cough, All grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-274, Dyspnea, All grades","Control: 0.070<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-274, Decreased appetite, All grades","Control: 0.090<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-274, Dizziness, All grades","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-274, Hepatitis, All grades","Control: 0.003<br />Experimental: 0.017<br />greater: experi<br />info: CHECKMATE-274, Rash, Grade 3-4","Control: 0.003<br />Experimental: 0.011<br />greater: experi<br />info: CHECKMATE-274, Fatigue/Asthenia, Grade 3-4","Control: 0.017<br />Experimental: 0.028<br />greater: experi<br />info: CHECKMATE-274, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: CHECKMATE-274, Nausea, Grade 3-4","Control: 0.006<br />Experimental: 0.009<br />greater: experi<br />info: CHECKMATE-274, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: CHECKMATE-274, Arthralgia, Grade 3-4","Control: 0.009<br />Experimental: 0.017<br />greater: experi<br />info: CHECKMATE-274, Renal dysfunction, Grade 3-4","Control: 0.003<br />Experimental: 0.009<br />greater: experi<br />info: CHECKMATE-274, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: CHECKMATE-274, Dizziness, Grade 3-4","Control: 0.006<br />Experimental: 0.040<br />greater: experi<br />info: CHECKMATE-274, Hepatitis, Grade 3-4","Control: 0.660<br />Experimental: 0.700<br />greater: experi<br />info: KEYNOTE-522, Fatigue/Asthenia, All grades","Control: 0.190<br />Experimental: 0.280<br />greater: experi<br />info: KEYNOTE-522, Pyrexia, All grades","Control: 0.660<br />Experimental: 0.670<br />greater: experi<br />info: KEYNOTE-522, Nausea, All grades","Control: 0.390<br />Experimental: 0.420<br />greater: experi<br />info: KEYNOTE-522, Constipation, All grades","Control: 0.340<br />Experimental: 0.410<br />greater: experi<br />info: KEYNOTE-522, Diarrhea, All grades","Control: 0.290<br />Experimental: 0.340<br />greater: experi<br />info: KEYNOTE-522, Stomatitis, All grades","Control: 0.280<br />Experimental: 0.310<br />greater: experi<br />info: KEYNOTE-522, Vomiting, All grades","Control: 0.230<br />Experimental: 0.240<br />greater: experi<br />info: KEYNOTE-522, Abdominal pain, All grades","Control: 0.580<br />Experimental: 0.610<br />greater: experi<br />info: KEYNOTE-522, Alopecia, All grades","Control: 0.410<br />Experimental: 0.520<br />greater: experi<br />info: KEYNOTE-522, Rash, All grades","Control: 0.290<br />Experimental: 0.300<br />greater: experi<br />info: KEYNOTE-522, Headache, All grades","Control: 0.190<br />Experimental: 0.200<br />greater: experi<br />info: KEYNOTE-522, Myalgia, All grades","Control: 0.240<br />Experimental: 0.260<br />greater: experi<br />info: KEYNOTE-522, Cough, All grades","Control: 0.170<br />Experimental: 0.230<br />greater: experi<br />info: KEYNOTE-522, Decreased appetite , All grades","Control: 0.190<br />Experimental: 0.210<br />greater: experi<br />info: KEYNOTE-522, Insomnia, All grades","Control: 0.039<br />Experimental: 0.080<br />greater: experi<br />info: KEYNOTE-522, Fatigue/Asthenia, Grade 3-4","Control: 0.003<br />Experimental: 0.013<br />greater: experi<br />info: KEYNOTE-522, Pyrexia, Grade 3-4","Control: 0.018<br />Experimental: 0.037<br />greater: experi<br />info: KEYNOTE-522, Nausea, Grade 3-4","Control: 0.018<br />Experimental: 0.032<br />greater: experi<br />info: KEYNOTE-522, Diarrhea, Grade 3-4","Control: 0.010<br />Experimental: 0.027<br />greater: experi<br />info: KEYNOTE-522, Stomatitis, Grade 3-4","Control: 0.015<br />Experimental: 0.027<br />greater: experi<br />info: KEYNOTE-522, Vomiting, Grade 3-4","Control: 0.005<br />Experimental: 0.050<br />greater: experi<br />info: KEYNOTE-522, Rash, Grade 3-4","Control: 0.023<br />Experimental: 0.033<br />greater: experi<br />info: KEYNOTE-522, Peripheral neuropathy, Grade 3-4","Control: 0.003<br />Experimental: 0.005<br />greater: experi<br />info: KEYNOTE-522, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: KEYNOTE-522, Myalgia, Grade 3-4","Control: 0.000<br />Experimental: 0.001<br />greater: experi<br />info: KEYNOTE-522, Cough, Grade 3-4","Control: 0.003<br />Experimental: 0.009<br />greater: experi<br />info: KEYNOTE-522, Decreased appetite , Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: KEYNOTE-522, Insomnia, Grade 3-4","Control: 0.210<br />Experimental: 0.230<br />greater: experi<br />info: CHECKMATE-577, Nausea, All grades","Control: 0.290<br />Experimental: 0.340<br />greater: experi<br />info: CHECKMATE-577, Fatigue/Asthenia, All grades","Control: 0.100<br />Experimental: 0.210<br />greater: experi<br />info: CHECKMATE-577, Rash, All grades","Control: 0.060<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-577, Pruritus, All grades","Control: 0.090<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-577, Weight decreased , All grades","Control: 0.200<br />Experimental: 0.210<br />greater: experi<br />info: CHECKMATE-577, Musculoskeletal pain, All grades","Control: 0.080<br />Experimental: 0.100<br />greater: experi<br />info: CHECKMATE-577, Arthralgia, All grades","Control: 0.100<br />Experimental: 0.150<br />greater: experi<br />info: CHECKMATE-577, Decreased appetite, All grades","Control: 0.015<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-577, Hypothyroidism, All grades","Control: 0.008<br />Experimental: 0.009<br />greater: experi<br />info: CHECKMATE-577, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: CHECKMATE-577, Nausea, Grade 3-4","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />info: CHECKMATE-577, Dyspnea, Grade 3-4","Control: 0.004<br />Experimental: 0.009<br />greater: experi<br />info: CHECKMATE-577, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: CHECKMATE-577, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: CHECKMATE-577, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: CHECKMATE-577, Arthralgia, Grade 3-4","Control: 0.008<br />Experimental: 0.009<br />greater: experi<br />info: CHECKMATE-577, Decreased appetite, Grade 3-4","Control: 0.630<br />Experimental: 0.670<br />greater: experi<br />info: KEYNOTE-590, Nausea, All grades","Control: 0.330<br />Experimental: 0.360<br />greater: experi<br />info: KEYNOTE-590, Diarrhea, All grades","Control: 0.320<br />Experimental: 0.340<br />greater: experi<br />info: KEYNOTE-590, Vomiting, All grades","Control: 0.260<br />Experimental: 0.270<br />greater: experi<br />info: KEYNOTE-590, Stomatitis, All grades","Control: 0.460<br />Experimental: 0.570<br />greater: experi<br />info: KEYNOTE-590, Fatigue/Asthenia, All grades","Control: 0.380<br />Experimental: 0.440<br />greater: experi<br />info: KEYNOTE-590, Decreased appetite, All grades","Control: 0.030<br />Experimental: 0.041<br />greater: experi<br />info: KEYNOTE-590, Diarrhea, Grade 3-4","Control: 0.050<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-590, Vomiting, Grade 3-4","Control: 0.038<br />Experimental: 0.060<br />greater: experi<br />info: KEYNOTE-590, Stomatitis, Grade 3-4","Control: 0.090<br />Experimental: 0.120<br />greater: experi<br />info: KEYNOTE-590, Fatigue/Asthenia, Grade 3-4","Control: 0.200<br />Experimental: 0.470<br />greater: experi<br />info: ADAURA, Diarrhea, All grades","Control: 0.070<br />Experimental: 0.320<br />greater: experi<br />info: ADAURA, Stomatitis, All grades","Control: 0.070<br />Experimental: 0.120<br />greater: experi<br />info: ADAURA, Abdominal Pain, All grades","Control: 0.190<br />Experimental: 0.400<br />greater: experi<br />info: ADAURA, Rash, All grades","Control: 0.038<br />Experimental: 0.370<br />greater: experi<br />info: ADAURA, Nail toxicity, All grades","Control: 0.070<br />Experimental: 0.290<br />greater: experi<br />info: ADAURA, Dry skin, All grades","Control: 0.090<br />Experimental: 0.190<br />greater: experi<br />info: ADAURA, Pruritus, All grades","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: ADAURA, Nasopharyngitis, All grades","Control: 0.100<br />Experimental: 0.130<br />greater: experi<br />info: ADAURA, Upper respiratory tract infection, All grades","Control: 0.070<br />Experimental: 0.100<br />greater: experi<br />info: ADAURA, Urinary Tract Infection, All grades","Control: 0.090<br />Experimental: 0.130<br />greater: experi<br />info: ADAURA, Fatigue/Asthenia, All grades","Control: 0.090<br />Experimental: 0.100<br />greater: experi<br />info: ADAURA, Dizziness, All grades","Control: 0.038<br />Experimental: 0.130<br />greater: experi<br />info: ADAURA, Decreased appetite, All grades","Control: 0.003<br />Experimental: 0.024<br />greater: experi<br />info: ADAURA, Diarrhea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.018<br />greater: experi<br />info: ADAURA, Stomatitis, Grade ≥ 3","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: ADAURA, Abdominal Pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: ADAURA, Rash, Grade ≥ 3","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />info: ADAURA, Nail toxicity, Grade ≥ 3","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: ADAURA, Dry skin, Grade ≥ 3","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: ADAURA, Upper respiratory tract infection, Grade ≥ 3","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: ADAURA, Urinary Tract Infection, Grade ≥ 3","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />info: ADAURA, Fatigue/Asthenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: ADAURA, Decreased appetite, Grade ≥ 3","Control: 0.230<br />Experimental: 0.280<br />greater: experi<br />info: KEYNOTE-355, Diarrhea, All grades","Control: 0.270<br />Experimental: 0.280<br />greater: experi<br />info: KEYNOTE-355, Constipation, All grades","Control: 0.220<br />Experimental: 0.260<br />greater: experi<br />info: KEYNOTE-355, Vomiting, All grades","Control: 0.160<br />Experimental: 0.260<br />greater: experi<br />info: KEYNOTE-355, Rash, All grades","Control: 0.200<br />Experimental: 0.230<br />greater: experi<br />info: KEYNOTE-355, Cough, All grades","Control: 0.140<br />Experimental: 0.210<br />greater: experi<br />info: KEYNOTE-355, Decreased appetite, All grades","Control: 0.043<br />Experimental: 0.050<br />greater: experi<br />info: KEYNOTE-355, Fatigue/Asthenia, Grade 3-4","Control: 0.004<br />Experimental: 0.005<br />greater: experi<br />info: KEYNOTE-355, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: KEYNOTE-355, Rash, Grade 3-4","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />info: KEYNOTE-355, Decreased appetite, Grade 3-4","Control: 0.350<br />Experimental: 0.440<br />greater: experi<br />info: VIALE-A , Nausea, All grades","Control: 0.330<br />Experimental: 0.430<br />greater: experi<br />info: VIALE-A , Diarrhea, All grades","Control: 0.230<br />Experimental: 0.300<br />greater: experi<br />info: VIALE-A , Vomiting, All grades","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: VIALE-A , Stomatitis, All grades","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: VIALE-A , Abdominal pain, All grades","Control: 0.190<br />Experimental: 0.420<br />greater: experi<br />info: VIALE-A , Febrile neutropenia, All grades","Control: 0.280<br />Experimental: 0.360<br />greater: experi<br />info: VIALE-A , Musculoskeletal pain, All grades","Control: 0.230<br />Experimental: 0.310<br />greater: experi<br />info: VIALE-A , Fatigue/Asthenia, All grades","Control: 0.190<br />Experimental: 0.270<br />greater: experi<br />info: VIALE-A , Edema, All grades","Control: 0.240<br />Experimental: 0.270<br />greater: experi<br />info: VIALE-A , Hemorrhage, All grades","Control: 0.080<br />Experimental: 0.120<br />greater: experi<br />info: VIALE-A , Hypotension, All grades","Control: 0.170<br />Experimental: 0.250<br />greater: experi<br />info: VIALE-A , Decreased appetite, All grades","Control: 0.150<br />Experimental: 0.250<br />greater: experi<br />info: VIALE-A , Rash, All grades","Control: 0.160<br />Experimental: 0.220<br />greater: experi<br />info: VIALE-A , Sepsis (excluding fungal), All grades","Control: 0.090<br />Experimental: 0.160<br />greater: experi<br />info: VIALE-A , Urinary tract infection, All grades","Control: 0.100<br />Experimental: 0.180<br />greater: experi<br />info: VIALE-A , Dyspnea, All grades","Control: 0.080<br />Experimental: 0.170<br />greater: experi<br />info: VIALE-A , Dizziness, All grades","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: VIALE-A , Nausea, Grade 3-4","Control: 0.030<br />Experimental: 0.050<br />greater: experi<br />info: VIALE-A , Diarrhea, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: VIALE-A , Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: VIALE-A , Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: VIALE-A , Abdominal pain, Grade 3-4","Control: 0.190<br />Experimental: 0.420<br />greater: experi<br />info: VIALE-A , Febrile neutropenia, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: VIALE-A , Musculoskeletal pain, Grade 3-4","Control: 0.020<br />Experimental: 0.060<br />greater: experi<br />info: VIALE-A , Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: VIALE-A , Edema, Grade 3-4","Control: 0.030<br />Experimental: 0.070<br />greater: experi<br />info: VIALE-A , Hemorrhage, Grade 3-4","Control: 0.030<br />Experimental: 0.050<br />greater: experi<br />info: VIALE-A , Hypotension, Grade 3-4","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />info: VIALE-A , Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: VIALE-A , Rash, Grade 3-4","Control: 0.140<br />Experimental: 0.220<br />greater: experi<br />info: VIALE-A , Sepsis (excluding fungal), Grade 3-4","Control: 0.020<br />Experimental: 0.040<br />greater: experi<br />info: VIALE-A , Dyspnea, Grade 3-4","Control: 0.240<br />Experimental: 0.650<br />greater: experi<br />info: QUAZAR, Nausea, All grades","Control: 0.100<br />Experimental: 0.600<br />greater: experi<br />info: QUAZAR, Vomiting, All grades","Control: 0.210<br />Experimental: 0.500<br />greater: experi<br />info: QUAZAR, Diarrhea, All grades","Control: 0.240<br />Experimental: 0.390<br />greater: experi<br />info: QUAZAR, Constipation, All grades","Control: 0.130<br />Experimental: 0.220<br />greater: experi<br />info: QUAZAR, Abdominal pain, All grades","Control: 0.250<br />Experimental: 0.440<br />greater: experi<br />info: QUAZAR, Fatigue/Asthenia, All grades","Control: 0.170<br />Experimental: 0.270<br />greater: experi<br />info: QUAZAR, Pneumonia, All grades","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: QUAZAR, Arthralgia, All grades","Control: 0.050<br />Experimental: 0.110<br />greater: experi<br />info: QUAZAR, Pain in extremity, All grades","Control: 0.060<br />Experimental: 0.130<br />greater: experi<br />info: QUAZAR, Decreased appetite, All grades","Control: 0.080<br />Experimental: 0.120<br />greater: experi<br />info: QUAZAR, Febrile neutropenia, All grades","Control: 0.090<br />Experimental: 0.110<br />greater: experi<br />info: QUAZAR, Dizziness, All grades","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: QUAZAR, Nausea, TYPO","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />info: QUAZAR, Vomiting, TYPO","Control: 0.010<br />Experimental: 0.050<br />greater: experi<br />info: QUAZAR, Diarrhea, TYPO","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: QUAZAR, Constipation, TYPO","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: QUAZAR, Abdominal pain, TYPO","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />info: QUAZAR, Fatigue/Asthenia, TYPO","Control: 0.050<br />Experimental: 0.090<br />greater: experi<br />info: QUAZAR, Pneumonia, TYPO","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: QUAZAR, Pain in extremity, TYPO","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: QUAZAR, Febrile neutropenia, TYPO","Control: 0.720<br />Experimental: 0.750<br />greater: experi<br />info: IMspire150, Rash, All grades","Control: 0.170<br />Experimental: 0.260<br />greater: experi<br />info: IMspire150, Pruritus, All grades","Control: 0.450<br />Experimental: 0.510<br />greater: experi<br />info: IMspire150, Fatigue/Asthenia, All grades","Control: 0.350<br />Experimental: 0.490<br />greater: experi<br />info: IMspire150, Pyrexia, All grades","Control: 0.210<br />Experimental: 0.260<br />greater: experi<br />info: IMspire150, Edema, All grades","Control: 0.360<br />Experimental: 0.500<br />greater: experi<br />info: IMspire150, Hepatotoxicity, All grades","Control: 0.150<br />Experimental: 0.230<br />greater: experi<br />info: IMspire150, Stomatitis, All grades","Control: 0.480<br />Experimental: 0.620<br />greater: experi<br />info: IMspire150, Musculoskeletal pain, All grades","Control: 0.100<br />Experimental: 0.220<br />greater: experi<br />info: IMspire150, Hypothyroidism, All grades","Control: 0.080<br />Experimental: 0.180<br />greater: experi<br />info: IMspire150, Hyperthyroidism, All grades","Control: 0.080<br />Experimental: 0.100<br />greater: experi<br />info: IMspire150, Infusion-related reaction, All grades","Control: 0.060<br />Experimental: 0.120<br />greater: experi<br />info: IMspire150, Pneumonitis, All grades","Control: 0.230<br />Experimental: 0.270<br />greater: experi<br />info: IMspire150, Rash, Grade 3-4","Control: 0.018<br />Experimental: 0.030<br />greater: experi<br />info: IMspire150, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: IMspire150, Edema, Grade 3-4","Control: 0.130<br />Experimental: 0.210<br />greater: experi<br />info: IMspire150, Hepatotoxicity, Grade 3-4","Control: 0.010<br />Experimental: 0.013<br />greater: experi<br />info: IMspire150, Stomatitis, Grade 3-4","Control: 0.032<br />Experimental: 0.043<br />greater: experi<br />info: IMspire150, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: IMspire150, Hyperthyroidism, Grade 3-4","Control: 0.010<br />Experimental: 0.026<br />greater: experi<br />info: IMspire150, Infusion-related reaction, Grade 3-4","Control: 0.010<br />Experimental: 0.013<br />greater: experi<br />info: IMspire150, Pneumonitis, Grade 3-4","Control: 0.070<br />Experimental: 0.100<br />greater: experi<br />info: IMspire150, Hypertension, Grade 3-4","Control: 0.760<br />Experimental: 0.810<br />greater: experi<br />info: RELAY, Infections, All grades","Control: 0.120<br />Experimental: 0.450<br />greater: experi<br />info: RELAY, Hypertension, All grades","Control: 0.360<br />Experimental: 0.420<br />greater: experi<br />info: RELAY, Stomatitis, All grades","Control: 0.030<br />Experimental: 0.100<br />greater: experi<br />info: RELAY, Gastrointestinal hemorrhage, All grades","Control: 0.010<br />Experimental: 0.090<br />greater: experi<br />info: RELAY, Gingival bleeding, All grades","Control: 0.080<br />Experimental: 0.340<br />greater: experi<br />info: RELAY, Proteinuria, All grades","Control: 0.200<br />Experimental: 0.340<br />greater: experi<br />info: RELAY, Alopecia, All grades","Control: 0.120<br />Experimental: 0.340<br />greater: experi<br />info: RELAY, Epistaxis, All grades","Control: 0.020<br />Experimental: 0.070<br />greater: experi<br />info: RELAY, Pulmonary hemorrhage, All grades","Control: 0.040<br />Experimental: 0.230<br />greater: experi<br />info: RELAY, Peripheral edema, All grades","Control: 0.070<br />Experimental: 0.150<br />greater: experi<br />info: RELAY, Headache, All grades","Control: 0.070<br />Experimental: 0.170<br />greater: experi<br />info: RELAY, Infections, Grade ≥ 3","Control: 0.050<br />Experimental: 0.240<br />greater: experi<br />info: RELAY, Hypertension, Grade ≥ 3","Control: 0.010<br />Experimental: 0.070<br />greater: experi<br />info: RELAY, Diarrhea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: RELAY, Stomatitis, Grade ≥ 3","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />info: RELAY, Proteinuria, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: RELAY, Peripheral edema, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: RELAY, Headache, Grade ≥ 3","Control: 0.047<br />Experimental: 0.520<br />greater: experi<br />info: INVICTUS , Alopecia, Grades 1-4","Control: 0.000<br />Experimental: 0.210<br />greater: experi<br />info: INVICTUS , Palmar-plantar erythrodysesthesia, Grades 1-4","Control: 0.070<br />Experimental: 0.130<br />greater: experi<br />info: INVICTUS , Dry skin, Grades 1-4","Control: 0.047<br />Experimental: 0.110<br />greater: experi<br />info: INVICTUS , Pruritus, Grades 1-4","Control: 0.230<br />Experimental: 0.420<br />greater: experi<br />info: INVICTUS , Fatigue/Asthenia, Grades 1-4","Control: 0.070<br />Experimental: 0.170<br />greater: experi<br />info: INVICTUS , Peripheral edema, Grades 1-4","Control: 0.120<br />Experimental: 0.390<br />greater: experi<br />info: INVICTUS , Nausea, Grades 1-4","Control: 0.300<br />Experimental: 0.360<br />greater: experi<br />info: INVICTUS , Abdominal pain, Grades 1-4","Control: 0.190<br />Experimental: 0.340<br />greater: experi<br />info: INVICTUS , Constipation, Grades 1-4","Control: 0.140<br />Experimental: 0.280<br />greater: experi<br />info: INVICTUS , Diarrhea, Grades 1-4","Control: 0.070<br />Experimental: 0.210<br />greater: experi<br />info: INVICTUS , Vomiting, Grades 1-4","Control: 0.000<br />Experimental: 0.110<br />greater: experi<br />info: INVICTUS , Stomatitis, Grades 1-4","Control: 0.120<br />Experimental: 0.320<br />greater: experi<br />info: INVICTUS , Myalgia, Grades 1-4","Control: 0.047<br />Experimental: 0.180<br />greater: experi<br />info: INVICTUS , Arthralgia, Grades 1-4","Control: 0.047<br />Experimental: 0.150<br />greater: experi<br />info: INVICTUS , Muscle spasms, Grades 1-4","Control: 0.210<br />Experimental: 0.270<br />greater: experi<br />info: INVICTUS , Decreased appetite, Grades 1-4","Control: 0.120<br />Experimental: 0.190<br />greater: experi<br />info: INVICTUS , Weight decreased , Grades 1-4","Control: 0.047<br />Experimental: 0.190<br />greater: experi<br />info: INVICTUS , Headache, Grades 1-4","Control: 0.047<br />Experimental: 0.140<br />greater: experi<br />info: INVICTUS , Hypertension, Grades 1-4","Control: 0.000<br />Experimental: 0.130<br />greater: experi<br />info: INVICTUS , Dyspnea, Grades 1-4","Control: 0.023<br />Experimental: 0.035<br />greater: experi<br />info: INVICTUS , Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />info: INVICTUS , Peripheral edema, Grade 3-4","Control: 0.000<br />Experimental: 0.035<br />greater: experi<br />info: INVICTUS , Nausea, Grade 3-4","Control: 0.047<br />Experimental: 0.070<br />greater: experi<br />info: INVICTUS , Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />info: INVICTUS , Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.035<br />greater: experi<br />info: INVICTUS , Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />info: INVICTUS , Myalgia, Grade 3-4","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />info: INVICTUS , Hypertension, Grade 3-4","Control: 0.320<br />Experimental: 0.530<br />greater: experi<br />info: PAOLA-1, Fatigue/Asthenia, Grades 1-4","Control: 0.220<br />Experimental: 0.530<br />greater: experi<br />info: PAOLA-1, Nausea, Grades 1-4","Control: 0.110<br />Experimental: 0.220<br />greater: experi<br />info: PAOLA-1, Vomiting, Grades 1-4","Control: 0.100<br />Experimental: 0.410<br />greater: experi<br />info: PAOLA-1, Anemia, Grades 1-4","Control: 0.090<br />Experimental: 0.240<br />greater: experi<br />info: PAOLA-1, Lymphopenia, Grades 1-4","Control: 0.100<br />Experimental: 0.180<br />greater: experi<br />info: PAOLA-1, Leukopenia, Grades 1-4","Control: 0.015<br />Experimental: 0.050<br />greater: experi<br />info: PAOLA-1, Fatigue/Asthenia, TYPO","Control: 0.007<br />Experimental: 0.024<br />greater: experi<br />info: PAOLA-1, Nausea, TYPO","Control: 0.004<br />Experimental: 0.170<br />greater: experi<br />info: PAOLA-1, Anemia, TYPO","Control: 0.011<br />Experimental: 0.070<br />greater: experi<br />info: PAOLA-1, Lymphopenia, TYPO","Control: 0.015<br />Experimental: 0.019<br />greater: experi<br />info: PAOLA-1, Leukopenia, TYPO","Control: 0.050<br />Experimental: 0.660<br />greater: experi<br />info: PRIMA, Thrombocytopenia, Grades 1-4","Control: 0.180<br />Experimental: 0.640<br />greater: experi<br />info: PRIMA, Anemia, Grades 1-4","Control: 0.080<br />Experimental: 0.420<br />greater: experi<br />info: PRIMA, Neutropenia, Grades 1-4","Control: 0.090<br />Experimental: 0.280<br />greater: experi<br />info: PRIMA, Leukopenia, Grades 1-4","Control: 0.280<br />Experimental: 0.570<br />greater: experi<br />info: PRIMA, Nausea, Grades 1-4","Control: 0.200<br />Experimental: 0.400<br />greater: experi<br />info: PRIMA, Constipation, Grades 1-4","Control: 0.120<br />Experimental: 0.220<br />greater: experi<br />info: PRIMA, Vomiting, Grades 1-4","Control: 0.410<br />Experimental: 0.510<br />greater: experi<br />info: PRIMA, Fatigue/Asthenia, Grades 1-4","Control: 0.070<br />Experimental: 0.140<br />greater: experi<br />info: PRIMA, AST/ALT elevation, Grades 1-4","Control: 0.080<br />Experimental: 0.190<br />greater: experi<br />info: PRIMA, Decreased appetite, Grades 1-4","Control: 0.380<br />Experimental: 0.390<br />greater: experi<br />info: PRIMA, Musculoskeletal pain, Grades 1-4","Control: 0.150<br />Experimental: 0.260<br />greater: experi<br />info: PRIMA, Headache, Grades 1-4","Control: 0.130<br />Experimental: 0.190<br />greater: experi<br />info: PRIMA, Dizziness, Grades 1-4","Control: 0.150<br />Experimental: 0.250<br />greater: experi<br />info: PRIMA, Insomnia, Grades 1-4","Control: 0.050<br />Experimental: 0.120<br />greater: experi<br />info: PRIMA, Acute kidney injury, Grades 1-4","Control: 0.130<br />Experimental: 0.220<br />greater: experi<br />info: PRIMA, Dyspnea, Grades 1-4","Control: 0.150<br />Experimental: 0.180<br />greater: experi<br />info: PRIMA, Cough, Grades 1-4","Control: 0.070<br />Experimental: 0.180<br />greater: experi<br />info: PRIMA, Hypertension, Grades 1-4","Control: 0.004<br />Experimental: 0.390<br />greater: experi<br />info: PRIMA, Thrombocytopenia, Grade 3-4","Control: 0.020<br />Experimental: 0.310<br />greater: experi<br />info: PRIMA, Anemia, Grade 3-4","Control: 0.010<br />Experimental: 0.210<br />greater: experi<br />info: PRIMA, Neutropenia, Grade 3-4","Control: 0.004<br />Experimental: 0.050<br />greater: experi<br />info: PRIMA, Leukopenia, Grade 3-4","Control: 0.004<br />Experimental: 0.010<br />greater: experi<br />info: PRIMA, Constipation, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: PRIMA, Fatigue/Asthenia, Grade 3-4","Control: 0.008<br />Experimental: 0.030<br />greater: experi<br />info: PRIMA, AST/ALT elevation, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: PRIMA, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: PRIMA, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: PRIMA, Headache, Grade 3-4","Control: 0.004<br />Experimental: 0.010<br />greater: experi<br />info: PRIMA, Insomnia, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: PRIMA, Acute kidney injury, Grade 3-4","Control: 0.010<br />Experimental: 0.060<br />greater: experi<br />info: PRIMA, Hypertension, Grade 3-4","Control: 0.530<br />Experimental: 0.810<br />greater: experi<br />info: HER2CLIMB, Diarrhea, All grades","Control: 0.440<br />Experimental: 0.580<br />greater: experi<br />info: HER2CLIMB, Nausea, All grades","Control: 0.250<br />Experimental: 0.360<br />greater: experi<br />info: HER2CLIMB, Vomiting, All grades","Control: 0.210<br />Experimental: 0.320<br />greater: experi<br />info: HER2CLIMB, Stomatitis, All grades","Control: 0.530<br />Experimental: 0.630<br />greater: experi<br />info: HER2CLIMB, Palmar-plantar erythrodysesthesia, All grades","Control: 0.150<br />Experimental: 0.200<br />greater: experi<br />info: HER2CLIMB, Rash, All grades","Control: 0.240<br />Experimental: 0.420<br />greater: experi<br />info: HER2CLIMB, Hepatotoxicity, All grades","Control: 0.200<br />Experimental: 0.250<br />greater: experi<br />info: HER2CLIMB, Decreased appetite, All grades","Control: 0.130<br />Experimental: 0.210<br />greater: experi<br />info: HER2CLIMB, Anemia, All grades","Control: 0.046<br />Experimental: 0.150<br />greater: experi<br />info: HER2CLIMB, Arthralgia, All grades","Control: 0.015<br />Experimental: 0.140<br />greater: experi<br />info: HER2CLIMB, Increased blood creatinine, All grades","Control: 0.060<br />Experimental: 0.130<br />greater: experi<br />info: HER2CLIMB, Weight decreased , All grades","Control: 0.070<br />Experimental: 0.130<br />greater: experi<br />info: HER2CLIMB, Peripheral neuropathy, All grades","Control: 0.050<br />Experimental: 0.120<br />greater: experi<br />info: HER2CLIMB, Epistaxis, All grades","Control: 0.090<br />Experimental: 0.120<br />greater: experi<br />info: HER2CLIMB, Diarrhea, Grade 3","Control: 0.030<br />Experimental: 0.037<br />greater: experi<br />info: HER2CLIMB, Nausea, Grade 3","Control: 0.005<br />Experimental: 0.025<br />greater: experi<br />info: HER2CLIMB, Stomatitis, Grade 3","Control: 0.090<br />Experimental: 0.130<br />greater: experi<br />info: HER2CLIMB, Palmar-plantar erythrodysesthesia, Grade 3","Control: 0.005<br />Experimental: 0.007<br />greater: experi<br />info: HER2CLIMB, Rash, Grade 3","Control: 0.036<br />Experimental: 0.090<br />greater: experi<br />info: HER2CLIMB, Hepatotoxicity, Grade 3","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: HER2CLIMB, Decreased appetite, Grade 3","Control: 0.025<br />Experimental: 0.037<br />greater: experi<br />info: HER2CLIMB, Anemia, Grade 3","Control: 0.005<br />Experimental: 0.010<br />greater: experi<br />info: HER2CLIMB, Weight decreased , Grade 3","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: HER2CLIMB, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: HER2CLIMB, Hepatotoxicity, Grade 4","Control: 0.560<br />Experimental: 0.650<br />greater: experi<br />info: CHECKMATE-648, Nausea, All grades","Control: 0.430<br />Experimental: 0.440<br />greater: experi<br />info: CHECKMATE-648, Constipation, All grades","Control: 0.350<br />Experimental: 0.440<br />greater: experi<br />info: CHECKMATE-648, Stomatitis, All grades","Control: 0.200<br />Experimental: 0.290<br />greater: experi<br />info: CHECKMATE-648, Diarrhea, All grades","Control: 0.190<br />Experimental: 0.230<br />greater: experi<br />info: CHECKMATE-648, Vomiting, All grades","Control: 0.120<br />Experimental: 0.140<br />greater: experi<br />info: CHECKMATE-648, Dysphagia, All grades","Control: 0.110<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-648, Abdominal pain, All grades","Control: 0.500<br />Experimental: 0.510<br />greater: experi<br />info: CHECKMATE-648, Decreased appetite, All grades","Control: 0.410<br />Experimental: 0.470<br />greater: experi<br />info: CHECKMATE-648, Fatigue/Asthenia, All grades","Control: 0.120<br />Experimental: 0.190<br />greater: experi<br />info: CHECKMATE-648, Pyrexia, All grades","Control: 0.130<br />Experimental: 0.160<br />greater: experi<br />info: CHECKMATE-648, Edema, All grades","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: CHECKMATE-648, Peripheral neuropathy, All grades","Control: 0.100<br />Experimental: 0.160<br />greater: experi<br />info: CHECKMATE-648, Insomnia, All grades","Control: 0.070<br />Experimental: 0.160<br />greater: experi<br />info: CHECKMATE-648, Rash, All grades","Control: 0.036<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-648, Pruritus, All grades","Control: 0.130<br />Experimental: 0.160<br />greater: experi<br />info: CHECKMATE-648, Cough, All grades","Control: 0.100<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-648, Pneumonia, All grades","Control: 0.003<br />Experimental: 0.070<br />greater: experi<br />info: CHECKMATE-648, Hypothyroidism, All grades","Control: 0.110<br />Experimental: 0.120<br />greater: experi<br />info: CHECKMATE-648, Weight decreased , All grades","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-648, Musculoskeletal pain, All grades","Control: 0.026<br />Experimental: 0.042<br />greater: experi<br />info: CHECKMATE-648, Nausea, Grade 3-4","Control: 0.030<br />Experimental: 0.090<br />greater: experi<br />info: CHECKMATE-648, Stomatitis, Grade 3-4","Control: 0.020<br />Experimental: 0.029<br />greater: experi<br />info: CHECKMATE-648, Diarrhea, Grade 3-4","Control: 0.049<br />Experimental: 0.070<br />greater: experi<br />info: CHECKMATE-648, Dysphagia, Grade 3-4","Control: 0.007<br />Experimental: 0.019<br />greater: experi<br />info: CHECKMATE-648, Abdominal pain, Grade 3-4","Control: 0.060<br />Experimental: 0.070<br />greater: experi<br />info: CHECKMATE-648, Decreased appetite, Grade 3-4","Control: 0.010<br />Experimental: 0.013<br />greater: experi<br />info: CHECKMATE-648, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: CHECKMATE-648, Rash, Grade 3-4","Control: 0.026<br />Experimental: 0.050<br />greater: experi<br />info: CHECKMATE-648, Pneumonia, Grade 3-4","Control: 0.200<br />Experimental: 0.220<br />greater: experi<br />info: CHECKMATE-648, Diarrhea, All grades","Control: 0.120<br />Experimental: 0.230<br />greater: experi<br />info: CHECKMATE-648, Pyrexia, All grades","Control: 0.070<br />Experimental: 0.310<br />greater: experi<br />info: CHECKMATE-648, Rash, All grades","Control: 0.036<br />Experimental: 0.170<br />greater: experi<br />info: CHECKMATE-648, Pruritus, All grades","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: CHECKMATE-648, Pneumonia, All grades","Control: 0.003<br />Experimental: 0.140<br />greater: experi<br />info: CHECKMATE-648, Hypothyroidism, All grades","Control: 0.110<br />Experimental: 0.120<br />greater: experi<br />info: CHECKMATE-648, Weight decreased , All grades","Control: 0.080<br />Experimental: 0.140<br />greater: experi<br />info: CHECKMATE-648, Musculoskeletal pain, All grades","Control: 0.049<br />Experimental: 0.050<br />greater: experi<br />info: CHECKMATE-648, Dysphagia, Grade 3-4","Control: 0.007<br />Experimental: 0.009<br />greater: experi<br />info: CHECKMATE-648, Abdominal pain, Grade 3-4","Control: 0.003<br />Experimental: 0.009<br />greater: experi<br />info: CHECKMATE-648, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.031<br />greater: experi<br />info: CHECKMATE-648, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />info: CHECKMATE-648, Pruritus, Grade 3-4","Control: 0.026<br />Experimental: 0.080<br />greater: experi<br />info: CHECKMATE-648, Pneumonia, Grade 3-4","Control: 0.010<br />Experimental: 0.019<br />greater: experi<br />info: CHECKMATE-648, Weight decreased , Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />info: CHECKMATE-648, Musculoskeletal pain, Grade 3-4","Control: 0.300<br />Experimental: 0.760<br />greater: experi<br />info: DESTINY-Breast03, Nausea, All grades","Control: 0.100<br />Experimental: 0.490<br />greater: experi<br />info: DESTINY-Breast03, Vomiting, All grades","Control: 0.200<br />Experimental: 0.340<br />greater: experi<br />info: DESTINY-Breast03, Constipation, All grades","Control: 0.070<br />Experimental: 0.290<br />greater: experi<br />info: DESTINY-Breast03, Diarrhea, All grades","Control: 0.080<br />Experimental: 0.210<br />greater: experi<br />info: DESTINY-Breast03, Abdominal pain, All grades","Control: 0.050<br />Experimental: 0.200<br />greater: experi<br />info: DESTINY-Breast03, Stomatitis, All grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: DESTINY-Breast03, Dyspepsia, All grades","Control: 0.350<br />Experimental: 0.490<br />greater: experi<br />info: DESTINY-Breast03, Fatigue/Asthenia, All grades","Control: 0.170<br />Experimental: 0.330<br />greater: experi<br />info: DESTINY-Breast03, Anemia, All grades","Control: 0.031<br />Experimental: 0.370<br />greater: experi<br />info: DESTINY-Breast03, Alopecia, All grades","Control: 0.250<br />Experimental: 0.310<br />greater: experi<br />info: DESTINY-Breast03, Musculoskeletal pain, All grades","Control: 0.170<br />Experimental: 0.290<br />greater: experi<br />info: DESTINY-Breast03, Decreased appetite, All grades","Control: 0.060<br />Experimental: 0.170<br />greater: experi<br />info: DESTINY-Breast03, Weight decreased , All grades","Control: 0.120<br />Experimental: 0.220<br />greater: experi<br />info: DESTINY-Breast03, Respiratory infection, All grades","Control: 0.100<br />Experimental: 0.110<br />greater: experi<br />info: DESTINY-Breast03, Cough, All grades","Control: 0.019<br />Experimental: 0.110<br />greater: experi<br />info: DESTINY-Breast03, Interstitial lung disease, All grades","Control: 0.160<br />Experimental: 0.220<br />greater: experi<br />info: DESTINY-Breast03, Headache, All grades","Control: 0.080<br />Experimental: 0.130<br />greater: experi<br />info: DESTINY-Breast03, Dizziness, All grades","Control: 0.004<br />Experimental: 0.070<br />greater: experi<br />info: DESTINY-Breast03, Nausea, Grade 3-4","Control: 0.008<br />Experimental: 0.016<br />greater: experi<br />info: DESTINY-Breast03, Vomiting, Grade 3-4","Control: 0.004<br />Experimental: 0.012<br />greater: experi<br />info: DESTINY-Breast03, Diarrhea, Grade 3-4","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />info: DESTINY-Breast03, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: DESTINY-Breast03, Stomatitis, Grade 3-4","Control: 0.008<br />Experimental: 0.060<br />greater: experi<br />info: DESTINY-Breast03, Fatigue/Asthenia, Grade 3-4","Control: 0.060<br />Experimental: 0.070<br />greater: experi<br />info: DESTINY-Breast03, Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: DESTINY-Breast03, Alopecia, Grade 3-4","Control: 0.004<br />Experimental: 0.012<br />greater: experi<br />info: DESTINY-Breast03, Musculoskeletal pain, Grade 3-4","Control: 0.004<br />Experimental: 0.016<br />greater: experi<br />info: DESTINY-Breast03, Decreased appetite, Grade 3-4","Control: 0.004<br />Experimental: 0.012<br />greater: experi<br />info: DESTINY-Breast03, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: DESTINY-Breast03, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: DESTINY-Breast03, Interstitial lung disease, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: DESTINY-Breast03, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: DESTINY-Breast03, Dizziness, Grade 3-4","Control: 0.230<br />Experimental: 0.430<br />greater: experi<br />info: VISION, Fatigue/Asthenia, All grades","Control: 0.150<br />Experimental: 0.210<br />greater: experi<br />info: VISION, Decreased appetite, All grades","Control: 0.090<br />Experimental: 0.110<br />greater: experi<br />info: VISION, Weight decreased , All grades","Control: 0.070<br />Experimental: 0.100<br />greater: experi<br />info: VISION, Peripheral edema, All grades","Control: 0.034<br />Experimental: 0.070<br />greater: experi<br />info: VISION, Pyrexia, All grades","Control: 0.005<br />Experimental: 0.390<br />greater: experi<br />info: VISION, Dry mouth, All grades","Control: 0.170<br />Experimental: 0.350<br />greater: experi<br />info: VISION, Nausea, All grades","Control: 0.110<br />Experimental: 0.200<br />greater: experi<br />info: VISION, Constipation, All grades","Control: 0.060<br />Experimental: 0.190<br />greater: experi<br />info: VISION, Vomiting, All grades","Control: 0.029<br />Experimental: 0.190<br />greater: experi<br />info: VISION, Diarrhea, All grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: VISION, Abdominal pain, All grades","Control: 0.130<br />Experimental: 0.320<br />greater: experi<br />info: VISION, Anemia, All grades","Control: 0.044<br />Experimental: 0.170<br />greater: experi<br />info: VISION, Thrombocytopenia, All grades","Control: 0.010<br />Experimental: 0.120<br />greater: experi<br />info: VISION, Urinary tract infection, All grades","Control: 0.060<br />Experimental: 0.090<br />greater: experi<br />info: VISION, Acute kidney injury, All grades","Control: 0.044<br />Experimental: 0.080<br />greater: experi<br />info: VISION, Dizziness, All grades","Control: 0.020<br />Experimental: 0.070<br />greater: experi<br />info: VISION, Headache, All grades","Control: 0.015<br />Experimental: 0.070<br />greater: experi<br />info: VISION, Dysgeusia, All grades","Control: 0.015<br />Experimental: 0.060<br />greater: experi<br />info: VISION, Fatigue/Asthenia, Grade 3-4","Control: 0.005<br />Experimental: 0.019<br />greater: experi<br />info: VISION, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: VISION, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: VISION, Pyrexia, Grade 3-4","Control: 0.005<br />Experimental: 0.013<br />greater: experi<br />info: VISION, Nausea, Grade 3-4","Control: 0.005<br />Experimental: 0.011<br />greater: experi<br />info: VISION, Constipation, Grade 3-4","Control: 0.005<br />Experimental: 0.009<br />greater: experi<br />info: VISION, Vomiting, Grade 3-4","Control: 0.005<br />Experimental: 0.008<br />greater: experi<br />info: VISION, Diarrhea, Grade 3-4","Control: 0.005<br />Experimental: 0.011<br />greater: experi<br />info: VISION, Abdominal pain, Grade 3-4","Control: 0.049<br />Experimental: 0.130<br />greater: experi<br />info: VISION, Anemia, Grade 3-4","Control: 0.010<br />Experimental: 0.080<br />greater: experi<br />info: VISION, Thrombocytopenia, Grade 3-4","Control: 0.005<br />Experimental: 0.038<br />greater: experi<br />info: VISION, Urinary tract infection, Grade 3-4","Control: 0.029<br />Experimental: 0.032<br />greater: experi<br />info: VISION, Acute kidney injury, Grade 3-4","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />info: VISION, Dizziness, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: VISION, Headache, Grade 3-4","Control: 0.310<br />Experimental: 0.450<br />greater: experi<br />info: RELATIVITY-047, Musculoskeletal pain, All grades","Control: 0.290<br />Experimental: 0.390<br />greater: experi<br />info: RELATIVITY-047, Fatigue/Asthenia, All grades","Control: 0.210<br />Experimental: 0.280<br />greater: experi<br />info: RELATIVITY-047, Rash, All grades","Control: 0.170<br />Experimental: 0.250<br />greater: experi<br />info: RELATIVITY-047, Pruritus, All grades","Control: 0.170<br />Experimental: 0.240<br />greater: experi<br />info: RELATIVITY-047, Diarrhea, All grades","Control: 0.140<br />Experimental: 0.170<br />greater: experi<br />info: RELATIVITY-047, Nausea, All grades","Control: 0.120<br />Experimental: 0.180<br />greater: experi<br />info: RELATIVITY-047, Headache, All grades","Control: 0.140<br />Experimental: 0.170<br />greater: experi<br />info: RELATIVITY-047, Hypothyroidism, All grades","Control: 0.070<br />Experimental: 0.150<br />greater: experi<br />info: RELATIVITY-047, Decreased appetite, All grades","Control: 0.110<br />Experimental: 0.150<br />greater: experi<br />info: RELATIVITY-047, Cough, All grades","Control: 0.017<br />Experimental: 0.042<br />greater: experi<br />info: RELATIVITY-047, Musculoskeletal pain, Grade 3-4","Control: 0.006<br />Experimental: 0.020<br />greater: experi<br />info: RELATIVITY-047, Fatigue/Asthenia, Grade 3-4","Control: 0.014<br />Experimental: 0.020<br />greater: experi<br />info: RELATIVITY-047, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: RELATIVITY-047, Nausea, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />info: RELATIVITY-047, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: RELATIVITY-047, Cough, Grade 3-4","Control: 0.320<br />Experimental: 0.340<br />greater: experi<br />info: CHECKMATE-816, Constipation, All grades","Control: 0.230<br />Experimental: 0.260<br />greater: experi<br />info: CHECKMATE-816, Fatigue/Asthenia, All grades","Control: 0.140<br />Experimental: 0.150<br />greater: experi<br />info: CHECKMATE-816, Malaise, All grades","Control: 0.070<br />Experimental: 0.200<br />greater: experi<br />info: CHECKMATE-816, Rash, All grades","Control: 0.060<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-816, Peripheral neuropathy, All grades","Control: 0.006<br />Experimental: 0.011<br />greater: experi<br />info: CHECKMATE-816, Vomiting, Grade 3-4","Control: 0.011<br />Experimental: 0.023<br />greater: experi<br />info: CHECKMATE-816, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.023<br />greater: experi<br />info: CHECKMATE-816, Rash, Grade 3-4","Control: 0.027<br />Experimental: 0.890<br />greater: experi<br />info: IMCgp100-202, Cytokine release syndrome, All grades","Control: 0.280<br />Experimental: 0.830<br />greater: experi<br />info: IMCgp100-202, Rash, All grades","Control: 0.230<br />Experimental: 0.690<br />greater: experi<br />info: IMCgp100-202, Pruritus, All grades","Control: 0.036<br />Experimental: 0.310<br />greater: experi<br />info: IMCgp100-202, Dry skin, All grades","Control: 0.050<br />Experimental: 0.280<br />greater: experi<br />info: IMCgp100-202, Skin Hypopigmentation, All grades","Control: 0.009<br />Experimental: 0.240<br />greater: experi<br />info: IMCgp100-202, Erythema, All grades","Control: 0.000<br />Experimental: 0.200<br />greater: experi<br />info: IMCgp100-202, Hair color changes, All grades","Control: 0.070<br />Experimental: 0.760<br />greater: experi<br />info: IMCgp100-202, Pyrexia, All grades","Control: 0.420<br />Experimental: 0.640<br />greater: experi<br />info: IMCgp100-202, Fatigue/Asthenia, All grades","Control: 0.036<br />Experimental: 0.480<br />greater: experi<br />info: IMCgp100-202, Chills, All grades","Control: 0.100<br />Experimental: 0.450<br />greater: experi<br />info: IMCgp100-202, Edema, All grades","Control: 0.260<br />Experimental: 0.490<br />greater: experi<br />info: IMCgp100-202, Nausea, All grades","Control: 0.330<br />Experimental: 0.450<br />greater: experi<br />info: IMCgp100-202, Abdominal pain, All grades","Control: 0.090<br />Experimental: 0.300<br />greater: experi<br />info: IMCgp100-202, Vomiting, All grades","Control: 0.200<br />Experimental: 0.250<br />greater: experi<br />info: IMCgp100-202, Diarrhea, All grades","Control: 0.027<br />Experimental: 0.390<br />greater: experi<br />info: IMCgp100-202, Hypotension, All grades","Control: 0.100<br />Experimental: 0.310<br />greater: experi<br />info: IMCgp100-202, Headache, All grades","Control: 0.160<br />Experimental: 0.220<br />greater: experi<br />info: IMCgp100-202, Arthralgia, All grades","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: IMCgp100-202, Cytokine release syndrome, Grade 3-4","Control: 0.000<br />Experimental: 0.180<br />greater: experi<br />info: IMCgp100-202, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.045<br />greater: experi<br />info: IMCgp100-202, Pruritus, Grade 3-4","Control: 0.009<br />Experimental: 0.037<br />greater: experi<br />info: IMCgp100-202, Pyrexia, Grade 3-4","Control: 0.009<br />Experimental: 0.060<br />greater: experi<br />info: IMCgp100-202, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: IMCgp100-202, Chills, Grade 3-4","Control: 0.009<br />Experimental: 0.020<br />greater: experi<br />info: IMCgp100-202, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />info: IMCgp100-202, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.033<br />greater: experi<br />info: IMCgp100-202, Hypotension, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: IMCgp100-202, Arthralgia, Grade 3-4","Control: 0.120<br />Experimental: 0.260<br />greater: experi<br />info: ASCEMBL, Upper respiratory tract infection, All grades","Control: 0.160<br />Experimental: 0.220<br />greater: experi<br />info: ASCEMBL, Musculoskeletal pain, All grades","Control: 0.039<br />Experimental: 0.120<br />greater: experi<br />info: ASCEMBL, Arthralgia, All grades","Control: 0.150<br />Experimental: 0.190<br />greater: experi<br />info: ASCEMBL, Headache, All grades","Control: 0.110<br />Experimental: 0.170<br />greater: experi<br />info: ASCEMBL, Fatigue/Asthenia, All grades","Control: 0.050<br />Experimental: 0.130<br />greater: experi<br />info: ASCEMBL, Hypertension, All grades","Control: 0.013<br />Experimental: 0.026<br />greater: experi<br />info: ASCEMBL, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.019<br />greater: experi<br />info: ASCEMBL, Headache, Grade 3-4","Control: 0.039<br />Experimental: 0.060<br />greater: experi<br />info: ASCEMBL, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: ASCEMBL, Nausea, Grade 3-4","Control: 0.014<br />Experimental: 0.170<br />greater: experi<br />info: IMpower010, Rash, All grades","Control: 0.006<br />Experimental: 0.100<br />greater: experi<br />info: IMpower010, Pruritus, All grades","Control: 0.006<br />Experimental: 0.140<br />greater: experi<br />info: IMpower010, Hypothyroidism, All grades","Control: 0.110<br />Experimental: 0.160<br />greater: experi<br />info: IMpower010, Cough, All grades","Control: 0.022<br />Experimental: 0.140<br />greater: experi<br />info: IMpower010, Pyrexia, All grades","Control: 0.050<br />Experimental: 0.140<br />greater: experi<br />info: IMpower010, Fatigue/Asthenia, All grades","Control: 0.070<br />Experimental: 0.120<br />greater: experi<br />info: IMpower010, Peripheral neuropathy, All grades","Control: 0.090<br />Experimental: 0.140<br />greater: experi<br />info: IMpower010, Musculoskeletal pain, All grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: IMpower010, Arthralgia, All grades","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />info: IMpower010, Rash, Grade 3-4","Control: 0.002<br />Experimental: 0.008<br />greater: experi<br />info: IMpower010, Pyrexia, Grade 3-4","Control: 0.002<br />Experimental: 0.006<br />greater: experi<br />info: IMpower010, Fatigue/Asthenia, Grade 3-4","Control: 0.002<br />Experimental: 0.004<br />greater: experi<br />info: IMpower010, Peripheral neuropathy, Grade 3-4","Control: 0.002<br />Experimental: 0.008<br />greater: experi<br />info: IMpower010, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: IMpower010, Arthralgia, Grade 3-4","Control: 0.090<br />Experimental: 0.840<br />greater: experi<br />info: monarchE, Diarrhea, All grades","Control: 0.090<br />Experimental: 0.300<br />greater: experi<br />info: monarchE, Nausea, All grades","Control: 0.046<br />Experimental: 0.180<br />greater: experi<br />info: monarchE, Vomiting, All grades","Control: 0.050<br />Experimental: 0.140<br />greater: experi<br />info: monarchE, Stomatitis, All grades","Control: 0.390<br />Experimental: 0.510<br />greater: experi<br />info: monarchE, Infections, All grades","Control: 0.180<br />Experimental: 0.410<br />greater: experi<br />info: monarchE, Fatigue/Asthenia, All grades","Control: 0.150<br />Experimental: 0.200<br />greater: experi<br />info: monarchE, Headache, All grades","Control: 0.070<br />Experimental: 0.110<br />greater: experi<br />info: monarchE, Dizziness, All grades","Control: 0.024<br />Experimental: 0.120<br />greater: experi<br />info: monarchE, Decreased appetite, All grades","Control: 0.045<br />Experimental: 0.110<br />greater: experi<br />info: monarchE, Rash, All grades","Control: 0.027<br />Experimental: 0.110<br />greater: experi<br />info: monarchE, Alopecia, All grades","Control: 0.002<br />Experimental: 0.080<br />greater: experi<br />info: monarchE, Diarrhea, Grade 3","Control: 0.001<br />Experimental: 0.005<br />greater: experi<br />info: monarchE, Nausea, Grade 3","Control: 0.001<br />Experimental: 0.005<br />greater: experi<br />info: monarchE, Vomiting, Grade 3","Control: 0.000<br />Experimental: 0.001<br />greater: experi<br />info: monarchE, Stomatitis, Grade 3","Control: 0.027<br />Experimental: 0.049<br />greater: experi<br />info: monarchE, Infections, Grade 3","Control: 0.001<br />Experimental: 0.029<br />greater: experi<br />info: monarchE, Fatigue/Asthenia, Grade 3","Control: 0.002<br />Experimental: 0.003<br />greater: experi<br />info: monarchE, Headache, Grade 3","Control: 0.001<br />Experimental: 0.006<br />greater: experi<br />info: monarchE, Decreased appetite, Grade 3","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: monarchE, Rash, Grade 3","Control: 0.001<br />Experimental: 0.006<br />greater: experi<br />info: monarchE, Infections, Grade 4","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: REACH-3, Musculoskeletal pain, All grades","Control: 0.090<br />Experimental: 0.160<br />greater: experi<br />info: REACH-3, Pyrexia, All grades","Control: 0.100<br />Experimental: 0.130<br />greater: experi<br />info: REACH-3, Fatigue/Asthenia, All grades","Control: 0.130<br />Experimental: 0.160<br />greater: experi<br />info: REACH-3, Hypertension, All grades","Control: 0.080<br />Experimental: 0.130<br />greater: experi<br />info: REACH-3, Cough, All grades","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: REACH-3, Dyspnea, All grades","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: REACH-3, Musculoskeletal pain, Grade ≥ 3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: REACH-3, Pyrexia, Grade ≥ 3","Control: 0.400<br />Experimental: 0.440<br />greater: experi<br />info: ASPEN, Upper respiratory tract infection, All grades","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: ASPEN, Nausea, All grades","Control: 0.070<br />Experimental: 0.160<br />greater: experi<br />info: ASPEN, Constipation, All grades","Control: 0.250<br />Experimental: 0.310<br />greater: experi<br />info: ASPEN, Fatigue/Asthenia, All grades","Control: 0.130<br />Experimental: 0.160<br />greater: experi<br />info: ASPEN, Pyrexia, All grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: ASPEN, Pruritus, All grades","Control: 0.390<br />Experimental: 0.450<br />greater: experi<br />info: ASPEN, Musculoskeletal pain, All grades","Control: 0.140<br />Experimental: 0.180<br />greater: experi<br />info: ASPEN, Headache, All grades","Control: 0.120<br />Experimental: 0.130<br />greater: experi<br />info: ASPEN, Dizziness, All grades","Control: 0.070<br />Experimental: 0.140<br />greater: experi<br />info: ASPEN, Dyspnea, All grades","Control: 0.020<br />Experimental: 0.030<br />greater: experi<br />info: ASPEN, Diarrhea, Grade 3-4","Control: 0.020<br />Experimental: 0.040<br />greater: experi<br />info: ASPEN, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: ASPEN, Pruritus, Grade 3-4","Control: 0.010<br />Experimental: 0.090<br />greater: experi<br />info: ASPEN, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: ASPEN, Dizziness, Grade 3-4","Control: 0.560<br />Experimental: 0.630<br />greater: experi<br />info: CLEAR, Fatigue/Asthenia, All Grades","Control: 0.500<br />Experimental: 0.620<br />greater: experi<br />info: CLEAR, Diarrhea, All Grades","Control: 0.330<br />Experimental: 0.360<br />greater: experi<br />info: CLEAR, Nausea, All Grades","Control: 0.180<br />Experimental: 0.270<br />greater: experi<br />info: CLEAR, Abdominal pain, All Grades","Control: 0.200<br />Experimental: 0.260<br />greater: experi<br />info: CLEAR, Vomiting, All Grades","Control: 0.190<br />Experimental: 0.250<br />greater: experi<br />info: CLEAR, Constipation, All Grades","Control: 0.410<br />Experimental: 0.580<br />greater: experi<br />info: CLEAR, Musculoskeletal pain, All Grades","Control: 0.320<br />Experimental: 0.570<br />greater: experi<br />info: CLEAR, Hypothyroidism, All Grades","Control: 0.430<br />Experimental: 0.560<br />greater: experi<br />info: CLEAR, Hypertension, All Grades","Control: 0.260<br />Experimental: 0.270<br />greater: experi<br />info: CLEAR, Hemorrhagic events, All Grades","Control: 0.310<br />Experimental: 0.410<br />greater: experi<br />info: CLEAR, Decreased appetite, All Grades","Control: 0.170<br />Experimental: 0.370<br />greater: experi<br />info: CLEAR, Rash, All Grades","Control: 0.040<br />Experimental: 0.300<br />greater: experi<br />info: CLEAR, Dysphonia, All Grades","Control: 0.130<br />Experimental: 0.300<br />greater: experi<br />info: CLEAR, Proteinuria, All Grades","Control: 0.160<br />Experimental: 0.210<br />greater: experi<br />info: CLEAR, Acute kidney injury, All Grades","Control: 0.090<br />Experimental: 0.300<br />greater: experi<br />info: CLEAR, Weight decreased , All Grades","Control: 0.210<br />Experimental: 0.250<br />greater: experi<br />info: CLEAR, Hepatotoxicity, All Grades","Control: 0.160<br />Experimental: 0.230<br />greater: experi<br />info: CLEAR, Headache, All Grades","Control: 0.080<br />Experimental: 0.090<br />greater: experi<br />info: CLEAR, Fatigue/Asthenia, Grade 3-4","Control: 0.060<br />Experimental: 0.100<br />greater: experi<br />info: CLEAR, Diarrhea, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: CLEAR, Nausea, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: CLEAR, Abdominal pain, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: CLEAR, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: CLEAR, Constipation, Grade 3-4","Control: 0.030<br />Experimental: 0.040<br />greater: experi<br />info: CLEAR, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: CLEAR, Hypothyroidism, Grade 3-4","Control: 0.200<br />Experimental: 0.290<br />greater: experi<br />info: CLEAR, Hypertension, Grade 3-4","Control: 0.040<br />Experimental: 0.050<br />greater: experi<br />info: CLEAR, Hemorrhagic events, Grade 3-4","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />info: CLEAR, Decreased appetite, Grade 3-4","Control: 0.010<br />Experimental: 0.050<br />greater: experi<br />info: CLEAR, Rash, Grade 3-4","Control: 0.030<br />Experimental: 0.080<br />greater: experi<br />info: CLEAR, Proteinuria, Grade 3-4","Control: 0.020<br />Experimental: 0.050<br />greater: experi<br />info: CLEAR, Acute kidney injury, Grade 3-4","Control: 0.000<br />Experimental: 0.080<br />greater: experi<br />info: CLEAR, Weight decreased , Grade 3-4","Control: 0.050<br />Experimental: 0.090<br />greater: experi<br />info: CLEAR, Hepatotoxicity, Grade 3-4","Control: 0.009<br />Experimental: 0.670<br />greater: experi<br />info: Study 309, Hypothyroidism, All Grades","Control: 0.060<br />Experimental: 0.670<br />greater: experi<br />info: Study 309, Hypertension, All Grades","Control: 0.150<br />Experimental: 0.250<br />greater: experi<br />info: Study 309, Hemorrhagic events, All Grades","Control: 0.540<br />Experimental: 0.580<br />greater: experi<br />info: Study 309, Fatigue/Asthenia, All Grades","Control: 0.200<br />Experimental: 0.550<br />greater: experi<br />info: Study 309, Diarrhea, All Grades","Control: 0.470<br />Experimental: 0.490<br />greater: experi<br />info: Study 309, Nausea, All Grades","Control: 0.210<br />Experimental: 0.370<br />greater: experi<br />info: Study 309, Vomiting, All Grades","Control: 0.260<br />Experimental: 0.350<br />greater: experi<br />info: Study 309, Stomatitis, All Grades","Control: 0.210<br />Experimental: 0.340<br />greater: experi<br />info: Study 309, Abdominal pain, All Grades","Control: 0.250<br />Experimental: 0.270<br />greater: experi<br />info: Study 309, Constipation, All Grades","Control: 0.270<br />Experimental: 0.530<br />greater: experi<br />info: Study 309, Musculoskeletal disorders, All Grades","Control: 0.210<br />Experimental: 0.440<br />greater: experi<br />info: Study 309, Decreased appetite, All Grades","Control: 0.060<br />Experimental: 0.340<br />greater: experi<br />info: Study 309, Weight decreased , All Grades","Control: 0.034<br />Experimental: 0.290<br />greater: experi<br />info: Study 309, Proteinuria, All Grades","Control: 0.130<br />Experimental: 0.310<br />greater: experi<br />info: Study 309, Urinary tract infection, All Grades","Control: 0.090<br />Experimental: 0.260<br />greater: experi<br />info: Study 309, Headache, All Grades","Control: 0.006<br />Experimental: 0.220<br />greater: experi<br />info: Study 309, Dysphonia, All Grades","Control: 0.009<br />Experimental: 0.230<br />greater: experi<br />info: Study 309, Palmar-plantar erythrodysesthesia, All Grades","Control: 0.049<br />Experimental: 0.200<br />greater: experi<br />info: Study 309, Rash, All Grades","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />info: Study 309, Hypothyroidism, Grade 3-4","Control: 0.025<br />Experimental: 0.390<br />greater: experi<br />info: Study 309, Hypertension, Grade 3-4","Control: 0.009<br />Experimental: 0.026<br />greater: experi<br />info: Study 309, Hemorrhagic events, Grade 3-4","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: Study 309, Fatigue/Asthenia, Grade 3-4","Control: 0.028<br />Experimental: 0.080<br />greater: experi<br />info: Study 309, Diarrhea, Grade 3-4","Control: 0.015<br />Experimental: 0.029<br />greater: experi<br />info: Study 309, Nausea, Grade 3-4","Control: 0.022<br />Experimental: 0.023<br />greater: experi<br />info: Study 309, Vomiting, Grade 3-4","Control: 0.012<br />Experimental: 0.026<br />greater: experi<br />info: Study 309, Stomatitis, Grade 3-4","Control: 0.012<br />Experimental: 0.026<br />greater: experi<br />info: Study 309, Abdominal pain, Grade 3-4","Control: 0.006<br />Experimental: 0.050<br />greater: experi<br />info: Study 309, Musculoskeletal disorders, Grade 3-4","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />info: Study 309, Decreased appetite, Grade 3-4","Control: 0.003<br />Experimental: 0.100<br />greater: experi<br />info: Study 309, Weight decreased , Grade 3-4","Control: 0.003<br />Experimental: 0.060<br />greater: experi<br />info: Study 309, Proteinuria, Grade 3-4","Control: 0.012<br />Experimental: 0.050<br />greater: experi<br />info: Study 309, Urinary tract infection, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />info: Study 309, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.029<br />greater: experi<br />info: Study 309, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.000<br />Experimental: 0.023<br />greater: experi<br />info: Study 309, Rash, Grade 3-4","Control: 0.390<br />Experimental: 0.460<br />greater: experi<br />info: APOLLO, Fatigue/Asthenia, All Grades","Control: 0.140<br />Experimental: 0.190<br />greater: experi<br />info: APOLLO, Pyrexia, All Grades","Control: 0.090<br />Experimental: 0.150<br />greater: experi<br />info: APOLLO, Edema peripheral, All Grades","Control: 0.270<br />Experimental: 0.380<br />greater: experi<br />info: APOLLO, Pneumonia, All Grades","Control: 0.220<br />Experimental: 0.360<br />greater: experi<br />info: APOLLO, Upper respiratory tract infection, All Grades","Control: 0.140<br />Experimental: 0.220<br />greater: experi<br />info: APOLLO, Diarrhea, All Grades","Control: 0.080<br />Experimental: 0.130<br />greater: experi<br />info: APOLLO, Cough, All Grades","Control: 0.050<br />Experimental: 0.130<br />greater: experi<br />info: APOLLO, Fatigue/Asthenia, Grade ≥ 3","Control: 0.170<br />Experimental: 0.230<br />greater: experi<br />info: APOLLO, Pneumonia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.050<br />greater: experi<br />info: APOLLO, Diarrhea, Grade ≥ 3","Control: 0.460<br />Experimental: 0.530<br />greater: experi<br />info: CHECKMATE-649, Peripheral neuropathy, All Grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-649, Headache, All Grades","Control: 0.440<br />Experimental: 0.480<br />greater: experi<br />info: CHECKMATE-649, Nausea, All Grades","Control: 0.340<br />Experimental: 0.390<br />greater: experi<br />info: CHECKMATE-649, Diarrhea, All Grades","Control: 0.290<br />Experimental: 0.310<br />greater: experi<br />info: CHECKMATE-649, Vomiting, All Grades","Control: 0.240<br />Experimental: 0.270<br />greater: experi<br />info: CHECKMATE-649, Abdominal pain, All Grades","Control: 0.210<br />Experimental: 0.250<br />greater: experi<br />info: CHECKMATE-649, Constipation, All Grades","Control: 0.130<br />Experimental: 0.170<br />greater: experi<br />info: CHECKMATE-649, Stomatitis, All Grades","Control: 0.400<br />Experimental: 0.440<br />greater: experi<br />info: CHECKMATE-649, Fatigue/Asthenia, All Grades","Control: 0.110<br />Experimental: 0.190<br />greater: experi<br />info: CHECKMATE-649, Pyrexia, All Grades","Control: 0.080<br />Experimental: 0.120<br />greater: experi<br />info: CHECKMATE-649, Edema, All Grades","Control: 0.260<br />Experimental: 0.290<br />greater: experi<br />info: CHECKMATE-649, Decreased appetite, All Grades","Control: 0.090<br />Experimental: 0.140<br />greater: experi<br />info: CHECKMATE-649, Hypoalbuminemia, All Grades","Control: 0.150<br />Experimental: 0.170<br />greater: experi<br />info: CHECKMATE-649, Weight decreased , All Grades","Control: 0.080<br />Experimental: 0.140<br />greater: experi<br />info: CHECKMATE-649, Increased lipase, All Grades","Control: 0.050<br />Experimental: 0.120<br />greater: experi<br />info: CHECKMATE-649, Increased amylase, All Grades","Control: 0.140<br />Experimental: 0.200<br />greater: experi<br />info: CHECKMATE-649, Musculoskeletal pain, All Grades","Control: 0.044<br />Experimental: 0.180<br />greater: experi<br />info: CHECKMATE-649, Rash, All Grades","Control: 0.120<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-649, Palmar-plantar erythrodysesthesia, All Grades","Control: 0.090<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-649, Cough, All Grades","Control: 0.070<br />Experimental: 0.100<br />greater: experi<br />info: CHECKMATE-649, Upper respiratory tract infection, All Grades","Control: 0.048<br />Experimental: 0.070<br />greater: experi<br />info: CHECKMATE-649, Peripheral neuropathy, Grade 3-4","Control: 0.003<br />Experimental: 0.008<br />greater: experi<br />info: CHECKMATE-649, Headache, Grade 3-4","Control: 0.037<br />Experimental: 0.050<br />greater: experi<br />info: CHECKMATE-649, Diarrhea, Grade 3-4","Control: 0.026<br />Experimental: 0.028<br />greater: experi<br />info: CHECKMATE-649, Abdominal pain, Grade 3-4","Control: 0.004<br />Experimental: 0.006<br />greater: experi<br />info: CHECKMATE-649, Constipation, Grade 3-4","Control: 0.008<br />Experimental: 0.018<br />greater: experi<br />info: CHECKMATE-649, Stomatitis, Grade 3-4","Control: 0.050<br />Experimental: 0.070<br />greater: experi<br />info: CHECKMATE-649, Fatigue/Asthenia, Grade 3-4","Control: 0.004<br />Experimental: 0.010<br />greater: experi<br />info: CHECKMATE-649, Pyrexia, Grade 3-4","Control: 0.001<br />Experimental: 0.005<br />greater: experi<br />info: CHECKMATE-649, Edema, Grade 3-4","Control: 0.025<br />Experimental: 0.036<br />greater: experi<br />info: CHECKMATE-649, Decreased appetite, Grade 3-4","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />info: CHECKMATE-649, Weight decreased , Grade 3-4","Control: 0.037<br />Experimental: 0.070<br />greater: experi<br />info: CHECKMATE-649, Increased lipase, Grade 3-4","Control: 0.004<br />Experimental: 0.031<br />greater: experi<br />info: CHECKMATE-649, Increased amylase, Grade 3-4","Control: 0.001<br />Experimental: 0.017<br />greater: experi<br />info: CHECKMATE-649, Rash, Grade 3-4","Control: 0.008<br />Experimental: 0.015<br />greater: experi<br />info: CHECKMATE-649, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.000<br />Experimental: 0.001<br />greater: experi<br />info: CHECKMATE-649, Cough, Grade 3-4","Control: 0.440<br />Experimental: 0.640<br />greater: experi<br />info: ASCENT, Neutropenia, All Grades","Control: 0.280<br />Experimental: 0.400<br />greater: experi<br />info: ASCENT, Anemia, All Grades","Control: 0.120<br />Experimental: 0.170<br />greater: experi<br />info: ASCENT, Leukopenia, All Grades","Control: 0.060<br />Experimental: 0.100<br />greater: experi<br />info: ASCENT, Lymphopenia, All Grades","Control: 0.170<br />Experimental: 0.590<br />greater: experi<br />info: ASCENT, Diarrhea, All Grades","Control: 0.260<br />Experimental: 0.570<br />greater: experi<br />info: ASCENT, Nausea, All Grades","Control: 0.160<br />Experimental: 0.330<br />greater: experi<br />info: ASCENT, Vomiting, All Grades","Control: 0.230<br />Experimental: 0.370<br />greater: experi<br />info: ASCENT, Constipation, All Grades","Control: 0.120<br />Experimental: 0.300<br />greater: experi<br />info: ASCENT, Abdominal Pain, All Grades","Control: 0.130<br />Experimental: 0.170<br />greater: experi<br />info: ASCENT, Stomatitis, All Grades","Control: 0.500<br />Experimental: 0.650<br />greater: experi<br />info: ASCENT, Fatigue/Asthenia, All Grades","Control: 0.140<br />Experimental: 0.150<br />greater: experi<br />info: ASCENT, Pyrexia, All Grades","Control: 0.080<br />Experimental: 0.130<br />greater: experi<br />info: ASCENT, Urinary tract infection, All Grades","Control: 0.030<br />Experimental: 0.120<br />greater: experi<br />info: ASCENT, Upper respiratory tract infection, All Grades","Control: 0.100<br />Experimental: 0.110<br />greater: experi<br />info: ASCENT, Alanine aminotransferase increased, All Grades","Control: 0.210<br />Experimental: 0.280<br />greater: experi<br />info: ASCENT, Decreased appetite, All Grades","Control: 0.130<br />Experimental: 0.160<br />greater: experi<br />info: ASCENT, Hypokalemia, All Grades","Control: 0.060<br />Experimental: 0.120<br />greater: experi<br />info: ASCENT, Hypomagnesaemia, All Grades","Control: 0.140<br />Experimental: 0.160<br />greater: experi<br />info: ASCENT, Back pain, All Grades","Control: 0.070<br />Experimental: 0.120<br />greater: experi<br />info: ASCENT, Arthralgia, All Grades","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: ASCENT, Headache, All Grades","Control: 0.070<br />Experimental: 0.100<br />greater: experi<br />info: ASCENT, Dizziness, All Grades","Control: 0.050<br />Experimental: 0.110<br />greater: experi<br />info: ASCENT, Insomnia, All Grades","Control: 0.180<br />Experimental: 0.240<br />greater: experi<br />info: ASCENT, Cough, All Grades","Control: 0.160<br />Experimental: 0.470<br />greater: experi<br />info: ASCENT, Alopecia, All Grades","Control: 0.050<br />Experimental: 0.120<br />greater: experi<br />info: ASCENT, Rash, All Grades","Control: 0.030<br />Experimental: 0.100<br />greater: experi<br />info: ASCENT, Pruritus, All Grades","Control: 0.340<br />Experimental: 0.520<br />greater: experi<br />info: ASCENT, Neutropenia, Grade 3-4","Control: 0.060<br />Experimental: 0.090<br />greater: experi<br />info: ASCENT, Anemia, Grade 3-4","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: ASCENT, Leukopenia, Grade 3-4","Control: 0.010<br />Experimental: 0.110<br />greater: experi<br />info: ASCENT, Diarrhea, Grade 3-4","Control: 0.004<br />Experimental: 0.030<br />greater: experi<br />info: ASCENT, Nausea, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: ASCENT, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: ASCENT, Constipation, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: ASCENT, Abdominal Pain, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: ASCENT, Stomatitis, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: ASCENT, Decreased appetite, Grade 3-4","Control: 0.004<br />Experimental: 0.030<br />greater: experi<br />info: ASCENT, Hypokalemia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: ASCENT, Arthralgia, Grade 3-4","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />info: ASCENT, Headache, Grade 3-4","Control: 0.033<br />Experimental: 0.460<br />greater: experi<br />info: IKEMA, Infusion-related reaction, All Grades","Control: 0.570<br />Experimental: 0.670<br />greater: experi<br />info: IKEMA, Upper respiratory tract infection, All Grades","Control: 0.300<br />Experimental: 0.360<br />greater: experi<br />info: IKEMA, Pneumonia, All Grades","Control: 0.130<br />Experimental: 0.240<br />greater: experi<br />info: IKEMA, Bronchitis, All Grades","Control: 0.320<br />Experimental: 0.370<br />greater: experi<br />info: IKEMA, Hypertension, All Grades","Control: 0.240<br />Experimental: 0.290<br />greater: experi<br />info: IKEMA, Dyspnea, All Grades","Control: 0.150<br />Experimental: 0.230<br />greater: experi<br />info: IKEMA, Cough, All Grades","Control: 0.290<br />Experimental: 0.360<br />greater: experi<br />info: IKEMA, Diarrhea, All Grades","Control: 0.090<br />Experimental: 0.150<br />greater: experi<br />info: IKEMA, Vomiting, All Grades","Control: 0.320<br />Experimental: 0.420<br />greater: experi<br />info: IKEMA, Fatigue/Asthenia, All Grades","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: IKEMA, Infusion-related reaction, Grade 3","Control: 0.070<br />Experimental: 0.090<br />greater: experi<br />info: IKEMA, Upper respiratory tract infection, Grade 3","Control: 0.150<br />Experimental: 0.190<br />greater: experi<br />info: IKEMA, Pneumonia, Grade 3","Control: 0.008<br />Experimental: 0.023<br />greater: experi<br />info: IKEMA, Bronchitis, Grade 3","Control: 0.180<br />Experimental: 0.200<br />greater: experi<br />info: IKEMA, Hypertension, Grade 3","Control: 0.008<br />Experimental: 0.050<br />greater: experi<br />info: IKEMA, Dyspnea, Grade 3","Control: 0.025<br />Experimental: 0.028<br />greater: experi<br />info: IKEMA, Diarrhea, Grade 3","Control: 0.008<br />Experimental: 0.011<br />greater: experi<br />info: IKEMA, Vomiting, Grade 3","Control: 0.033<br />Experimental: 0.050<br />greater: experi<br />info: IKEMA, Fatigue/Asthenia, Grade 3","Control: 0.025<br />Experimental: 0.034<br />greater: experi<br />info: IKEMA, Pneumonia, Grade 4","Control: 0.480<br />Experimental: 0.670<br />greater: experi<br />info: TIVO-3, Fatigue/Asthenia, All Grades","Control: 0.310<br />Experimental: 0.440<br />greater: experi<br />info: TIVO-3, Hypertension, All Grades","Control: 0.120<br />Experimental: 0.170<br />greater: experi<br />info: TIVO-3, Bleeding, All Grades","Control: 0.180<br />Experimental: 0.300<br />greater: experi<br />info: TIVO-3, Nausea, All Grades","Control: 0.170<br />Experimental: 0.180<br />greater: experi<br />info: TIVO-3, Vomiting, All Grades","Control: 0.300<br />Experimental: 0.390<br />greater: experi<br />info: TIVO-3, Decreased appetite, All Grades","Control: 0.090<br />Experimental: 0.270<br />greater: experi<br />info: TIVO-3, Dysphonia, All Grades","Control: 0.150<br />Experimental: 0.220<br />greater: experi<br />info: TIVO-3, Cough, All Grades","Control: 0.110<br />Experimental: 0.150<br />greater: experi<br />info: TIVO-3, Dyspnea, All Grades","Control: 0.110<br />Experimental: 0.240<br />greater: experi<br />info: TIVO-3, Hypothyroidism, All Grades","Control: 0.160<br />Experimental: 0.190<br />greater: experi<br />info: TIVO-3, Back pain, All Grades","Control: 0.120<br />Experimental: 0.130<br />greater: experi<br />info: TIVO-3, Fatigue/Asthenia, Grade 3-4","Control: 0.170<br />Experimental: 0.240<br />greater: experi<br />info: TIVO-3, Hypertension, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: TIVO-3, Bleeding, Grade 3-4","Control: 0.040<br />Experimental: 0.050<br />greater: experi<br />info: TIVO-3, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: TIVO-3, Dysphonia, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: TIVO-3, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: TIVO-3, Hypothyroidism, Grade 3-4","Control: 0.050<br />Experimental: 0.160<br />greater: experi<br />info: Study B7461006, Mood effects, All Grades","Control: 0.150<br />Experimental: 0.340<br />greater: experi<br />info: Study B7461006, Peripheral neuropathy, All Grades","Control: 0.060<br />Experimental: 0.210<br />greater: experi<br />info: Study B7461006, Cognitive effects, All Grades","Control: 0.100<br />Experimental: 0.110<br />greater: experi<br />info: Study B7461006, Sleep effects, All Grades","Control: 0.160<br />Experimental: 0.200<br />greater: experi<br />info: Study B7461006, Dyspnea, All Grades","Control: 0.000<br />Experimental: 0.027<br />greater: experi<br />info: Study B7461006, Respiratory failure, All Grades","Control: 0.021<br />Experimental: 0.180<br />greater: experi<br />info: Study B7461006, Hypertension, All Grades","Control: 0.110<br />Experimental: 0.190<br />greater: experi<br />info: Study B7461006, Arthralgia, All Grades","Control: 0.070<br />Experimental: 0.150<br />greater: experi<br />info: Study B7461006, Myalgia, All Grades","Control: 0.110<br />Experimental: 0.150<br />greater: experi<br />info: Study B7461006, Back pain, All Grades","Control: 0.080<br />Experimental: 0.170<br />greater: experi<br />info: Study B7461006, Pain in extremity, All Grades","Control: 0.400<br />Experimental: 0.560<br />greater: experi<br />info: Study B7461006, Edema, All Grades","Control: 0.130<br />Experimental: 0.380<br />greater: experi<br />info: Study B7461006, Weight Increased, All Grades","Control: 0.130<br />Experimental: 0.170<br />greater: experi<br />info: Study B7461006, Pyrexia, All Grades","Control: 0.077<br />Experimental: 0.110<br />greater: experi<br />info: Study B7461006, Upper respiratory tract infection, All Grades","Control: 0.021<br />Experimental: 0.067<br />greater: experi<br />info: Study B7461006, Bronchitis, All Grades","Control: 0.085<br />Experimental: 0.110<br />greater: experi<br />info: Study B7461006, Rash, All Grades","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: Study B7461006, Mood effects, Grade 3-4","Control: 0.007<br />Experimental: 0.020<br />greater: experi<br />info: Study B7461006, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: Study B7461006, Cognitive effects, Grade 3-4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />info: Study B7461006, Sleep effects, Grade 3-4","Control: 0.021<br />Experimental: 0.027<br />greater: experi<br />info: Study B7461006, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: Study B7461006, Respiratory failure, Grade 3-4","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />info: Study B7461006, Hypertension, Grade 3-4","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />info: Study B7461006, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: Study B7461006, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: Study B7461006, Myalgia, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: Study B7461006, Back pain, Grade 3-4","Control: 0.014<br />Experimental: 0.040<br />greater: experi<br />info: Study B7461006, Edema, Grade 3-4","Control: 0.021<br />Experimental: 0.170<br />greater: experi<br />info: Study B7461006, Weight Increased, Grade 3-4","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />info: Study B7461006, Chest pain, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: Study B7461006, Bronchitis, Grade 3-4","Control: 0.060<br />Experimental: 0.150<br />greater: experi<br />info: Study 1624, Rash, All Grades","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: Study 1624, Cough, All Grades","Control: 0.000<br />Experimental: 0.014<br />greater: experi<br />info: Study 1624, Rash, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />info: Study 1624, Decreased appetite, Grade 3-4","Control: 0.470<br />Experimental: 0.640<br />greater: experi<br />info: CHECKMATE-9ER, Diarrhea, Grades 1-4","Control: 0.150<br />Experimental: 0.220<br />greater: experi<br />info: CHECKMATE-9ER, Abdominal pain, Grades 1-4","Control: 0.500<br />Experimental: 0.510<br />greater: experi<br />info: CHECKMATE-9ER, Fatigue/Asthenia, Grades 1-4","Control: 0.260<br />Experimental: 0.440<br />greater: experi<br />info: CHECKMATE-9ER, Hepatotoxicity, Grades 1-4","Control: 0.140<br />Experimental: 0.360<br />greater: experi<br />info: CHECKMATE-9ER, Rash, Grades 1-4","Control: 0.044<br />Experimental: 0.190<br />greater: experi<br />info: CHECKMATE-9ER, Pruritus, Grades 1-4","Control: 0.300<br />Experimental: 0.340<br />greater: experi<br />info: CHECKMATE-9ER, Hypothyroidism, Grades 1-4","Control: 0.290<br />Experimental: 0.330<br />greater: experi<br />info: CHECKMATE-9ER, Musculoskeletal pain, Grades 1-4","Control: 0.090<br />Experimental: 0.180<br />greater: experi<br />info: CHECKMATE-9ER, Arthralgia, Grades 1-4","Control: 0.200<br />Experimental: 0.280<br />greater: experi<br />info: CHECKMATE-9ER, Decreased appetite, Grades 1-4","Control: 0.220<br />Experimental: 0.240<br />greater: experi<br />info: CHECKMATE-9ER, Dysgeusia, Grades 1-4","Control: 0.120<br />Experimental: 0.160<br />greater: experi<br />info: CHECKMATE-9ER, Headache, Grades 1-4","Control: 0.170<br />Experimental: 0.200<br />greater: experi<br />info: CHECKMATE-9ER, Cough, Grades 1-4","Control: 0.034<br />Experimental: 0.170<br />greater: experi<br />info: CHECKMATE-9ER, Dysphonia , Grades 1-4","Control: 0.080<br />Experimental: 0.200<br />greater: experi<br />info: CHECKMATE-9ER, Upper respiratory tract infection, Grades 1-4","Control: 0.044<br />Experimental: 0.070<br />greater: experi<br />info: CHECKMATE-9ER, Diarrhea, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />info: CHECKMATE-9ER, Nausea, Grade 3-4","Control: 0.003<br />Experimental: 0.019<br />greater: experi<br />info: CHECKMATE-9ER, Abdominal pain, Grade 3-4","Control: 0.003<br />Experimental: 0.019<br />greater: experi<br />info: CHECKMATE-9ER, Vomiting, Grade 3-4","Control: 0.050<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-9ER, Hepatotoxicity, Grade 3-4","Control: 0.000<br />Experimental: 0.031<br />greater: experi<br />info: CHECKMATE-9ER, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: CHECKMATE-9ER, Pruritus, Grade 3-4","Control: 0.031<br />Experimental: 0.038<br />greater: experi<br />info: CHECKMATE-9ER, Musculoskeletal pain, Grade 3-4","Control: 0.013<br />Experimental: 0.019<br />greater: experi<br />info: CHECKMATE-9ER, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: CHECKMATE-9ER, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: CHECKMATE-9ER, Dysphonia , Grade 3-4","Control: 0.210<br />Experimental: 0.400<br />greater: experi<br />info: ANDROMEDA, Upper respiratory tract infection, All Grades","Control: 0.090<br />Experimental: 0.150<br />greater: experi<br />info: ANDROMEDA, Pneumonia, All Grades","Control: 0.300<br />Experimental: 0.360<br />greater: experi<br />info: ANDROMEDA, Diarrhea, All Grades","Control: 0.290<br />Experimental: 0.340<br />greater: experi<br />info: ANDROMEDA, Constipation, All Grades","Control: 0.200<br />Experimental: 0.310<br />greater: experi<br />info: ANDROMEDA, Peripheral sensory neuropathy, All Grades","Control: 0.200<br />Experimental: 0.260<br />greater: experi<br />info: ANDROMEDA, Dyspnea, All Grades","Control: 0.110<br />Experimental: 0.200<br />greater: experi<br />info: ANDROMEDA, Cough, All Grades","Control: 0.060<br />Experimental: 0.120<br />greater: experi<br />info: ANDROMEDA, Back pain, All Grades","Control: 0.050<br />Experimental: 0.100<br />greater: experi<br />info: ANDROMEDA, Arthralgia, All Grades","Control: 0.050<br />Experimental: 0.100<br />greater: experi<br />info: ANDROMEDA, Muscle spasms, All Grades","Control: 0.050<br />Experimental: 0.110<br />greater: experi<br />info: ANDROMEDA, Arrhythmia, All Grades","Control: 0.000<br />Experimental: 0.110<br />greater: experi<br />info: ANDROMEDA, Injection site reactions, All Grades","Control: 0.050<br />Experimental: 0.100<br />greater: experi<br />info: ANDROMEDA, Pneumonia, Grade 3-4","Control: 0.040<br />Experimental: 0.060<br />greater: experi<br />info: ANDROMEDA, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: ANDROMEDA, Constipation, Grade 3-4","Control: 0.020<br />Experimental: 0.030<br />greater: experi<br />info: ANDROMEDA, Peripheral sensory neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: ANDROMEDA, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: ANDROMEDA, Back pain, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: ANDROMEDA, Muscle spasms, Grade 3-4","Control: 0.020<br />Experimental: 0.040<br />greater: experi<br />info: ANDROMEDA, Arrhythmia, Grade 3-4","Control: 0.470<br />Experimental: 0.630<br />greater: experi<br />info: DESTINY-Gastric01, Nausea, All Grades","Control: 0.080<br />Experimental: 0.260<br />greater: experi<br />info: DESTINY-Gastric01, Vomiting, All Grades","Control: 0.230<br />Experimental: 0.240<br />greater: experi<br />info: DESTINY-Gastric01, Constipation, All Grades","Control: 0.048<br />Experimental: 0.110<br />greater: experi<br />info: DESTINY-Gastric01, Stomatitis, All Grades","Control: 0.450<br />Experimental: 0.600<br />greater: experi<br />info: DESTINY-Gastric01, Decreased appetite, All Grades","Control: 0.032<br />Experimental: 0.060<br />greater: experi<br />info: DESTINY-Gastric01, Dehydration, All Grades","Control: 0.310<br />Experimental: 0.580<br />greater: experi<br />info: DESTINY-Gastric01, Anemia, All Grades","Control: 0.032<br />Experimental: 0.048<br />greater: experi<br />info: DESTINY-Gastric01, Febrile neutropenia, All Grades","Control: 0.440<br />Experimental: 0.550<br />greater: experi<br />info: DESTINY-Gastric01, Fatigue/Asthenia, All Grades","Control: 0.160<br />Experimental: 0.240<br />greater: experi<br />info: DESTINY-Gastric01, Pyrexia, All Grades","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />info: DESTINY-Gastric01, Edema peripheral, All Grades","Control: 0.150<br />Experimental: 0.220<br />greater: experi<br />info: DESTINY-Gastric01, Alopecia, All Grades","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />info: DESTINY-Gastric01, Interstitial lung disease, All Grades","Control: 0.016<br />Experimental: 0.080<br />greater: experi<br />info: DESTINY-Gastric01, Hepatic function abnormal, All Grades","Control: 0.016<br />Experimental: 0.048<br />greater: experi<br />info: DESTINY-Gastric01, Nausea, Grade 3-4","Control: 0.016<br />Experimental: 0.024<br />greater: experi<br />info: DESTINY-Gastric01, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.016<br />greater: experi<br />info: DESTINY-Gastric01, Stomatitis, Grade 3-4","Control: 0.130<br />Experimental: 0.170<br />greater: experi<br />info: DESTINY-Gastric01, Decreased appetite, Grade 3-4","Control: 0.016<br />Experimental: 0.024<br />greater: experi<br />info: DESTINY-Gastric01, Dehydration, Grade 3-4","Control: 0.230<br />Experimental: 0.380<br />greater: experi<br />info: DESTINY-Gastric01, Anemia, Grade 3-4","Control: 0.032<br />Experimental: 0.048<br />greater: experi<br />info: DESTINY-Gastric01, Febrile neutropenia, Grade 3-4","Control: 0.048<br />Experimental: 0.090<br />greater: experi<br />info: DESTINY-Gastric01, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.024<br />greater: experi<br />info: DESTINY-Gastric01, Interstitial lung disease, Grade 3-4","Control: 0.016<br />Experimental: 0.032<br />greater: experi<br />info: DESTINY-Gastric01, Hepatic function abnormal, Grade 3-4","Control: 0.520<br />Experimental: 0.540<br />greater: experi<br />info: HERO, Hot flush, All Grades","Control: 0.290<br />Experimental: 0.300<br />greater: experi<br />info: HERO, Musculoskeletal pain, All Grades","Control: 0.240<br />Experimental: 0.260<br />greater: experi<br />info: HERO, Fatigue/Asthenia, All Grades","Control: 0.070<br />Experimental: 0.120<br />greater: experi<br />info: HERO, Diarrhea, All Grades","Control: 0.100<br />Experimental: 0.120<br />greater: experi<br />info: HERO, Constipation, All Grades","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: HERO, Hot flush, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: HERO, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: HERO, Diarrhea, Grade 3-4","Control: 0.100<br />Experimental: 0.500<br />greater: experi<br />info: BOSTON, Nausea, All Grades","Control: 0.250<br />Experimental: 0.320<br />greater: experi<br />info: BOSTON, Diarrhea, All Grades","Control: 0.044<br />Experimental: 0.210<br />greater: experi<br />info: BOSTON, Vomiting, All Grades","Control: 0.210<br />Experimental: 0.590<br />greater: experi<br />info: BOSTON, Fatigue/Asthenia, All Grades","Control: 0.110<br />Experimental: 0.150<br />greater: experi<br />info: BOSTON, Pyrexia, All Grades","Control: 0.050<br />Experimental: 0.350<br />greater: experi<br />info: BOSTON, Appetite decrease, All Grades","Control: 0.120<br />Experimental: 0.260<br />greater: experi<br />info: BOSTON, Weight decreased , All Grades","Control: 0.039<br />Experimental: 0.120<br />greater: experi<br />info: BOSTON, Dizziness, All Grades","Control: 0.220<br />Experimental: 0.290<br />greater: experi<br />info: BOSTON, Upper respiratory tract infection, All Grades","Control: 0.060<br />Experimental: 0.220<br />greater: experi<br />info: BOSTON, Cataract, All Grades","Control: 0.060<br />Experimental: 0.130<br />greater: experi<br />info: BOSTON, Vision blurred, All Grades","Control: 0.000<br />Experimental: 0.080<br />greater: experi<br />info: BOSTON, Nausea, Grade 3-4","Control: 0.010<br />Experimental: 0.060<br />greater: experi<br />info: BOSTON, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.041<br />greater: experi<br />info: BOSTON, Vomiting, Grade 3-4","Control: 0.050<br />Experimental: 0.280<br />greater: experi<br />info: BOSTON, Fatigue/Asthenia, Grade 3-4","Control: 0.010<br />Experimental: 0.015<br />greater: experi<br />info: BOSTON, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.036<br />greater: experi<br />info: BOSTON, Appetite decrease, Grade 3-4","Control: 0.010<br />Experimental: 0.021<br />greater: experi<br />info: BOSTON, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: BOSTON, Dizziness, Grade 3-4","Control: 0.015<br />Experimental: 0.036<br />greater: experi<br />info: BOSTON, Upper respiratory tract infection, Grade 3-4","Control: 0.015<br />Experimental: 0.090<br />greater: experi<br />info: BOSTON, Cataract, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: BOSTON, Vision blurred, Grade 3-4","Control: 0.470<br />Experimental: 0.570<br />greater: experi<br />info: SOPHIA, Fatigue/Asthenia, All Grades","Control: 0.140<br />Experimental: 0.190<br />greater: experi<br />info: SOPHIA, Pyrexia, All Grades","Control: 0.320<br />Experimental: 0.330<br />greater: experi<br />info: SOPHIA, Nausea, All Grades","Control: 0.140<br />Experimental: 0.210<br />greater: experi<br />info: SOPHIA, Vomiting, All Grades","Control: 0.170<br />Experimental: 0.190<br />greater: experi<br />info: SOPHIA, Constipation, All Grades","Control: 0.150<br />Experimental: 0.180<br />greater: experi<br />info: SOPHIA, Alopecia, All Grades","Control: 0.160<br />Experimental: 0.190<br />greater: experi<br />info: SOPHIA, Headache, All Grades","Control: 0.150<br />Experimental: 0.160<br />greater: experi<br />info: SOPHIA, Peripheral neuropathy, All Grades","Control: 0.120<br />Experimental: 0.140<br />greater: experi<br />info: SOPHIA, Cough, All Grades","Control: 0.110<br />Experimental: 0.130<br />greater: experi<br />info: SOPHIA, Dyspnea, All Grades","Control: 0.120<br />Experimental: 0.140<br />greater: experi<br />info: SOPHIA, Arthralgia/Myalgia, All Grades","Control: 0.090<br />Experimental: 0.110<br />greater: experi<br />info: SOPHIA, Pain in extremity, All Grades","Control: 0.030<br />Experimental: 0.130<br />greater: experi<br />info: SOPHIA, Infusion-related reaction, All Grades","Control: 0.045<br />Experimental: 0.070<br />greater: experi<br />info: SOPHIA, Fatigue/Asthenia, Grade 3-4","Control: 0.004<br />Experimental: 0.011<br />greater: experi<br />info: SOPHIA, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />info: SOPHIA, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: SOPHIA, Pain in extremity, Grade 3-4","Control: 0.000<br />Experimental: 0.015<br />greater: experi<br />info: SOPHIA, Infusion-related reaction, Grade 3-4","Control: 0.240<br />Experimental: 0.410<br />greater: experi<br />info: KEYNOTE-204, Upper respiratory tract infection, All Grades","Control: 0.030<br />Experimental: 0.110<br />greater: experi<br />info: KEYNOTE-204, Urinary tract infection, All Grades","Control: 0.290<br />Experimental: 0.320<br />greater: experi<br />info: KEYNOTE-204, Musculoskeletal pain, All Grades","Control: 0.170<br />Experimental: 0.220<br />greater: experi<br />info: KEYNOTE-204, Diarrhea, All Grades","Control: 0.190<br />Experimental: 0.200<br />greater: experi<br />info: KEYNOTE-204, Rash, All Grades","Control: 0.120<br />Experimental: 0.180<br />greater: experi<br />info: KEYNOTE-204, Pruritus, All Grades","Control: 0.140<br />Experimental: 0.200<br />greater: experi<br />info: KEYNOTE-204, Cough, All Grades","Control: 0.030<br />Experimental: 0.110<br />greater: experi<br />info: KEYNOTE-204, Pneumonitis, All Grades","Control: 0.070<br />Experimental: 0.110<br />greater: experi<br />info: KEYNOTE-204, Dyspnea, All Grades","Control: 0.030<br />Experimental: 0.190<br />greater: experi<br />info: KEYNOTE-204, Hypothyroidism, All Grades","Control: 0.000<br />Experimental: 0.014<br />greater: experi<br />info: KEYNOTE-204, Upper respiratory tract infection, Grade 3-4","Control: 0.013<br />Experimental: 0.027<br />greater: experi<br />info: KEYNOTE-204, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.014<br />greater: experi<br />info: KEYNOTE-204, Vomiting, Grade 3-4","Control: 0.013<br />Experimental: 0.050<br />greater: experi<br />info: KEYNOTE-204, Pneumonitis, Grade 3-4","Control: 0.046<br />Experimental: 0.180<br />greater: experi<br />info: CHECKMATE-743, Pyrexia, All Grades","Control: 0.080<br />Experimental: 0.170<br />greater: experi<br />info: CHECKMATE-743, Edema, All Grades","Control: 0.170<br />Experimental: 0.380<br />greater: experi<br />info: CHECKMATE-743, Musculoskeletal pain, All Grades","Control: 0.011<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-743, Arthralgia, All Grades","Control: 0.110<br />Experimental: 0.340<br />greater: experi<br />info: CHECKMATE-743, Rash, All Grades","Control: 0.014<br />Experimental: 0.210<br />greater: experi<br />info: CHECKMATE-743, Pruritus, All Grades","Control: 0.120<br />Experimental: 0.320<br />greater: experi<br />info: CHECKMATE-743, Diarrhea, All Grades","Control: 0.100<br />Experimental: 0.150<br />greater: experi<br />info: CHECKMATE-743, Abdominal pain, All Grades","Control: 0.160<br />Experimental: 0.270<br />greater: experi<br />info: CHECKMATE-743, Dyspnea, All Grades","Control: 0.090<br />Experimental: 0.230<br />greater: experi<br />info: CHECKMATE-743, Cough, All Grades","Control: 0.014<br />Experimental: 0.150<br />greater: experi<br />info: CHECKMATE-743, Hypothyroidism, All Grades","Control: 0.070<br />Experimental: 0.120<br />greater: experi<br />info: CHECKMATE-743, Upper respiratory tract infection, All Grades","Control: 0.042<br />Experimental: 0.100<br />greater: experi<br />info: CHECKMATE-743, Pneumonia, All Grades","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />info: CHECKMATE-743, Pyrexia, Grade 3-4","Control: 0.011<br />Experimental: 0.033<br />greater: experi<br />info: CHECKMATE-743, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: CHECKMATE-743, Arthralgia, Grade 3-4","Control: 0.004<br />Experimental: 0.027<br />greater: experi<br />info: CHECKMATE-743, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: CHECKMATE-743, Pruritus, Grade 3-4","Control: 0.011<br />Experimental: 0.060<br />greater: experi<br />info: CHECKMATE-743, Diarrhea, Grade 3-4","Control: 0.007<br />Experimental: 0.010<br />greater: experi<br />info: CHECKMATE-743, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: CHECKMATE-743, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: CHECKMATE-743, Upper respiratory tract infection, Grade 3-4","Control: 0.021<br />Experimental: 0.040<br />greater: experi<br />info: CHECKMATE-743, Pneumonia, Grade 3-4","Control: 0.280<br />Experimental: 0.410<br />greater: experi<br />info: CANDOR, Infusion-related reaction, All Grades","Control: 0.280<br />Experimental: 0.320<br />greater: experi<br />info: CANDOR, Fatigue/Asthenia, All Grades","Control: 0.150<br />Experimental: 0.200<br />greater: experi<br />info: CANDOR, Pyrexia, All Grades","Control: 0.290<br />Experimental: 0.400<br />greater: experi<br />info: CANDOR, Respiratory infection, All Grades","Control: 0.120<br />Experimental: 0.180<br />greater: experi<br />info: CANDOR, Pneumonia, All Grades","Control: 0.120<br />Experimental: 0.170<br />greater: experi<br />info: CANDOR, Bronchitis, All Grades","Control: 0.300<br />Experimental: 0.370<br />greater: experi<br />info: CANDOR, Thrombocytopenia, All Grades","Control: 0.310<br />Experimental: 0.330<br />greater: experi<br />info: CANDOR, Anemia, All Grades","Control: 0.140<br />Experimental: 0.320<br />greater: experi<br />info: CANDOR, Diarrhea, All Grades","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: CANDOR, Nausea, All Grades","Control: 0.280<br />Experimental: 0.310<br />greater: experi<br />info: CANDOR, Hypertension, All Grades","Control: 0.110<br />Experimental: 0.180<br />greater: experi<br />info: CANDOR, Insomnia, All Grades","Control: 0.100<br />Experimental: 0.160<br />greater: experi<br />info: CANDOR, Back pain, All Grades","Control: 0.050<br />Experimental: 0.120<br />greater: experi<br />info: CANDOR, Infusion-related reaction, Grade 3-4","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />info: CANDOR, Fatigue/Asthenia, Grade 3-4","Control: 0.007<br />Experimental: 0.019<br />greater: experi<br />info: CANDOR, Pyrexia, Grade 3-4","Control: 0.033<br />Experimental: 0.070<br />greater: experi<br />info: CANDOR, Respiratory infection, Grade 3-4","Control: 0.090<br />Experimental: 0.130<br />greater: experi<br />info: CANDOR, Pneumonia, Grade 3-4","Control: 0.013<br />Experimental: 0.026<br />greater: experi<br />info: CANDOR, Bronchitis, Grade 3-4","Control: 0.160<br />Experimental: 0.250<br />greater: experi<br />info: CANDOR, Thrombocytopenia, Grade 3-4","Control: 0.140<br />Experimental: 0.170<br />greater: experi<br />info: CANDOR, Anemia, Grade 3-4","Control: 0.007<br />Experimental: 0.039<br />greater: experi<br />info: CANDOR, Diarrhea, Grade 3-4","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: CANDOR, Hypertension, Grade 3-4","Control: 0.026<br />Experimental: 0.039<br />greater: experi<br />info: CANDOR, Dyspnea, Grade 3-4","Control: 0.020<br />Experimental: 0.039<br />greater: experi<br />info: CANDOR, Insomnia, Grade 3-4","Control: 0.013<br />Experimental: 0.019<br />greater: experi<br />info: CANDOR, Back pain, Grade 3-4","Control: 0.130<br />Experimental: 0.350<br />greater: experi<br />info: JAVELIN Bladder 100, Fatigue/Asthenia, All Grades","Control: 0.035<br />Experimental: 0.150<br />greater: experi<br />info: JAVELIN Bladder 100, Pyrexia, All Grades","Control: 0.150<br />Experimental: 0.240<br />greater: experi<br />info: JAVELIN Bladder 100, Musculoskeletal pain, All Grades","Control: 0.060<br />Experimental: 0.160<br />greater: experi<br />info: JAVELIN Bladder 100, Arthralgia, All Grades","Control: 0.023<br />Experimental: 0.200<br />greater: experi<br />info: JAVELIN Bladder 100, Rash, All Grades","Control: 0.017<br />Experimental: 0.170<br />greater: experi<br />info: JAVELIN Bladder 100, Pruritus, All Grades","Control: 0.110<br />Experimental: 0.200<br />greater: experi<br />info: JAVELIN Bladder 100, Urinary tract infection, All Grades","Control: 0.049<br />Experimental: 0.170<br />greater: experi<br />info: JAVELIN Bladder 100, Diarrhea, All Grades","Control: 0.090<br />Experimental: 0.160<br />greater: experi<br />info: JAVELIN Bladder 100, Constipation, All Grades","Control: 0.060<br />Experimental: 0.160<br />greater: experi<br />info: JAVELIN Bladder 100, Nausea, All Grades","Control: 0.035<br />Experimental: 0.130<br />greater: experi<br />info: JAVELIN Bladder 100, Vomiting, All Grades","Control: 0.046<br />Experimental: 0.140<br />greater: experi<br />info: JAVELIN Bladder 100, Cough, All Grades","Control: 0.070<br />Experimental: 0.140<br />greater: experi<br />info: JAVELIN Bladder 100, Decreased appetite, All Grades","Control: 0.006<br />Experimental: 0.120<br />greater: experi<br />info: JAVELIN Bladder 100, Hypothyroidism, All Grades","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />info: JAVELIN Bladder 100, Infusion-related reaction, All Grades","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: JAVELIN Bladder 100, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: JAVELIN Bladder 100, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />info: JAVELIN Bladder 100, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: JAVELIN Bladder 100, Pruritus, Grade 3-4","Control: 0.038<br />Experimental: 0.060<br />greater: experi<br />info: JAVELIN Bladder 100, Urinary tract infection, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />info: JAVELIN Bladder 100, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: JAVELIN Bladder 100, Constipation, Grade 3-4","Control: 0.006<br />Experimental: 0.012<br />greater: experi<br />info: JAVELIN Bladder 100, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: JAVELIN Bladder 100, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: JAVELIN Bladder 100, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />info: JAVELIN Bladder 100, Infusion-related reaction, Grade 3-4","Control: 0.070<br />Experimental: 0.120<br />greater: experi<br />info: ATTRACTION-3, Pruritus, All Grades","Control: 0.170<br />Experimental: 0.180<br />greater: experi<br />info: ATTRACTION-3, Diarrhea, All Grades","Control: 0.140<br />Experimental: 0.170<br />greater: experi<br />info: ATTRACTION-3, Upper respiratory tract infection, All Grades","Control: 0.140<br />Experimental: 0.160<br />greater: experi<br />info: ATTRACTION-3, Cough, All Grades","Control: 0.014<br />Experimental: 0.110<br />greater: experi<br />info: ATTRACTION-3, Hypothyroidism, All Grades","Control: 0.010<br />Experimental: 0.019<br />greater: experi<br />info: ATTRACTION-3, Rash, Grade 3-4","Control: 0.014<br />Experimental: 0.019<br />greater: experi<br />info: ATTRACTION-3, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: ATTRACTION-3, Upper respiratory tract infection, Grade 3-4","Control: 0.240<br />Experimental: 0.300<br />greater: experi<br />info: IMbrave150, Hypertension, All Grades","Control: 0.100<br />Experimental: 0.180<br />greater: experi<br />info: IMbrave150, Pyrexia, All Grades","Control: 0.070<br />Experimental: 0.200<br />greater: experi<br />info: IMbrave150, Proteinuria, All Grades","Control: 0.100<br />Experimental: 0.110<br />greater: experi<br />info: IMbrave150, Weight decreased , All Grades","Control: 0.100<br />Experimental: 0.190<br />greater: experi<br />info: IMbrave150, Pruritus, All Grades","Control: 0.080<br />Experimental: 0.100<br />greater: experi<br />info: IMbrave150, Vomiting, All Grades","Control: 0.100<br />Experimental: 0.120<br />greater: experi<br />info: IMbrave150, Cough, All Grades","Control: 0.045<br />Experimental: 0.100<br />greater: experi<br />info: IMbrave150, Epistaxis, All Grades","Control: 0.000<br />Experimental: 0.110<br />greater: experi<br />info: IMbrave150, Infusion-related reaction, All Grades","Control: 0.120<br />Experimental: 0.150<br />greater: experi<br />info: IMbrave150, Hypertension, Grade 3-4","Control: 0.006<br />Experimental: 0.030<br />greater: experi<br />info: IMbrave150, Proteinuria, Grade 3-4","Control: 0.000<br />Experimental: 0.024<br />greater: experi<br />info: IMbrave150, Infusion-related reaction, Grade 3-4","Control: 0.400<br />Experimental: 0.490<br />greater: experi<br />info: CHECKMATE-9LA, Fatigue/Asthenia, All Grades","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: CHECKMATE-9LA, Pyrexia, All Grades","Control: 0.270<br />Experimental: 0.390<br />greater: experi<br />info: CHECKMATE-9LA, Musculoskeletal pain, All Grades","Control: 0.180<br />Experimental: 0.310<br />greater: experi<br />info: CHECKMATE-9LA, Diarrhea, All Grades","Control: 0.170<br />Experimental: 0.180<br />greater: experi<br />info: CHECKMATE-9LA, Vomiting, All Grades","Control: 0.110<br />Experimental: 0.120<br />greater: experi<br />info: CHECKMATE-9LA, Abdominal pain, All Grades","Control: 0.100<br />Experimental: 0.300<br />greater: experi<br />info: CHECKMATE-9LA, Rash, All Grades","Control: 0.029<br />Experimental: 0.210<br />greater: experi<br />info: CHECKMATE-9LA, Pruritus, All Grades","Control: 0.100<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-9LA, Alopecia, All Grades","Control: 0.220<br />Experimental: 0.280<br />greater: experi<br />info: CHECKMATE-9LA, Decreased appetite, All Grades","Control: 0.150<br />Experimental: 0.190<br />greater: experi<br />info: CHECKMATE-9LA, Cough, All Grades","Control: 0.140<br />Experimental: 0.180<br />greater: experi<br />info: CHECKMATE-9LA, Dyspnea, All Grades","Control: 0.034<br />Experimental: 0.190<br />greater: experi<br />info: CHECKMATE-9LA, Hypothyroidism, All Grades","Control: 0.070<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-9LA, Headache, All Grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-9LA, Dizziness, All Grades","Control: 0.049<br />Experimental: 0.050<br />greater: experi<br />info: CHECKMATE-9LA, Fatigue/Asthenia, Grade 3-4","Control: 0.020<br />Experimental: 0.045<br />greater: experi<br />info: CHECKMATE-9LA, Musculoskeletal pain, Grade 3-4","Control: 0.009<br />Experimental: 0.017<br />greater: experi<br />info: CHECKMATE-9LA, Nausea, Grade 3-4","Control: 0.017<br />Experimental: 0.060<br />greater: experi<br />info: CHECKMATE-9LA, Diarrhea, Grade 3-4","Control: 0.014<br />Experimental: 0.020<br />greater: experi<br />info: CHECKMATE-9LA, Vomiting, Grade 3-4","Control: 0.003<br />Experimental: 0.047<br />greater: experi<br />info: CHECKMATE-9LA, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: CHECKMATE-9LA, Pruritus, Grade 3-4","Control: 0.006<br />Experimental: 0.008<br />greater: experi<br />info: CHECKMATE-9LA, Alopecia, Grade 3-4","Control: 0.017<br />Experimental: 0.020<br />greater: experi<br />info: CHECKMATE-9LA, Decreased appetite, Grade 3-4","Control: 0.032<br />Experimental: 0.047<br />greater: experi<br />info: CHECKMATE-9LA, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: CHECKMATE-9LA, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: CHECKMATE-9LA, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />info: CHECKMATE-9LA, Dizziness, Grade 3-4","Control: 0.088<br />Experimental: 0.130<br />greater: experi<br />info: ALTA 1L, Stomatitis, All Grades","Control: 0.170<br />Experimental: 0.400<br />greater: experi<br />info: ALTA 1L, Rash, All Grades","Control: 0.058<br />Experimental: 0.200<br />greater: experi<br />info: ALTA 1L, Pruritus, All Grades","Control: 0.200<br />Experimental: 0.350<br />greater: experi<br />info: ALTA 1L, Cough, All Grades","Control: 0.220<br />Experimental: 0.250<br />greater: experi<br />info: ALTA 1L, Dyspnea, All Grades","Control: 0.022<br />Experimental: 0.051<br />greater: experi<br />info: ALTA 1L, ILD/Pneumonitis, All Grades","Control: 0.080<br />Experimental: 0.320<br />greater: experi<br />info: ALTA 1L, Hypertension, All Grades","Control: 0.230<br />Experimental: 0.280<br />greater: experi<br />info: ALTA 1L, Myalgia, All Grades","Control: 0.170<br />Experimental: 0.210<br />greater: experi<br />info: ALTA 1L, Back pain, All Grades","Control: 0.120<br />Experimental: 0.140<br />greater: experi<br />info: ALTA 1L, Arthralgia, All Grades","Control: 0.170<br />Experimental: 0.220<br />greater: experi<br />info: ALTA 1L, Headache, All Grades","Control: 0.007<br />Experimental: 0.130<br />greater: experi<br />info: ALTA 1L, Increased Blood cholesterol, All Grades","Control: 0.066<br />Experimental: 0.150<br />greater: experi<br />info: ALTA 1L, Pneumonia, All Grades","Control: 0.100<br />Experimental: 0.120<br />greater: experi<br />info: ALTA 1L, Upper respiratory tract infection, All Grades","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: ALTA 1L, Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.029<br />greater: experi<br />info: ALTA 1L, Rash, Grade 3-4","Control: 0.007<br />Experimental: 0.029<br />greater: experi<br />info: ALTA 1L, ILD/Pneumonitis, Grade 3-4","Control: 0.029<br />Experimental: 0.130<br />greater: experi<br />info: ALTA 1L, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: ALTA 1L, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.022<br />greater: experi<br />info: ALTA 1L, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: ALTA 1L, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: ALTA 1L, Bradycardia, Grade 3-4","Control: 0.029<br />Experimental: 0.051<br />greater: experi<br />info: ALTA 1L, Pneumonia, Grade 3-4","Control: 0.150<br />Experimental: 0.460<br />greater: experi<br />info: PROfound, Anemia, Grades 1-4 ","Control: 0.030<br />Experimental: 0.120<br />greater: experi<br />info: PROfound, Thrombocytopenia, Grades 1-4 ","Control: 0.190<br />Experimental: 0.410<br />greater: experi<br />info: PROfound, Nausea, Grades 1-4 ","Control: 0.070<br />Experimental: 0.210<br />greater: experi<br />info: PROfound, Diarrhea, Grades 1-4 ","Control: 0.120<br />Experimental: 0.180<br />greater: experi<br />info: PROfound, Vomiting, Grades 1-4 ","Control: 0.320<br />Experimental: 0.410<br />greater: experi<br />info: PROfound, Fatigue/Asthenia, Grades 1-4 ","Control: 0.180<br />Experimental: 0.300<br />greater: experi<br />info: PROfound, Decreased appetite, Grades 1-4 ","Control: 0.020<br />Experimental: 0.110<br />greater: experi<br />info: PROfound, Cough, Grades 1-4 ","Control: 0.030<br />Experimental: 0.100<br />greater: experi<br />info: PROfound, Dyspnea, Grades 1-4 ","Control: 0.050<br />Experimental: 0.210<br />greater: experi<br />info: PROfound, Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.040<br />greater: experi<br />info: PROfound, Thrombocytopenia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: PROfound, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: PROfound, Diarrhea, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: PROfound, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: PROfound, Dyspnea, Grade 3-4","Control: 0.090<br />Experimental: 0.140<br />greater: experi<br />info: IMpower110, Pyrexia, All Grades","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: IMpower110, Dyspnea, All Grades","Control: 0.100<br />Experimental: 0.120<br />greater: experi<br />info: IMpower110, Cough, All Grades","Control: 0.008<br />Experimental: 0.010<br />greater: experi<br />info: IMpower110, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: IMpower110, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />info: IMpower110, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />info: IMpower110, Cough, Grade 3-4","Control: 0.420<br />Experimental: 0.440<br />greater: experi<br />info: CHECKMATE-227, Fatigue/Asthenia, All Grades","Control: 0.110<br />Experimental: 0.180<br />greater: experi<br />info: CHECKMATE-227, Pyrexia, All Grades","Control: 0.120<br />Experimental: 0.140<br />greater: experi<br />info: CHECKMATE-227, Edema, All Grades","Control: 0.100<br />Experimental: 0.340<br />greater: experi<br />info: CHECKMATE-227, Rash, All Grades","Control: 0.033<br />Experimental: 0.210<br />greater: experi<br />info: CHECKMATE-227, Pruritus, All Grades","Control: 0.260<br />Experimental: 0.310<br />greater: experi<br />info: CHECKMATE-227, Decreased appetite, All Grades","Control: 0.160<br />Experimental: 0.270<br />greater: experi<br />info: CHECKMATE-227, Musculoskeletal pain, All Grades","Control: 0.025<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-227, Arthralgia, All Grades","Control: 0.160<br />Experimental: 0.260<br />greater: experi<br />info: CHECKMATE-227, Diarrhea/colitis, All Grades","Control: 0.090<br />Experimental: 0.100<br />greater: experi<br />info: CHECKMATE-227, Abdominal pain, All Grades","Control: 0.160<br />Experimental: 0.260<br />greater: experi<br />info: CHECKMATE-227, Dyspnea, All Grades","Control: 0.130<br />Experimental: 0.230<br />greater: experi<br />info: CHECKMATE-227, Cough, All Grades","Control: 0.100<br />Experimental: 0.210<br />greater: experi<br />info: CHECKMATE-227, Hepatitis, All Grades","Control: 0.012<br />Experimental: 0.160<br />greater: experi<br />info: CHECKMATE-227, Hypothyroidism, All Grades","Control: 0.005<br />Experimental: 0.100<br />greater: experi<br />info: CHECKMATE-227, Hyperthyroidism, All Grades","Control: 0.080<br />Experimental: 0.130<br />greater: experi<br />info: CHECKMATE-227, Pneumonia, All Grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: CHECKMATE-227, Headache, All Grades","Control: 0.044<br />Experimental: 0.060<br />greater: experi<br />info: CHECKMATE-227, Fatigue/Asthenia, Grade 3-4","Control: 0.004<br />Experimental: 0.005<br />greater: experi<br />info: CHECKMATE-227, Pyrexia, Grade 3-4","Control: 0.004<br />Experimental: 0.047<br />greater: experi<br />info: CHECKMATE-227, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: CHECKMATE-227, Pruritus, Grade 3-4","Control: 0.014<br />Experimental: 0.023<br />greater: experi<br />info: CHECKMATE-227, Decreased appetite, Grade 3-4","Control: 0.007<br />Experimental: 0.019<br />greater: experi<br />info: CHECKMATE-227, Musculoskeletal pain, Grade 3-4","Control: 0.002<br />Experimental: 0.009<br />greater: experi<br />info: CHECKMATE-227, Arthralgia, Grade 3-4","Control: 0.009<br />Experimental: 0.036<br />greater: experi<br />info: CHECKMATE-227, Diarrhea/colitis, Grade 3-4","Control: 0.021<br />Experimental: 0.043<br />greater: experi<br />info: CHECKMATE-227, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />info: CHECKMATE-227, Cough, Grade 3-4","Control: 0.012<br />Experimental: 0.090<br />greater: experi<br />info: CHECKMATE-227, Hepatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: CHECKMATE-227, Hypothyroidism, Grade 3-4","Control: 0.040<br />Experimental: 0.070<br />greater: experi<br />info: CHECKMATE-227, Pneumonia, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: CHECKMATE-227, Headache, Grade 3-4","Control: 0.780<br />Experimental: 0.800<br />greater: experi<br />info: E1912, Fatigue/Asthenia, All Grades","Control: 0.170<br />Experimental: 0.280<br />greater: experi<br />info: E1912, Peripheral edema, All Grades","Control: 0.080<br />Experimental: 0.230<br />greater: experi<br />info: E1912, Pain, All Grades","Control: 0.350<br />Experimental: 0.610<br />greater: experi<br />info: E1912, Musculoskeletal pain, All Grades","Control: 0.100<br />Experimental: 0.410<br />greater: experi<br />info: E1912, Arthralgia, All Grades","Control: 0.270<br />Experimental: 0.530<br />greater: experi<br />info: E1912, Diarrhea, All Grades","Control: 0.080<br />Experimental: 0.220<br />greater: experi<br />info: E1912, Stomatitis, All Grades","Control: 0.100<br />Experimental: 0.190<br />greater: experi<br />info: E1912, Abdominal pain, All Grades","Control: 0.290<br />Experimental: 0.490<br />greater: experi<br />info: E1912, Rash, All Grades","Control: 0.040<br />Experimental: 0.360<br />greater: experi<br />info: E1912, Bruising, All Grades","Control: 0.220<br />Experimental: 0.420<br />greater: experi<br />info: E1912, Hypertension, All Grades","Control: 0.080<br />Experimental: 0.310<br />greater: experi<br />info: E1912, Hemorrhage, All Grades","Control: 0.270<br />Experimental: 0.400<br />greater: experi<br />info: E1912, Headache, All Grades","Control: 0.130<br />Experimental: 0.210<br />greater: experi<br />info: E1912, Dizziness, All Grades","Control: 0.130<br />Experimental: 0.190<br />greater: experi<br />info: E1912, Peripheral neuropathy, All Grades","Control: 0.250<br />Experimental: 0.320<br />greater: experi<br />info: E1912, Cough, All Grades","Control: 0.210<br />Experimental: 0.220<br />greater: experi<br />info: E1912, Dyspnea, All Grades","Control: 0.190<br />Experimental: 0.290<br />greater: experi<br />info: E1912, Upper respiratory tract infection, All Grades","Control: 0.030<br />Experimental: 0.160<br />greater: experi<br />info: E1912, Skin infection, All Grades","Control: 0.040<br />Experimental: 0.190<br />greater: experi<br />info: E1912, Hyperuricemia, All Grades","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: E1912, Peripheral edema, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: E1912, Pain, Grade ≥ 3","Control: 0.020<br />Experimental: 0.050<br />greater: experi<br />info: E1912, Musculoskeletal pain, Grade ≥ 3","Control: 0.010<br />Experimental: 0.050<br />greater: experi<br />info: E1912, Arthralgia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />info: E1912, Diarrhea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: E1912, Abdominal pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: E1912, Vomiting, Grade ≥ 3","Control: 0.060<br />Experimental: 0.190<br />greater: experi<br />info: E1912, Hypertension, Grade ≥ 3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: E1912, Hemorrhage, Grade ≥ 3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: E1912, Dyspnea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: E1912, Hyperuricemia, Grade ≥ 3","Control: 0.500<br />Experimental: 0.510<br />greater: experi<br />info: BEACON CRC, Fatigue/Asthenia, All Grades","Control: 0.150<br />Experimental: 0.170<br />greater: experi<br />info: BEACON CRC, Pyrexia, All Grades","Control: 0.030<br />Experimental: 0.270<br />greater: experi<br />info: BEACON CRC, Arthralgia, All Grades","Control: 0.040<br />Experimental: 0.150<br />greater: experi<br />info: BEACON CRC, Myopathy, All Grades","Control: 0.010<br />Experimental: 0.100<br />greater: experi<br />info: BEACON CRC, Pain in extremity, All Grades","Control: 0.060<br />Experimental: 0.140<br />greater: experi<br />info: BEACON CRC, Pruritus, All Grades","Control: 0.000<br />Experimental: 0.140<br />greater: experi<br />info: BEACON CRC, Melanocytic nevus, All Grades","Control: 0.120<br />Experimental: 0.130<br />greater: experi<br />info: BEACON CRC, Dry skin, All Grades","Control: 0.030<br />Experimental: 0.200<br />greater: experi<br />info: BEACON CRC, Headache, All Grades","Control: 0.060<br />Experimental: 0.120<br />greater: experi<br />info: BEACON CRC, Peripheral neuropathy, All Grades","Control: 0.090<br />Experimental: 0.190<br />greater: experi<br />info: BEACON CRC, Hemorrhage, All Grades","Control: 0.060<br />Experimental: 0.130<br />greater: experi<br />info: BEACON CRC, Insomnia, All Grades","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: BEACON CRC, Arthralgia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: BEACON CRC, Myopathy, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: BEACON CRC, Peripheral neuropathy, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: BEACON CRC, Hemorrhage, Grade ≥ 3","Control: 0.090<br />Experimental: 0.150<br />greater: experi<br />info: CASPIAN , Cough/Productive Cough, All Grades","Control: 0.004<br />Experimental: 0.100<br />greater: experi<br />info: CASPIAN , Hyperthyroidism, All Grades","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: CASPIAN , Rash, All Grades","Control: 0.170<br />Experimental: 0.180<br />greater: experi<br />info: CASPIAN , Decreased appetite, All Grades","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: CASPIAN , Cough/Productive Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />info: CASPIAN , Constipation, Grade 3-4","Control: 0.008<br />Experimental: 0.011<br />greater: experi<br />info: CASPIAN , Alopecia, Grade 3-4","Control: 0.023<br />Experimental: 0.034<br />greater: experi<br />info: CASPIAN , Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.380<br />greater: experi<br />info: ICARIA-MM, Infusion-related reaction, All grades","Control: 0.230<br />Experimental: 0.310<br />greater: experi<br />info: ICARIA-MM, Pneumonia, All grades","Control: 0.420<br />Experimental: 0.570<br />greater: experi<br />info: ICARIA-MM, Upper respiratory tract infection, All grades","Control: 0.020<br />Experimental: 0.120<br />greater: experi<br />info: ICARIA-MM, Febrile neutropenia, All grades","Control: 0.120<br />Experimental: 0.170<br />greater: experi<br />info: ICARIA-MM, Dyspnea, All grades","Control: 0.190<br />Experimental: 0.260<br />greater: experi<br />info: ICARIA-MM, Diarrhea, All grades","Control: 0.090<br />Experimental: 0.150<br />greater: experi<br />info: ICARIA-MM, Nausea, All grades","Control: 0.034<br />Experimental: 0.120<br />greater: experi<br />info: ICARIA-MM, Vomiting, All grades","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />info: ICARIA-MM, Infusion-related reaction, Grade 3","Control: 0.160<br />Experimental: 0.220<br />greater: experi<br />info: ICARIA-MM, Pneumonia, Grade 3","Control: 0.034<br />Experimental: 0.090<br />greater: experi<br />info: ICARIA-MM, Upper respiratory tract infection, Grade 3","Control: 0.013<br />Experimental: 0.110<br />greater: experi<br />info: ICARIA-MM, Febrile neutropenia, Grade 3","Control: 0.013<br />Experimental: 0.050<br />greater: experi<br />info: ICARIA-MM, Dyspnea, Grade 3","Control: 0.007<br />Experimental: 0.020<br />greater: experi<br />info: ICARIA-MM, Diarrhea, Grade 3","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />info: ICARIA-MM, Vomiting, Grade 3","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />info: ICARIA-MM, Infusion-related reaction, Grade 4","Control: 0.027<br />Experimental: 0.033<br />greater: experi<br />info: ICARIA-MM, Pneumonia, Grade 4","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />info: ICARIA-MM, Febrile neutropenia, Grade 4","Control: 0.660<br />Experimental: 0.830<br />greater: experi<br />info: NALA, Diarrhea, All Grades","Control: 0.420<br />Experimental: 0.530<br />greater: experi<br />info: NALA, Nausea, All Grades","Control: 0.310<br />Experimental: 0.460<br />greater: experi<br />info: NALA, Vomiting, All Grades","Control: 0.130<br />Experimental: 0.310<br />greater: experi<br />info: NALA, Constipation, All Grades","Control: 0.032<br />Experimental: 0.080<br />greater: experi<br />info: NALA, Abdominal distension, All Grades","Control: 0.400<br />Experimental: 0.450<br />greater: experi<br />info: NALA, Fatigue/Asthenia, All Grades","Control: 0.023<br />Experimental: 0.043<br />greater: experi<br />info: NALA, Malaise, All Grades","Control: 0.013<br />Experimental: 0.040<br />greater: experi<br />info: NALA, Influenza-like illness, All Grades","Control: 0.042<br />Experimental: 0.090<br />greater: experi<br />info: NALA, Urinary tract infection, All Grades","Control: 0.045<br />Experimental: 0.080<br />greater: experi<br />info: NALA, Upper respiratory tract infection, All Grades","Control: 0.220<br />Experimental: 0.350<br />greater: experi<br />info: NALA, Decreased appetite, All Grades","Control: 0.080<br />Experimental: 0.100<br />greater: experi<br />info: NALA, Back Pain, All Grades","Control: 0.060<br />Experimental: 0.100<br />greater: experi<br />info: NALA, Arthralgia, All Grades","Control: 0.019<br />Experimental: 0.050<br />greater: experi<br />info: NALA, Muscle spasms, All Grades","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: NALA, Dizziness, All Grades","Control: 0.010<br />Experimental: 0.070<br />greater: experi<br />info: NALA, Renal impairment, All Grades","Control: 0.019<br />Experimental: 0.046<br />greater: experi<br />info: NALA, Dysuria, All Grades","Control: 0.130<br />Experimental: 0.250<br />greater: experi<br />info: NALA, Diarrhea, Grade 3","Control: 0.029<br />Experimental: 0.043<br />greater: experi<br />info: NALA, Nausea, Grade 3","Control: 0.019<br />Experimental: 0.040<br />greater: experi<br />info: NALA, Vomiting, Grade 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: NALA, Constipation, Grade 3","Control: 0.045<br />Experimental: 0.060<br />greater: experi<br />info: NALA, Fatigue/Asthenia, Grade 3","Control: 0.006<br />Experimental: 0.007<br />greater: experi<br />info: NALA, Urinary tract infection, Grade 3","Control: 0.023<br />Experimental: 0.026<br />greater: experi<br />info: NALA, Decreased appetite, Grade 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />info: NALA, Renal impairment, Grade 3","Control: 0.120<br />Experimental: 0.210<br />greater: experi<br />info: KEYNOTE-091, Pruritus, Grade 1–2","Control: 0.050<br />Experimental: 0.210<br />greater: experi<br />info: KEYNOTE-091, Hypothyroidism, Grade 1–2","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />info: KEYNOTE-091, Arthralgia, Grade 1–2","Control: 0.140<br />Experimental: 0.170<br />greater: experi<br />info: KEYNOTE-091, Diarrhea, Grade 1–2","Control: 0.150<br />Experimental: 0.160<br />greater: experi<br />info: KEYNOTE-091, Fatigue/Asthenia, Grade 1–2","Control: 0.030<br />Experimental: 0.110<br />greater: experi<br />info: KEYNOTE-091, Hyperthyroidism, Grade 1–2","Control: 0.060<br />Experimental: 0.090<br />greater: experi<br />info: KEYNOTE-091, Nausea, Grade 1–2","Control: 0.060<br />Experimental: 0.090<br />greater: experi<br />info: KEYNOTE-091, Nasopharyngitis, Grade 1–2","Control: 0.050<br />Experimental: 0.080<br />greater: experi<br />info: KEYNOTE-091, Rash, Grade 1–2","Control: 0.050<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-091, Increased alanine aminotransferase, Grade 1–2","Control: 0.050<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-091, Asthenia, Grade 1–2","Control: 0.030<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-091, Maculopapular rash, Grade 1–2","Control: 0.050<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-091, Aspartate aminotransferase increased, Grade 1–2","Control: 0.040<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-091, Decreased appetite, Grade 1–2","Control: 0.040<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-091, Weight decreased , Grade 1–2","Control: 0.060<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE-091, Increased blood creatinine, Grade 1–2","Control: 0.030<br />Experimental: 0.060<br />greater: experi<br />info: KEYNOTE-091, Myalgia, Grade 1–2","Control: 0.030<br />Experimental: 0.060<br />greater: experi<br />info: KEYNOTE-091, Productive cough, Grade 1–2","Control: 0.020<br />Experimental: 0.050<br />greater: experi<br />info: KEYNOTE-091, Pneumonitis, Grade 1–2","Control: 0.040<br />Experimental: 0.050<br />greater: experi<br />info: KEYNOTE-091, Dry skin, Grade 1–2","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-091, Hypothyroidism, Grade 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-091, Cough, Grade 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-091, Hyperthyroidism, Grade 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-091, Nausea, Grade 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-091, Rash, Grade 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-091, Back pain, Grade 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-091, Maculopapular rash, Grade 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-091, Myalgia, Grade 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE-091, Pneumonitis, Grade 4","Control: 0.260<br />Experimental: 0.930<br />greater: experi<br />info: ZUMA-7, Pyrexia, Any Grade","Control: 0.420<br />Experimental: 0.710<br />greater: experi<br />info: ZUMA-7, Neutropenia, Any Grade","Control: 0.150<br />Experimental: 0.440<br />greater: experi<br />info: ZUMA-7, Hypotension, Any Grade","Control: 0.390<br />Experimental: 0.420<br />greater: experi<br />info: ZUMA-7, Diarrhea, Any Grade","Control: 0.260<br />Experimental: 0.410<br />greater: experi<br />info: ZUMA-7, Headache, Any Grade","Control: 0.100<br />Experimental: 0.340<br />greater: experi<br />info: ZUMA-7, Sinus tachycardia, Any Grade","Control: 0.260<br />Experimental: 0.320<br />greater: experi<br />info: ZUMA-7, Leukopenia, Any Grade","Control: 0.080<br />Experimental: 0.280<br />greater: experi<br />info: ZUMA-7, Chills, Any Grade","Control: 0.170<br />Experimental: 0.260<br />greater: experi<br />info: ZUMA-7, Hypophosphatemia, Any Grade","Control: 0.110<br />Experimental: 0.250<br />greater: experi<br />info: ZUMA-7, Cough, Any Grade","Control: 0.080<br />Experimental: 0.220<br />greater: experi<br />info: ZUMA-7, Hypoxia, Any Grade","Control: 0.120<br />Experimental: 0.210<br />greater: experi<br />info: ZUMA-7, Dizziness, Any Grade","Control: 0.010<br />Experimental: 0.260<br />greater: experi<br />info: ZUMA-7, Tremor, Any Grade","Control: 0.020<br />Experimental: 0.240<br />greater: experi<br />info: ZUMA-7, Confusional state, Any Grade","Control: 0.000<br />Experimental: 0.210<br />greater: experi<br />info: ZUMA-7, Aphasia, Any Grade","Control: 0.010<br />Experimental: 0.170<br />greater: experi<br />info: ZUMA-7, Encephalopathy, Any Grade","Control: 0.010<br />Experimental: 0.090<br />greater: experi<br />info: ZUMA-7, Pyrexia, Grade ≥3","Control: 0.410<br />Experimental: 0.690<br />greater: experi<br />info: ZUMA-7, Neutropenia, Grade ≥3","Control: 0.030<br />Experimental: 0.110<br />greater: experi<br />info: ZUMA-7, Hypotension, Grade ≥3","Control: 0.020<br />Experimental: 0.060<br />greater: experi<br />info: ZUMA-7, Fatigue/Asthenia, Grade ≥3","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: ZUMA-7, Headache, Grade ≥3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: ZUMA-7, Sinus tachycardia, Grade ≥3","Control: 0.220<br />Experimental: 0.290<br />greater: experi<br />info: ZUMA-7, Leukopenia, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: ZUMA-7, Chills, Grade ≥3","Control: 0.120<br />Experimental: 0.180<br />greater: experi<br />info: ZUMA-7, Hypophosphatemia, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: ZUMA-7, Cough, Grade ≥3","Control: 0.040<br />Experimental: 0.090<br />greater: experi<br />info: ZUMA-7, Hypoxia, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: ZUMA-7, Tremor, Grade ≥3","Control: 0.000<br />Experimental: 0.050<br />greater: experi<br />info: ZUMA-7, Confusional state, Grade ≥3","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />info: ZUMA-7, Aphasia, Grade ≥3","Control: 0.000<br />Experimental: 0.120<br />greater: experi<br />info: ZUMA-7, Encephalopathy, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: ZUMA-7, Paresthesia, Grade ≥3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />info: ZUMA-7, Delirium, Grade ≥3","Control: 0.444<br />Experimental: 0.525<br />greater: experi<br />info: KEYNOTE-811, Diarrhea, Any grade","Control: 0.444<br />Experimental: 0.488<br />greater: experi<br />info: KEYNOTE-811, Nausea, Any grade","Control: 0.273<br />Experimental: 0.309<br />greater: experi<br />info: KEYNOTE-811, Vomiting, Any grade","Control: 0.199<br />Experimental: 0.235<br />greater: experi<br />info: KEYNOTE-811, Fatigue/Asthenia, Any grade","Control: 0.185<br />Experimental: 0.230<br />greater: experi<br />info: KEYNOTE-811, Peripheral sensory neuropathy, Any grade","Control: 0.130<br />Experimental: 0.207<br />greater: experi<br />info: KEYNOTE-811, Aspartate aminotransferase increased, Any grade","Control: 0.171<br />Experimental: 0.189<br />greater: experi<br />info: KEYNOTE-811, Weight decreased , Any grade","Control: 0.162<br />Experimental: 0.184<br />greater: experi<br />info: KEYNOTE-811, Palmar-plantar erythrodysesthesia, Any grade","Control: 0.153<br />Experimental: 0.157<br />greater: experi<br />info: KEYNOTE-811, Neutropenia, Any grade","Control: 0.116<br />Experimental: 0.147<br />greater: experi<br />info: KEYNOTE-811, Hypokalemia, Any grade","Control: 0.102<br />Experimental: 0.143<br />greater: experi<br />info: KEYNOTE-811, Alanine aminotransferase increased, Any grade","Control: 0.093<br />Experimental: 0.143<br />greater: experi<br />info: KEYNOTE-811, Infusion-related reaction, Any grade","Control: 0.120<br />Experimental: 0.143<br />greater: experi<br />info: KEYNOTE-811, pyrexia, Any grade","Control: 0.088<br />Experimental: 0.111<br />greater: experi<br />info: KEYNOTE-811, Malaise, Any grade","Control: 0.102<br />Experimental: 0.111<br />greater: experi<br />info: KEYNOTE-811, Stomatitis, Any grade","Control: 0.056<br />Experimental: 0.101<br />greater: experi<br />info: KEYNOTE-811, Blood bilirubin increased, Any grade","Control: 0.019<br />Experimental: 0.046<br />greater: experi<br />info: KEYNOTE-811, Vomiting, Grade 3-5","Control: 0.069<br />Experimental: 0.078<br />greater: experi<br />info: KEYNOTE-811, Platelet count decreased, Grade 3-5","Control: 0.028<br />Experimental: 0.041<br />greater: experi<br />info: KEYNOTE-811, Fatigue/Asthenia, Grade 3-5","Control: 0.014<br />Experimental: 0.028<br />greater: experi<br />info: KEYNOTE-811, Peripheral sensory neuropathy, Grade 3-5","Control: 0.005<br />Experimental: 0.009<br />greater: experi<br />info: KEYNOTE-811, Weight decreased , Grade 3-5","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: KEYNOTE-811, Constipation, Grade 3-5","Control: 0.009<br />Experimental: 0.018<br />greater: experi<br />info: KEYNOTE-811, Infusion-related reaction, Grade 3-5","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />info: KEYNOTE-811, pyrexia, Grade 3-5","Control: 0.005<br />Experimental: 0.014<br />greater: experi<br />info: KEYNOTE-811, Blood bilirubin increased, Grade 3-5","Control: 0.009<br />Experimental: 0.032<br />greater: experi<br />info: KEYNOTE-811, Thrombocytopenia, Grade 3-5","Control: 0.050<br />Experimental: 0.180<br />greater: experi<br />info: KEYNOTE‑177, Arthralgia, Any grade","Control: 0.140<br />Experimental: 0.180<br />greater: experi<br />info: KEYNOTE‑177, Pyrexia, Any grade","Control: 0.080<br />Experimental: 0.160<br />greater: experi<br />info: KEYNOTE‑177, Pruritus, Any grade","Control: 0.160<br />Experimental: 0.170<br />greater: experi<br />info: KEYNOTE‑177, Cough, Any grade","Control: 0.080<br />Experimental: 0.160<br />greater: experi<br />info: KEYNOTE‑177, Aspartate aminotransferase increased, Any grade","Control: 0.110<br />Experimental: 0.140<br />greater: experi<br />info: KEYNOTE‑177, Alanine aminotransferase increased, Any grade","Control: 0.040<br />Experimental: 0.140<br />greater: experi<br />info: KEYNOTE‑177, Blood alkaline phosphatase increase, Any grade","Control: 0.100<br />Experimental: 0.140<br />greater: experi<br />info: KEYNOTE‑177, Dyspnea, Any grade","Control: 0.110<br />Experimental: 0.130<br />greater: experi<br />info: KEYNOTE‑177, Rash, Any grade","Control: 0.080<br />Experimental: 0.130<br />greater: experi<br />info: KEYNOTE‑177, Upper abdominal pain, Any grade","Control: 0.070<br />Experimental: 0.130<br />greater: experi<br />info: KEYNOTE‑177, Nasopharyngitis, Any grade","Control: 0.090<br />Experimental: 0.120<br />greater: experi<br />info: KEYNOTE‑177, Dry skin, Any grade","Control: 0.110<br />Experimental: 0.120<br />greater: experi<br />info: KEYNOTE‑177, Hypertension, Any grade","Control: 0.020<br />Experimental: 0.120<br />greater: experi<br />info: KEYNOTE‑177, Hypothyroidism, Any grade","Control: 0.080<br />Experimental: 0.120<br />greater: experi<br />info: KEYNOTE‑177, Pain in extremity, Any grade","Control: 0.080<br />Experimental: 0.120<br />greater: experi<br />info: KEYNOTE‑177, Peripheral edema, Any grade","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />info: KEYNOTE‑177, Dry mouth, Any grade","Control: 0.060<br />Experimental: 0.100<br />greater: experi<br />info: KEYNOTE‑177, Upper respiratory tract infection, Any grade","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE‑177, Arthralgia, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE‑177, Pyrexia, Grade ≥3","Control: 0.020<br />Experimental: 0.030<br />greater: experi<br />info: KEYNOTE‑177, Aspartate aminotransferase increased, Grade ≥3","Control: 0.020<br />Experimental: 0.030<br />greater: experi<br />info: KEYNOTE‑177, Alanine aminotransferase increased, Grade ≥3","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />info: KEYNOTE‑177, Blood alkaline phosphatase increase, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />info: KEYNOTE‑177, Dyspnea, Grade ≥3","Control: 0.050<br />Experimental: 0.070<br />greater: experi<br />info: KEYNOTE‑177, Hypertension, Grade ≥3"],"key":["TALAPRO-2, Fatigue/Asthenia, Grades 1-4","TALAPRO-2, Fatigue/Asthenia, Grade 3","TALAPRO-2, Nausea, Grades 1-4","TALAPRO-2, Nausea, Grade 3","TALAPRO-2, Decreased appetite, Grades 1-4","TALAPRO-2, Fractures, Grades 1-4","TALAPRO-2, Fractures, Grade 3","TALAPRO-2, Dizziness, Grades 1-4","TALAPRO-2, Dysgeusia, Grades 1-4","PROpel, Anemia, Grades 1-4","PROpel, Lymphopenia, Grades 1-4","PROpel, Fatigue/Asthenia, Grades 1-4","PROpel, Nausea, Grades 1-4","PROpel, Diarrhea, Grades 1-4","PROpel, Abdominal pain, Grades 1-4","PROpel, Decreased appetite, Grades 1-4","PROpel, Dizziness, Grades 1-4","PROpel, Anemia, Grade 3-4","PROpel, Lymphopenia, Grade 3-4","PROpel, Fatigue/Asthenia, Grade 3-4","PROpel, Diarrhea, Grade 3-4","PROpel, Decreased appetite, Grade 3-4","PROpel, Dizziness, Grade 3-4","POLARIX, Anemia, All grades","POLARIX, Febrile neutropenia, All grades","POLARIX, Increased blood creatinine, All grades","POLARIX, Aspartate aminotransferase increased, All grades","POLARIX, Alkaline phosphatase increased, All grades","POLARIX, Uric acid increased, All grades","POLARIX, Weight decreased , All grades","POLARIX, Nausea, All grades","POLARIX, Diarrhea, All grades","POLARIX, Mucositis, All grades","POLARIX, Abdominal pain, All grades","POLARIX, Vomiting, All grades","POLARIX, Pyrexia, All grades","POLARIX, Edema, All grades","POLARIX, Rash, All grades","POLARIX, Upper respiratory tract infection, All grades","POLARIX, Decreased appetite, All grades","POLARIX, Cough, All grades","POLARIX, Anemia, Grade 3-4","POLARIX, Thrombocytopenia, Grade 3-4","POLARIX, Febrile neutropenia, Grade 3-4","POLARIX, Alanine aminotransferase increased, Grade 3-4","POLARIX, Uric acid increased, Grade 3-4","POLARIX, Weight decreased , Grade 3-4","POLARIX, Peripheral neuropathy, Grade 3-4","POLARIX, Nausea, Grade 3-4","POLARIX, Diarrhea, Grade 3-4","POLARIX, Constipation, Grade 3-4","POLARIX, Mucositis, Grade 3-4","POLARIX, Vomiting, Grade 3-4","POLARIX, Pyrexia, Grade 3-4","POLARIX, Edema, Grade 3-4","POLARIX, Rash, Grade 3-4","POLARIX, Decreased appetite, Grade 3-4","TROPiCS-02, Diarrhea, All grades","TROPiCS-02, Nausea, All grades","TROPiCS-02, Constipation, All grades","TROPiCS-02, Vomiting, All grades","TROPiCS-02, Abdominal Pain, All grades","TROPiCS-02, Dyspepsia, All grades","TROPiCS-02, Fatigue/Asthenia, All grades","TROPiCS-02, Hypokalemia, All grades","TROPiCS-02, Arthralgia, All grades","TROPiCS-02, Headache, All grades","TROPiCS-02, Dyspnea, All grades","TROPiCS-02, Cough, All grades","TROPiCS-02, Alopecia, All grades","TROPiCS-02, Pruritus, All grades","TROPiCS-02, Diarrhea, Grade 3-4","TROPiCS-02, Constipation, Grade 3-4","TROPiCS-02, Fatigue/Asthenia, Grade 3-4","TROPiCS-02, Decreased appetite, Grade 3-4","TROPiCS-02, Hypokalemia, Grade 3-4","EMERALD, Musculoskeletal pain, All grades","EMERALD, Nausea, All grades","EMERALD, Vomiting, All grades","EMERALD, Diarrhea, All grades","EMERALD, Constipation, All grades","EMERALD, Abdominal pain, All grades","EMERALD, Dyspepsia, All grades","EMERALD, Decreased appetite , All grades","EMERALD, Hot flush , All grades","EMERALD, Musculoskeletal pain, Grade 3-4","EMERALD, Nausea, Grade 3-4","EMERALD, Vomiting, Grade 3-4","EMERALD, Abdominal pain, Grade 3-4","EMERALD, Fatigue/Asthenia, Grade 3-4","EMERALD, Decreased appetite , Grade 3-4","EMERALD, Headache, Grade 3-4","SEQUOIA, Musculoskeletal pain, All grades","SEQUOIA, Upper respiratory tract infection, All grades","SEQUOIA, Pneumonia, All grades","SEQUOIA, Hemorrhage, All grades","SEQUOIA, Hypertension, All grades","SEQUOIA, Bruising, All grades","SEQUOIA, Cough, All grades","SEQUOIA, Diarrhea, All grades","SEQUOIA, Second primary malignancyl, All grades","SEQUOIA, Headache, All grades","SEQUOIA, Dizziness, All grades","SEQUOIA, Musculoskeletal pain, Grade 3-4","SEQUOIA, Upper respiratory tract infection, Grade 3-4","SEQUOIA, Pneumonia, Grade 3-4","SEQUOIA, Hemorrhage, Grade 3-4","SEQUOIA, Hypertension, Grade 3-4","SEQUOIA, Constipation, Grade 3-4","SEQUOIA, Second primary malignancyl, Grade 3-4","SEQUOIA, Dizziness, Grade 3-4","ALPINE, Upper respiratory tract infection, All grades","ALPINE, COVID-19, All grades","ALPINE, Bruising, All grades","ALPINE, Dizziness, All grades","ALPINE, COVID-19, Grade 3-4","ALPINE, Rash, Grade 3-4","ALPINE, Diarrhea, Grade 3-4","ALPINE, Cough, Grade 3-4","POSEIDON, Cough/Productive Cough, All grades","POSEIDON, Nausea, All grades","POSEIDON, Diarrhea, All grades","POSEIDON, Vomiting, All grades","POSEIDON, Stomatitis, All grades","POSEIDON, Hypothyroidism, All grades","POSEIDON, Rash, All grades","POSEIDON, Alopecia, All grades","POSEIDON, Pruritus, All grades","POSEIDON, Fatigue/Asthenia, All grades","POSEIDON, Pyrexia, All grades","POSEIDON, Musculoskeletal Pain, All grades","POSEIDON, Decreased appetite, All grades","POSEIDON, Pneumonia, All grades","POSEIDON, Upper respiratory tract infection, All grades","POSEIDON, Headache, All grades","POSEIDON, Rash, Grade 3-4","POSEIDON, Fatigue/Asthenia, Grade 3-4","POSEIDON, Decreased appetite, Grade 3-4","POSEIDON, Pneumonia, Grade 3-4","Study 16113, Rash, All grades","Study 16113, Nausea, All grades","Study 16113, Constipation, All grades","Study 16113, Vomiting, All grades","Study 16113, Diarrhea, All grades","Study 16113, Fatigue/Asthenia, All grades","Study 16113, Peripheral neuropathy, All grades","Study 16113, Decreased appetite, All grades","Study 16113, Weight decreased , All grades","Study 16113, Dyspnea, All grades","Study 16113, Insomnia, All grades","Study 16113, Rash, Grade 3-4","Study 16113, Musculoskeletal pain, Grade 3-4","Study 16113, Constipation, Grade 3-4","Study 16113, Diarrhea, Grade 3-4","Study 16113, Fatigue/Asthenia, Grade 3-4","Study 16113, Decreased appetite, Grade 3-4","Study 16113, Weight decreased , Grade 3-4","Study 16113, Dyspnea, Grade 3-4","HIMALAYA, Pruritus, All grades","HIMALAYA, Pyrexia, All grades","HIMALAYA, Insomnia, All grades","HIMALAYA, Hypothyroidism, All grades","HIMALAYA, Musculoskeletal pain, All grades","HIMALAYA, Diarrhea, Grade 3-4","HIMALAYA, Decreased appetite, Grade 3-4","HIMALAYA, Insomnia, Grade 3-4","HIMALAYA, Musculoskeletal pain, Grade 3-4","TOPAZ-1, Pyrexia, All grades","TOPAZ-1, Nausea, All grades","TOPAZ-1, Constipation, All grades","TOPAZ-1, Abdominal pain, All grades","TOPAZ-1, Diarrhea, All grades","TOPAZ-1, Decreased appetite, All grades","TOPAZ-1, Rash, All grades","TOPAZ-1, Pruritus, All grades","TOPAZ-1, Pyrexia, Grade 3-4","TOPAZ-1, Constipation, Grade 3-4","TOPAZ-1, Decreased appetite, Grade 3-4","TOPAZ-1, Rash, Grade 3-4","ARASENS, Constipation, All grades","ARASENS, Decreased Appetite, All grades","ARASENS, Rash, All grades","ARASENS, Hemorrhage, All grades","ARASENS, Weight Increased, All grades","ARASENS, Hypertension, All grades","ARASENS, Rash, Grade 3-4","ARASENS, Weight Increased, Grade 3-4","ARASENS, Hypertension, Grade 3-4","DESTINY-Breast04, Nausea, All grades","DESTINY-Breast04, Vomiting, All grades","DESTINY-Breast04, Constipation, All grades","DESTINY-Breast04, Diarrhea, All grades","DESTINY-Breast04, Abdominal pain, All grades","DESTINY-Breast04, Stomatitis, All grades","DESTINY-Breast04, Fatigue/Asthenia, All grades","DESTINY-Breast04, Alopecia, All grades","DESTINY-Breast04, Anemia, All grades","DESTINY-Breast04, Decreased appetite, All grades","DESTINY-Breast04, Musculoskeletal pain, All grades","DESTINY-Breast04, Weight decreased , All grades","DESTINY-Breast04, Hemorrhage, All grades","DESTINY-Breast04, Headache, All grades","DESTINY-Breast04, Dizziness, All grades","DESTINY-Breast04, Upper respiratory tract infection, All grades","DESTINY-Breast04, Interstitial lung disease, All grades","DESTINY-Breast04, Dyspnea, All grades","DESTINY-Breast04, Nausea, Grade 3-4","DESTINY-Breast04, Vomiting, Grade 3-4","DESTINY-Breast04, Constipation, Grade 3-4","DESTINY-Breast04, Abdominal pain, Grade 3-4","DESTINY-Breast04, Fatigue/Asthenia, Grade 3-4","DESTINY-Breast04, Pyrexia, Grade 3-4","DESTINY-Breast04, Anemia, Grade 3-4","DESTINY-Breast04, Decreased appetite, Grade 3-4","DESTINY-Breast04, Musculoskeletal pain, Grade 3-4","DESTINY-Breast04, Weight decreased , Grade 3-4","DESTINY-Breast04, Headache, Grade 3-4","DESTINY-Breast04, Dizziness, Grade 3-4","DESTINY-Breast04, Upper respiratory tract infection, Grade 3-4","DESTINY-Breast04, Interstitial lung disease, Grade 3-4","DESTINY-Breast04, Dyspnea, Grade 3-4","TRANSFORM, Neutropenia, Grade 1–2","TRANSFORM, Anemia, Grade 1–2","TRANSFORM, Cytokine release syndrome, Grade 1–2","TRANSFORM, Headache, Grade 1–2","TRANSFORM, Fatigue/Asthenia, Grade 1–2","TRANSFORM, Constipation, Grade 1–2","TRANSFORM, Pyrexia, Grade 1–2","TRANSFORM, Lymphopenia, Grade 1–2","TRANSFORM, Dizziness, Grade 1–2","TRANSFORM, Insomnia, Grade 1–2","TRANSFORM, Hypotension, Grade 1–2","TRANSFORM, Leukopenia, Grade 1–2","TRANSFORM, Febrile neutropenia, Grade 1–2","TRANSFORM, Arthralgia, Grade 1–2","TRANSFORM, Cough, Grade 1–2","TRANSFORM, Dyspnea, Grade 1–2","TRANSFORM, Bone pain, Grade 1–2","TRANSFORM, Tremor, Grade 1–2","TRANSFORM, Myalgia, Grade 1–2","TRANSFORM, Asthenia, Grade 1–2","TRANSFORM, Hypertension, Grade 1–2","TRANSFORM, Neutropenia, Grade ≥ 3","TRANSFORM, Cytokine release syndrome, Grade ≥ 3","TRANSFORM, Prolonged cytopeniat, Grade ≥ 3","TRANSFORM, Headache, Grade ≥ 3","TRANSFORM, Constipation, Grade ≥ 3","TRANSFORM, Lymphopenia, Grade ≥ 3","TRANSFORM, Hypotension, Grade ≥ 3","TRANSFORM, Peripheral edema, Grade ≥ 3","TRANSFORM, Leukopenia, Grade ≥ 3","TRANSFORM, Abdominal pain, Grade ≥ 3","TRANSFORM, Tremor, Grade ≥ 3","TRANSFORM, Myalgia, Grade ≥ 3","TRANSFORM, Asthenia, Grade ≥ 3","TRANSFORM, Hypertension, Grade ≥ 3","AG120-C-009, Nausea, All grades","AG120-C-009, Vomiting, All grades","AG120-C-009, Electrocardiogram QT prolonged, All grades","AG120-C-009, Insomnia, All grades","AG120-C-009, Differentiation Syndrome, All grades","AG120-C-009, Leukocytosis, All grades","AG120-C-009, Hematoma, All grades","AG120-C-009, Hypertension, All grades","AG120-C-009, Arthralgia, All grades","AG120-C-009, Dyspnea, All grades","AG120-C-009, Headache, All grades","AG120-C-009, Electrocardiogram QT prolonged, Grade ≥ 3","AG120-C-009, Insomnia, Grade ≥ 3","AG120-C-009, Differentiation Syndrome, Grade ≥ 3","AG120-C-009, Arthralgia, Grade ≥ 3","OlympiA, Nausea, Grades 1-4","OlympiA, Vomiting, Grades 1-4","OlympiA, Diarrhea, Grades 1-4","OlympiA, Stomatitis, Grades 1-4","OlympiA, Fatigue/Asthenia, Grades 1-4","OlympiA, Anemia, Grades 1-4","OlympiA, Leukopenia, Grades 1-4","OlympiA, Neutropenia, Grades 1-4","OlympiA, Headache, Grades 1-4","OlympiA, Dysgeusia, Grades 1-4","OlympiA, Dizziness, Grades 1-4","OlympiA, Decreased appetite, Grades 1-4","OlympiA, Nausea, Grade 3-4","OlympiA, Vomiting, Grade 3-4","OlympiA, Stomatitis, Grade 3-4","OlympiA, Fatigue/Asthenia, Grade 3-4","OlympiA, Anemia, Grade 3-4","OlympiA, Leukopenia, Grade 3-4","OlympiA, Neutropenia, Grade 3-4","OlympiA, Headache, Grade 3-4","OlympiA, Decreased appetite, Grade 3-4","KEYNOTE-716, Hypothyroidism, All grades","KEYNOTE-716, Hyperthyroidism, All grades","KEYNOTE-716, Diarrhea, All grades","KEYNOTE-716, Nausea, All grades","KEYNOTE-716, Fatigue/Asthenia, All grades","KEYNOTE-716, Asthenia, All grades","KEYNOTE-716, Arthralgia, All grades","KEYNOTE-716, Myalgia, All grades","KEYNOTE-716, Increased alanine aminotransferase, All grades","KEYNOTE-716, Aspartate aminotransferase increased, All grades","KEYNOTE-716, Pruritus, All grades","KEYNOTE-716, Rash, All grades","KEYNOTE-716, Rash maculopapular, All grades","KEYNOTE-716, Hyperthyroidism, Grade ≥ 3","KEYNOTE-716, Fatigue/Asthenia, Grade ≥ 3","KEYNOTE-716, Asthenia, Grade ≥ 3","KEYNOTE-716, Arthralgia, Grade ≥ 3","KEYNOTE-716, Myalgia, Grade ≥ 3","KEYNOTE-716, Pruritus, Grade ≥ 3","KEYNOTE-716, Rash maculopapular, Grade ≥ 3","KEYNOTE-564, Musculoskeletal pain, All grades","KEYNOTE-564, Fatigue/Asthenia, All grades","KEYNOTE-564, Rash, All grades","KEYNOTE-564, Pruritus, All grades","KEYNOTE-564, Diarrhea, All grades","KEYNOTE-564, Nausea, All grades","KEYNOTE-564, Hypothyroidism, All grades","KEYNOTE-564, Hyperthyroidism , All grades","KEYNOTE-564, Cough, All grades","KEYNOTE-564, Headache, All grades","KEYNOTE-564, Hepatotoxicity, All grades","KEYNOTE-564, Acute kidney injury, All grades","KEYNOTE-564, Musculoskeletal pain, Grade 3-4","KEYNOTE-564, Fatigue/Asthenia, Grade 3-4","KEYNOTE-564, Rash, Grade 3-4","KEYNOTE-564, Pruritus, Grade 3-4","KEYNOTE-564, Diarrhea, Grade 3-4","KEYNOTE-564, Nausea, Grade 3-4","KEYNOTE-564, Abdominal pain, Grade 3-4","KEYNOTE-564, Hypothyroidism, Grade 3-4","KEYNOTE-564, Hyperthyroidism , Grade 3-4","KEYNOTE-564, Headache, Grade 3-4","KEYNOTE-564, Hepatotoxicity, Grade 3-4","KEYNOTE-564, Acute kidney injury, Grade 3-4","KEYNOTE-826, Peripheral neuropathy, All grades","KEYNOTE-826, Rash, All grades","KEYNOTE-826, Fatigue/Asthenia, All grades","KEYNOTE-826, Diarrhea, All grades","KEYNOTE-826, Arthralgia, All grades","KEYNOTE-826, Hypertension, All grades","KEYNOTE-826, Rash, Grade 3-4","KEYNOTE-826, Fatigue/Asthenia, Grade 3-4","KEYNOTE-826, Nausea, Grade 3-4","KEYNOTE-826, Vomiting, Grade 3-4","KEYNOTE-826, Urinary tract infection, Grade 3-4","COSMIC-311, Diarrhea, All grades","COSMIC-311, Nausea, All grades","COSMIC-311, Vomiting, All grades","COSMIC-311, Stomatitis, All grades","COSMIC-311, Dry mouth, All grades","COSMIC-311, Fatigue/Asthenia, All grades","COSMIC-311, Decreased appetite, All grades","COSMIC-311, Palmar-plantar erythrodysesthesia, All grades","COSMIC-311, Hypertension, All grades","COSMIC-311, Weight decreased , All grades","COSMIC-311, Dysgeusia, All grades","COSMIC-311, Headache, All grades","COSMIC-311, Dysphonia, All grades","COSMIC-311, Pulmonary embolism, All grades","COSMIC-311, Proteinuria, All grades","COSMIC-311, Diarrhea, Grade 3-4","COSMIC-311, Nausea, Grade 3-4","COSMIC-311, Vomiting, Grade 3-4","COSMIC-311, Stomatitis, Grade 3-4","COSMIC-311, Dry mouth, Grade 3-4","COSMIC-311, Fatigue/Asthenia, Grade 3-4","COSMIC-311, Decreased appetite, Grade 3-4","COSMIC-311, Palmar-plantar erythrodysesthesia, Grade 3-4","COSMIC-311, Hypertension, Grade 3-4","COSMIC-311, Weight decreased , Grade 3-4","COSMIC-311, Headache, Grade 3-4","COSMIC-311, Pulmonary embolism, Grade 3-4","COSMIC-311, Proteinuria, Grade 3-4","Study AG120-C-005, Fatigue/Asthenia, All grades","Study AG120-C-005, Nausea, All grades","Study AG120-C-005, Diarrhea, All grades","Study AG120-C-005, Abdominal pain, All grades","Study AG120-C-005, Ascites, All grades","Study AG120-C-005, Vomiting, All grades","Study AG120-C-005, Cough, All grades","Study AG120-C-005, Decreased appetite, All grades","Study AG120-C-005, Anemia, All grades","Study AG120-C-005, Rash, All grades","Study AG120-C-005, Headache, All grades","Study AG120-C-005, Neuropathy, All grades","Study AG120-C-005, Ascites, Grade ≥ 3","Study AG120-C-005, Vomiting, Grade ≥ 3","Study AG120-C-005, Decreased appetite, Grade ≥ 3","Study AG120-C-005, Anemia, Grade ≥ 3","Study AG120-C-005, Rash, Grade ≥ 3","CHECKMATE-274, Rash, All grades","CHECKMATE-274, Pruritus, All grades","CHECKMATE-274, Fatigue/Asthenia, All grades","CHECKMATE-274, Diarrhea, All grades","CHECKMATE-274, Nausea, All grades","CHECKMATE-274, Musculoskeletal pain, All grades","CHECKMATE-274, Hyperthyroidism, All grades","CHECKMATE-274, Hypothyroidism, All grades","CHECKMATE-274, Renal dysfunction, All grades","CHECKMATE-274, Cough, All grades","CHECKMATE-274, Dyspnea, All grades","CHECKMATE-274, Decreased appetite, All grades","CHECKMATE-274, Dizziness, All grades","CHECKMATE-274, Hepatitis, All grades","CHECKMATE-274, Rash, Grade 3-4","CHECKMATE-274, Fatigue/Asthenia, Grade 3-4","CHECKMATE-274, Diarrhea, Grade 3-4","CHECKMATE-274, Nausea, Grade 3-4","CHECKMATE-274, Abdominal pain, Grade 3-4","CHECKMATE-274, Arthralgia, Grade 3-4","CHECKMATE-274, Renal dysfunction, Grade 3-4","CHECKMATE-274, Decreased appetite, Grade 3-4","CHECKMATE-274, Dizziness, Grade 3-4","CHECKMATE-274, Hepatitis, Grade 3-4","KEYNOTE-522, Fatigue/Asthenia, All grades","KEYNOTE-522, Pyrexia, All grades","KEYNOTE-522, Nausea, All grades","KEYNOTE-522, Constipation, All grades","KEYNOTE-522, Diarrhea, All grades","KEYNOTE-522, Stomatitis, All grades","KEYNOTE-522, Vomiting, All grades","KEYNOTE-522, Abdominal pain, All grades","KEYNOTE-522, Alopecia, All grades","KEYNOTE-522, Rash, All grades","KEYNOTE-522, Headache, All grades","KEYNOTE-522, Myalgia, All grades","KEYNOTE-522, Cough, All grades","KEYNOTE-522, Decreased appetite , All grades","KEYNOTE-522, Insomnia, All grades","KEYNOTE-522, Fatigue/Asthenia, Grade 3-4","KEYNOTE-522, Pyrexia, Grade 3-4","KEYNOTE-522, Nausea, Grade 3-4","KEYNOTE-522, Diarrhea, Grade 3-4","KEYNOTE-522, Stomatitis, Grade 3-4","KEYNOTE-522, Vomiting, Grade 3-4","KEYNOTE-522, Rash, Grade 3-4","KEYNOTE-522, Peripheral neuropathy, Grade 3-4","KEYNOTE-522, Arthralgia, Grade 3-4","KEYNOTE-522, Myalgia, Grade 3-4","KEYNOTE-522, Cough, Grade 3-4","KEYNOTE-522, Decreased appetite , Grade 3-4","KEYNOTE-522, Insomnia, Grade 3-4","CHECKMATE-577, Nausea, All grades","CHECKMATE-577, Fatigue/Asthenia, All grades","CHECKMATE-577, Rash, All grades","CHECKMATE-577, Pruritus, All grades","CHECKMATE-577, Weight decreased , All grades","CHECKMATE-577, Musculoskeletal pain, All grades","CHECKMATE-577, Arthralgia, All grades","CHECKMATE-577, Decreased appetite, All grades","CHECKMATE-577, Hypothyroidism, All grades","CHECKMATE-577, Diarrhea, Grade 3-4","CHECKMATE-577, Nausea, Grade 3-4","CHECKMATE-577, Dyspnea, Grade 3-4","CHECKMATE-577, Rash, Grade 3-4","CHECKMATE-577, Pruritus, Grade 3-4","CHECKMATE-577, Weight decreased , Grade 3-4","CHECKMATE-577, Arthralgia, Grade 3-4","CHECKMATE-577, Decreased appetite, Grade 3-4","KEYNOTE-590, Nausea, All grades","KEYNOTE-590, Diarrhea, All grades","KEYNOTE-590, Vomiting, All grades","KEYNOTE-590, Stomatitis, All grades","KEYNOTE-590, Fatigue/Asthenia, All grades","KEYNOTE-590, Decreased appetite, All grades","KEYNOTE-590, Diarrhea, Grade 3-4","KEYNOTE-590, Vomiting, Grade 3-4","KEYNOTE-590, Stomatitis, Grade 3-4","KEYNOTE-590, Fatigue/Asthenia, Grade 3-4","ADAURA, Diarrhea, All grades","ADAURA, Stomatitis, All grades","ADAURA, Abdominal Pain, All grades","ADAURA, Rash, All grades","ADAURA, Nail toxicity, All grades","ADAURA, Dry skin, All grades","ADAURA, Pruritus, All grades","ADAURA, Nasopharyngitis, All grades","ADAURA, Upper respiratory tract infection, All grades","ADAURA, Urinary Tract Infection, All grades","ADAURA, Fatigue/Asthenia, All grades","ADAURA, Dizziness, All grades","ADAURA, Decreased appetite, All grades","ADAURA, Diarrhea, Grade ≥ 3","ADAURA, Stomatitis, Grade ≥ 3","ADAURA, Abdominal Pain, Grade ≥ 3","ADAURA, Rash, Grade ≥ 3","ADAURA, Nail toxicity, Grade ≥ 3","ADAURA, Dry skin, Grade ≥ 3","ADAURA, Upper respiratory tract infection, Grade ≥ 3","ADAURA, Urinary Tract Infection, Grade ≥ 3","ADAURA, Fatigue/Asthenia, Grade ≥ 3","ADAURA, Decreased appetite, Grade ≥ 3","KEYNOTE-355, Diarrhea, All grades","KEYNOTE-355, Constipation, All grades","KEYNOTE-355, Vomiting, All grades","KEYNOTE-355, Rash, All grades","KEYNOTE-355, Cough, All grades","KEYNOTE-355, Decreased appetite, All grades","KEYNOTE-355, Fatigue/Asthenia, Grade 3-4","KEYNOTE-355, Constipation, Grade 3-4","KEYNOTE-355, Rash, Grade 3-4","KEYNOTE-355, Decreased appetite, Grade 3-4","VIALE-A , Nausea, All grades","VIALE-A , Diarrhea, All grades","VIALE-A , Vomiting, All grades","VIALE-A , Stomatitis, All grades","VIALE-A , Abdominal pain, All grades","VIALE-A , Febrile neutropenia, All grades","VIALE-A , Musculoskeletal pain, All grades","VIALE-A , Fatigue/Asthenia, All grades","VIALE-A , Edema, All grades","VIALE-A , Hemorrhage, All grades","VIALE-A , Hypotension, All grades","VIALE-A , Decreased appetite, All grades","VIALE-A , Rash, All grades","VIALE-A , Sepsis (excluding fungal), All grades","VIALE-A , Urinary tract infection, All grades","VIALE-A , Dyspnea, All grades","VIALE-A , Dizziness, All grades","VIALE-A , Nausea, Grade 3-4","VIALE-A , Diarrhea, Grade 3-4","VIALE-A , Vomiting, Grade 3-4","VIALE-A , Stomatitis, Grade 3-4","VIALE-A , Abdominal pain, Grade 3-4","VIALE-A , Febrile neutropenia, Grade 3-4","VIALE-A , Musculoskeletal pain, Grade 3-4","VIALE-A , Fatigue/Asthenia, Grade 3-4","VIALE-A , Edema, Grade 3-4","VIALE-A , Hemorrhage, Grade 3-4","VIALE-A , Hypotension, Grade 3-4","VIALE-A , Decreased appetite, Grade 3-4","VIALE-A , Rash, Grade 3-4","VIALE-A , Sepsis (excluding fungal), Grade 3-4","VIALE-A , Dyspnea, Grade 3-4","QUAZAR, Nausea, All grades","QUAZAR, Vomiting, All grades","QUAZAR, Diarrhea, All grades","QUAZAR, Constipation, All grades","QUAZAR, Abdominal pain, All grades","QUAZAR, Fatigue/Asthenia, All grades","QUAZAR, Pneumonia, All grades","QUAZAR, Arthralgia, All grades","QUAZAR, Pain in extremity, All grades","QUAZAR, Decreased appetite, All grades","QUAZAR, Febrile neutropenia, All grades","QUAZAR, Dizziness, All grades","QUAZAR, Nausea, TYPO","QUAZAR, Vomiting, TYPO","QUAZAR, Diarrhea, TYPO","QUAZAR, Constipation, TYPO","QUAZAR, Abdominal pain, TYPO","QUAZAR, Fatigue/Asthenia, TYPO","QUAZAR, Pneumonia, TYPO","QUAZAR, Pain in extremity, TYPO","QUAZAR, Febrile neutropenia, TYPO","IMspire150, Rash, All grades","IMspire150, Pruritus, All grades","IMspire150, Fatigue/Asthenia, All grades","IMspire150, Pyrexia, All grades","IMspire150, Edema, All grades","IMspire150, Hepatotoxicity, All grades","IMspire150, Stomatitis, All grades","IMspire150, Musculoskeletal pain, All grades","IMspire150, Hypothyroidism, All grades","IMspire150, Hyperthyroidism, All grades","IMspire150, Infusion-related reaction, All grades","IMspire150, Pneumonitis, All grades","IMspire150, Rash, Grade 3-4","IMspire150, Fatigue/Asthenia, Grade 3-4","IMspire150, Edema, Grade 3-4","IMspire150, Hepatotoxicity, Grade 3-4","IMspire150, Stomatitis, Grade 3-4","IMspire150, Musculoskeletal pain, Grade 3-4","IMspire150, Hyperthyroidism, Grade 3-4","IMspire150, Infusion-related reaction, Grade 3-4","IMspire150, Pneumonitis, Grade 3-4","IMspire150, Hypertension, Grade 3-4","RELAY, Infections, All grades","RELAY, Hypertension, All grades","RELAY, Stomatitis, All grades","RELAY, Gastrointestinal hemorrhage, All grades","RELAY, Gingival bleeding, All grades","RELAY, Proteinuria, All grades","RELAY, Alopecia, All grades","RELAY, Epistaxis, All grades","RELAY, Pulmonary hemorrhage, All grades","RELAY, Peripheral edema, All grades","RELAY, Headache, All grades","RELAY, Infections, Grade ≥ 3","RELAY, Hypertension, Grade ≥ 3","RELAY, Diarrhea, Grade ≥ 3","RELAY, Stomatitis, Grade ≥ 3","RELAY, Proteinuria, Grade ≥ 3","RELAY, Peripheral edema, Grade ≥ 3","RELAY, Headache, Grade ≥ 3","INVICTUS , Alopecia, Grades 1-4","INVICTUS , Palmar-plantar erythrodysesthesia, Grades 1-4","INVICTUS , Dry skin, Grades 1-4","INVICTUS , Pruritus, Grades 1-4","INVICTUS , Fatigue/Asthenia, Grades 1-4","INVICTUS , Peripheral edema, Grades 1-4","INVICTUS , Nausea, Grades 1-4","INVICTUS , Abdominal pain, Grades 1-4","INVICTUS , Constipation, Grades 1-4","INVICTUS , Diarrhea, Grades 1-4","INVICTUS , Vomiting, Grades 1-4","INVICTUS , Stomatitis, Grades 1-4","INVICTUS , Myalgia, Grades 1-4","INVICTUS , Arthralgia, Grades 1-4","INVICTUS , Muscle spasms, Grades 1-4","INVICTUS , Decreased appetite, Grades 1-4","INVICTUS , Weight decreased , Grades 1-4","INVICTUS , Headache, Grades 1-4","INVICTUS , Hypertension, Grades 1-4","INVICTUS , Dyspnea, Grades 1-4","INVICTUS , Fatigue/Asthenia, Grade 3-4","INVICTUS , Peripheral edema, Grade 3-4","INVICTUS , Nausea, Grade 3-4","INVICTUS , Abdominal pain, Grade 3-4","INVICTUS , Constipation, Grade 3-4","INVICTUS , Vomiting, Grade 3-4","INVICTUS , Myalgia, Grade 3-4","INVICTUS , Hypertension, Grade 3-4","PAOLA-1, Fatigue/Asthenia, Grades 1-4","PAOLA-1, Nausea, Grades 1-4","PAOLA-1, Vomiting, Grades 1-4","PAOLA-1, Anemia, Grades 1-4","PAOLA-1, Lymphopenia, Grades 1-4","PAOLA-1, Leukopenia, Grades 1-4","PAOLA-1, Fatigue/Asthenia, TYPO","PAOLA-1, Nausea, TYPO","PAOLA-1, Anemia, TYPO","PAOLA-1, Lymphopenia, TYPO","PAOLA-1, Leukopenia, TYPO","PRIMA, Thrombocytopenia, Grades 1-4","PRIMA, Anemia, Grades 1-4","PRIMA, Neutropenia, Grades 1-4","PRIMA, Leukopenia, Grades 1-4","PRIMA, Nausea, Grades 1-4","PRIMA, Constipation, Grades 1-4","PRIMA, Vomiting, Grades 1-4","PRIMA, Fatigue/Asthenia, Grades 1-4","PRIMA, AST/ALT elevation, Grades 1-4","PRIMA, Decreased appetite, Grades 1-4","PRIMA, Musculoskeletal pain, Grades 1-4","PRIMA, Headache, Grades 1-4","PRIMA, Dizziness, Grades 1-4","PRIMA, Insomnia, Grades 1-4","PRIMA, Acute kidney injury, Grades 1-4","PRIMA, Dyspnea, Grades 1-4","PRIMA, Cough, Grades 1-4","PRIMA, Hypertension, Grades 1-4","PRIMA, Thrombocytopenia, Grade 3-4","PRIMA, Anemia, Grade 3-4","PRIMA, Neutropenia, Grade 3-4","PRIMA, Leukopenia, Grade 3-4","PRIMA, Constipation, Grade 3-4","PRIMA, Fatigue/Asthenia, Grade 3-4","PRIMA, AST/ALT elevation, Grade 3-4","PRIMA, Decreased appetite, Grade 3-4","PRIMA, Musculoskeletal pain, Grade 3-4","PRIMA, Headache, Grade 3-4","PRIMA, Insomnia, Grade 3-4","PRIMA, Acute kidney injury, Grade 3-4","PRIMA, Hypertension, Grade 3-4","HER2CLIMB, Diarrhea, All grades","HER2CLIMB, Nausea, All grades","HER2CLIMB, Vomiting, All grades","HER2CLIMB, Stomatitis, All grades","HER2CLIMB, Palmar-plantar erythrodysesthesia, All grades","HER2CLIMB, Rash, All grades","HER2CLIMB, Hepatotoxicity, All grades","HER2CLIMB, Decreased appetite, All grades","HER2CLIMB, Anemia, All grades","HER2CLIMB, Arthralgia, All grades","HER2CLIMB, Increased blood creatinine, All grades","HER2CLIMB, Weight decreased , All grades","HER2CLIMB, Peripheral neuropathy, All grades","HER2CLIMB, Epistaxis, All grades","HER2CLIMB, Diarrhea, Grade 3","HER2CLIMB, Nausea, Grade 3","HER2CLIMB, Stomatitis, Grade 3","HER2CLIMB, Palmar-plantar erythrodysesthesia, Grade 3","HER2CLIMB, Rash, Grade 3","HER2CLIMB, Hepatotoxicity, Grade 3","HER2CLIMB, Decreased appetite, Grade 3","HER2CLIMB, Anemia, Grade 3","HER2CLIMB, Weight decreased , Grade 3","HER2CLIMB, Diarrhea, Grade 4","HER2CLIMB, Hepatotoxicity, Grade 4","CHECKMATE-648, Nausea, All grades","CHECKMATE-648, Constipation, All grades","CHECKMATE-648, Stomatitis, All grades","CHECKMATE-648, Diarrhea, All grades","CHECKMATE-648, Vomiting, All grades","CHECKMATE-648, Dysphagia, All grades","CHECKMATE-648, Abdominal pain, All grades","CHECKMATE-648, Decreased appetite, All grades","CHECKMATE-648, Fatigue/Asthenia, All grades","CHECKMATE-648, Pyrexia, All grades","CHECKMATE-648, Edema, All grades","CHECKMATE-648, Peripheral neuropathy, All grades","CHECKMATE-648, Insomnia, All grades","CHECKMATE-648, Rash, All grades","CHECKMATE-648, Pruritus, All grades","CHECKMATE-648, Cough, All grades","CHECKMATE-648, Pneumonia, All grades","CHECKMATE-648, Hypothyroidism, All grades","CHECKMATE-648, Weight decreased , All grades","CHECKMATE-648, Musculoskeletal pain, All grades","CHECKMATE-648, Nausea, Grade 3-4","CHECKMATE-648, Stomatitis, Grade 3-4","CHECKMATE-648, Diarrhea, Grade 3-4","CHECKMATE-648, Dysphagia, Grade 3-4","CHECKMATE-648, Abdominal pain, Grade 3-4","CHECKMATE-648, Decreased appetite, Grade 3-4","CHECKMATE-648, Peripheral neuropathy, Grade 3-4","CHECKMATE-648, Rash, Grade 3-4","CHECKMATE-648, Pneumonia, Grade 3-4","CHECKMATE-648, Diarrhea, All grades","CHECKMATE-648, Pyrexia, All grades","CHECKMATE-648, Rash, All grades","CHECKMATE-648, Pruritus, All grades","CHECKMATE-648, Pneumonia, All grades","CHECKMATE-648, Hypothyroidism, All grades","CHECKMATE-648, Weight decreased , All grades","CHECKMATE-648, Musculoskeletal pain, All grades","CHECKMATE-648, Dysphagia, Grade 3-4","CHECKMATE-648, Abdominal pain, Grade 3-4","CHECKMATE-648, Pyrexia, Grade 3-4","CHECKMATE-648, Rash, Grade 3-4","CHECKMATE-648, Pruritus, Grade 3-4","CHECKMATE-648, Pneumonia, Grade 3-4","CHECKMATE-648, Weight decreased , Grade 3-4","CHECKMATE-648, Musculoskeletal pain, Grade 3-4","DESTINY-Breast03, Nausea, All grades","DESTINY-Breast03, Vomiting, All grades","DESTINY-Breast03, Constipation, All grades","DESTINY-Breast03, Diarrhea, All grades","DESTINY-Breast03, Abdominal pain, All grades","DESTINY-Breast03, Stomatitis, All grades","DESTINY-Breast03, Dyspepsia, All grades","DESTINY-Breast03, Fatigue/Asthenia, All grades","DESTINY-Breast03, Anemia, All grades","DESTINY-Breast03, Alopecia, All grades","DESTINY-Breast03, Musculoskeletal pain, All grades","DESTINY-Breast03, Decreased appetite, All grades","DESTINY-Breast03, Weight decreased , All grades","DESTINY-Breast03, Respiratory infection, All grades","DESTINY-Breast03, Cough, All grades","DESTINY-Breast03, Interstitial lung disease, All grades","DESTINY-Breast03, Headache, All grades","DESTINY-Breast03, Dizziness, All grades","DESTINY-Breast03, Nausea, Grade 3-4","DESTINY-Breast03, Vomiting, Grade 3-4","DESTINY-Breast03, Diarrhea, Grade 3-4","DESTINY-Breast03, Abdominal pain, Grade 3-4","DESTINY-Breast03, Stomatitis, Grade 3-4","DESTINY-Breast03, Fatigue/Asthenia, Grade 3-4","DESTINY-Breast03, Anemia, Grade 3-4","DESTINY-Breast03, Alopecia, Grade 3-4","DESTINY-Breast03, Musculoskeletal pain, Grade 3-4","DESTINY-Breast03, Decreased appetite, Grade 3-4","DESTINY-Breast03, Weight decreased , Grade 3-4","DESTINY-Breast03, Cough, Grade 3-4","DESTINY-Breast03, Interstitial lung disease, Grade 3-4","DESTINY-Breast03, Headache, Grade 3-4","DESTINY-Breast03, Dizziness, Grade 3-4","VISION, Fatigue/Asthenia, All grades","VISION, Decreased appetite, All grades","VISION, Weight decreased , All grades","VISION, Peripheral edema, All grades","VISION, Pyrexia, All grades","VISION, Dry mouth, All grades","VISION, Nausea, All grades","VISION, Constipation, All grades","VISION, Vomiting, All grades","VISION, Diarrhea, All grades","VISION, Abdominal pain, All grades","VISION, Anemia, All grades","VISION, Thrombocytopenia, All grades","VISION, Urinary tract infection, All grades","VISION, Acute kidney injury, All grades","VISION, Dizziness, All grades","VISION, Headache, All grades","VISION, Dysgeusia, All grades","VISION, Fatigue/Asthenia, Grade 3-4","VISION, Decreased appetite, Grade 3-4","VISION, Weight decreased , Grade 3-4","VISION, Pyrexia, Grade 3-4","VISION, Nausea, Grade 3-4","VISION, Constipation, Grade 3-4","VISION, Vomiting, Grade 3-4","VISION, Diarrhea, Grade 3-4","VISION, Abdominal pain, Grade 3-4","VISION, Anemia, Grade 3-4","VISION, Thrombocytopenia, Grade 3-4","VISION, Urinary tract infection, Grade 3-4","VISION, Acute kidney injury, Grade 3-4","VISION, Dizziness, Grade 3-4","VISION, Headache, Grade 3-4","RELATIVITY-047, Musculoskeletal pain, All grades","RELATIVITY-047, Fatigue/Asthenia, All grades","RELATIVITY-047, Rash, All grades","RELATIVITY-047, Pruritus, All grades","RELATIVITY-047, Diarrhea, All grades","RELATIVITY-047, Nausea, All grades","RELATIVITY-047, Headache, All grades","RELATIVITY-047, Hypothyroidism, All grades","RELATIVITY-047, Decreased appetite, All grades","RELATIVITY-047, Cough, All grades","RELATIVITY-047, Musculoskeletal pain, Grade 3-4","RELATIVITY-047, Fatigue/Asthenia, Grade 3-4","RELATIVITY-047, Diarrhea, Grade 3-4","RELATIVITY-047, Nausea, Grade 3-4","RELATIVITY-047, Decreased appetite, Grade 3-4","RELATIVITY-047, Cough, Grade 3-4","CHECKMATE-816, Constipation, All grades","CHECKMATE-816, Fatigue/Asthenia, All grades","CHECKMATE-816, Malaise, All grades","CHECKMATE-816, Rash, All grades","CHECKMATE-816, Peripheral neuropathy, All grades","CHECKMATE-816, Vomiting, Grade 3-4","CHECKMATE-816, Fatigue/Asthenia, Grade 3-4","CHECKMATE-816, Rash, Grade 3-4","IMCgp100-202, Cytokine release syndrome, All grades","IMCgp100-202, Rash, All grades","IMCgp100-202, Pruritus, All grades","IMCgp100-202, Dry skin, All grades","IMCgp100-202, Skin Hypopigmentation, All grades","IMCgp100-202, Erythema, All grades","IMCgp100-202, Hair color changes, All grades","IMCgp100-202, Pyrexia, All grades","IMCgp100-202, Fatigue/Asthenia, All grades","IMCgp100-202, Chills, All grades","IMCgp100-202, Edema, All grades","IMCgp100-202, Nausea, All grades","IMCgp100-202, Abdominal pain, All grades","IMCgp100-202, Vomiting, All grades","IMCgp100-202, Diarrhea, All grades","IMCgp100-202, Hypotension, All grades","IMCgp100-202, Headache, All grades","IMCgp100-202, Arthralgia, All grades","IMCgp100-202, Cytokine release syndrome, Grade 3-4","IMCgp100-202, Rash, Grade 3-4","IMCgp100-202, Pruritus, Grade 3-4","IMCgp100-202, Pyrexia, Grade 3-4","IMCgp100-202, Fatigue/Asthenia, Grade 3-4","IMCgp100-202, Chills, Grade 3-4","IMCgp100-202, Nausea, Grade 3-4","IMCgp100-202, Vomiting, Grade 3-4","IMCgp100-202, Hypotension, Grade 3-4","IMCgp100-202, Arthralgia, Grade 3-4","ASCEMBL, Upper respiratory tract infection, All grades","ASCEMBL, Musculoskeletal pain, All grades","ASCEMBL, Arthralgia, All grades","ASCEMBL, Headache, All grades","ASCEMBL, Fatigue/Asthenia, All grades","ASCEMBL, Hypertension, All grades","ASCEMBL, Musculoskeletal pain, Grade 3-4","ASCEMBL, Headache, Grade 3-4","ASCEMBL, Hypertension, Grade 3-4","ASCEMBL, Nausea, Grade 3-4","IMpower010, Rash, All grades","IMpower010, Pruritus, All grades","IMpower010, Hypothyroidism, All grades","IMpower010, Cough, All grades","IMpower010, Pyrexia, All grades","IMpower010, Fatigue/Asthenia, All grades","IMpower010, Peripheral neuropathy, All grades","IMpower010, Musculoskeletal pain, All grades","IMpower010, Arthralgia, All grades","IMpower010, Rash, Grade 3-4","IMpower010, Pyrexia, Grade 3-4","IMpower010, Fatigue/Asthenia, Grade 3-4","IMpower010, Peripheral neuropathy, Grade 3-4","IMpower010, Musculoskeletal pain, Grade 3-4","IMpower010, Arthralgia, Grade 3-4","monarchE, Diarrhea, All grades","monarchE, Nausea, All grades","monarchE, Vomiting, All grades","monarchE, Stomatitis, All grades","monarchE, Infections, All grades","monarchE, Fatigue/Asthenia, All grades","monarchE, Headache, All grades","monarchE, Dizziness, All grades","monarchE, Decreased appetite, All grades","monarchE, Rash, All grades","monarchE, Alopecia, All grades","monarchE, Diarrhea, Grade 3","monarchE, Nausea, Grade 3","monarchE, Vomiting, Grade 3","monarchE, Stomatitis, Grade 3","monarchE, Infections, Grade 3","monarchE, Fatigue/Asthenia, Grade 3","monarchE, Headache, Grade 3","monarchE, Decreased appetite, Grade 3","monarchE, Rash, Grade 3","monarchE, Infections, Grade 4","REACH-3, Musculoskeletal pain, All grades","REACH-3, Pyrexia, All grades","REACH-3, Fatigue/Asthenia, All grades","REACH-3, Hypertension, All grades","REACH-3, Cough, All grades","REACH-3, Dyspnea, All grades","REACH-3, Musculoskeletal pain, Grade ≥ 3","REACH-3, Pyrexia, Grade ≥ 3","ASPEN, Upper respiratory tract infection, All grades","ASPEN, Nausea, All grades","ASPEN, Constipation, All grades","ASPEN, Fatigue/Asthenia, All grades","ASPEN, Pyrexia, All grades","ASPEN, Pruritus, All grades","ASPEN, Musculoskeletal pain, All grades","ASPEN, Headache, All grades","ASPEN, Dizziness, All grades","ASPEN, Dyspnea, All grades","ASPEN, Diarrhea, Grade 3-4","ASPEN, Pyrexia, Grade 3-4","ASPEN, Pruritus, Grade 3-4","ASPEN, Musculoskeletal pain, Grade 3-4","ASPEN, Dizziness, Grade 3-4","CLEAR, Fatigue/Asthenia, All Grades","CLEAR, Diarrhea, All Grades","CLEAR, Nausea, All Grades","CLEAR, Abdominal pain, All Grades","CLEAR, Vomiting, All Grades","CLEAR, Constipation, All Grades","CLEAR, Musculoskeletal pain, All Grades","CLEAR, Hypothyroidism, All Grades","CLEAR, Hypertension, All Grades","CLEAR, Hemorrhagic events, All Grades","CLEAR, Decreased appetite, All Grades","CLEAR, Rash, All Grades","CLEAR, Dysphonia, All Grades","CLEAR, Proteinuria, All Grades","CLEAR, Acute kidney injury, All Grades","CLEAR, Weight decreased , All Grades","CLEAR, Hepatotoxicity, All Grades","CLEAR, Headache, All Grades","CLEAR, Fatigue/Asthenia, Grade 3-4","CLEAR, Diarrhea, Grade 3-4","CLEAR, Nausea, Grade 3-4","CLEAR, Abdominal pain, Grade 3-4","CLEAR, Vomiting, Grade 3-4","CLEAR, Constipation, Grade 3-4","CLEAR, Musculoskeletal pain, Grade 3-4","CLEAR, Hypothyroidism, Grade 3-4","CLEAR, Hypertension, Grade 3-4","CLEAR, Hemorrhagic events, Grade 3-4","CLEAR, Decreased appetite, Grade 3-4","CLEAR, Rash, Grade 3-4","CLEAR, Proteinuria, Grade 3-4","CLEAR, Acute kidney injury, Grade 3-4","CLEAR, Weight decreased , Grade 3-4","CLEAR, Hepatotoxicity, Grade 3-4","Study 309, Hypothyroidism, All Grades","Study 309, Hypertension, All Grades","Study 309, Hemorrhagic events, All Grades","Study 309, Fatigue/Asthenia, All Grades","Study 309, Diarrhea, All Grades","Study 309, Nausea, All Grades","Study 309, Vomiting, All Grades","Study 309, Stomatitis, All Grades","Study 309, Abdominal pain, All Grades","Study 309, Constipation, All Grades","Study 309, Musculoskeletal disorders, All Grades","Study 309, Decreased appetite, All Grades","Study 309, Weight decreased , All Grades","Study 309, Proteinuria, All Grades","Study 309, Urinary tract infection, All Grades","Study 309, Headache, All Grades","Study 309, Dysphonia, All Grades","Study 309, Palmar-plantar erythrodysesthesia, All Grades","Study 309, Rash, All Grades","Study 309, Hypothyroidism, Grade 3-4","Study 309, Hypertension, Grade 3-4","Study 309, Hemorrhagic events, Grade 3-4","Study 309, Fatigue/Asthenia, Grade 3-4","Study 309, Diarrhea, Grade 3-4","Study 309, Nausea, Grade 3-4","Study 309, Vomiting, Grade 3-4","Study 309, Stomatitis, Grade 3-4","Study 309, Abdominal pain, Grade 3-4","Study 309, Musculoskeletal disorders, Grade 3-4","Study 309, Decreased appetite, Grade 3-4","Study 309, Weight decreased , Grade 3-4","Study 309, Proteinuria, Grade 3-4","Study 309, Urinary tract infection, Grade 3-4","Study 309, Headache, Grade 3-4","Study 309, Palmar-plantar erythrodysesthesia, Grade 3-4","Study 309, Rash, Grade 3-4","APOLLO, Fatigue/Asthenia, All Grades","APOLLO, Pyrexia, All Grades","APOLLO, Edema peripheral, All Grades","APOLLO, Pneumonia, All Grades","APOLLO, Upper respiratory tract infection, All Grades","APOLLO, Diarrhea, All Grades","APOLLO, Cough, All Grades","APOLLO, Fatigue/Asthenia, Grade ≥ 3","APOLLO, Pneumonia, Grade ≥ 3","APOLLO, Diarrhea, Grade ≥ 3","CHECKMATE-649, Peripheral neuropathy, All Grades","CHECKMATE-649, Headache, All Grades","CHECKMATE-649, Nausea, All Grades","CHECKMATE-649, Diarrhea, All Grades","CHECKMATE-649, Vomiting, All Grades","CHECKMATE-649, Abdominal pain, All Grades","CHECKMATE-649, Constipation, All Grades","CHECKMATE-649, Stomatitis, All Grades","CHECKMATE-649, Fatigue/Asthenia, All Grades","CHECKMATE-649, Pyrexia, All Grades","CHECKMATE-649, Edema, All Grades","CHECKMATE-649, Decreased appetite, All Grades","CHECKMATE-649, Hypoalbuminemia, All Grades","CHECKMATE-649, Weight decreased , All Grades","CHECKMATE-649, Increased lipase, All Grades","CHECKMATE-649, Increased amylase, All Grades","CHECKMATE-649, Musculoskeletal pain, All Grades","CHECKMATE-649, Rash, All Grades","CHECKMATE-649, Palmar-plantar erythrodysesthesia, All Grades","CHECKMATE-649, Cough, All Grades","CHECKMATE-649, Upper respiratory tract infection, All Grades","CHECKMATE-649, Peripheral neuropathy, Grade 3-4","CHECKMATE-649, Headache, Grade 3-4","CHECKMATE-649, Diarrhea, Grade 3-4","CHECKMATE-649, Abdominal pain, Grade 3-4","CHECKMATE-649, Constipation, Grade 3-4","CHECKMATE-649, Stomatitis, Grade 3-4","CHECKMATE-649, Fatigue/Asthenia, Grade 3-4","CHECKMATE-649, Pyrexia, Grade 3-4","CHECKMATE-649, Edema, Grade 3-4","CHECKMATE-649, Decreased appetite, Grade 3-4","CHECKMATE-649, Weight decreased , Grade 3-4","CHECKMATE-649, Increased lipase, Grade 3-4","CHECKMATE-649, Increased amylase, Grade 3-4","CHECKMATE-649, Rash, Grade 3-4","CHECKMATE-649, Palmar-plantar erythrodysesthesia, Grade 3-4","CHECKMATE-649, Cough, Grade 3-4","ASCENT, Neutropenia, All Grades","ASCENT, Anemia, All Grades","ASCENT, Leukopenia, All Grades","ASCENT, Lymphopenia, All Grades","ASCENT, Diarrhea, All Grades","ASCENT, Nausea, All Grades","ASCENT, Vomiting, All Grades","ASCENT, Constipation, All Grades","ASCENT, Abdominal Pain, All Grades","ASCENT, Stomatitis, All Grades","ASCENT, Fatigue/Asthenia, All Grades","ASCENT, Pyrexia, All Grades","ASCENT, Urinary tract infection, All Grades","ASCENT, Upper respiratory tract infection, All Grades","ASCENT, Alanine aminotransferase increased, All Grades","ASCENT, Decreased appetite, All Grades","ASCENT, Hypokalemia, All Grades","ASCENT, Hypomagnesaemia, All Grades","ASCENT, Back pain, All Grades","ASCENT, Arthralgia, All Grades","ASCENT, Headache, All Grades","ASCENT, Dizziness, All Grades","ASCENT, Insomnia, All Grades","ASCENT, Cough, All Grades","ASCENT, Alopecia, All Grades","ASCENT, Rash, All Grades","ASCENT, Pruritus, All Grades","ASCENT, Neutropenia, Grade 3-4","ASCENT, Anemia, Grade 3-4","ASCENT, Leukopenia, Grade 3-4","ASCENT, Diarrhea, Grade 3-4","ASCENT, Nausea, Grade 3-4","ASCENT, Vomiting, Grade 3-4","ASCENT, Constipation, Grade 3-4","ASCENT, Abdominal Pain, Grade 3-4","ASCENT, Stomatitis, Grade 3-4","ASCENT, Decreased appetite, Grade 3-4","ASCENT, Hypokalemia, Grade 3-4","ASCENT, Arthralgia, Grade 3-4","ASCENT, Headache, Grade 3-4","IKEMA, Infusion-related reaction, All Grades","IKEMA, Upper respiratory tract infection, All Grades","IKEMA, Pneumonia, All Grades","IKEMA, Bronchitis, All Grades","IKEMA, Hypertension, All Grades","IKEMA, Dyspnea, All Grades","IKEMA, Cough, All Grades","IKEMA, Diarrhea, All Grades","IKEMA, Vomiting, All Grades","IKEMA, Fatigue/Asthenia, All Grades","IKEMA, Infusion-related reaction, Grade 3","IKEMA, Upper respiratory tract infection, Grade 3","IKEMA, Pneumonia, Grade 3","IKEMA, Bronchitis, Grade 3","IKEMA, Hypertension, Grade 3","IKEMA, Dyspnea, Grade 3","IKEMA, Diarrhea, Grade 3","IKEMA, Vomiting, Grade 3","IKEMA, Fatigue/Asthenia, Grade 3","IKEMA, Pneumonia, Grade 4","TIVO-3, Fatigue/Asthenia, All Grades","TIVO-3, Hypertension, All Grades","TIVO-3, Bleeding, All Grades","TIVO-3, Nausea, All Grades","TIVO-3, Vomiting, All Grades","TIVO-3, Decreased appetite, All Grades","TIVO-3, Dysphonia, All Grades","TIVO-3, Cough, All Grades","TIVO-3, Dyspnea, All Grades","TIVO-3, Hypothyroidism, All Grades","TIVO-3, Back pain, All Grades","TIVO-3, Fatigue/Asthenia, Grade 3-4","TIVO-3, Hypertension, Grade 3-4","TIVO-3, Bleeding, Grade 3-4","TIVO-3, Decreased appetite, Grade 3-4","TIVO-3, Dysphonia, Grade 3-4","TIVO-3, Dyspnea, Grade 3-4","TIVO-3, Hypothyroidism, Grade 3-4","Study B7461006, Mood effects, All Grades","Study B7461006, Peripheral neuropathy, All Grades","Study B7461006, Cognitive effects, All Grades","Study B7461006, Sleep effects, All Grades","Study B7461006, Dyspnea, All Grades","Study B7461006, Respiratory failure, All Grades","Study B7461006, Hypertension, All Grades","Study B7461006, Arthralgia, All Grades","Study B7461006, Myalgia, All Grades","Study B7461006, Back pain, All Grades","Study B7461006, Pain in extremity, All Grades","Study B7461006, Edema, All Grades","Study B7461006, Weight Increased, All Grades","Study B7461006, Pyrexia, All Grades","Study B7461006, Upper respiratory tract infection, All Grades","Study B7461006, Bronchitis, All Grades","Study B7461006, Rash, All Grades","Study B7461006, Mood effects, Grade 3-4","Study B7461006, Peripheral neuropathy, Grade 3-4","Study B7461006, Cognitive effects, Grade 3-4","Study B7461006, Sleep effects, Grade 3-4","Study B7461006, Dyspnea, Grade 3-4","Study B7461006, Respiratory failure, Grade 3-4","Study B7461006, Hypertension, Grade 3-4","Study B7461006, Diarrhea, Grade 3-4","Study B7461006, Arthralgia, Grade 3-4","Study B7461006, Myalgia, Grade 3-4","Study B7461006, Back pain, Grade 3-4","Study B7461006, Edema, Grade 3-4","Study B7461006, Weight Increased, Grade 3-4","Study B7461006, Chest pain, Grade 3-4","Study B7461006, Bronchitis, Grade 3-4","Study 1624, Rash, All Grades","Study 1624, Cough, All Grades","Study 1624, Rash, Grade 3-4","Study 1624, Decreased appetite, Grade 3-4","CHECKMATE-9ER, Diarrhea, Grades 1-4","CHECKMATE-9ER, Abdominal pain, Grades 1-4","CHECKMATE-9ER, Fatigue/Asthenia, Grades 1-4","CHECKMATE-9ER, Hepatotoxicity, Grades 1-4","CHECKMATE-9ER, Rash, Grades 1-4","CHECKMATE-9ER, Pruritus, Grades 1-4","CHECKMATE-9ER, Hypothyroidism, Grades 1-4","CHECKMATE-9ER, Musculoskeletal pain, Grades 1-4","CHECKMATE-9ER, Arthralgia, Grades 1-4","CHECKMATE-9ER, Decreased appetite, Grades 1-4","CHECKMATE-9ER, Dysgeusia, Grades 1-4","CHECKMATE-9ER, Headache, Grades 1-4","CHECKMATE-9ER, Cough, Grades 1-4","CHECKMATE-9ER, Dysphonia , Grades 1-4","CHECKMATE-9ER, Upper respiratory tract infection, Grades 1-4","CHECKMATE-9ER, Diarrhea, Grade 3-4","CHECKMATE-9ER, Nausea, Grade 3-4","CHECKMATE-9ER, Abdominal pain, Grade 3-4","CHECKMATE-9ER, Vomiting, Grade 3-4","CHECKMATE-9ER, Hepatotoxicity, Grade 3-4","CHECKMATE-9ER, Rash, Grade 3-4","CHECKMATE-9ER, Pruritus, Grade 3-4","CHECKMATE-9ER, Musculoskeletal pain, Grade 3-4","CHECKMATE-9ER, Decreased appetite, Grade 3-4","CHECKMATE-9ER, Cough, Grade 3-4","CHECKMATE-9ER, Dysphonia , Grade 3-4","ANDROMEDA, Upper respiratory tract infection, All Grades","ANDROMEDA, Pneumonia, All Grades","ANDROMEDA, Diarrhea, All Grades","ANDROMEDA, Constipation, All Grades","ANDROMEDA, Peripheral sensory neuropathy, All Grades","ANDROMEDA, Dyspnea, All Grades","ANDROMEDA, Cough, All Grades","ANDROMEDA, Back pain, All Grades","ANDROMEDA, Arthralgia, All Grades","ANDROMEDA, Muscle spasms, All Grades","ANDROMEDA, Arrhythmia, All Grades","ANDROMEDA, Injection site reactions, All Grades","ANDROMEDA, Pneumonia, Grade 3-4","ANDROMEDA, Diarrhea, Grade 3-4","ANDROMEDA, Constipation, Grade 3-4","ANDROMEDA, Peripheral sensory neuropathy, Grade 3-4","ANDROMEDA, Cough, Grade 3-4","ANDROMEDA, Back pain, Grade 3-4","ANDROMEDA, Muscle spasms, Grade 3-4","ANDROMEDA, Arrhythmia, Grade 3-4","DESTINY-Gastric01, Nausea, All Grades","DESTINY-Gastric01, Vomiting, All Grades","DESTINY-Gastric01, Constipation, All Grades","DESTINY-Gastric01, Stomatitis, All Grades","DESTINY-Gastric01, Decreased appetite, All Grades","DESTINY-Gastric01, Dehydration, All Grades","DESTINY-Gastric01, Anemia, All Grades","DESTINY-Gastric01, Febrile neutropenia, All Grades","DESTINY-Gastric01, Fatigue/Asthenia, All Grades","DESTINY-Gastric01, Pyrexia, All Grades","DESTINY-Gastric01, Edema peripheral, All Grades","DESTINY-Gastric01, Alopecia, All Grades","DESTINY-Gastric01, Interstitial lung disease, All Grades","DESTINY-Gastric01, Hepatic function abnormal, All Grades","DESTINY-Gastric01, Nausea, Grade 3-4","DESTINY-Gastric01, Diarrhea, Grade 3-4","DESTINY-Gastric01, Stomatitis, Grade 3-4","DESTINY-Gastric01, Decreased appetite, Grade 3-4","DESTINY-Gastric01, Dehydration, Grade 3-4","DESTINY-Gastric01, Anemia, Grade 3-4","DESTINY-Gastric01, Febrile neutropenia, Grade 3-4","DESTINY-Gastric01, Fatigue/Asthenia, Grade 3-4","DESTINY-Gastric01, Interstitial lung disease, Grade 3-4","DESTINY-Gastric01, Hepatic function abnormal, Grade 3-4","HERO, Hot flush, All Grades","HERO, Musculoskeletal pain, All Grades","HERO, Fatigue/Asthenia, All Grades","HERO, Diarrhea, All Grades","HERO, Constipation, All Grades","HERO, Hot flush, Grade 3-4","HERO, Fatigue/Asthenia, Grade 3-4","HERO, Diarrhea, Grade 3-4","BOSTON, Nausea, All Grades","BOSTON, Diarrhea, All Grades","BOSTON, Vomiting, All Grades","BOSTON, Fatigue/Asthenia, All Grades","BOSTON, Pyrexia, All Grades","BOSTON, Appetite decrease, All Grades","BOSTON, Weight decreased , All Grades","BOSTON, Dizziness, All Grades","BOSTON, Upper respiratory tract infection, All Grades","BOSTON, Cataract, All Grades","BOSTON, Vision blurred, All Grades","BOSTON, Nausea, Grade 3-4","BOSTON, Diarrhea, Grade 3-4","BOSTON, Vomiting, Grade 3-4","BOSTON, Fatigue/Asthenia, Grade 3-4","BOSTON, Pyrexia, Grade 3-4","BOSTON, Appetite decrease, Grade 3-4","BOSTON, Weight decreased , Grade 3-4","BOSTON, Dizziness, Grade 3-4","BOSTON, Upper respiratory tract infection, Grade 3-4","BOSTON, Cataract, Grade 3-4","BOSTON, Vision blurred, Grade 3-4","SOPHIA, Fatigue/Asthenia, All Grades","SOPHIA, Pyrexia, All Grades","SOPHIA, Nausea, All Grades","SOPHIA, Vomiting, All Grades","SOPHIA, Constipation, All Grades","SOPHIA, Alopecia, All Grades","SOPHIA, Headache, All Grades","SOPHIA, Peripheral neuropathy, All Grades","SOPHIA, Cough, All Grades","SOPHIA, Dyspnea, All Grades","SOPHIA, Arthralgia/Myalgia, All Grades","SOPHIA, Pain in extremity, All Grades","SOPHIA, Infusion-related reaction, All Grades","SOPHIA, Fatigue/Asthenia, Grade 3-4","SOPHIA, Nausea, Grade 3-4","SOPHIA, Cough, Grade 3-4","SOPHIA, Pain in extremity, Grade 3-4","SOPHIA, Infusion-related reaction, Grade 3-4","KEYNOTE-204, Upper respiratory tract infection, All Grades","KEYNOTE-204, Urinary tract infection, All Grades","KEYNOTE-204, Musculoskeletal pain, All Grades","KEYNOTE-204, Diarrhea, All Grades","KEYNOTE-204, Rash, All Grades","KEYNOTE-204, Pruritus, All Grades","KEYNOTE-204, Cough, All Grades","KEYNOTE-204, Pneumonitis, All Grades","KEYNOTE-204, Dyspnea, All Grades","KEYNOTE-204, Hypothyroidism, All Grades","KEYNOTE-204, Upper respiratory tract infection, Grade 3-4","KEYNOTE-204, Diarrhea, Grade 3-4","KEYNOTE-204, Vomiting, Grade 3-4","KEYNOTE-204, Pneumonitis, Grade 3-4","CHECKMATE-743, Pyrexia, All Grades","CHECKMATE-743, Edema, All Grades","CHECKMATE-743, Musculoskeletal pain, All Grades","CHECKMATE-743, Arthralgia, All Grades","CHECKMATE-743, Rash, All Grades","CHECKMATE-743, Pruritus, All Grades","CHECKMATE-743, Diarrhea, All Grades","CHECKMATE-743, Abdominal pain, All Grades","CHECKMATE-743, Dyspnea, All Grades","CHECKMATE-743, Cough, All Grades","CHECKMATE-743, Hypothyroidism, All Grades","CHECKMATE-743, Upper respiratory tract infection, All Grades","CHECKMATE-743, Pneumonia, All Grades","CHECKMATE-743, Pyrexia, Grade 3-4","CHECKMATE-743, Musculoskeletal pain, Grade 3-4","CHECKMATE-743, Arthralgia, Grade 3-4","CHECKMATE-743, Rash, Grade 3-4","CHECKMATE-743, Pruritus, Grade 3-4","CHECKMATE-743, Diarrhea, Grade 3-4","CHECKMATE-743, Abdominal pain, Grade 3-4","CHECKMATE-743, Cough, Grade 3-4","CHECKMATE-743, Upper respiratory tract infection, Grade 3-4","CHECKMATE-743, Pneumonia, Grade 3-4","CANDOR, Infusion-related reaction, All Grades","CANDOR, Fatigue/Asthenia, All Grades","CANDOR, Pyrexia, All Grades","CANDOR, Respiratory infection, All Grades","CANDOR, Pneumonia, All Grades","CANDOR, Bronchitis, All Grades","CANDOR, Thrombocytopenia, All Grades","CANDOR, Anemia, All Grades","CANDOR, Diarrhea, All Grades","CANDOR, Nausea, All Grades","CANDOR, Hypertension, All Grades","CANDOR, Insomnia, All Grades","CANDOR, Back pain, All Grades","CANDOR, Infusion-related reaction, Grade 3-4","CANDOR, Fatigue/Asthenia, Grade 3-4","CANDOR, Pyrexia, Grade 3-4","CANDOR, Respiratory infection, Grade 3-4","CANDOR, Pneumonia, Grade 3-4","CANDOR, Bronchitis, Grade 3-4","CANDOR, Thrombocytopenia, Grade 3-4","CANDOR, Anemia, Grade 3-4","CANDOR, Diarrhea, Grade 3-4","CANDOR, Hypertension, Grade 3-4","CANDOR, Dyspnea, Grade 3-4","CANDOR, Insomnia, Grade 3-4","CANDOR, Back pain, Grade 3-4","JAVELIN Bladder 100, Fatigue/Asthenia, All Grades","JAVELIN Bladder 100, Pyrexia, All Grades","JAVELIN Bladder 100, Musculoskeletal pain, All Grades","JAVELIN Bladder 100, Arthralgia, All Grades","JAVELIN Bladder 100, Rash, All Grades","JAVELIN Bladder 100, Pruritus, All Grades","JAVELIN Bladder 100, Urinary tract infection, All Grades","JAVELIN Bladder 100, Diarrhea, All Grades","JAVELIN Bladder 100, Constipation, All Grades","JAVELIN Bladder 100, Nausea, All Grades","JAVELIN Bladder 100, Vomiting, All Grades","JAVELIN Bladder 100, Cough, All Grades","JAVELIN Bladder 100, Decreased appetite, All Grades","JAVELIN Bladder 100, Hypothyroidism, All Grades","JAVELIN Bladder 100, Infusion-related reaction, All Grades","JAVELIN Bladder 100, Pyrexia, Grade 3-4","JAVELIN Bladder 100, Arthralgia, Grade 3-4","JAVELIN Bladder 100, Rash, Grade 3-4","JAVELIN Bladder 100, Pruritus, Grade 3-4","JAVELIN Bladder 100, Urinary tract infection, Grade 3-4","JAVELIN Bladder 100, Diarrhea, Grade 3-4","JAVELIN Bladder 100, Constipation, Grade 3-4","JAVELIN Bladder 100, Vomiting, Grade 3-4","JAVELIN Bladder 100, Cough, Grade 3-4","JAVELIN Bladder 100, Hypothyroidism, Grade 3-4","JAVELIN Bladder 100, Infusion-related reaction, Grade 3-4","ATTRACTION-3, Pruritus, All Grades","ATTRACTION-3, Diarrhea, All Grades","ATTRACTION-3, Upper respiratory tract infection, All Grades","ATTRACTION-3, Cough, All Grades","ATTRACTION-3, Hypothyroidism, All Grades","ATTRACTION-3, Rash, Grade 3-4","ATTRACTION-3, Diarrhea, Grade 3-4","ATTRACTION-3, Upper respiratory tract infection, Grade 3-4","IMbrave150, Hypertension, All Grades","IMbrave150, Pyrexia, All Grades","IMbrave150, Proteinuria, All Grades","IMbrave150, Weight decreased , All Grades","IMbrave150, Pruritus, All Grades","IMbrave150, Vomiting, All Grades","IMbrave150, Cough, All Grades","IMbrave150, Epistaxis, All Grades","IMbrave150, Infusion-related reaction, All Grades","IMbrave150, Hypertension, Grade 3-4","IMbrave150, Proteinuria, Grade 3-4","IMbrave150, Infusion-related reaction, Grade 3-4","CHECKMATE-9LA, Fatigue/Asthenia, All Grades","CHECKMATE-9LA, Pyrexia, All Grades","CHECKMATE-9LA, Musculoskeletal pain, All Grades","CHECKMATE-9LA, Diarrhea, All Grades","CHECKMATE-9LA, Vomiting, All Grades","CHECKMATE-9LA, Abdominal pain, All Grades","CHECKMATE-9LA, Rash, All Grades","CHECKMATE-9LA, Pruritus, All Grades","CHECKMATE-9LA, Alopecia, All Grades","CHECKMATE-9LA, Decreased appetite, All Grades","CHECKMATE-9LA, Cough, All Grades","CHECKMATE-9LA, Dyspnea, All Grades","CHECKMATE-9LA, Hypothyroidism, All Grades","CHECKMATE-9LA, Headache, All Grades","CHECKMATE-9LA, Dizziness, All Grades","CHECKMATE-9LA, Fatigue/Asthenia, Grade 3-4","CHECKMATE-9LA, Musculoskeletal pain, Grade 3-4","CHECKMATE-9LA, Nausea, Grade 3-4","CHECKMATE-9LA, Diarrhea, Grade 3-4","CHECKMATE-9LA, Vomiting, Grade 3-4","CHECKMATE-9LA, Rash, Grade 3-4","CHECKMATE-9LA, Pruritus, Grade 3-4","CHECKMATE-9LA, Alopecia, Grade 3-4","CHECKMATE-9LA, Decreased appetite, Grade 3-4","CHECKMATE-9LA, Dyspnea, Grade 3-4","CHECKMATE-9LA, Hypothyroidism, Grade 3-4","CHECKMATE-9LA, Headache, Grade 3-4","CHECKMATE-9LA, Dizziness, Grade 3-4","ALTA 1L, Stomatitis, All Grades","ALTA 1L, Rash, All Grades","ALTA 1L, Pruritus, All Grades","ALTA 1L, Cough, All Grades","ALTA 1L, Dyspnea, All Grades","ALTA 1L, ILD/Pneumonitis, All Grades","ALTA 1L, Hypertension, All Grades","ALTA 1L, Myalgia, All Grades","ALTA 1L, Back pain, All Grades","ALTA 1L, Arthralgia, All Grades","ALTA 1L, Headache, All Grades","ALTA 1L, Increased Blood cholesterol, All Grades","ALTA 1L, Pneumonia, All Grades","ALTA 1L, Upper respiratory tract infection, All Grades","ALTA 1L, Stomatitis, Grade 3-4","ALTA 1L, Rash, Grade 3-4","ALTA 1L, ILD/Pneumonitis, Grade 3-4","ALTA 1L, Hypertension, Grade 3-4","ALTA 1L, Pyrexia, Grade 3-4","ALTA 1L, Headache, Grade 3-4","ALTA 1L, Peripheral neuropathy, Grade 3-4","ALTA 1L, Bradycardia, Grade 3-4","ALTA 1L, Pneumonia, Grade 3-4","PROfound, Anemia, Grades 1-4 ","PROfound, Thrombocytopenia, Grades 1-4 ","PROfound, Nausea, Grades 1-4 ","PROfound, Diarrhea, Grades 1-4 ","PROfound, Vomiting, Grades 1-4 ","PROfound, Fatigue/Asthenia, Grades 1-4 ","PROfound, Decreased appetite, Grades 1-4 ","PROfound, Cough, Grades 1-4 ","PROfound, Dyspnea, Grades 1-4 ","PROfound, Anemia, Grade 3-4","PROfound, Thrombocytopenia, Grade 3-4","PROfound, Nausea, Grade 3-4","PROfound, Diarrhea, Grade 3-4","PROfound, Vomiting, Grade 3-4","PROfound, Dyspnea, Grade 3-4","IMpower110, Pyrexia, All Grades","IMpower110, Dyspnea, All Grades","IMpower110, Cough, All Grades","IMpower110, Constipation, Grade 3-4","IMpower110, Decreased appetite, Grade 3-4","IMpower110, Dyspnea, Grade 3-4","IMpower110, Cough, Grade 3-4","CHECKMATE-227, Fatigue/Asthenia, All Grades","CHECKMATE-227, Pyrexia, All Grades","CHECKMATE-227, Edema, All Grades","CHECKMATE-227, Rash, All Grades","CHECKMATE-227, Pruritus, All Grades","CHECKMATE-227, Decreased appetite, All Grades","CHECKMATE-227, Musculoskeletal pain, All Grades","CHECKMATE-227, Arthralgia, All Grades","CHECKMATE-227, Diarrhea/colitis, All Grades","CHECKMATE-227, Abdominal pain, All Grades","CHECKMATE-227, Dyspnea, All Grades","CHECKMATE-227, Cough, All Grades","CHECKMATE-227, Hepatitis, All Grades","CHECKMATE-227, Hypothyroidism, All Grades","CHECKMATE-227, Hyperthyroidism, All Grades","CHECKMATE-227, Pneumonia, All Grades","CHECKMATE-227, Headache, All Grades","CHECKMATE-227, Fatigue/Asthenia, Grade 3-4","CHECKMATE-227, Pyrexia, Grade 3-4","CHECKMATE-227, Rash, Grade 3-4","CHECKMATE-227, Pruritus, Grade 3-4","CHECKMATE-227, Decreased appetite, Grade 3-4","CHECKMATE-227, Musculoskeletal pain, Grade 3-4","CHECKMATE-227, Arthralgia, Grade 3-4","CHECKMATE-227, Diarrhea/colitis, Grade 3-4","CHECKMATE-227, Dyspnea, Grade 3-4","CHECKMATE-227, Cough, Grade 3-4","CHECKMATE-227, Hepatitis, Grade 3-4","CHECKMATE-227, Hypothyroidism, Grade 3-4","CHECKMATE-227, Pneumonia, Grade 3-4","CHECKMATE-227, Headache, Grade 3-4","E1912, Fatigue/Asthenia, All Grades","E1912, Peripheral edema, All Grades","E1912, Pain, All Grades","E1912, Musculoskeletal pain, All Grades","E1912, Arthralgia, All Grades","E1912, Diarrhea, All Grades","E1912, Stomatitis, All Grades","E1912, Abdominal pain, All Grades","E1912, Rash, All Grades","E1912, Bruising, All Grades","E1912, Hypertension, All Grades","E1912, Hemorrhage, All Grades","E1912, Headache, All Grades","E1912, Dizziness, All Grades","E1912, Peripheral neuropathy, All Grades","E1912, Cough, All Grades","E1912, Dyspnea, All Grades","E1912, Upper respiratory tract infection, All Grades","E1912, Skin infection, All Grades","E1912, Hyperuricemia, All Grades","E1912, Peripheral edema, Grade ≥ 3","E1912, Pain, Grade ≥ 3","E1912, Musculoskeletal pain, Grade ≥ 3","E1912, Arthralgia, Grade ≥ 3","E1912, Diarrhea, Grade ≥ 3","E1912, Abdominal pain, Grade ≥ 3","E1912, Vomiting, Grade ≥ 3","E1912, Hypertension, Grade ≥ 3","E1912, Hemorrhage, Grade ≥ 3","E1912, Dyspnea, Grade ≥ 3","E1912, Hyperuricemia, Grade ≥ 3","BEACON CRC, Fatigue/Asthenia, All Grades","BEACON CRC, Pyrexia, All Grades","BEACON CRC, Arthralgia, All Grades","BEACON CRC, Myopathy, All Grades","BEACON CRC, Pain in extremity, All Grades","BEACON CRC, Pruritus, All Grades","BEACON CRC, Melanocytic nevus, All Grades","BEACON CRC, Dry skin, All Grades","BEACON CRC, Headache, All Grades","BEACON CRC, Peripheral neuropathy, All Grades","BEACON CRC, Hemorrhage, All Grades","BEACON CRC, Insomnia, All Grades","BEACON CRC, Arthralgia, Grade ≥ 3","BEACON CRC, Myopathy, Grade ≥ 3","BEACON CRC, Peripheral neuropathy, Grade ≥ 3","BEACON CRC, Hemorrhage, Grade ≥ 3","CASPIAN , Cough/Productive Cough, All Grades","CASPIAN , Hyperthyroidism, All Grades","CASPIAN , Rash, All Grades","CASPIAN , Decreased appetite, All Grades","CASPIAN , Cough/Productive Cough, Grade 3-4","CASPIAN , Constipation, Grade 3-4","CASPIAN , Alopecia, Grade 3-4","CASPIAN , Fatigue/Asthenia, Grade 3-4","ICARIA-MM, Infusion-related reaction, All grades","ICARIA-MM, Pneumonia, All grades","ICARIA-MM, Upper respiratory tract infection, All grades","ICARIA-MM, Febrile neutropenia, All grades","ICARIA-MM, Dyspnea, All grades","ICARIA-MM, Diarrhea, All grades","ICARIA-MM, Nausea, All grades","ICARIA-MM, Vomiting, All grades","ICARIA-MM, Infusion-related reaction, Grade 3","ICARIA-MM, Pneumonia, Grade 3","ICARIA-MM, Upper respiratory tract infection, Grade 3","ICARIA-MM, Febrile neutropenia, Grade 3","ICARIA-MM, Dyspnea, Grade 3","ICARIA-MM, Diarrhea, Grade 3","ICARIA-MM, Vomiting, Grade 3","ICARIA-MM, Infusion-related reaction, Grade 4","ICARIA-MM, Pneumonia, Grade 4","ICARIA-MM, Febrile neutropenia, Grade 4","NALA, Diarrhea, All Grades","NALA, Nausea, All Grades","NALA, Vomiting, All Grades","NALA, Constipation, All Grades","NALA, Abdominal distension, All Grades","NALA, Fatigue/Asthenia, All Grades","NALA, Malaise, All Grades","NALA, Influenza-like illness, All Grades","NALA, Urinary tract infection, All Grades","NALA, Upper respiratory tract infection, All Grades","NALA, Decreased appetite, All Grades","NALA, Back Pain, All Grades","NALA, Arthralgia, All Grades","NALA, Muscle spasms, All Grades","NALA, Dizziness, All Grades","NALA, Renal impairment, All Grades","NALA, Dysuria, All Grades","NALA, Diarrhea, Grade 3","NALA, Nausea, Grade 3","NALA, Vomiting, Grade 3","NALA, Constipation, Grade 3","NALA, Fatigue/Asthenia, Grade 3","NALA, Urinary tract infection, Grade 3","NALA, Decreased appetite, Grade 3","NALA, Renal impairment, Grade 3","KEYNOTE-091, Pruritus, Grade 1–2","KEYNOTE-091, Hypothyroidism, Grade 1–2","KEYNOTE-091, Arthralgia, Grade 1–2","KEYNOTE-091, Diarrhea, Grade 1–2","KEYNOTE-091, Fatigue/Asthenia, Grade 1–2","KEYNOTE-091, Hyperthyroidism, Grade 1–2","KEYNOTE-091, Nausea, Grade 1–2","KEYNOTE-091, Nasopharyngitis, Grade 1–2","KEYNOTE-091, Rash, Grade 1–2","KEYNOTE-091, Increased alanine aminotransferase, Grade 1–2","KEYNOTE-091, Asthenia, Grade 1–2","KEYNOTE-091, Maculopapular rash, Grade 1–2","KEYNOTE-091, Aspartate aminotransferase increased, Grade 1–2","KEYNOTE-091, Decreased appetite, Grade 1–2","KEYNOTE-091, Weight decreased , Grade 1–2","KEYNOTE-091, Increased blood creatinine, Grade 1–2","KEYNOTE-091, Myalgia, Grade 1–2","KEYNOTE-091, Productive cough, Grade 1–2","KEYNOTE-091, Pneumonitis, Grade 1–2","KEYNOTE-091, Dry skin, Grade 1–2","KEYNOTE-091, Hypothyroidism, Grade 3","KEYNOTE-091, Cough, Grade 3","KEYNOTE-091, Hyperthyroidism, Grade 3","KEYNOTE-091, Nausea, Grade 3","KEYNOTE-091, Rash, Grade 3","KEYNOTE-091, Back pain, Grade 3","KEYNOTE-091, Maculopapular rash, Grade 3","KEYNOTE-091, Myalgia, Grade 3","KEYNOTE-091, Pneumonitis, Grade 4","ZUMA-7, Pyrexia, Any Grade","ZUMA-7, Neutropenia, Any Grade","ZUMA-7, Hypotension, Any Grade","ZUMA-7, Diarrhea, Any Grade","ZUMA-7, Headache, Any Grade","ZUMA-7, Sinus tachycardia, Any Grade","ZUMA-7, Leukopenia, Any Grade","ZUMA-7, Chills, Any Grade","ZUMA-7, Hypophosphatemia, Any Grade","ZUMA-7, Cough, Any Grade","ZUMA-7, Hypoxia, Any Grade","ZUMA-7, Dizziness, Any Grade","ZUMA-7, Tremor, Any Grade","ZUMA-7, Confusional state, Any Grade","ZUMA-7, Aphasia, Any Grade","ZUMA-7, Encephalopathy, Any Grade","ZUMA-7, Pyrexia, Grade ≥3","ZUMA-7, Neutropenia, Grade ≥3","ZUMA-7, Hypotension, Grade ≥3","ZUMA-7, Fatigue/Asthenia, Grade ≥3","ZUMA-7, Headache, Grade ≥3","ZUMA-7, Sinus tachycardia, Grade ≥3","ZUMA-7, Leukopenia, Grade ≥3","ZUMA-7, Chills, Grade ≥3","ZUMA-7, Hypophosphatemia, Grade ≥3","ZUMA-7, Cough, Grade ≥3","ZUMA-7, Hypoxia, Grade ≥3","ZUMA-7, Tremor, Grade ≥3","ZUMA-7, Confusional state, Grade ≥3","ZUMA-7, Aphasia, Grade ≥3","ZUMA-7, Encephalopathy, Grade ≥3","ZUMA-7, Paresthesia, Grade ≥3","ZUMA-7, Delirium, Grade ≥3","KEYNOTE-811, Diarrhea, Any grade","KEYNOTE-811, Nausea, Any grade","KEYNOTE-811, Vomiting, Any grade","KEYNOTE-811, Fatigue/Asthenia, Any grade","KEYNOTE-811, Peripheral sensory neuropathy, Any grade","KEYNOTE-811, Aspartate aminotransferase increased, Any grade","KEYNOTE-811, Weight decreased , Any grade","KEYNOTE-811, Palmar-plantar erythrodysesthesia, Any grade","KEYNOTE-811, Neutropenia, Any grade","KEYNOTE-811, Hypokalemia, Any grade","KEYNOTE-811, Alanine aminotransferase increased, Any grade","KEYNOTE-811, Infusion-related reaction, Any grade","KEYNOTE-811, pyrexia, Any grade","KEYNOTE-811, Malaise, Any grade","KEYNOTE-811, Stomatitis, Any grade","KEYNOTE-811, Blood bilirubin increased, Any grade","KEYNOTE-811, Vomiting, Grade 3-5","KEYNOTE-811, Platelet count decreased, Grade 3-5","KEYNOTE-811, Fatigue/Asthenia, Grade 3-5","KEYNOTE-811, Peripheral sensory neuropathy, Grade 3-5","KEYNOTE-811, Weight decreased , Grade 3-5","KEYNOTE-811, Constipation, Grade 3-5","KEYNOTE-811, Infusion-related reaction, Grade 3-5","KEYNOTE-811, pyrexia, Grade 3-5","KEYNOTE-811, Blood bilirubin increased, Grade 3-5","KEYNOTE-811, Thrombocytopenia, Grade 3-5","KEYNOTE‑177, Arthralgia, Any grade","KEYNOTE‑177, Pyrexia, Any grade","KEYNOTE‑177, Pruritus, Any grade","KEYNOTE‑177, Cough, Any grade","KEYNOTE‑177, Aspartate aminotransferase increased, Any grade","KEYNOTE‑177, Alanine aminotransferase increased, Any grade","KEYNOTE‑177, Blood alkaline phosphatase increase, Any grade","KEYNOTE‑177, Dyspnea, Any grade","KEYNOTE‑177, Rash, Any grade","KEYNOTE‑177, Upper abdominal pain, Any grade","KEYNOTE‑177, Nasopharyngitis, Any grade","KEYNOTE‑177, Dry skin, Any grade","KEYNOTE‑177, Hypertension, Any grade","KEYNOTE‑177, Hypothyroidism, Any grade","KEYNOTE‑177, Pain in extremity, Any grade","KEYNOTE‑177, Peripheral edema, Any grade","KEYNOTE‑177, Dry mouth, Any grade","KEYNOTE‑177, Upper respiratory tract infection, Any grade","KEYNOTE‑177, Arthralgia, Grade ≥3","KEYNOTE‑177, Pyrexia, Grade ≥3","KEYNOTE‑177, Aspartate aminotransferase increased, Grade ≥3","KEYNOTE‑177, Alanine aminotransferase increased, Grade ≥3","KEYNOTE‑177, Blood alkaline phosphatase increase, Grade ≥3","KEYNOTE‑177, Dyspnea, Grade ≥3","KEYNOTE‑177, Hypertension, Grade ≥3"],"type":"scatter","mode":"markers","marker":{"autocolorscale":false,"color":"rgba(109,177,191,1)","opacity":0.55,"size":5.66929133858268,"symbol":"circle","line":{"width":1.88976377952756,"color":"rgba(109,177,191,1)"}},"hoveron":"points","name":"experi","legendgroup":"experi","showlegend":true,"xaxis":"x","yaxis":"y","hoverinfo":"text","_isNestedKey":false,"frame":null},{"x":[0.1,null,null,null,0.13,null,null],"y":[null,null,null,0.2,null,0.92,0.06],"text":["Control: 0.100<br />Experimental:    NA<br />greater: NA<br />info: POLARIX, Dyspnea, All grades","Control:    NA<br />Experimental:    NA<br />greater: NA<br />info: IMCgp100-202, Skin Hypopigmentation, Grade 3-4","Control:    NA<br />Experimental:    NA<br />greater: NA<br />info: IMCgp100-202, Hair color changes, Grade 3-4","Control:    NA<br />Experimental: 0.200<br />greater: NA<br />info: KEYNOTE-204, Pyrexia, All Grades","Control: 0.130<br />Experimental:    NA<br />greater: NA<br />info: KEYNOTE-204, pyrexia, All Grades","Control:    NA<br />Experimental: 0.920<br />greater: NA<br />info: ZUMA-7, Cytokine release syndrome, Any Grade","Control:    NA<br />Experimental: 0.060<br />greater: NA<br />info: ZUMA-7, Cytokine release syndrome, Grade ≥3"],"key":["POLARIX, Dyspnea, All grades","IMCgp100-202, Skin Hypopigmentation, Grade 3-4","IMCgp100-202, Hair color changes, Grade 3-4","KEYNOTE-204, Pyrexia, All Grades","KEYNOTE-204, pyrexia, All Grades","ZUMA-7, Cytokine release syndrome, Any Grade","ZUMA-7, Cytokine release syndrome, Grade ≥3"],"type":"scatter","mode":"markers","marker":{"autocolorscale":false,"color":"rgba(127,127,127,1)","opacity":0.55,"size":5.66929133858268,"symbol":"circle","line":{"width":1.88976377952756,"color":"rgba(127,127,127,1)"}},"hoveron":"points","name":"NA","legendgroup":"NA","showlegend":true,"xaxis":"x","yaxis":"y","hoverinfo":"text","_isNestedKey":false,"frame":null}],"layout":{"margin":{"t":48.1461187214612,"r":7.30593607305936,"b":44.5662100456621,"l":48.9497716894977},"font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":14.6118721461187},"title":{"text":"Adverse Events, all reported","font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":17.5342465753425},"x":0,"xref":"paper"},"xaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[-0.01,1.01],"tickmode":"array","ticktext":["0%","25%","50%","75%","100%"],"tickvals":[0,0.25,0.5,0.75,1],"categoryorder":"array","categoryarray":["0%","25%","50%","75%","100%"],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.65296803652968,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"Roboto Condensed","size":11.689497716895},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176,"zeroline":false,"anchor":"y","title":{"text":"Control","font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":14.6118721461187}},"hoverformat":".2f"},"yaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[-0.01,1.01],"tickmode":"array","ticktext":["0%","25%","50%","75%","100%"],"tickvals":[0,0.25,0.5,0.75,1],"categoryorder":"array","categoryarray":["0%","25%","50%","75%","100%"],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.65296803652968,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"Roboto Condensed","size":11.689497716895},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176,"zeroline":false,"anchor":"x","title":{"text":"Experimental","font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":14.6118721461187}},"hoverformat":".2f"},"shapes":[{"type":"rect","fillcolor":null,"line":{"color":null,"width":0,"linetype":[]},"yref":"paper","xref":"paper","x0":0,"x1":1,"y0":0,"y1":1}],"showlegend":false,"legend":{"bgcolor":null,"bordercolor":null,"borderwidth":0,"font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":11.689497716895}},"hovermode":"closest","barmode":"relative"},"config":{"doubleClick":"reset","modeBarButtonsToAdd":["hoverclosest","hovercompare"],"showSendToCloud":false},"source":"A","attrs":{"2ee035166e2f":{"intercept":{},"slope":{},"type":"scatter"},"2ee03d2a4c89":{"x":{},"y":{},"colour":{},"key":{}}},"cur_data":"2ee035166e2f","visdat":{"2ee035166e2f":["function (y) ","x"],"2ee03d2a4c89":["function (y) ","x"]},"highlight":{"on":"plotly_click","persistent":false,"dynamic":false,"selectize":false,"opacityDim":0.2,"selected":{"opacity":1},"debounce":0},"shinyEvents":["plotly_hover","plotly_click","plotly_selected","plotly_relayout","plotly_brushed","plotly_brushing","plotly_clickannotation","plotly_doubleclick","plotly_deselect","plotly_afterplot","plotly_sunburstclick"],"base_url":"https://plot.ly"},"evals":[],"jsHooks":[]}</script>
</div>
</div>
</section>
<section id="relationship" class="level6">
<h6 class="anchored" data-anchor-id="relationship">|- Relationship</h6>
<p>This is the same but added a linear regression (green line)</p>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-4-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<p>Full linear model:</p>
<div class="cell">
<div class="cell-output cell-output-stdout">
<pre><code>
Call:
lm(formula = Experimental ~ Control, data = .)

Residuals:
     Min       1Q   Median       3Q      Max 
-0.58836 -0.03769 -0.02530  0.02451  0.82681 

Coefficients:
            Estimate Std. Error t value Pr(&gt;|t|)    
(Intercept) 0.037687   0.002173   17.35   &lt;2e-16 ***
Control     0.944617   0.013584   69.54   &lt;2e-16 ***
---
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1

Residual standard error: 0.09158 on 2721 degrees of freedom
  (7 observations deleted due to missingness)
Multiple R-squared:  0.6399,    Adjusted R-squared:  0.6398 
F-statistic:  4835 on 1 and 2721 DF,  p-value: &lt; 2.2e-16</code></pre>
</div>
</div>
</section>
<section id="placebo-vs.-active-control" class="level6">
<h6 class="anchored" data-anchor-id="placebo-vs.-active-control">|- Placebo vs.&nbsp;Active Control</h6>
<p>Compares placebo vs.&nbsp;active controls</p>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-6-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<p>Full models</p>
<div class="cell">
<div class="cell-output cell-output-stdout">
<pre><code>$`Active-control`

Call:
lm(formula = Experimental ~ Control, data = .)

Residuals:
     Min       1Q   Median       3Q      Max 
-0.52489 -0.03951 -0.02804  0.02690  0.82747 

Coefficients:
            Estimate Std. Error t value Pr(&gt;|t|)    
(Intercept) 0.039512   0.003333   11.86   &lt;2e-16 ***
Control     0.852649   0.019356   44.05   &lt;2e-16 ***
---
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1

Residual standard error: 0.102 on 1466 degrees of freedom
  (7 observations deleted due to missingness)
Multiple R-squared:  0.5696,    Adjusted R-squared:  0.5693 
F-statistic:  1940 on 1 and 1466 DF,  p-value: &lt; 2.2e-16


$`Placebo-control`

Call:
lm(formula = Experimental ~ Control, data = .)

Residuals:
     Min       1Q   Median       3Q      Max 
-0.23244 -0.03338 -0.02338  0.01453  0.70722 

Coefficients:
            Estimate Std. Error t value Pr(&gt;|t|)    
(Intercept)  0.03338    0.00253   13.20   &lt;2e-16 ***
Control      1.10438    0.01753   62.99   &lt;2e-16 ***
---
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1

Residual standard error: 0.07316 on 1253 degrees of freedom
Multiple R-squared:   0.76, Adjusted R-squared:  0.7598 
F-statistic:  3968 on 1 and 1253 DF,  p-value: &lt; 2.2e-16</code></pre>
</div>
</div>
</section>
</section>
<section id="highest-grade-events" class="level4">
<h4 class="anchored" data-anchor-id="highest-grade-events">Highest Grade Events</h4>
<p>This sectionis only the highest stratification level listed for adverse events.</p>
<section id="difference-1" class="level6">
<h6 class="anchored" data-anchor-id="difference-1">|- Difference</h6>
<p>Same as above but just for the highest grade reported for each adverse event.</p>
<div class="cell">
<div class="cell-output-display">
<div class="plotly html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-a8063042360fcae3e04d" style="width:100%;height:325px;"></div>
<script type="application/json" data-for="htmlwidget-a8063042360fcae3e04d">{"x":{"data":[{"x":[-0.01,1.01],"y":[-0.01,1.01],"text":"intercept: 0<br />slope: 1","type":"scatter","mode":"lines","line":{"width":3.77952755905512,"color":"rgba(190,190,190,1)","dash":"solid"},"hoveron":"points","showlegend":false,"xaxis":"x","yaxis":"y","hoverinfo":"text","frame":null},{"x":[0.01,0,0,0,0,0.005,0,0,0,0,0,0.016,0,0,0,0,0.05,0.07,0.05,0.72,0.02,0.01,0.11,0.04,0.17,0.15,0.02,0.02,0.03,0.007,0,0,0.028,0.007,0.021,0,0.035,0.014,0,0.014,0.007,0.014,0.16,0.003,0.02,0.015,0.05,0.003,0,0.003,0.08,0.006,0.14,0.003,0.08,0.044,0.003,0,0.04,0,0.01,0.032,0,0,0,0,0,0,0,0.003,0,0,0,0.016,0.09,0,0,0,0,0,0,0.01,0.03,0,0.02,0.015,0,0.008,0.008,0.004,0.023,0.023,0,0.03,0.023,0.004,0.015,0.011,0.004,0.018,0.007,0.018,0.032,0.01,0.06,0.013,0.007,0.007,0.007,0,0,0.013,0.007,0.07,0,0.007,0.007,0.007,0.014,0.032,0,0.06,0,0.025,0.021,0,0.01,0,0,0.01,0.01,0,0,0.007,0,0.025,0.032,0.01,0.021,0.006,0.017,0.026,0.006,0.06,0,0.1,0.04,0.01,0,0,0.05,0.11,0,0,0,0,0,0.09,0,0.06,0,0.01,0,0.04,0.15,0.17,0.01,0.01,0.01,0.01,0.02,0.01,0.01,0.04,0.01,0,0.03,0.05,0.01,0.04,0.13,0,0.005,0.05,0.048,0,0.014,0.005,0.09,0,0.005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.01,0,0.01,0,0,0,0.038,0.05,0,0.06,0,0,0,0.026,0,0,0.009,0.006,0.009,0.006,0.036,0,0.015,0,0,0.029,0.029,0.007,0,0.007,0.036,0.007,0.022,0,0,0,0,0.029,0.007,0.007,0.029,0,0.022,0.007,0.022,0,0.01,0.05,0.008,0.042,0.019,0.004,0,0,0.047,0.023,0.023,0,0,0,0,0,0,0,0,0.007,0.005,0.005,0,0.025,0.023,0,0,0.009,0.018,0,0.013,0.05,0,0,0.009,0.037,0.13,0.006,0.11,0.012,0.019,0.004,0.004,0.01,0.01,0.01,0.01,0,0,0.01,0.01,0.03,0.01,0.01,0.01,0.01,0.01,0.05,0.01,0.01,0.02,0,0,0,0,0,0,0,0,0,0,0,0,0.05,0.01,0.03,0.03,0.1,0.01,0.08,0,0,0,0.01,0,0,0.01,0.02,0.03,0.008,0.011,0,0.019,0,0.011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003,0,0,0,0,0.006,0.003,0.015,0.006,0.006,0,0.015,0.021,0,0,0.003,0.009,0.015,0,0,0,0,0,0.005,0.003,0.04,0.06,0,0,0.003,0.003,0.12,0.029,0.018,0.06,0,0.018,0,0.02,0.003,0.006,0.014,0,0.017,0,0.05,0.047,0.006,0.49,0,0.02,0,0,0.03,0.03,0,0,0.01,0.02,0.21,0.04,0.01,0.07,0,0.03,0.03,0,0,0.02,0,0.64,0.02,0,0.01,0.003,0,0.049,0,0.003,0.003,0,0.003,0.03,0.01,0,0.01,0.003,0.06,0.02,0,0.049,0,0.003,0.026,0.01,0.03,0.03,0.05,0,0,0.05,0,0.04,0.01,0,0,0.004,0.004,0.011,0.016,0.005,0.002,0,0.011,0,0.03,0.009,0.009,0.016,0.44,0.018,0.42,0.005,0.39,0,0.04,0.04,0.01,0.27,0.07,0.05,0.57,0.01,0,0,0.005,0.003,0,0.006,0.019,0.003,0.001,0,0,0.011,0.023,0.006,0.011,0,0.036,0.027,0,0,0,0.009,0.01,0.01,0,0.01,0,0.01,0,0.026,0,0.11,0.013,0.08,0.013,0,0,0,0,0.013,0.01,0.026,0.11,0.06,0,0,0,0,0,0,0,0,0,0,0,0.01,0.01,0.01,0.02,0.02,0.07,0.02,0,0,0,0,0,0,0,0.01,0.01,0.09,0.14,0.01,0.01,0.1,0,0.02,0.02,0.01,0.03,0,0,0.05,0,0.02,0,0.003,0,0.003,0,0,0.009,0,0.003,0.006,0.09,0,0.01,0.04,0.02,0.008,0,0.003,0.01,0.006,0,0,0,0,0.02,0.015,0,0.004,0.004,0.035,0.015,0,0.008,0.012,0.005,0.093,0.005,0.037,0.042,0.083,0.019,0.065,0.009,0.056,0.023,0.051,0.074,0.009,0.019,0.023,0.003,0.02,0.037,0.001,0.042,0.01,0,0.02,0.004,0,0.09,0,0,0.02,0,0.02,0.004,0,0.004],"y":[0,0,0,0,0,0,0,0,0,0,0,0.006,0,0,0,0,0.041,0.07,0.03,0.67,0.02,0,0.02,0,0.01,0.01,0.02,0.01,0.03,0,0,0,0.013,0,0.007,0,0.02,0.013,0,0.007,0,0.007,0.034,0,0.011,0.006,0.05,0.003,0,0,0.08,0,0.13,0.003,0.08,0.034,0.003,0,0.04,0,0.01,0.008,0,0,0,0,0,0,0,0.003,0,0,0,0.011,0.046,0,0,0,0,0,0,0.01,0.01,0,0.01,0.015,0,0.004,0.008,0.004,0.023,0.011,0,0,0.011,0.004,0.008,0.008,0,0.018,0.007,0.017,0.027,0.01,0.06,0.007,0.007,0.007,0,0,0,0,0,0.007,0,0,0,0.003,0.01,0.023,0,0.043,0,0.007,0,0,0,0,0,0.01,0.01,0,0,0,0,0.01,0.01,0.01,0.017,0.003,0.017,0.012,0.003,0.05,0,0.05,0.02,0.01,0,0,0,0.06,0,0,0,0,0,0.04,0,0.01,0,0,0,0.03,0,0,0,0,0,0,0,0,0.01,0,0.01,0,0.01,0.01,0.01,0,0.08,0,0,0.019,0.014,0,0,0,0.05,0,0.005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.01,0,0.01,0,0,0,0.012,0.018,0,0.02,0,0,0,0,0,0,0.006,0.006,0.006,0.006,0.007,0,0.007,0,0,0.007,0.022,0.007,0,0,0.029,0.007,0.015,0,0,0,0,0.022,0,0.007,0.022,0,0.007,0,0.007,0,0.01,0.03,0,0.014,0.003,0,0,0,0.012,0.012,0.012,0,0,0,0,0,0,0,0,0.002,0.003,0.002,0,0.01,0.01,0,0,0.008,0.013,0,0,0.013,0,0,0.009,0.025,0.13,0.006,0.09,0.012,0.017,0,0,0.004,0.01,0.01,0.01,0,0,0,0.01,0.02,0.01,0.01,0.01,0.01,0.01,0.04,0.01,0.01,0.01,0,0,0,0,0,0,0,0,0,0,0,0,0.04,0,0.01,0.01,0.02,0,0.07,0,0,0,0.01,0,0,0.01,0,0.01,0.008,0.011,0,0.004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.003,0,0,0,0,0,0,0.015,0,0,0,0.006,0.018,0,0,0,0.006,0.012,0,0,0,0,0,0,0.003,0.018,0.039,0,0,0,0.003,0.028,0.006,0.012,0.06,0,0.015,0,0.015,0.003,0.002,0.014,0,0.013,0,0,0,0.003,0.49,0,0.01,0,0,0.01,0,0,0,0.01,0,0.12,0.04,0,0.03,0,0,0.03,0,0,0,0,0.49,0.01,0,0.01,0.003,0,0.035,0,0,0.003,0,0.003,0.023,0.006,0,0.003,0.003,0.04,0.019,0,0.025,0,0,0.006,0,0.006,0.016,0.03,0,0,0.04,0,0.03,0,0,0,0,0.004,0.008,0.011,0,0,0,0.007,0,0.025,0.002,0.007,0.011,0.44,0.005,0.39,0.005,0.3,0,0.04,0.02,0.01,0.02,0.06,0.02,0.15,0,0,0,0.004,0.003,0,0,0.014,0.003,0.001,0,0,0,0.011,0.006,0.006,0,0.029,0.012,0,0,0,0.004,0.01,0.01,0,0.01,0,0.01,0,0,0,0,0.006,0.006,0.006,0,0,0,0,0.007,0.003,0.02,0.09,0.042,0,0,0,0,0,0,0,0,0,0,0,0.01,0.01,0.01,0.01,0.02,0.05,0,0,0,0,0,0,0,0,0.01,0.01,0.04,0.09,0,0,0.04,0,0,0,0,0.02,0,0,0.03,0,0.02,0,0.003,0,0.003,0,0,0.006,0,0.003,0.003,0.06,0,0.01,0.04,0.02,0.005,0,0,0.005,0,0,0,0,0,0.01,0.008,0,0.002,0.002,0.008,0.013,0,0.006,0.006,0.005,0.088,0.005,0.023,0.023,0.074,0,0.051,0.005,0.046,0.014,0.051,0.074,0.005,0.009,0.018,0.003,0.013,0.032,0.001,0.042,0.01,0,0.01,0,0,0.06,0,0,0.02,0,0.004,0.004,0,0.004],"text":["Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: talazoparib + enzalutamide, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: talazoparib + enzalutamide, Dizziness, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: talazoparib + enzalutamide, Dysgeusia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: talazoparib + enzalutamide, Fatigue/Asthenia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: talazoparib + enzalutamide, Fractures, Grade 4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />event: talazoparib + enzalutamide, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Bronchitis, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Cough, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Dyspnea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Fatigue/Asthenia, Grade 4","Control: 0.016<br />Experimental: 0.006<br />greater: control<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Hypertension, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Infusion-related reaction, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Upper respiratory tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Vomiting, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab + chemotherapy, Constipation, Grade 3-4","Control: 0.050<br />Experimental: 0.041<br />greater: control<br />event: pembrolizumab + chemotherapy, Decreased appetite, Grade 3-4","Control: 0.070<br />Experimental: 0.070<br />greater: control<br />event: pembrolizumab + chemotherapy, Nausea, Grade 3-4","Control: 0.050<br />Experimental: 0.030<br />greater: control<br />event: pembrolizumab + chemotherapy, Weight decreased , Grade 3-4","Control: 0.720<br />Experimental: 0.670<br />greater: control<br />event: tivozanib, Any, Grade 3-4","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />event: tivozanib, Back pain, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: tivozanib, Cough, Grade 3-4","Control: 0.110<br />Experimental: 0.020<br />greater: control<br />event: tivozanib, Diarrhea, Grade 3-4","Control: 0.040<br />Experimental: 0.000<br />greater: control<br />event: tivozanib, Nausea, Grade 3-4","Control: 0.170<br />Experimental: 0.010<br />greater: control<br />event: tivozanib, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.150<br />Experimental: 0.010<br />greater: control<br />event: tivozanib, Rash, Grade 3-4","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />event: tivozanib, Stomatitis, Grade 3-4","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />event: tivozanib, Vomiting, Grade 3-4","Control: 0.030<br />Experimental: 0.030<br />greater: control<br />event: tivozanib, Weight decreased , Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: lorlatinib, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lorlatinib, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lorlatinib, Dizziness, Grade 3-4","Control: 0.028<br />Experimental: 0.013<br />greater: control<br />event: lorlatinib, Fatigue/Asthenia, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: lorlatinib, Headache, Grade 3-4","Control: 0.021<br />Experimental: 0.007<br />greater: control<br />event: lorlatinib, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lorlatinib, Pain in extremity, Grade 3-4","Control: 0.035<br />Experimental: 0.020<br />greater: control<br />event: lorlatinib, Pneumonia, Grade 3-4","Control: 0.014<br />Experimental: 0.013<br />greater: control<br />event: lorlatinib, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lorlatinib, Rash, Grade 3-4","Control: 0.014<br />Experimental: 0.007<br />greater: control<br />event: lorlatinib, Upper respiratory tract infection, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: lorlatinib, Vision disorder, Grade 3-4","Control: 0.014<br />Experimental: 0.007<br />greater: control<br />event: lorlatinib, Vomiting, Grade 3-4","Control: 0.160<br />Experimental: 0.034<br />greater: control<br />event: cemiplimab-rwlc, Anemia, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />event: cemiplimab-rwlc, Cough, Grade 3-4","Control: 0.020<br />Experimental: 0.011<br />greater: control<br />event: cemiplimab-rwlc, Fatigue/Asthenia, Grade 3-4","Control: 0.015<br />Experimental: 0.006<br />greater: control<br />event: cemiplimab-rwlc, Musculoskeletal pain, Grade 3-4","Control: 0.050<br />Experimental: 0.050<br />greater: control<br />event: cemiplimab-rwlc, Pneumonia, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + cabozantinib, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + cabozantinib, Dysgeusia, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + cabozantinib, Dyspepsia, Grade 3-4","Control: 0.080<br />Experimental: 0.080<br />greater: control<br />event: nivolumab + cabozantinib, Fatigue/Asthenia, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + cabozantinib, Headache, Grade 3-4","Control: 0.140<br />Experimental: 0.130<br />greater: control<br />event: nivolumab + cabozantinib, Hypertension, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + cabozantinib, Hypothyroidism, Grade 3-4","Control: 0.080<br />Experimental: 0.080<br />greater: control<br />event: nivolumab + cabozantinib, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.044<br />Experimental: 0.034<br />greater: control<br />event: nivolumab + cabozantinib, Stomatitis, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + cabozantinib, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Arthralgia, Grade 3-4","Control: 0.040<br />Experimental: 0.040<br />greater: control<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Injection site reactions, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Upper respiratory tract infection, Grade 3-4","Control: 0.032<br />Experimental: 0.008<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Edema peripheral, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: osimertinib, Cough, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: osimertinib, Dizziness, Grade ≥ 3","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: osimertinib, Musculoskeletal Pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: osimertinib, Nasopharyngitis, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: osimertinib, Pruritus, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: relugolix, Constipation, Grade 3-4","Control: 0.016<br />Experimental: 0.011<br />greater: control<br />event: relugolix, Musculoskeletal pain, Grade 3-4","Control: 0.090<br />Experimental: 0.046<br />greater: control<br />event: selinexor + bortezomib + dexamethasone, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan-hziy, Abdominal Pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan-hziy, Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan-hziy, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan-hziy, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan-hziy, Dyspepsia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan-hziy, Dyspnea, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: sacituzumab govitecan-hziy, Headache, Grade 3-4","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />event: sacituzumab govitecan-hziy, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan-hziy, Pruritus, Grade 3-4","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />event: sacituzumab govitecan-hziy, Vomiting, Grade 3-4","Control: 0.015<br />Experimental: 0.015<br />greater: control<br />event: margetuximab + chemotherapy, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: margetuximab + chemotherapy, Alopecia, Grade 3-4","Control: 0.008<br />Experimental: 0.004<br />greater: control<br />event: margetuximab + chemotherapy, Arthralgia/Myalgia, Grade 3-4","Control: 0.008<br />Experimental: 0.008<br />greater: control<br />event: margetuximab + chemotherapy, Constipation, Grade 3-4","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />event: margetuximab + chemotherapy, Decreased appetite, Grade 3-4","Control: 0.023<br />Experimental: 0.023<br />greater: control<br />event: margetuximab + chemotherapy, Diarrhea, Grade 3-4","Control: 0.023<br />Experimental: 0.011<br />greater: control<br />event: margetuximab + chemotherapy, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: margetuximab + chemotherapy, Headache, Grade 3-4","Control: 0.030<br />Experimental: 0.000<br />greater: control<br />event: margetuximab + chemotherapy, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.023<br />Experimental: 0.011<br />greater: control<br />event: margetuximab + chemotherapy, Peripheral neuropathy, Grade 3-4","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />event: margetuximab + chemotherapy, Pyrexia, Grade 3-4","Control: 0.015<br />Experimental: 0.008<br />greater: control<br />event: margetuximab + chemotherapy, Vomiting, Grade 3-4","Control: 0.011<br />Experimental: 0.008<br />greater: control<br />event: pembrolizumab + chemotherapy, Alopecia, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab + chemotherapy, Cough, Grade 3-4","Control: 0.018<br />Experimental: 0.018<br />greater: control<br />event: pembrolizumab + chemotherapy, Diarrhea, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />event: pembrolizumab + chemotherapy, Headache, Grade 3-4","Control: 0.018<br />Experimental: 0.017<br />greater: control<br />event: pembrolizumab + chemotherapy, Nausea, Grade 3-4","Control: 0.032<br />Experimental: 0.027<br />greater: control<br />event: pembrolizumab + chemotherapy, Vomiting, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: venetoclax + azacitidine, Dizziness, Grade 3-4","Control: 0.060<br />Experimental: 0.060<br />greater: control<br />event: venetoclax + azacitidine, Urinary tract infection, Grade 3-4","Control: 0.013<br />Experimental: 0.007<br />greater: control<br />event: pembrolizumab, Abdominal pain, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />event: pembrolizumab, Cough, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />event: pembrolizumab, Dyspnea, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Hypothyroidism, Grade 3-4","Control: 0.013<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Musculoskeletal pain, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Nausea, Grade 3-4","Control: 0.070<br />Experimental: 0.007<br />greater: control<br />event: pembrolizumab, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Pruritus, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Rash, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Urinary tract infection, Grade 3-4","Control: 0.007<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + ipilimumab, Constipation, Grade 3-4","Control: 0.014<br />Experimental: 0.010<br />greater: control<br />event: nivolumab + ipilimumab, Decreased appetite, Grade 3-4","Control: 0.032<br />Experimental: 0.023<br />greater: control<br />event: nivolumab + ipilimumab, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + ipilimumab, Edema, Grade 3-4","Control: 0.060<br />Experimental: 0.043<br />greater: control<br />event: nivolumab + ipilimumab, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + ipilimumab, Hypothyroidism, Grade 3-4","Control: 0.025<br />Experimental: 0.007<br />greater: control<br />event: nivolumab + ipilimumab, Nausea, Grade 3-4","Control: 0.021<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + ipilimumab, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: elacestrant, Constipation, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: elacestrant, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: elacestrant, Dyspepsia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: elacestrant, Hot flush , Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: azacitidine, Arthralgia, TYPO","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: azacitidine, Decreased appetite, TYPO","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: azacitidine, Dizziness, TYPO","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: carfilzomib + daratumumab + dexamethasone, Cough, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: carfilzomib + daratumumab + dexamethasone, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab +  cobimetinib + vemurafenib, Hypothyroidism, Grade 3-4","Control: 0.025<br />Experimental: 0.010<br />greater: control<br />event: atezolizumab +  cobimetinib + vemurafenib, Nausea, Grade 3-4","Control: 0.032<br />Experimental: 0.010<br />greater: control<br />event: atezolizumab +  cobimetinib + vemurafenib, Photosensitivity reaction, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: atezolizumab +  cobimetinib + vemurafenib, Pruritus, Grade 3-4","Control: 0.021<br />Experimental: 0.017<br />greater: control<br />event: atezolizumab +  cobimetinib + vemurafenib, Pyrexia, Grade 3-4","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />event: avelumab, Decreased appetite, Grade 3-4","Control: 0.017<br />Experimental: 0.017<br />greater: control<br />event: avelumab, Fatigue/Asthenia, Grade 3-4","Control: 0.026<br />Experimental: 0.012<br />greater: control<br />event: avelumab, Musculoskeletal pain, Grade 3-4","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />event: avelumab, Nausea, Grade 3-4","Control: 0.060<br />Experimental: 0.050<br />greater: control<br />event: pembrolizumab, Abdominal pain, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Alopecia, Grade ≥3","Control: 0.100<br />Experimental: 0.050<br />greater: control<br />event: pembrolizumab, Anemia, Grade ≥3","Control: 0.040<br />Experimental: 0.020<br />greater: control<br />event: pembrolizumab, Asthenia, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Back pain, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Constipation, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Cough, Grade ≥3","Control: 0.050<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Decreased appetite, Grade ≥3","Control: 0.110<br />Experimental: 0.060<br />greater: control<br />event: pembrolizumab, Diarrhea, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Dizziness, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Dry mouth, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Dry skin, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Dyspepsia, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Epistaxis, Grade ≥3","Control: 0.090<br />Experimental: 0.040<br />greater: control<br />event: pembrolizumab, Fatigue/Asthenia, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Headache, Grade ≥3","Control: 0.060<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Hypokalemia, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Hypothyroidism, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Mucosal inflammation, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Nasopharyngitis, Grade ≥3","Control: 0.040<br />Experimental: 0.030<br />greater: control<br />event: pembrolizumab, Nausea, Grade ≥3","Control: 0.150<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Neutropenia, Grade ≥3","Control: 0.170<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Neutrophil count decreased, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, PPE syndrome, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Pain in extremity, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Peripheral edema, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Peripheral neuropathy, Grade ≥3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Peripheral sensory neuropathy, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Pruritus, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Rash, Grade ≥3","Control: 0.040<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Stomatitis, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Upper abdominal pain, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Upper respiratory tract infection, Grade ≥3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Urinary tract infection, Grade ≥3","Control: 0.050<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Vomiting, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Weight decreased , Grade ≥3","Control: 0.040<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, White-cell count decrease, Grade ≥3","Control: 0.130<br />Experimental: 0.080<br />greater: control<br />event: nivolumab, Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Constipation, Grade 3-4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Cough, Grade 3-4","Control: 0.050<br />Experimental: 0.019<br />greater: control<br />event: nivolumab, Decreased appetite, Grade 3-4","Control: 0.048<br />Experimental: 0.014<br />greater: control<br />event: nivolumab, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Hypothyroidism, Grade 3-4","Control: 0.014<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Musculoskeletal pain, Grade 3-4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Nausea, Grade 3-4","Control: 0.090<br />Experimental: 0.050<br />greater: control<br />event: nivolumab, Pneumonia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Pruritus, Grade 3-4","Control: 0.005<br />Experimental: 0.005<br />greater: control<br />event: nivolumab, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Arthralgia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Aspartate aminotransferase increased, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Asthenia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Back pain, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Constipation, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Cough, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Dry skin, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Dyspnea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Fatigue/Asthenia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Headache, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Hypertension, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Hyperthyroidism, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Hypothyroidism, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Increased alanine aminotransferase, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Increased blood creatinine, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Influenza-like illness, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Maculopapular rash, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Myalgia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Nasopharyngitis, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Pain in extremity, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Paresthesia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Productive cough, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Pruritus, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Pyrexia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Rash, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Upper respiratory tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Weight Increased, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Weight decreased , Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ramucirumab + erlotinib, Alopecia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ramucirumab + erlotinib, Epistaxis, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ramucirumab + erlotinib, Gastrointestinal hemorrhage, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ramucirumab + erlotinib, Gingival bleeding, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ramucirumab + erlotinib, Pulmonary hemorrhage, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Abdominal Pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Cough, Grade 3-4","Control: 0.038<br />Experimental: 0.012<br />greater: control<br />event: atezolizumab + bevacizumab, Decreased Appetite, Grade 3-4","Control: 0.050<br />Experimental: 0.018<br />greater: control<br />event: atezolizumab + bevacizumab, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Epistaxis, Grade 3-4","Control: 0.060<br />Experimental: 0.020<br />greater: control<br />event: atezolizumab + bevacizumab, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Pyrexia, Grade 3-4","Control: 0.026<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab + bevacizumab, Weight decreased , Grade 3-4","Control: 0.009<br />Experimental: 0.006<br />greater: control<br />event: nivolumab + ipilimumab + chemotherapy, Abdominal pain, Grade 3-4","Control: 0.006<br />Experimental: 0.006<br />greater: control<br />event: nivolumab + ipilimumab + chemotherapy, Constipation, Grade 3-4","Control: 0.009<br />Experimental: 0.006<br />greater: control<br />event: nivolumab + ipilimumab + chemotherapy, Cough, Grade 3-4","Control: 0.006<br />Experimental: 0.006<br />greater: control<br />event: nivolumab + ipilimumab + chemotherapy, Pyrexia, Grade 3-4","Control: 0.036<br />Experimental: 0.007<br />greater: control<br />event: brigatinib, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Arthralgia, Grade 3-4","Control: 0.015<br />Experimental: 0.007<br />greater: control<br />event: brigatinib, Back pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Cough, Grade 3-4","Control: 0.029<br />Experimental: 0.007<br />greater: control<br />event: brigatinib, Decreased Appetite, Grade 3-4","Control: 0.029<br />Experimental: 0.022<br />greater: control<br />event: brigatinib, Diarrhea, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />event: brigatinib, Dizziness, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Dysgeusia, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Dyspepsia, Grade 3-4","Control: 0.036<br />Experimental: 0.029<br />greater: control<br />event: brigatinib, Dyspnea, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />event: brigatinib, Edema, Grade 3-4","Control: 0.022<br />Experimental: 0.015<br />greater: control<br />event: brigatinib, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Gastroesophageal reflux disease, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Increased Blood cholesterol, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Myalgia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Nasopharyngitis, Grade 3-4","Control: 0.029<br />Experimental: 0.022<br />greater: control<br />event: brigatinib, Nausea, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Pain in extremity, Grade 3-4","Control: 0.007<br />Experimental: 0.007<br />greater: control<br />event: brigatinib, Pruritus, Grade 3-4","Control: 0.029<br />Experimental: 0.022<br />greater: control<br />event: brigatinib, Pulmonary embolism, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Upper respiratory tract infection, Grade 3-4","Control: 0.022<br />Experimental: 0.007<br />greater: control<br />event: brigatinib, Urinary tract infection, Grade 3-4","Control: 0.007<br />Experimental: 0.000<br />greater: control<br />event: brigatinib, Visual Disturbance0e, Grade 3-4","Control: 0.022<br />Experimental: 0.007<br />greater: control<br />event: brigatinib, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: olaparib, Cough, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: olaparib, Decreased appetite, Grade 3-4","Control: 0.050<br />Experimental: 0.030<br />greater: control<br />event: olaparib, Fatigue/Asthenia, Grade 3-4","Control: 0.008<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab, Diarrhea, Grade 3-4","Control: 0.042<br />Experimental: 0.014<br />greater: control<br />event: atezolizumab, Fatigue/Asthenia, Grade 3-4","Control: 0.019<br />Experimental: 0.003<br />greater: control<br />event: atezolizumab, Nausea, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Arthralgia, Grade 3-4","Control: 0.047<br />Experimental: 0.012<br />greater: control<br />event: ripretinib, Asthenia, Grade 3-4","Control: 0.023<br />Experimental: 0.012<br />greater: control<br />event: ripretinib, Decreased appetite, Grade 3-4","Control: 0.023<br />Experimental: 0.012<br />greater: control<br />event: ripretinib, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Dry skin, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Muscle spasms, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ripretinib, Weight decreased , Grade 3-4","Control: 0.007<br />Experimental: 0.002<br />greater: control<br />event: nivolumab + ipilimumab, Abdominal pain, Grade 3-4","Control: 0.005<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + ipilimumab, Constipation, Grade 3-4","Control: 0.005<br />Experimental: 0.002<br />greater: control<br />event: nivolumab + ipilimumab, Edema, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + ipilimumab, Hyperthyroidism, Grade 3-4","Control: 0.025<br />Experimental: 0.010<br />greater: control<br />event: nivolumab + ipilimumab, Nausea, Grade 3-4","Control: 0.023<br />Experimental: 0.010<br />greater: control<br />event: nivolumab + ipilimumab, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Bruising, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Cough, Grade 3-4","Control: 0.009<br />Experimental: 0.008<br />greater: control<br />event: zanubrutinib, Diarrhea, Grade 3-4","Control: 0.018<br />Experimental: 0.013<br />greater: control<br />event: zanubrutinib, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Headache, Grade 3-4","Control: 0.013<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Nausea, Grade 3-4","Control: 0.050<br />Experimental: 0.013<br />greater: control<br />event: zanubrutinib, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Bruising, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Dizziness, Grade 3-4","Control: 0.009<br />Experimental: 0.009<br />greater: control<br />event: zanubrutinib, Fatigue/Asthenia, Grade 3-4","Control: 0.037<br />Experimental: 0.025<br />greater: control<br />event: zanubrutinib, Hemorrhage, Grade 3-4","Control: 0.130<br />Experimental: 0.130<br />greater: control<br />event: zanubrutinib, Hypertension, Grade 3-4","Control: 0.006<br />Experimental: 0.006<br />greater: control<br />event: zanubrutinib, Musculoskeletal pain, Grade 3-4","Control: 0.110<br />Experimental: 0.090<br />greater: control<br />event: zanubrutinib, Pneumonia, Grade 3-4","Control: 0.012<br />Experimental: 0.012<br />greater: control<br />event: zanubrutinib, Upper respiratory tract infection, Grade 3-4","Control: 0.019<br />Experimental: 0.017<br />greater: control<br />event: olaparib + bevacizumab, Vomiting, TYPO","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />event: niraparib, Cough, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />event: niraparib, Dizziness, Grade 3-4","Control: 0.010<br />Experimental: 0.004<br />greater: control<br />event: niraparib, Dyspnea, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: niraparib, Nausea, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: niraparib, Vomiting, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Bruising, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ibrutinib + rituximab, Constipation, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ibrutinib + rituximab, Cough, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: ibrutinib + rituximab, Decreased appetite, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Dizziness, Grade ≥ 3","Control: 0.030<br />Experimental: 0.020<br />greater: control<br />event: ibrutinib + rituximab, Fatigue/Asthenia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Headache, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Insomnia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Nausea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Peripheral neuropathy, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Pyrexia, Grade ≥ 3","Control: 0.050<br />Experimental: 0.040<br />greater: control<br />event: ibrutinib + rituximab, Rash, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Skin infection, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Stomatitis, Grade ≥ 3","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />event: ibrutinib + rituximab, Upper respiratory tract infection, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Anemia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Arthralgia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Epistaxis, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Increased blood creatinine, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Palmar-plantar erythrodysesthesia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Peripheral neuropathy, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Rash, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Stomatitis, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Vomiting, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tucatinib + trastuzumab + capecitabine, Weight decreased , Grade 4","Control: 0.050<br />Experimental: 0.040<br />greater: control<br />event: encorafenib + cetuximab, Abdominal pain, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: encorafenib + cetuximab, Constipation, Grade ≥ 3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />event: encorafenib + cetuximab, Decreased appetite, Grade ≥ 3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />event: encorafenib + cetuximab, Dermatitis acneiform, Grade ≥ 3","Control: 0.100<br />Experimental: 0.020<br />greater: control<br />event: encorafenib + cetuximab, Diarrhea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: encorafenib + cetuximab, Dry skin, Grade ≥ 3","Control: 0.080<br />Experimental: 0.070<br />greater: control<br />event: encorafenib + cetuximab, Fatigue/Asthenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: encorafenib + cetuximab, Headache, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: encorafenib + cetuximab, Insomnia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: encorafenib + cetuximab, Melanocytic nevus, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: encorafenib + cetuximab, Nausea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: encorafenib + cetuximab, Pain in extremity, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: encorafenib + cetuximab, Pruritus, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: encorafenib + cetuximab, Pyrexia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />event: encorafenib + cetuximab, Rash, Grade ≥ 3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />event: encorafenib + cetuximab, Vomiting, Grade ≥ 3","Control: 0.008<br />Experimental: 0.008<br />greater: control<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Decreased appetite, Grade 3-4","Control: 0.011<br />Experimental: 0.011<br />greater: control<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Hyperthyroidism, Grade 3-4","Control: 0.019<br />Experimental: 0.004<br />greater: control<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Rash, Grade 3-4","Control: 0.011<br />Experimental: 0.000<br />greater: control<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + pomalidomide + dexamethasone, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + pomalidomide + dexamethasone, Dyspnea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + pomalidomide + dexamethasone, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + pomalidomide + dexamethasone, Upper respiratory tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: isatuximab-irfc + pomalidomide + dexamethasone, Vomiting, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Abdominal distension, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Arthralgia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Back Pain, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Constipation, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Dizziness, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Dysuria, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Fatigue/Asthenia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Influenza-like illness, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Malaise, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Muscle spasms, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Nausea, Grade 4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: neratinib +  Capecitabine, Renal impairment, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Upper respiratory tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Urinary tract infection, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: neratinib +  Capecitabine, Vomiting, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Alopecia, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Constipation, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Cough/Productive Cough, Grade 3-4","Control: 0.015<br />Experimental: 0.015<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Diarrhea, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Edema, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Hypothyroidism, Grade 3-4","Control: 0.015<br />Experimental: 0.006<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Musculoskeletal Pain, Grade 3-4","Control: 0.021<br />Experimental: 0.018<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Pyrexia, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Stomatitis, Grade 3-4","Control: 0.009<br />Experimental: 0.006<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Upper respiratory tract infection, Grade 3-4","Control: 0.015<br />Experimental: 0.012<br />greater: control<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Insomnia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Vomiting, Grade 3-4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />event: olaparib + abiraterone + prednisone (or prednisolone), Abdominal pain, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: olaparib + abiraterone + prednisone (or prednisolone), Nausea, Grade 3-4","Control: 0.040<br />Experimental: 0.018<br />greater: control<br />event: tremelimumab + durvalumab, Abdominal pain, Grade 3-4","Control: 0.060<br />Experimental: 0.039<br />greater: control<br />event: tremelimumab + durvalumab, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab, Nausea, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />event: tremelimumab + durvalumab, Pruritus, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: tremelimumab + durvalumab, Pyrexia, Grade 3-4","Control: 0.120<br />Experimental: 0.028<br />greater: control<br />event: tremelimumab + durvalumab, Rash, Grade 3-4","Control: 0.029<br />Experimental: 0.006<br />greater: control<br />event: durvalumab + gemcitabine + cisplatin, Abdominal pain, Grade 3-4","Control: 0.018<br />Experimental: 0.012<br />greater: control<br />event: durvalumab + gemcitabine + cisplatin, Diarrhea, Grade 3-4","Control: 0.060<br />Experimental: 0.060<br />greater: control<br />event: durvalumab + gemcitabine + cisplatin, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: durvalumab + gemcitabine + cisplatin, Insomnia, Grade 3-4","Control: 0.018<br />Experimental: 0.015<br />greater: control<br />event: durvalumab + gemcitabine + cisplatin, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: durvalumab + gemcitabine + cisplatin, Pruritus, Grade 3-4","Control: 0.020<br />Experimental: 0.015<br />greater: control<br />event: durvalumab + gemcitabine + cisplatin, Vomiting, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: darolutamide + docetaxel, Constipation, Grade 3-4","Control: 0.006<br />Experimental: 0.002<br />greater: control<br />event: darolutamide + docetaxel, Decreased Appetite, Grade 3-4","Control: 0.014<br />Experimental: 0.014<br />greater: control<br />event: darolutamide + docetaxel, Hemorrhage, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Alopecia, Grade 3-4","Control: 0.017<br />Experimental: 0.013<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Hemorrhage, Grade 3-4","Control: 0.050<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Peripheral neuropathy, Grade 3-4","Control: 0.047<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Rash, Grade 3-4","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Stomatitis, Grade 3-4","Control: 0.490<br />Experimental: 0.490<br />greater: control<br />event: lisocabtagene maraleucel, Anemia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Arthralgia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />event: lisocabtagene maraleucel, Back pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Bone pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Cough, Grade ≥ 3","Control: 0.030<br />Experimental: 0.010<br />greater: control<br />event: lisocabtagene maraleucel, Decreased appetite, Grade ≥ 3","Control: 0.030<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Diarrhea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Dizziness, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Dyspepsia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: lisocabtagene maraleucel, Dyspnea, Grade ≥ 3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Fatigue/Asthenia, Grade ≥ 3","Control: 0.210<br />Experimental: 0.120<br />greater: control<br />event: lisocabtagene maraleucel, Febrile neutropenia, Grade ≥ 3","Control: 0.040<br />Experimental: 0.040<br />greater: control<br />event: lisocabtagene maraleucel, Hypokalemia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Hypomagnesaemia, Grade ≥ 3","Control: 0.070<br />Experimental: 0.030<br />greater: control<br />event: lisocabtagene maraleucel, Hypophosphatemia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Insomnia, Grade ≥ 3","Control: 0.030<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Mucosal inflammation, Grade ≥ 3","Control: 0.030<br />Experimental: 0.030<br />greater: control<br />event: lisocabtagene maraleucel, Nausea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Peripheral sensory neuropathy, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Pyrexia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Stomatitis, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lisocabtagene maraleucel, Tachycardia, Grade ≥ 3","Control: 0.640<br />Experimental: 0.490<br />greater: control<br />event: lisocabtagene maraleucel, Thrombocytopenia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />event: lisocabtagene maraleucel, Vomiting, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + chemotherapy, Alopecia, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: nivolumab + chemotherapy, Constipation, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + chemotherapy, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + chemotherapy, Edema, Grade 3-4","Control: 0.049<br />Experimental: 0.035<br />greater: control<br />event: nivolumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + chemotherapy, Hypothyroidism, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + chemotherapy, Insomnia, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + chemotherapy, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + chemotherapy, Pruritus, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + chemotherapy, Pyrexia, Grade 3-4","Control: 0.030<br />Experimental: 0.023<br />greater: control<br />event: nivolumab + chemotherapy, Vomiting, Grade 3-4","Control: 0.010<br />Experimental: 0.006<br />greater: control<br />event: nivolumab + chemotherapy, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + ipilimumab, Alopecia, Grade 3-4","Control: 0.010<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + ipilimumab, Constipation, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + ipilimumab, Cough, Grade 3-4","Control: 0.060<br />Experimental: 0.040<br />greater: control<br />event: nivolumab + ipilimumab, Decreased appetite, Grade 3-4","Control: 0.020<br />Experimental: 0.019<br />greater: control<br />event: nivolumab + ipilimumab, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + ipilimumab, Edema, Grade 3-4","Control: 0.049<br />Experimental: 0.025<br />greater: control<br />event: nivolumab + ipilimumab, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + ipilimumab, Hypothyroidism, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + ipilimumab, Insomnia, Grade 3-4","Control: 0.026<br />Experimental: 0.006<br />greater: control<br />event: nivolumab + ipilimumab, Nausea, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + ipilimumab, Peripheral neuropathy, Grade 3-4","Control: 0.030<br />Experimental: 0.006<br />greater: control<br />event: nivolumab + ipilimumab, Stomatitis, Grade 3-4","Control: 0.030<br />Experimental: 0.016<br />greater: control<br />event: nivolumab + ipilimumab, Vomiting, Grade 3-4","Control: 0.050<br />Experimental: 0.030<br />greater: control<br />event: ivosidenib + azacitidine, Dyspnea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ivosidenib + azacitidine, Headache, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ivosidenib + azacitidine, Hematoma, Grade ≥ 3","Control: 0.050<br />Experimental: 0.040<br />greater: control<br />event: ivosidenib + azacitidine, Hypertension, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ivosidenib + azacitidine, Leukocytosis, Grade ≥ 3","Control: 0.040<br />Experimental: 0.030<br />greater: control<br />event: ivosidenib + azacitidine, Nausea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: ivosidenib + azacitidine, Vomiting, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Dyspepsia, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Epistaxis, Grade 3-4","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Peripheral neuropathy, Grade 3-4","Control: 0.011<br />Experimental: 0.008<br />greater: control<br />event: fam-trastuzumab deruxtecan-nxki, Respiratory infection, Grade 3-4","Control: 0.016<br />Experimental: 0.011<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Abdominal pain, Grade 3-4","Control: 0.005<br />Experimental: 0.000<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Alkaline phosphatase increased, Grade 3-4","Control: 0.002<br />Experimental: 0.000<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Altered taste, Grade 3-4","Control: 0.011<br />Experimental: 0.007<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Aspartate aminotransferase increased, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Cough, Grade 3-4","Control: 0.030<br />Experimental: 0.025<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Fatigue/Asthenia, Grade 3-4","Control: 0.009<br />Experimental: 0.002<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Headache, Grade 3-4","Control: 0.009<br />Experimental: 0.007<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Increased blood creatinine, Grade 3-4","Control: 0.016<br />Experimental: 0.011<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Infusion-related reaction, Grade 3-4","Control: 0.440<br />Experimental: 0.440<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Lymphopenia, Grade 3-4","Control: 0.018<br />Experimental: 0.005<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Musculoskeletal pain, Grade 3-4","Control: 0.420<br />Experimental: 0.390<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Neutropenia, Grade 3-4","Control: 0.005<br />Experimental: 0.005<br />greater: control<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Upper respiratory tract infection, Grade 3-4","Control: 0.390<br />Experimental: 0.300<br />greater: control<br />event: axicabtagene ciloleucel, Anemia, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: axicabtagene ciloleucel, Constipation, Grade ≥3","Control: 0.040<br />Experimental: 0.040<br />greater: control<br />event: axicabtagene ciloleucel, Decreased appetite, Grade ≥3","Control: 0.040<br />Experimental: 0.020<br />greater: control<br />event: axicabtagene ciloleucel, Diarrhea, Grade ≥3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: axicabtagene ciloleucel, Dizziness, Grade ≥3","Control: 0.270<br />Experimental: 0.020<br />greater: control<br />event: axicabtagene ciloleucel, Febrile neutropenia, Grade ≥3","Control: 0.070<br />Experimental: 0.060<br />greater: control<br />event: axicabtagene ciloleucel, Hypokalemia, Grade ≥3","Control: 0.050<br />Experimental: 0.020<br />greater: control<br />event: axicabtagene ciloleucel, Nausea, Grade ≥3","Control: 0.570<br />Experimental: 0.150<br />greater: control<br />event: axicabtagene ciloleucel, Thrombocytopenia, Grade ≥3","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: axicabtagene ciloleucel, Vomiting, Grade ≥3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Dry mouth, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Dysgeusia, Grade 3-4","Control: 0.005<br />Experimental: 0.004<br />greater: control<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Peripheral edema, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: relatlimab-rmbw +nivolumab, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: relatlimab-rmbw +nivolumab, Hypothyroidism, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />event: relatlimab-rmbw +nivolumab, Pruritus, Grade 3-4","Control: 0.019<br />Experimental: 0.014<br />greater: control<br />event: relatlimab-rmbw +nivolumab, Rash, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: olaparib, Diarrhea, Grade 3-4","Control: 0.001<br />Experimental: 0.001<br />greater: control<br />event: olaparib, Dizziness, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: olaparib, Dysgeusia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + platinum-doublet chemotherapy, Alopecia, Grade 3-4","Control: 0.011<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + platinum-doublet chemotherapy, Constipation, Grade 3-4","Control: 0.023<br />Experimental: 0.011<br />greater: control<br />event: nivolumab + platinum-doublet chemotherapy, Decreased appetite, Grade 3-4","Control: 0.006<br />Experimental: 0.006<br />greater: control<br />event: nivolumab + platinum-doublet chemotherapy, Malaise, Grade 3-4","Control: 0.011<br />Experimental: 0.006<br />greater: control<br />event: nivolumab + platinum-doublet chemotherapy, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab + platinum-doublet chemotherapy, Peripheral neuropathy, Grade 3-4","Control: 0.036<br />Experimental: 0.029<br />greater: control<br />event: tebentafusp-tebn, Abdominal pain, Grade 3-4","Control: 0.027<br />Experimental: 0.012<br />greater: control<br />event: tebentafusp-tebn, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tebentafusp-tebn, Dry skin, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tebentafusp-tebn, Edema, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: tebentafusp-tebn, Erythema, Grade 3-4","Control: 0.009<br />Experimental: 0.004<br />greater: control<br />event: tebentafusp-tebn, Headache, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Aspartate aminotransferase increased, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Diarrhea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Hypothyroidism, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Increased alanine aminotransferase, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Nausea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: pembrolizumab, Rash, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab, Cough, Grade 3-4","Control: 0.026<br />Experimental: 0.000<br />greater: control<br />event: asciminib, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: asciminib, Arthralgia, Grade 3-4","Control: 0.110<br />Experimental: 0.000<br />greater: control<br />event: asciminib, Diarrhea, Grade 3-4","Control: 0.013<br />Experimental: 0.006<br />greater: control<br />event: asciminib, Fatigue/Asthenia, Grade 3-4","Control: 0.080<br />Experimental: 0.006<br />greater: control<br />event: asciminib, Rash, Grade 3-4","Control: 0.013<br />Experimental: 0.006<br />greater: control<br />event: asciminib, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: atezolizumab, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Alopecia, Grade 3-4","Control: 0.013<br />Experimental: 0.007<br />greater: control<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Arthralgia, Grade 3-4","Control: 0.010<br />Experimental: 0.003<br />greater: control<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Constipation, Grade 3-4","Control: 0.026<br />Experimental: 0.020<br />greater: control<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Diarrhea, Grade 3-4","Control: 0.110<br />Experimental: 0.090<br />greater: control<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Hypertension, Grade 3-4","Control: 0.060<br />Experimental: 0.042<br />greater: control<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Alopecia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Decreased appetite, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Dizziness, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Fatigue/Asthenia, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Headache, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Nausea, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Rash, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Stomatitis, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: abemaciclib + endocrine therapy, Vomiting, Grade 4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ruxolitinib, Cough, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ruxolitinib, Diarrhea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ruxolitinib, Dyspnea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: ruxolitinib, Edema, Grade ≥ 3","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />event: ruxolitinib, Fatigue/Asthenia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />event: ruxolitinib, Hemorrhage, Grade ≥ 3","Control: 0.070<br />Experimental: 0.050<br />greater: control<br />event: ruxolitinib, Hypertension, Grade ≥ 3","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />event: ruxolitinib, Nausea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: cabozantinib, Dysgeusia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: cabozantinib, Dysphonia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Bruising, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Edema peripheral, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: zanubrutinib, Fatigue/Asthenia, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: zanubrutinib, Headache, Grade 3-4","Control: 0.090<br />Experimental: 0.040<br />greater: control<br />event: zanubrutinib, Hemorrhage, Grade 3-4","Control: 0.140<br />Experimental: 0.090<br />greater: control<br />event: zanubrutinib, Hypertension, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Muscle spasms, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Nausea, Grade 3-4","Control: 0.100<br />Experimental: 0.040<br />greater: control<br />event: zanubrutinib, Pneumonia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Rash, Grade 3-4","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Upper respiratory tract infection, Grade 3-4","Control: 0.020<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Urinary tract infection, Grade 3-4","Control: 0.010<br />Experimental: 0.000<br />greater: control<br />event: zanubrutinib, Vomiting, Grade 3-4","Control: 0.030<br />Experimental: 0.020<br />greater: control<br />event: ivosidenib, Abdominal pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ivosidenib, Cough, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ivosidenib, Diarrhea, Grade ≥ 3","Control: 0.050<br />Experimental: 0.030<br />greater: control<br />event: ivosidenib, Fatigue/Asthenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ivosidenib, Headache, Grade ≥ 3","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />event: ivosidenib, Nausea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: ivosidenib, Neuropathy, Grade ≥ 3","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Cough, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Hyperthyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Hypothyroidism, Grade 3-4","Control: 0.009<br />Experimental: 0.006<br />greater: control<br />event: nivolumab, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Pruritus, Grade 3-4","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab, Pyrexia, Grade 3-4","Control: 0.006<br />Experimental: 0.003<br />greater: control<br />event: nivolumab, Upper respiratory tract infection, Grade 3-4","Control: 0.090<br />Experimental: 0.060<br />greater: control<br />event: nivolumab, Urinary tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: lenvatinib + pembrolizumab, Dysphonia, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: lenvatinib + pembrolizumab, Headache, Grade 3-4","Control: 0.040<br />Experimental: 0.040<br />greater: control<br />event: lenvatinib + pembrolizumab, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />event: lenvatinib + pembrolizumab, Stomatitis, Grade 3-4","Control: 0.008<br />Experimental: 0.005<br />greater: control<br />event: pembrolizumab + chemotherapy, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab + chemotherapy, Alopecia, Grade 3-4","Control: 0.003<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab + chemotherapy, Constipation, Grade 3-4","Control: 0.010<br />Experimental: 0.005<br />greater: control<br />event: pembrolizumab + chemotherapy, Headache, Grade 3-4","Control: 0.006<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab + lenvatinib, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab + lenvatinib, Dysphonia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Cough, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Edema peripheral, Grade ≥ 3","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Pyrexia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />event: daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Upper respiratory tract infection, Grade ≥ 3","Control: 0.015<br />Experimental: 0.008<br />greater: control<br />event: nivolumab, Abdominal Pain, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Constipation, Grade 3-4","Control: 0.004<br />Experimental: 0.002<br />greater: control<br />event: nivolumab, Cough, Grade 3-4","Control: 0.004<br />Experimental: 0.002<br />greater: control<br />event: nivolumab, Dyspepsia, Grade 3-4","Control: 0.035<br />Experimental: 0.008<br />greater: control<br />event: nivolumab, Dysphagia, Grade 3-4","Control: 0.015<br />Experimental: 0.013<br />greater: control<br />event: nivolumab, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: nivolumab, Hypothyroidism, Grade 3-4","Control: 0.008<br />Experimental: 0.006<br />greater: control<br />event: nivolumab, Musculoskeletal pain, Grade 3-4","Control: 0.012<br />Experimental: 0.006<br />greater: control<br />event: nivolumab, Vomiting, Grade 3-4","Control: 0.005<br />Experimental: 0.005<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Alanine aminotransferase increased, Grade 3-5","Control: 0.093<br />Experimental: 0.088<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Anemia, Grade 3-5","Control: 0.005<br />Experimental: 0.005<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Aspartate aminotransferase increased, Grade 3-5","Control: 0.037<br />Experimental: 0.023<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Asthenia, Grade 3-5","Control: 0.042<br />Experimental: 0.023<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Decreased appetite, Grade 3-5","Control: 0.083<br />Experimental: 0.074<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Diarrhea, Grade 3-5","Control: 0.019<br />Experimental: 0.000<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Hypoalbuminemia, Grade 3-5","Control: 0.065<br />Experimental: 0.051<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Hypokalemia, Grade 3-5","Control: 0.009<br />Experimental: 0.005<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Malaise, Grade 3-5","Control: 0.056<br />Experimental: 0.046<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Nausea, Grade 3-5","Control: 0.023<br />Experimental: 0.014<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Neuropathy peripheral, Grade 3-5","Control: 0.051<br />Experimental: 0.051<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Neutropenia, Grade 3-5","Control: 0.074<br />Experimental: 0.074<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Neutrophil count decreased, Grade 3-5","Control: 0.009<br />Experimental: 0.005<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Palmar-plantar erythrodysesthesia, Grade 3-5","Control: 0.019<br />Experimental: 0.009<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, Stomatitis, Grade 3-5","Control: 0.023<br />Experimental: 0.018<br />greater: control<br />event: pembrolizumab + trastuzumab + chemotherapy, White-cell count decreased, Grade 3-5","Control: 0.003<br />Experimental: 0.003<br />greater: control<br />event: nivolumab + chemotherapy, Hypoalbuminemia, Grade 3-4","Control: 0.020<br />Experimental: 0.013<br />greater: control<br />event: nivolumab + chemotherapy, Musculoskeletal pain, Grade 3-4","Control: 0.037<br />Experimental: 0.032<br />greater: control<br />event: nivolumab + chemotherapy, Nausea, Grade 3-4","Control: 0.001<br />Experimental: 0.001<br />greater: control<br />event: nivolumab + chemotherapy, Upper respiratory tract infection, Grade 3-4","Control: 0.042<br />Experimental: 0.042<br />greater: control<br />event: nivolumab + chemotherapy, Vomiting, Grade 3-4","Control: 0.010<br />Experimental: 0.010<br />greater: control<br />event: sacituzumab govitecan, Alanine aminotransferase increased, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan, Alopecia, Grade 3-4","Control: 0.020<br />Experimental: 0.010<br />greater: control<br />event: sacituzumab govitecan, Back pain, Grade 3-4","Control: 0.004<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan, Dizziness, Grade 3-4","Control: 0.090<br />Experimental: 0.060<br />greater: control<br />event: sacituzumab govitecan, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan, Hypomagnesaemia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan, Insomnia, Grade 3-4","Control: 0.020<br />Experimental: 0.020<br />greater: control<br />event: sacituzumab govitecan, Lymphopenia, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan, Pruritus, Grade 3-4","Control: 0.020<br />Experimental: 0.004<br />greater: control<br />event: sacituzumab govitecan, Pyrexia, Grade 3-4","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />event: sacituzumab govitecan, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.000<br />greater: control<br />event: sacituzumab govitecan, Upper respiratory tract infection, Grade 3-4","Control: 0.004<br />Experimental: 0.004<br />greater: control<br />event: sacituzumab govitecan, Urinary tract infection, Grade 3-4"],"key":["talazoparib + enzalutamide, Decreased appetite, Grade 4","talazoparib + enzalutamide, Dizziness, Grade 4","talazoparib + enzalutamide, Dysgeusia, Grade 4","talazoparib + enzalutamide, Fatigue/Asthenia, Grade 4","talazoparib + enzalutamide, Fractures, Grade 4","talazoparib + enzalutamide, Nausea, Grade 4","isatuximab-irfc + Carfilzomib + Dexamethasone, Bronchitis, Grade 4","isatuximab-irfc + Carfilzomib + Dexamethasone, Cough, Grade 4","isatuximab-irfc + Carfilzomib + Dexamethasone, Diarrhea, Grade 4","isatuximab-irfc + Carfilzomib + Dexamethasone, Dyspnea, Grade 4","isatuximab-irfc + Carfilzomib + Dexamethasone, Fatigue/Asthenia, Grade 4","isatuximab-irfc + Carfilzomib + Dexamethasone, Hypertension, Grade 4","isatuximab-irfc + Carfilzomib + Dexamethasone, Infusion-related reaction, Grade 4","isatuximab-irfc + Carfilzomib + Dexamethasone, Upper respiratory tract infection, Grade 4","isatuximab-irfc + Carfilzomib + Dexamethasone, Vomiting, Grade 4","pembrolizumab + chemotherapy, Constipation, Grade 3-4","pembrolizumab + chemotherapy, Decreased appetite, Grade 3-4","pembrolizumab + chemotherapy, Nausea, Grade 3-4","pembrolizumab + chemotherapy, Weight decreased , Grade 3-4","tivozanib, Any, Grade 3-4","tivozanib, Back pain, Grade 3-4","tivozanib, Cough, Grade 3-4","tivozanib, Diarrhea, Grade 3-4","tivozanib, Nausea, Grade 3-4","tivozanib, Palmar-plantar erythrodysesthesia, Grade 3-4","tivozanib, Rash, Grade 3-4","tivozanib, Stomatitis, Grade 3-4","tivozanib, Vomiting, Grade 3-4","tivozanib, Weight decreased , Grade 3-4","lorlatinib, Constipation, Grade 3-4","lorlatinib, Cough, Grade 3-4","lorlatinib, Dizziness, Grade 3-4","lorlatinib, Fatigue/Asthenia, Grade 3-4","lorlatinib, Headache, Grade 3-4","lorlatinib, Nausea, Grade 3-4","lorlatinib, Pain in extremity, Grade 3-4","lorlatinib, Pneumonia, Grade 3-4","lorlatinib, Pyrexia, Grade 3-4","lorlatinib, Rash, Grade 3-4","lorlatinib, Upper respiratory tract infection, Grade 3-4","lorlatinib, Vision disorder, Grade 3-4","lorlatinib, Vomiting, Grade 3-4","cemiplimab-rwlc, Anemia, Grade 3-4","cemiplimab-rwlc, Cough, Grade 3-4","cemiplimab-rwlc, Fatigue/Asthenia, Grade 3-4","cemiplimab-rwlc, Musculoskeletal pain, Grade 3-4","cemiplimab-rwlc, Pneumonia, Grade 3-4","nivolumab + cabozantinib, Arthralgia, Grade 3-4","nivolumab + cabozantinib, Dysgeusia, Grade 3-4","nivolumab + cabozantinib, Dyspepsia, Grade 3-4","nivolumab + cabozantinib, Fatigue/Asthenia, Grade 3-4","nivolumab + cabozantinib, Headache, Grade 3-4","nivolumab + cabozantinib, Hypertension, Grade 3-4","nivolumab + cabozantinib, Hypothyroidism, Grade 3-4","nivolumab + cabozantinib, Palmar-plantar erythrodysesthesia, Grade 3-4","nivolumab + cabozantinib, Stomatitis, Grade 3-4","nivolumab + cabozantinib, Upper respiratory tract infection, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Arthralgia, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Dyspnea, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Injection site reactions, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Upper respiratory tract infection, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Abdominal pain, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Alopecia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Constipation, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Edema peripheral, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Pyrexia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Vomiting, Grade 3-4","osimertinib, Cough, Grade ≥ 3","osimertinib, Dizziness, Grade ≥ 3","osimertinib, Musculoskeletal Pain, Grade ≥ 3","osimertinib, Nasopharyngitis, Grade ≥ 3","osimertinib, Pruritus, Grade ≥ 3","relugolix, Constipation, Grade 3-4","relugolix, Musculoskeletal pain, Grade 3-4","selinexor + bortezomib + dexamethasone, Peripheral neuropathy, Grade 3-4","sacituzumab govitecan-hziy, Abdominal Pain, Grade 3-4","sacituzumab govitecan-hziy, Alopecia, Grade 3-4","sacituzumab govitecan-hziy, Arthralgia, Grade 3-4","sacituzumab govitecan-hziy, Cough, Grade 3-4","sacituzumab govitecan-hziy, Dyspepsia, Grade 3-4","sacituzumab govitecan-hziy, Dyspnea, Grade 3-4","sacituzumab govitecan-hziy, Headache, Grade 3-4","sacituzumab govitecan-hziy, Nausea, Grade 3-4","sacituzumab govitecan-hziy, Pruritus, Grade 3-4","sacituzumab govitecan-hziy, Vomiting, Grade 3-4","margetuximab + chemotherapy, Abdominal pain, Grade 3-4","margetuximab + chemotherapy, Alopecia, Grade 3-4","margetuximab + chemotherapy, Arthralgia/Myalgia, Grade 3-4","margetuximab + chemotherapy, Constipation, Grade 3-4","margetuximab + chemotherapy, Decreased appetite, Grade 3-4","margetuximab + chemotherapy, Diarrhea, Grade 3-4","margetuximab + chemotherapy, Dyspnea, Grade 3-4","margetuximab + chemotherapy, Headache, Grade 3-4","margetuximab + chemotherapy, Palmar-plantar erythrodysesthesia, Grade 3-4","margetuximab + chemotherapy, Peripheral neuropathy, Grade 3-4","margetuximab + chemotherapy, Pyrexia, Grade 3-4","margetuximab + chemotherapy, Vomiting, Grade 3-4","pembrolizumab + chemotherapy, Alopecia, Grade 3-4","pembrolizumab + chemotherapy, Cough, Grade 3-4","pembrolizumab + chemotherapy, Diarrhea, Grade 3-4","pembrolizumab + chemotherapy, Headache, Grade 3-4","pembrolizumab + chemotherapy, Nausea, Grade 3-4","pembrolizumab + chemotherapy, Vomiting, Grade 3-4","venetoclax + azacitidine, Dizziness, Grade 3-4","venetoclax + azacitidine, Urinary tract infection, Grade 3-4","pembrolizumab, Abdominal pain, Grade 3-4","pembrolizumab, Cough, Grade 3-4","pembrolizumab, Dyspnea, Grade 3-4","pembrolizumab, Fatigue/Asthenia, Grade 3-4","pembrolizumab, Headache, Grade 3-4","pembrolizumab, Hypothyroidism, Grade 3-4","pembrolizumab, Musculoskeletal pain, Grade 3-4","pembrolizumab, Nausea, Grade 3-4","pembrolizumab, Peripheral neuropathy, Grade 3-4","pembrolizumab, Pruritus, Grade 3-4","pembrolizumab, Rash, Grade 3-4","pembrolizumab, Urinary tract infection, Grade 3-4","nivolumab + ipilimumab, Constipation, Grade 3-4","nivolumab + ipilimumab, Decreased appetite, Grade 3-4","nivolumab + ipilimumab, Dyspnea, Grade 3-4","nivolumab + ipilimumab, Edema, Grade 3-4","nivolumab + ipilimumab, Fatigue/Asthenia, Grade 3-4","nivolumab + ipilimumab, Hypothyroidism, Grade 3-4","nivolumab + ipilimumab, Nausea, Grade 3-4","nivolumab + ipilimumab, Vomiting, Grade 3-4","elacestrant, Constipation, Grade 3-4","elacestrant, Diarrhea, Grade 3-4","elacestrant, Dyspepsia, Grade 3-4","elacestrant, Hot flush , Grade 3-4","azacitidine, Arthralgia, TYPO","azacitidine, Decreased appetite, TYPO","azacitidine, Dizziness, TYPO","carfilzomib + daratumumab + dexamethasone, Cough, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Nausea, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Hypothyroidism, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Nausea, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Photosensitivity reaction, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Pruritus, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Pyrexia, Grade 3-4","avelumab, Decreased appetite, Grade 3-4","avelumab, Fatigue/Asthenia, Grade 3-4","avelumab, Musculoskeletal pain, Grade 3-4","avelumab, Nausea, Grade 3-4","pembrolizumab, Abdominal pain, Grade ≥3","pembrolizumab, Alopecia, Grade ≥3","pembrolizumab, Anemia, Grade ≥3","pembrolizumab, Asthenia, Grade ≥3","pembrolizumab, Back pain, Grade ≥3","pembrolizumab, Constipation, Grade ≥3","pembrolizumab, Cough, Grade ≥3","pembrolizumab, Decreased appetite, Grade ≥3","pembrolizumab, Diarrhea, Grade ≥3","pembrolizumab, Dizziness, Grade ≥3","pembrolizumab, Dry mouth, Grade ≥3","pembrolizumab, Dry skin, Grade ≥3","pembrolizumab, Dyspepsia, Grade ≥3","pembrolizumab, Epistaxis, Grade ≥3","pembrolizumab, Fatigue/Asthenia, Grade ≥3","pembrolizumab, Headache, Grade ≥3","pembrolizumab, Hypokalemia, Grade ≥3","pembrolizumab, Hypothyroidism, Grade ≥3","pembrolizumab, Mucosal inflammation, Grade ≥3","pembrolizumab, Nasopharyngitis, Grade ≥3","pembrolizumab, Nausea, Grade ≥3","pembrolizumab, Neutropenia, Grade ≥3","pembrolizumab, Neutrophil count decreased, Grade ≥3","pembrolizumab, PPE syndrome, Grade ≥3","pembrolizumab, Pain in extremity, Grade ≥3","pembrolizumab, Peripheral edema, Grade ≥3","pembrolizumab, Peripheral neuropathy, Grade ≥3","pembrolizumab, Peripheral sensory neuropathy, Grade ≥3","pembrolizumab, Pruritus, Grade ≥3","pembrolizumab, Rash, Grade ≥3","pembrolizumab, Stomatitis, Grade ≥3","pembrolizumab, Upper abdominal pain, Grade ≥3","pembrolizumab, Upper respiratory tract infection, Grade ≥3","pembrolizumab, Urinary tract infection, Grade ≥3","pembrolizumab, Vomiting, Grade ≥3","pembrolizumab, Weight decreased , Grade ≥3","pembrolizumab, White-cell count decrease, Grade ≥3","nivolumab, Anemia, Grade 3-4","nivolumab, Constipation, Grade 3-4","nivolumab, Cough, Grade 3-4","nivolumab, Decreased appetite, Grade 3-4","nivolumab, Fatigue/Asthenia, Grade 3-4","nivolumab, Hypothyroidism, Grade 3-4","nivolumab, Musculoskeletal pain, Grade 3-4","nivolumab, Nausea, Grade 3-4","nivolumab, Pneumonia, Grade 3-4","nivolumab, Pruritus, Grade 3-4","nivolumab, Pyrexia, Grade 3-4","pembrolizumab, Arthralgia, Grade 4","pembrolizumab, Aspartate aminotransferase increased, Grade 4","pembrolizumab, Asthenia, Grade 4","pembrolizumab, Back pain, Grade 4","pembrolizumab, Constipation, Grade 4","pembrolizumab, Cough, Grade 4","pembrolizumab, Decreased appetite, Grade 4","pembrolizumab, Diarrhea, Grade 4","pembrolizumab, Dry skin, Grade 4","pembrolizumab, Dyspnea, Grade 4","pembrolizumab, Fatigue/Asthenia, Grade 4","pembrolizumab, Headache, Grade 4","pembrolizumab, Hypertension, Grade 4","pembrolizumab, Hyperthyroidism, Grade 4","pembrolizumab, Hypothyroidism, Grade 4","pembrolizumab, Increased alanine aminotransferase, Grade 4","pembrolizumab, Increased blood creatinine, Grade 4","pembrolizumab, Influenza-like illness, Grade 4","pembrolizumab, Maculopapular rash, Grade 4","pembrolizumab, Myalgia, Grade 4","pembrolizumab, Nasopharyngitis, Grade 4","pembrolizumab, Nausea, Grade 4","pembrolizumab, Pain in extremity, Grade 4","pembrolizumab, Paresthesia, Grade 4","pembrolizumab, Productive cough, Grade 4","pembrolizumab, Pruritus, Grade 4","pembrolizumab, Pyrexia, Grade 4","pembrolizumab, Rash, Grade 4","pembrolizumab, Upper respiratory tract infection, Grade 4","pembrolizumab, Weight Increased, Grade 4","pembrolizumab, Weight decreased , Grade 4","ramucirumab + erlotinib, Alopecia, Grade ≥ 3","ramucirumab + erlotinib, Epistaxis, Grade ≥ 3","ramucirumab + erlotinib, Gastrointestinal hemorrhage, Grade ≥ 3","ramucirumab + erlotinib, Gingival bleeding, Grade ≥ 3","ramucirumab + erlotinib, Pulmonary hemorrhage, Grade ≥ 3","atezolizumab + bevacizumab, Abdominal Pain, Grade 3-4","atezolizumab + bevacizumab, Constipation, Grade 3-4","atezolizumab + bevacizumab, Cough, Grade 3-4","atezolizumab + bevacizumab, Decreased Appetite, Grade 3-4","atezolizumab + bevacizumab, Diarrhea, Grade 3-4","atezolizumab + bevacizumab, Epistaxis, Grade 3-4","atezolizumab + bevacizumab, Fatigue/Asthenia, Grade 3-4","atezolizumab + bevacizumab, Nausea, Grade 3-4","atezolizumab + bevacizumab, Pruritus, Grade 3-4","atezolizumab + bevacizumab, Pyrexia, Grade 3-4","atezolizumab + bevacizumab, Rash, Grade 3-4","atezolizumab + bevacizumab, Vomiting, Grade 3-4","atezolizumab + bevacizumab, Weight decreased , Grade 3-4","nivolumab + ipilimumab + chemotherapy, Abdominal pain, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Constipation, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Cough, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Pyrexia, Grade 3-4","brigatinib, Abdominal pain, Grade 3-4","brigatinib, Arthralgia, Grade 3-4","brigatinib, Back pain, Grade 3-4","brigatinib, Constipation, Grade 3-4","brigatinib, Cough, Grade 3-4","brigatinib, Decreased Appetite, Grade 3-4","brigatinib, Diarrhea, Grade 3-4","brigatinib, Dizziness, Grade 3-4","brigatinib, Dysgeusia, Grade 3-4","brigatinib, Dyspepsia, Grade 3-4","brigatinib, Dyspnea, Grade 3-4","brigatinib, Edema, Grade 3-4","brigatinib, Fatigue/Asthenia, Grade 3-4","brigatinib, Gastroesophageal reflux disease, Grade 3-4","brigatinib, Increased Blood cholesterol, Grade 3-4","brigatinib, Myalgia, Grade 3-4","brigatinib, Nasopharyngitis, Grade 3-4","brigatinib, Nausea, Grade 3-4","brigatinib, Pain in extremity, Grade 3-4","brigatinib, Pruritus, Grade 3-4","brigatinib, Pulmonary embolism, Grade 3-4","brigatinib, Upper respiratory tract infection, Grade 3-4","brigatinib, Urinary tract infection, Grade 3-4","brigatinib, Visual Disturbance0e, Grade 3-4","brigatinib, Vomiting, Grade 3-4","olaparib, Cough, Grade 3-4","olaparib, Decreased appetite, Grade 3-4","olaparib, Fatigue/Asthenia, Grade 3-4","atezolizumab, Diarrhea, Grade 3-4","atezolizumab, Fatigue/Asthenia, Grade 3-4","atezolizumab, Nausea, Grade 3-4","atezolizumab, Pyrexia, Grade 3-4","ripretinib, Alopecia, Grade 3-4","ripretinib, Arthralgia, Grade 3-4","ripretinib, Asthenia, Grade 3-4","ripretinib, Decreased appetite, Grade 3-4","ripretinib, Diarrhea, Grade 3-4","ripretinib, Dry skin, Grade 3-4","ripretinib, Dyspnea, Grade 3-4","ripretinib, Headache, Grade 3-4","ripretinib, Muscle spasms, Grade 3-4","ripretinib, Palmar-plantar erythrodysesthesia, Grade 3-4","ripretinib, Pruritus, Grade 3-4","ripretinib, Stomatitis, Grade 3-4","ripretinib, Weight decreased , Grade 3-4","nivolumab + ipilimumab, Abdominal pain, Grade 3-4","nivolumab + ipilimumab, Constipation, Grade 3-4","nivolumab + ipilimumab, Edema, Grade 3-4","nivolumab + ipilimumab, Hyperthyroidism, Grade 3-4","nivolumab + ipilimumab, Nausea, Grade 3-4","nivolumab + ipilimumab, Vomiting, Grade 3-4","zanubrutinib, Bruising, Grade 3-4","zanubrutinib, Cough, Grade 3-4","zanubrutinib, Diarrhea, Grade 3-4","zanubrutinib, Fatigue/Asthenia, Grade 3-4","zanubrutinib, Headache, Grade 3-4","zanubrutinib, Nausea, Grade 3-4","zanubrutinib, Rash, Grade 3-4","zanubrutinib, Bruising, Grade 3-4","zanubrutinib, Dizziness, Grade 3-4","zanubrutinib, Fatigue/Asthenia, Grade 3-4","zanubrutinib, Hemorrhage, Grade 3-4","zanubrutinib, Hypertension, Grade 3-4","zanubrutinib, Musculoskeletal pain, Grade 3-4","zanubrutinib, Pneumonia, Grade 3-4","zanubrutinib, Upper respiratory tract infection, Grade 3-4","olaparib + bevacizumab, Vomiting, TYPO","niraparib, Cough, Grade 3-4","niraparib, Dizziness, Grade 3-4","niraparib, Dyspnea, Grade 3-4","niraparib, Nausea, Grade 3-4","niraparib, Vomiting, Grade 3-4","ibrutinib + rituximab, Bruising, Grade ≥ 3","ibrutinib + rituximab, Constipation, Grade ≥ 3","ibrutinib + rituximab, Cough, Grade ≥ 3","ibrutinib + rituximab, Decreased appetite, Grade ≥ 3","ibrutinib + rituximab, Dizziness, Grade ≥ 3","ibrutinib + rituximab, Fatigue/Asthenia, Grade ≥ 3","ibrutinib + rituximab, Headache, Grade ≥ 3","ibrutinib + rituximab, Insomnia, Grade ≥ 3","ibrutinib + rituximab, Nausea, Grade ≥ 3","ibrutinib + rituximab, Peripheral neuropathy, Grade ≥ 3","ibrutinib + rituximab, Pyrexia, Grade ≥ 3","ibrutinib + rituximab, Rash, Grade ≥ 3","ibrutinib + rituximab, Skin infection, Grade ≥ 3","ibrutinib + rituximab, Stomatitis, Grade ≥ 3","ibrutinib + rituximab, Upper respiratory tract infection, Grade ≥ 3","tucatinib + trastuzumab + capecitabine, Anemia, Grade 4","tucatinib + trastuzumab + capecitabine, Arthralgia, Grade 4","tucatinib + trastuzumab + capecitabine, Decreased appetite, Grade 4","tucatinib + trastuzumab + capecitabine, Epistaxis, Grade 4","tucatinib + trastuzumab + capecitabine, Increased blood creatinine, Grade 4","tucatinib + trastuzumab + capecitabine, Nausea, Grade 4","tucatinib + trastuzumab + capecitabine, Palmar-plantar erythrodysesthesia, Grade 4","tucatinib + trastuzumab + capecitabine, Peripheral neuropathy, Grade 4","tucatinib + trastuzumab + capecitabine, Rash, Grade 4","tucatinib + trastuzumab + capecitabine, Stomatitis, Grade 4","tucatinib + trastuzumab + capecitabine, Vomiting, Grade 4","tucatinib + trastuzumab + capecitabine, Weight decreased , Grade 4","encorafenib + cetuximab, Abdominal pain, Grade ≥ 3","encorafenib + cetuximab, Constipation, Grade ≥ 3","encorafenib + cetuximab, Decreased appetite, Grade ≥ 3","encorafenib + cetuximab, Dermatitis acneiform, Grade ≥ 3","encorafenib + cetuximab, Diarrhea, Grade ≥ 3","encorafenib + cetuximab, Dry skin, Grade ≥ 3","encorafenib + cetuximab, Fatigue/Asthenia, Grade ≥ 3","encorafenib + cetuximab, Headache, Grade ≥ 3","encorafenib + cetuximab, Insomnia, Grade ≥ 3","encorafenib + cetuximab, Melanocytic nevus, Grade ≥ 3","encorafenib + cetuximab, Nausea, Grade ≥ 3","encorafenib + cetuximab, Pain in extremity, Grade ≥ 3","encorafenib + cetuximab, Pruritus, Grade ≥ 3","encorafenib + cetuximab, Pyrexia, Grade ≥ 3","encorafenib + cetuximab, Rash, Grade ≥ 3","encorafenib + cetuximab, Vomiting, Grade ≥ 3","durvalumab + Etoposide + either Carboplatin or Cisplatin , Decreased appetite, Grade 3-4","durvalumab + Etoposide + either Carboplatin or Cisplatin , Diarrhea, Grade 3-4","durvalumab + Etoposide + either Carboplatin or Cisplatin , Hyperthyroidism, Grade 3-4","durvalumab + Etoposide + either Carboplatin or Cisplatin , Nausea, Grade 3-4","durvalumab + Etoposide + either Carboplatin or Cisplatin , Rash, Grade 3-4","durvalumab + Etoposide + either Carboplatin or Cisplatin , Vomiting, Grade 3-4","isatuximab-irfc + pomalidomide + dexamethasone, Diarrhea, Grade 4","isatuximab-irfc + pomalidomide + dexamethasone, Dyspnea, Grade 4","isatuximab-irfc + pomalidomide + dexamethasone, Nausea, Grade 4","isatuximab-irfc + pomalidomide + dexamethasone, Upper respiratory tract infection, Grade 4","isatuximab-irfc + pomalidomide + dexamethasone, Vomiting, Grade 4","neratinib +  Capecitabine, Abdominal distension, Grade 4","neratinib +  Capecitabine, Arthralgia, Grade 4","neratinib +  Capecitabine, Back Pain, Grade 4","neratinib +  Capecitabine, Constipation, Grade 4","neratinib +  Capecitabine, Decreased appetite, Grade 4","neratinib +  Capecitabine, Diarrhea, Grade 4","neratinib +  Capecitabine, Dizziness, Grade 4","neratinib +  Capecitabine, Dysuria, Grade 4","neratinib +  Capecitabine, Fatigue/Asthenia, Grade 4","neratinib +  Capecitabine, Influenza-like illness, Grade 4","neratinib +  Capecitabine, Malaise, Grade 4","neratinib +  Capecitabine, Muscle spasms, Grade 4","neratinib +  Capecitabine, Nausea, Grade 4","neratinib +  Capecitabine, Renal impairment, Grade 4","neratinib +  Capecitabine, Upper respiratory tract infection, Grade 4","neratinib +  Capecitabine, Urinary tract infection, Grade 4","neratinib +  Capecitabine, Vomiting, Grade 4","tremelimumab + durvalumab + platinum-based chemotherapy, Alopecia, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Constipation, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Cough/Productive Cough, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Diarrhea, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Edema, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Headache, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Hypothyroidism, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Musculoskeletal Pain, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Nausea, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Pruritus, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Pyrexia, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Stomatitis, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Upper respiratory tract infection, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Vomiting, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Alopecia, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Insomnia, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Nausea, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Peripheral neuropathy, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Vomiting, Grade 3-4","olaparib + abiraterone + prednisone (or prednisolone), Abdominal pain, Grade 3-4","olaparib + abiraterone + prednisone (or prednisolone), Nausea, Grade 3-4","tremelimumab + durvalumab, Abdominal pain, Grade 3-4","tremelimumab + durvalumab, Fatigue/Asthenia, Grade 3-4","tremelimumab + durvalumab, Hypothyroidism, Grade 3-4","tremelimumab + durvalumab, Nausea, Grade 3-4","tremelimumab + durvalumab, Pruritus, Grade 3-4","tremelimumab + durvalumab, Pyrexia, Grade 3-4","tremelimumab + durvalumab, Rash, Grade 3-4","durvalumab + gemcitabine + cisplatin, Abdominal pain, Grade 3-4","durvalumab + gemcitabine + cisplatin, Diarrhea, Grade 3-4","durvalumab + gemcitabine + cisplatin, Fatigue/Asthenia, Grade 3-4","durvalumab + gemcitabine + cisplatin, Insomnia, Grade 3-4","durvalumab + gemcitabine + cisplatin, Nausea, Grade 3-4","durvalumab + gemcitabine + cisplatin, Pruritus, Grade 3-4","durvalumab + gemcitabine + cisplatin, Vomiting, Grade 3-4","darolutamide + docetaxel, Constipation, Grade 3-4","darolutamide + docetaxel, Decreased Appetite, Grade 3-4","darolutamide + docetaxel, Hemorrhage, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Alopecia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Diarrhea, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Hemorrhage, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Peripheral neuropathy, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Rash, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Stomatitis, Grade 3-4","lisocabtagene maraleucel, Anemia, Grade ≥ 3","lisocabtagene maraleucel, Arthralgia, Grade ≥ 3","lisocabtagene maraleucel, Back pain, Grade ≥ 3","lisocabtagene maraleucel, Bone pain, Grade ≥ 3","lisocabtagene maraleucel, Cough, Grade ≥ 3","lisocabtagene maraleucel, Decreased appetite, Grade ≥ 3","lisocabtagene maraleucel, Diarrhea, Grade ≥ 3","lisocabtagene maraleucel, Dizziness, Grade ≥ 3","lisocabtagene maraleucel, Dyspepsia, Grade ≥ 3","lisocabtagene maraleucel, Dyspnea, Grade ≥ 3","lisocabtagene maraleucel, Fatigue/Asthenia, Grade ≥ 3","lisocabtagene maraleucel, Febrile neutropenia, Grade ≥ 3","lisocabtagene maraleucel, Hypokalemia, Grade ≥ 3","lisocabtagene maraleucel, Hypomagnesaemia, Grade ≥ 3","lisocabtagene maraleucel, Hypophosphatemia, Grade ≥ 3","lisocabtagene maraleucel, Insomnia, Grade ≥ 3","lisocabtagene maraleucel, Mucosal inflammation, Grade ≥ 3","lisocabtagene maraleucel, Nausea, Grade ≥ 3","lisocabtagene maraleucel, Peripheral sensory neuropathy, Grade ≥ 3","lisocabtagene maraleucel, Pyrexia, Grade ≥ 3","lisocabtagene maraleucel, Stomatitis, Grade ≥ 3","lisocabtagene maraleucel, Tachycardia, Grade ≥ 3","lisocabtagene maraleucel, Thrombocytopenia, Grade ≥ 3","lisocabtagene maraleucel, Vomiting, Grade ≥ 3","nivolumab + chemotherapy, Alopecia, Grade 3-4","nivolumab + chemotherapy, Constipation, Grade 3-4","nivolumab + chemotherapy, Cough, Grade 3-4","nivolumab + chemotherapy, Edema, Grade 3-4","nivolumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","nivolumab + chemotherapy, Hypothyroidism, Grade 3-4","nivolumab + chemotherapy, Insomnia, Grade 3-4","nivolumab + chemotherapy, Musculoskeletal pain, Grade 3-4","nivolumab + chemotherapy, Pruritus, Grade 3-4","nivolumab + chemotherapy, Pyrexia, Grade 3-4","nivolumab + chemotherapy, Vomiting, Grade 3-4","nivolumab + chemotherapy, Weight decreased , Grade 3-4","nivolumab + ipilimumab, Alopecia, Grade 3-4","nivolumab + ipilimumab, Constipation, Grade 3-4","nivolumab + ipilimumab, Cough, Grade 3-4","nivolumab + ipilimumab, Decreased appetite, Grade 3-4","nivolumab + ipilimumab, Diarrhea, Grade 3-4","nivolumab + ipilimumab, Edema, Grade 3-4","nivolumab + ipilimumab, Fatigue/Asthenia, Grade 3-4","nivolumab + ipilimumab, Hypothyroidism, Grade 3-4","nivolumab + ipilimumab, Insomnia, Grade 3-4","nivolumab + ipilimumab, Nausea, Grade 3-4","nivolumab + ipilimumab, Peripheral neuropathy, Grade 3-4","nivolumab + ipilimumab, Stomatitis, Grade 3-4","nivolumab + ipilimumab, Vomiting, Grade 3-4","ivosidenib + azacitidine, Dyspnea, Grade ≥ 3","ivosidenib + azacitidine, Headache, Grade ≥ 3","ivosidenib + azacitidine, Hematoma, Grade ≥ 3","ivosidenib + azacitidine, Hypertension, Grade ≥ 3","ivosidenib + azacitidine, Leukocytosis, Grade ≥ 3","ivosidenib + azacitidine, Nausea, Grade ≥ 3","ivosidenib + azacitidine, Vomiting, Grade ≥ 3","fam-trastuzumab deruxtecan-nxki, Constipation, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Dyspepsia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Epistaxis, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Peripheral neuropathy, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Respiratory infection, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Abdominal pain, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Alkaline phosphatase increased, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Alopecia, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Altered taste, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Aspartate aminotransferase increased, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Cough, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Fatigue/Asthenia, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Headache, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Increased blood creatinine, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Infusion-related reaction, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Lymphopenia, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Musculoskeletal pain, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Neutropenia, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Upper respiratory tract infection, Grade 3-4","axicabtagene ciloleucel, Anemia, Grade ≥3","axicabtagene ciloleucel, Constipation, Grade ≥3","axicabtagene ciloleucel, Decreased appetite, Grade ≥3","axicabtagene ciloleucel, Diarrhea, Grade ≥3","axicabtagene ciloleucel, Dizziness, Grade ≥3","axicabtagene ciloleucel, Febrile neutropenia, Grade ≥3","axicabtagene ciloleucel, Hypokalemia, Grade ≥3","axicabtagene ciloleucel, Nausea, Grade ≥3","axicabtagene ciloleucel, Thrombocytopenia, Grade ≥3","axicabtagene ciloleucel, Vomiting, Grade ≥3","lutetium Lu 177 vipivotide tetraxetan + standard of care, Dry mouth, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Dysgeusia, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Peripheral edema, Grade 3-4","relatlimab-rmbw +nivolumab, Headache, Grade 3-4","relatlimab-rmbw +nivolumab, Hypothyroidism, Grade 3-4","relatlimab-rmbw +nivolumab, Pruritus, Grade 3-4","relatlimab-rmbw +nivolumab, Rash, Grade 3-4","olaparib, Diarrhea, Grade 3-4","olaparib, Dizziness, Grade 3-4","olaparib, Dysgeusia, Grade 3-4","nivolumab + platinum-doublet chemotherapy, Alopecia, Grade 3-4","nivolumab + platinum-doublet chemotherapy, Constipation, Grade 3-4","nivolumab + platinum-doublet chemotherapy, Decreased appetite, Grade 3-4","nivolumab + platinum-doublet chemotherapy, Malaise, Grade 3-4","nivolumab + platinum-doublet chemotherapy, Nausea, Grade 3-4","nivolumab + platinum-doublet chemotherapy, Peripheral neuropathy, Grade 3-4","tebentafusp-tebn, Abdominal pain, Grade 3-4","tebentafusp-tebn, Diarrhea, Grade 3-4","tebentafusp-tebn, Dry skin, Grade 3-4","tebentafusp-tebn, Edema, Grade 3-4","tebentafusp-tebn, Erythema, Grade 3-4","tebentafusp-tebn, Headache, Grade 3-4","pembrolizumab, Aspartate aminotransferase increased, Grade ≥ 3","pembrolizumab, Diarrhea, Grade ≥ 3","pembrolizumab, Hypothyroidism, Grade ≥ 3","pembrolizumab, Increased alanine aminotransferase, Grade ≥ 3","pembrolizumab, Nausea, Grade ≥ 3","pembrolizumab, Rash, Grade ≥ 3","pembrolizumab, Cough, Grade 3-4","asciminib, Abdominal pain, Grade 3-4","asciminib, Arthralgia, Grade 3-4","asciminib, Diarrhea, Grade 3-4","asciminib, Fatigue/Asthenia, Grade 3-4","asciminib, Rash, Grade 3-4","asciminib, Upper respiratory tract infection, Grade 3-4","atezolizumab, Cough, Grade 3-4","atezolizumab, Hypothyroidism, Grade 3-4","atezolizumab, Pruritus, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Alopecia, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Arthralgia, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Constipation, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Diarrhea, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Hypertension, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Peripheral neuropathy, Grade 3-4","abemaciclib + endocrine therapy, Alopecia, Grade 4","abemaciclib + endocrine therapy, Decreased appetite, Grade 4","abemaciclib + endocrine therapy, Diarrhea, Grade 4","abemaciclib + endocrine therapy, Dizziness, Grade 4","abemaciclib + endocrine therapy, Fatigue/Asthenia, Grade 4","abemaciclib + endocrine therapy, Headache, Grade 4","abemaciclib + endocrine therapy, Nausea, Grade 4","abemaciclib + endocrine therapy, Rash, Grade 4","abemaciclib + endocrine therapy, Stomatitis, Grade 4","abemaciclib + endocrine therapy, Vomiting, Grade 4","ruxolitinib, Cough, Grade ≥ 3","ruxolitinib, Diarrhea, Grade ≥ 3","ruxolitinib, Dyspnea, Grade ≥ 3","ruxolitinib, Edema, Grade ≥ 3","ruxolitinib, Fatigue/Asthenia, Grade ≥ 3","ruxolitinib, Hemorrhage, Grade ≥ 3","ruxolitinib, Hypertension, Grade ≥ 3","ruxolitinib, Nausea, Grade ≥ 3","cabozantinib, Dysgeusia, Grade 3-4","cabozantinib, Dysphonia, Grade 3-4","zanubrutinib, Bruising, Grade 3-4","zanubrutinib, Constipation, Grade 3-4","zanubrutinib, Cough, Grade 3-4","zanubrutinib, Dyspnea, Grade 3-4","zanubrutinib, Edema peripheral, Grade 3-4","zanubrutinib, Fatigue/Asthenia, Grade 3-4","zanubrutinib, Headache, Grade 3-4","zanubrutinib, Hemorrhage, Grade 3-4","zanubrutinib, Hypertension, Grade 3-4","zanubrutinib, Muscle spasms, Grade 3-4","zanubrutinib, Nausea, Grade 3-4","zanubrutinib, Pneumonia, Grade 3-4","zanubrutinib, Rash, Grade 3-4","zanubrutinib, Upper respiratory tract infection, Grade 3-4","zanubrutinib, Urinary tract infection, Grade 3-4","zanubrutinib, Vomiting, Grade 3-4","ivosidenib, Abdominal pain, Grade ≥ 3","ivosidenib, Cough, Grade ≥ 3","ivosidenib, Diarrhea, Grade ≥ 3","ivosidenib, Fatigue/Asthenia, Grade ≥ 3","ivosidenib, Headache, Grade ≥ 3","ivosidenib, Nausea, Grade ≥ 3","ivosidenib, Neuropathy, Grade ≥ 3","nivolumab, Constipation, Grade 3-4","nivolumab, Cough, Grade 3-4","nivolumab, Dyspnea, Grade 3-4","nivolumab, Hyperthyroidism, Grade 3-4","nivolumab, Hypothyroidism, Grade 3-4","nivolumab, Musculoskeletal pain, Grade 3-4","nivolumab, Pruritus, Grade 3-4","nivolumab, Pyrexia, Grade 3-4","nivolumab, Upper respiratory tract infection, Grade 3-4","nivolumab, Urinary tract infection, Grade 3-4","lenvatinib + pembrolizumab, Dysphonia, Grade 3-4","lenvatinib + pembrolizumab, Headache, Grade 3-4","lenvatinib + pembrolizumab, Palmar-plantar erythrodysesthesia, Grade 3-4","lenvatinib + pembrolizumab, Stomatitis, Grade 3-4","pembrolizumab + chemotherapy, Abdominal pain, Grade 3-4","pembrolizumab + chemotherapy, Alopecia, Grade 3-4","pembrolizumab + chemotherapy, Constipation, Grade 3-4","pembrolizumab + chemotherapy, Headache, Grade 3-4","pembrolizumab + lenvatinib, Constipation, Grade 3-4","pembrolizumab + lenvatinib, Dysphonia, Grade 3-4","daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Cough, Grade ≥ 3","daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Edema peripheral, Grade ≥ 3","daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Pyrexia, Grade ≥ 3","daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Upper respiratory tract infection, Grade ≥ 3","nivolumab, Abdominal Pain, Grade 3-4","nivolumab, Constipation, Grade 3-4","nivolumab, Cough, Grade 3-4","nivolumab, Dyspepsia, Grade 3-4","nivolumab, Dysphagia, Grade 3-4","nivolumab, Fatigue/Asthenia, Grade 3-4","nivolumab, Hypothyroidism, Grade 3-4","nivolumab, Musculoskeletal pain, Grade 3-4","nivolumab, Vomiting, Grade 3-4","pembrolizumab + trastuzumab + chemotherapy, Alanine aminotransferase increased, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Anemia, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Aspartate aminotransferase increased, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Asthenia, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Decreased appetite, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Diarrhea, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Hypoalbuminemia, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Hypokalemia, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Malaise, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Nausea, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Neuropathy peripheral, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Neutropenia, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Neutrophil count decreased, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Palmar-plantar erythrodysesthesia, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Stomatitis, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, White-cell count decreased, Grade 3-5","nivolumab + chemotherapy, Hypoalbuminemia, Grade 3-4","nivolumab + chemotherapy, Musculoskeletal pain, Grade 3-4","nivolumab + chemotherapy, Nausea, Grade 3-4","nivolumab + chemotherapy, Upper respiratory tract infection, Grade 3-4","nivolumab + chemotherapy, Vomiting, Grade 3-4","sacituzumab govitecan, Alanine aminotransferase increased, Grade 3-4","sacituzumab govitecan, Alopecia, Grade 3-4","sacituzumab govitecan, Back pain, Grade 3-4","sacituzumab govitecan, Cough, Grade 3-4","sacituzumab govitecan, Dizziness, Grade 3-4","sacituzumab govitecan, Fatigue/Asthenia, Grade 3-4","sacituzumab govitecan, Hypomagnesaemia, Grade 3-4","sacituzumab govitecan, Insomnia, Grade 3-4","sacituzumab govitecan, Lymphopenia, Grade 3-4","sacituzumab govitecan, Pruritus, Grade 3-4","sacituzumab govitecan, Pyrexia, Grade 3-4","sacituzumab govitecan, Rash, Grade 3-4","sacituzumab govitecan, Upper respiratory tract infection, Grade 3-4","sacituzumab govitecan, Urinary tract infection, Grade 3-4"],"type":"scatter","mode":"markers","marker":{"autocolorscale":false,"color":"rgba(48,26,75,1)","opacity":0.55,"size":5.66929133858268,"symbol":"circle","line":{"width":1.88976377952756,"color":"rgba(48,26,75,1)"}},"hoveron":"points","name":"control","legendgroup":"control","showlegend":true,"xaxis":"x","yaxis":"y","hoverinfo":"text","_isNestedKey":false,"frame":null},{"x":[0.025,0.03,0.09,0.038,0.05,0.01,0.04,0,0.01,0.12,0.17,0,0,0,0,0.007,0,0.007,0.021,0.014,0,0,0,0.007,0,0,0.021,0.003,0,0.003,0,0.013,0.044,0,0.05,0.031,0.003,0,0,0.003,0.02,0,0,0,0.04,0,0.02,0.05,0.23,0.13,0.016,0.016,0.048,0.032,0.016,0,0.016,0,0,0,0.003,0,0.003,0,0,0,0,0,0,0,0,0,0.015,0.01,0,0.05,0,0.01,0.015,0,0,0.01,0,0,0.01,0.04,0,0,0.045,0,0.004,0,0.004,0.004,0.043,0,0,0.01,0.03,0.02,0,0.02,0.19,0.03,0.03,0.01,0.01,0,0.14,0,0.01,0.013,0.013,0,0,0.007,0,0,0.011,0.011,0.021,0,0.007,0.004,0,0.009,0.004,0.01,0,0.01,0.009,0,0.01,0,0.01,0.01,0.08,0.01,0,0.05,0,0.14,0.013,0.013,0.007,0.026,0.08,0.13,0.05,0.02,0.09,0.007,0.033,0.16,0,0.018,0.13,0.07,0,0.01,0.032,0.01,0.23,0.01,0,0,0,0.003,0,0,0,0,0,0.038,0.006,0.02,0,0.02,0.01,0,0.05,0,0.014,0.01,0,0,0.01,0,0.05,0.07,0,0,0.01,0.12,0,0.006,0.006,0.017,0.017,0,0.032,0.049,0,0,0.02,0.009,0,0.003,0.014,0,0,0.029,0.007,0,0.029,0,0,0,0.05,0,0,0,0,0.01,0.008,0,0,0,0.047,0,0.023,0,0,0,0,0,0.002,0,0.014,0.009,0.021,0.044,0,0.012,0,0.007,0.04,0,0.004,0.004,0,0,0.004,0.026,0.004,0.04,0.004,0.009,0.046,0,0.009,0.009,0.004,0.015,0.015,0.011,0.007,0.008,0,0.02,0.004,0,0.01,0,0.01,0.004,0.004,0,0.01,0.004,0.01,0.01,0.01,0.01,0.01,0.06,0,0.02,0,0,0,0,0,0,0,0,0,0.008,0,0,0.023,0.007,0,0.027,0.012,0.045,0.042,0.006,0,0,0,0.007,0.02,0,0,0,0.033,0,0.003,0,0.015,0.018,0.008,0.043,0,0.008,0.003,0.009,0.006,0,0.037,0.002,0.012,0,0.05,0,0.012,0,0.012,0.047,0,0,0.006,0,0,0,0,0,0.01,0,0,0,0.01,0.01,0,0.12,0.09,0,0.51,0,0.03,0,0.007,0.06,0.02,0.049,0.026,0.01,0.026,0,0.03,0.007,0.049,0.003,0.026,0,0.003,0,0.01,0.01,0.08,0.03,0,0.004,0,0.06,0,0.004,0.004,0,0.008,0,0,0.004,0.004,0,0.008,0.004,0.005,0.11,0.002,0.007,0.018,0.002,0.09,0.005,0.005,0.011,0,0,0.06,0.16,0.007,0.002,0,0,0,0,0.01,0,0.02,0.01,0.12,0.03,0.04,0.22,0.41,0,0.01,0.01,0,0.005,0.029,0.049,0.005,0.005,0.005,0,0.015,0,0.005,0,0.01,0.005,0.005,0,0,0.003,0.014,0.006,0.017,0,0.003,0,0.007,0.001,0.003,0,0.008,0,0,0.011,0,0.006,0,0,0,0.009,0,0.009,0,0.009,0,0,0,0,0,0,0,0,0,0.002,0.002,0.002,0.002,0,0.006,0,0,0.006,0,0,0.004,0,0.039,0.013,0,0,0.002,0.002,0.002,0.002,0,0.06,0.016,0.003,0.08,0.019,0.001,0,0.01,0,0,0,0,0,0.03,0,0,0,0,0,0,0,0.02,0,0.01,0,0.02,0,0.07,0,0,0,0.006,0,0.003,0.017,0,0.003,0.006,0,0.003,0.009,0.01,0.02,0,0.01,0.06,0.08,0.04,0.05,0.2,0,0.03,0.01,0.03,0.01,0.01,0,0.003,0,0.003,0.018,0.039,0,0,0.018,0.023,0.003,0.005,0.01,0.015,0.012,0,0.028,0.06,0.003,0.009,0.025,0,0.006,0.015,0,0.003,0,0.012,0.012,0.022,0.003,0.01,0.05,0.17,0,0.008,0.008,0.004,0,0,0.004,0,0.005,0,0.028,0.009,0.014,0.069,0.009,0.019,0.005,0,0.026,0.004,0,0.025,0.037,0.001,0.05,0.003,0.004,0.037,0.008,0.048,0.004,0.001,0.008,0.007,0.01,0.06,0,0,0.01,0.01,0.004,0.004,0.06,0.004,0.34,0.01,0.01],"y":[0.034,0.041,0.12,0.06,0.07,0.03,0.05,0.01,0.03,0.13,0.24,0.01,0.007,0.007,0.02,0.013,0.02,0.013,0.027,0.04,0.1,0.02,0.007,0.02,0.02,0.013,0.17,0.006,0.014,0.019,0.003,0.019,0.07,0.003,0.11,0.038,0.006,0.003,0.031,0.019,0.04,0.02,0.02,0.01,0.06,0.01,0.03,0.1,0.38,0.17,0.024,0.024,0.09,0.048,0.032,0.024,0.048,0.016,0.003,0.006,0.024,0.003,0.006,0.009,0.006,0.018,0.006,0.003,0.002,0.003,0.006,0.036,0.09,0.06,0.01,0.28,0.08,0.015,0.036,0.01,0.041,0.021,0.01,0.02,0.1,0.08,0.02,0.004,0.07,0.015,0.011,0.008,0.005,0.008,0.05,0.02,0.01,0.04,0.05,0.04,0.01,0.06,0.42,0.07,0.05,0.02,0.02,0.01,0.22,0.01,0.02,0.027,0.05,0.014,0.014,0.01,0.01,0.007,0.06,0.033,0.04,0.01,0.013,0.027,0.003,0.01,0.008,0.02,0.02,0.07,0.025,0.008,0.02,0.01,0.05,0.04,0.11,0.03,0.01,0.09,0.03,0.17,0.019,0.026,0.039,0.039,0.11,0.18,0.12,0.039,0.13,0.019,0.07,0.25,0.01,0.03,0.21,0.1,0.01,0.026,0.043,0.013,0.27,0.013,0.006,0.006,0.003,0.006,0.003,0.009,0.003,0.003,0.012,0.06,0.012,0.03,0.01,0.03,0.03,0.01,0.07,0.01,0.019,0.019,0.01,0.01,0.07,0.01,0.24,0.17,0.01,0.03,0.02,0.15,0.024,0.03,0.008,0.02,0.06,0.006,0.047,0.05,0.006,0.003,0.045,0.017,0.008,0.047,0.02,0.007,0.022,0.13,0.029,0.007,0.051,0.007,0.029,0.007,0.21,0.01,0.02,0.01,0.04,0.02,0.01,0.003,0.007,0.007,0.07,0.012,0.035,0.07,0.012,0.035,0.012,0.035,0.009,0.002,0.023,0.036,0.043,0.06,0.005,0.09,0.005,0.019,0.07,0.005,0.005,0.047,0.004,0.008,0.04,0.07,0.017,0.05,0.06,0.013,0.07,0.003,0.015,0.012,0.17,0.05,0.019,0.07,0.024,0.03,0.002,0.31,0.01,0.01,0.03,0.004,0.06,0.01,0.05,0.01,0.21,0.39,0.02,0.05,0.04,0.02,0.02,0.19,0.01,0.05,0.02,0.01,0.02,0.005,0.002,0.01,0.02,0.01,0.01,0.011,0.008,0.008,0.034,0.013,0.013,0.033,0.015,0.05,0.08,0.024,0.003,0.01,0.013,0.022,0.038,0.016,0.013,0.013,0.16,0.01,0.01,0.003,0.023,0.05,0.013,0.06,0.003,0.026,0.006,0.021,0.015,0.009,0.07,0.018,0.021,0.005,0.1,0.008,0.024,0.005,0.013,0.09,0.003,0.013,0.013,0.046,0.003,0.003,0.016,0.003,0.03,0.01,0.02,0.01,0.04,0.04,0.03,0.15,0.25,0.01,0.8,0.01,0.43,0.01,0.019,0.07,0.029,0.07,0.042,0.013,0.05,0.006,0.09,0.009,0.05,0.006,0.08,0.009,0.009,0.031,0.019,0.04,0.1,0.1,0.01,0.008,0.004,0.07,0.004,0.016,0.012,0.004,0.06,0.004,0.008,0.012,0.07,0.008,0.016,0.012,0.014,0.14,0.011,0.011,0.039,0.005,0.15,0.014,0.011,0.016,0.014,0.007,0.08,0.18,0.011,0.009,0.07,0.01,0.05,0.01,0.02,0.12,0.06,0.03,0.18,0.11,0.09,0.29,0.69,0.01,0.09,0.02,0.01,0.011,0.032,0.13,0.011,0.019,0.008,0.009,0.06,0.008,0.013,0.004,0.08,0.038,0.009,0.004,0.003,0.006,0.02,0.02,0.042,0.006,0.09,0.002,0.018,0.002,0.03,0.008,0.05,0.001,0.007,0.023,0.023,0.011,0.008,0.004,0.008,0.06,0.033,0.02,0.045,0.037,0.18,0.012,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.004,0.012,0.027,0.012,0.002,0.037,0.002,0.002,0.012,0.004,0.002,0.014,0.019,0.06,0.026,0.006,0.006,0.006,0.008,0.004,0.008,0.012,0.07,0.02,0.036,0.09,0.026,0.006,0.01,0.02,0.03,0.07,0.01,0.1,0.02,0.1,0.03,0.1,0.01,0.02,0.05,0.01,0.01,0.03,0.01,0.09,0.01,0.04,0.07,0.09,0.02,0.01,0.02,0.009,0.003,0.009,0.028,0.003,0.011,0.04,0.006,0.017,0.017,0.02,0.05,0.01,0.04,0.1,0.09,0.05,0.09,0.29,0.01,0.04,0.03,0.08,0.05,0.03,0.08,0.005,0.001,0.009,0.032,0.08,0.005,0.005,0.037,0.033,0.013,0.05,0.027,0.027,0.026,0.07,0.08,0.11,0.006,0.026,0.39,0.009,0.05,0.029,0.029,0.06,0.023,0.026,0.05,0.023,0.1,0.05,0.13,0.23,0.002,0.009,0.009,0.008,0.008,0.004,0.009,0.004,0.014,0.005,0.041,0.018,0.028,0.078,0.032,0.046,0.009,0.005,0.028,0.006,0.001,0.036,0.05,0.005,0.07,0.008,0.031,0.07,0.015,0.07,0.01,0.017,0.018,0.013,0.03,0.09,0.004,0.004,0.02,0.11,0.008,0.03,0.11,0.03,0.52,0.02,0.02],"text":["Control: 0.025<br />Experimental: 0.034<br />greater: experi<br />event: isatuximab-irfc + Carfilzomib + Dexamethasone, Pneumonia, Grade 4","Control: 0.030<br />Experimental: 0.041<br />greater: experi<br />event: pembrolizumab + chemotherapy, Diarrhea, Grade 3-4","Control: 0.090<br />Experimental: 0.120<br />greater: experi<br />event: pembrolizumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.038<br />Experimental: 0.060<br />greater: experi<br />event: pembrolizumab + chemotherapy, Stomatitis, Grade 3-4","Control: 0.050<br />Experimental: 0.070<br />greater: experi<br />event: pembrolizumab + chemotherapy, Vomiting, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: tivozanib, Bleeding, Grade 3-4","Control: 0.040<br />Experimental: 0.050<br />greater: experi<br />event: tivozanib, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: tivozanib, Dysphonia, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: tivozanib, Dyspnea, Grade 3-4","Control: 0.120<br />Experimental: 0.130<br />greater: experi<br />event: tivozanib, Fatigue/Asthenia, Grade 3-4","Control: 0.170<br />Experimental: 0.240<br />greater: experi<br />event: tivozanib, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: tivozanib, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: lorlatinib, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: lorlatinib, Back pain, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: lorlatinib, Bronchitis, Grade 3-4","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />event: lorlatinib, Chest pain, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: lorlatinib, Cognitive effects, Grade 3-4","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />event: lorlatinib, Diarrhea, Grade 3-4","Control: 0.021<br />Experimental: 0.027<br />greater: experi<br />event: lorlatinib, Dyspnea, Grade 3-4","Control: 0.014<br />Experimental: 0.040<br />greater: experi<br />event: lorlatinib, Edema, Grade 3-4","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />event: lorlatinib, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: lorlatinib, Mood effects, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: lorlatinib, Myalgia, Grade 3-4","Control: 0.007<br />Experimental: 0.020<br />greater: experi<br />event: lorlatinib, Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: lorlatinib, Respiratory failure, Grade 3-4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />event: lorlatinib, Sleep effects, Grade 3-4","Control: 0.021<br />Experimental: 0.170<br />greater: experi<br />event: lorlatinib, Weight Increased, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />event: cemiplimab-rwlc, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.014<br />greater: experi<br />event: cemiplimab-rwlc, Rash, Grade 3-4","Control: 0.003<br />Experimental: 0.019<br />greater: experi<br />event: nivolumab + cabozantinib, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: nivolumab + cabozantinib, Cough, Grade 3-4","Control: 0.013<br />Experimental: 0.019<br />greater: experi<br />event: nivolumab + cabozantinib, Decreased appetite, Grade 3-4","Control: 0.044<br />Experimental: 0.070<br />greater: experi<br />event: nivolumab + cabozantinib, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: nivolumab + cabozantinib, Dysphonia , Grade 3-4","Control: 0.050<br />Experimental: 0.110<br />greater: experi<br />event: nivolumab + cabozantinib, Hepatotoxicity, Grade 3-4","Control: 0.031<br />Experimental: 0.038<br />greater: experi<br />event: nivolumab + cabozantinib, Musculoskeletal pain, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />event: nivolumab + cabozantinib, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: nivolumab + cabozantinib, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.031<br />greater: experi<br />event: nivolumab + cabozantinib, Rash, Grade 3-4","Control: 0.003<br />Experimental: 0.019<br />greater: experi<br />event: nivolumab + cabozantinib, Vomiting, Grade 3-4","Control: 0.020<br />Experimental: 0.040<br />greater: experi<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Arrhythmia, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Back pain, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Cough, Grade 3-4","Control: 0.040<br />Experimental: 0.060<br />greater: experi<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Muscle spasms, Grade 3-4","Control: 0.020<br />Experimental: 0.030<br />greater: experi<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Peripheral sensory neuropathy, Grade 3-4","Control: 0.050<br />Experimental: 0.100<br />greater: experi<br />event: D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Pneumonia, Grade 3-4","Control: 0.230<br />Experimental: 0.380<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Anemia, Grade 3-4","Control: 0.130<br />Experimental: 0.170<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Decreased appetite, Grade 3-4","Control: 0.016<br />Experimental: 0.024<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Dehydration, Grade 3-4","Control: 0.016<br />Experimental: 0.024<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Diarrhea, Grade 3-4","Control: 0.048<br />Experimental: 0.090<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Fatigue/Asthenia, Grade 3-4","Control: 0.032<br />Experimental: 0.048<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Febrile neutropenia, Grade 3-4","Control: 0.016<br />Experimental: 0.032<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Hepatic function abnormal, Grade 3-4","Control: 0.000<br />Experimental: 0.024<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Interstitial lung disease, Grade 3-4","Control: 0.016<br />Experimental: 0.048<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.016<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: osimertinib, Abdominal Pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: osimertinib, Decreased appetite, Grade ≥ 3","Control: 0.003<br />Experimental: 0.024<br />greater: experi<br />event: osimertinib, Diarrhea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: osimertinib, Dry skin, Grade ≥ 3","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />event: osimertinib, Fatigue/Asthenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />event: osimertinib, Nail toxicity, Grade ≥ 3","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: osimertinib, Rash, Grade ≥ 3","Control: 0.000<br />Experimental: 0.018<br />greater: experi<br />event: osimertinib, Stomatitis, Grade ≥ 3","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: osimertinib, Upper respiratory tract infection, Grade ≥ 3","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: osimertinib, Urinary Tract Infection, Grade ≥ 3","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: relugolix, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: relugolix, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: relugolix, Hot flush, Grade 3-4","Control: 0.000<br />Experimental: 0.036<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Appetite decrease, Grade 3-4","Control: 0.015<br />Experimental: 0.090<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Cataract, Grade 3-4","Control: 0.010<br />Experimental: 0.060<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Dizziness, Grade 3-4","Control: 0.050<br />Experimental: 0.280<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.080<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Nausea, Grade 3-4","Control: 0.010<br />Experimental: 0.015<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Pyrexia, Grade 3-4","Control: 0.015<br />Experimental: 0.036<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Vision blurred, Grade 3-4","Control: 0.000<br />Experimental: 0.041<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Vomiting, Grade 3-4","Control: 0.010<br />Experimental: 0.021<br />greater: experi<br />event: selinexor + bortezomib + dexamethasone, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: sacituzumab govitecan-hziy, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: sacituzumab govitecan-hziy, Decreased appetite, Grade 3-4","Control: 0.010<br />Experimental: 0.100<br />greater: experi<br />event: sacituzumab govitecan-hziy, Diarrhea, Grade 3-4","Control: 0.040<br />Experimental: 0.080<br />greater: experi<br />event: sacituzumab govitecan-hziy, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: sacituzumab govitecan-hziy, Hypokalemia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: margetuximab + chemotherapy, Cough, Grade 3-4","Control: 0.045<br />Experimental: 0.070<br />greater: experi<br />event: margetuximab + chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.015<br />greater: experi<br />event: margetuximab + chemotherapy, Infusion-related reaction, Grade 3-4","Control: 0.004<br />Experimental: 0.011<br />greater: experi<br />event: margetuximab + chemotherapy, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: margetuximab + chemotherapy, Pain in extremity, Grade 3-4","Control: 0.004<br />Experimental: 0.005<br />greater: experi<br />event: pembrolizumab + chemotherapy, Constipation, Grade 3-4","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />event: pembrolizumab + chemotherapy, Decreased appetite, Grade 3-4","Control: 0.043<br />Experimental: 0.050<br />greater: experi<br />event: pembrolizumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: pembrolizumab + chemotherapy, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: venetoclax + azacitidine, Abdominal pain, Grade 3-4","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />event: venetoclax + azacitidine, Decreased appetite, Grade 3-4","Control: 0.030<br />Experimental: 0.050<br />greater: experi<br />event: venetoclax + azacitidine, Diarrhea, Grade 3-4","Control: 0.020<br />Experimental: 0.040<br />greater: experi<br />event: venetoclax + azacitidine, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: venetoclax + azacitidine, Edema, Grade 3-4","Control: 0.020<br />Experimental: 0.060<br />greater: experi<br />event: venetoclax + azacitidine, Fatigue/Asthenia, Grade 3-4","Control: 0.190<br />Experimental: 0.420<br />greater: experi<br />event: venetoclax + azacitidine, Febrile neutropenia, Grade 3-4","Control: 0.030<br />Experimental: 0.070<br />greater: experi<br />event: venetoclax + azacitidine, Hemorrhage, Grade 3-4","Control: 0.030<br />Experimental: 0.050<br />greater: experi<br />event: venetoclax + azacitidine, Hypotension, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: venetoclax + azacitidine, Musculoskeletal pain, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: venetoclax + azacitidine, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: venetoclax + azacitidine, Rash, Grade 3-4","Control: 0.140<br />Experimental: 0.220<br />greater: experi<br />event: venetoclax + azacitidine, Sepsis (excluding fungal), Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: venetoclax + azacitidine, Stomatitis, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: venetoclax + azacitidine, Vomiting, Grade 3-4","Control: 0.013<br />Experimental: 0.027<br />greater: experi<br />event: pembrolizumab, Diarrhea, Grade 3-4","Control: 0.013<br />Experimental: 0.050<br />greater: experi<br />event: pembrolizumab, Pneumonitis, Grade 3-4","Control: 0.000<br />Experimental: 0.014<br />greater: experi<br />event: pembrolizumab, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.014<br />greater: experi<br />event: pembrolizumab, Vomiting, Grade 3-4","Control: 0.007<br />Experimental: 0.010<br />greater: experi<br />event: nivolumab + ipilimumab, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: nivolumab + ipilimumab, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: nivolumab + ipilimumab, Cough, Grade 3-4","Control: 0.011<br />Experimental: 0.060<br />greater: experi<br />event: nivolumab + ipilimumab, Diarrhea, Grade 3-4","Control: 0.011<br />Experimental: 0.033<br />greater: experi<br />event: nivolumab + ipilimumab, Musculoskeletal pain, Grade 3-4","Control: 0.021<br />Experimental: 0.040<br />greater: experi<br />event: nivolumab + ipilimumab, Pneumonia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: nivolumab + ipilimumab, Pruritus, Grade 3-4","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />event: nivolumab + ipilimumab, Pyrexia, Grade 3-4","Control: 0.004<br />Experimental: 0.027<br />greater: experi<br />event: nivolumab + ipilimumab, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: nivolumab + ipilimumab, Upper respiratory tract infection, Grade 3-4","Control: 0.009<br />Experimental: 0.010<br />greater: experi<br />event: elacestrant, Abdominal pain, Grade 3-4","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />event: elacestrant, Decreased appetite , Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: elacestrant, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: elacestrant, Headache, Grade 3-4","Control: 0.010<br />Experimental: 0.070<br />greater: experi<br />event: elacestrant, Musculoskeletal pain, Grade 3-4","Control: 0.009<br />Experimental: 0.025<br />greater: experi<br />event: elacestrant, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: elacestrant, Vomiting, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: azacitidine, Abdominal pain, TYPO","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: azacitidine, Constipation, TYPO","Control: 0.010<br />Experimental: 0.050<br />greater: experi<br />event: azacitidine, Diarrhea, TYPO","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />event: azacitidine, Fatigue/Asthenia, TYPO","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />event: azacitidine, Febrile neutropenia, TYPO","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: azacitidine, Nausea, TYPO","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: azacitidine, Pain in extremity, TYPO","Control: 0.050<br />Experimental: 0.090<br />greater: experi<br />event: azacitidine, Pneumonia, TYPO","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />event: azacitidine, Vomiting, TYPO","Control: 0.140<br />Experimental: 0.170<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Anemia, Grade 3-4","Control: 0.013<br />Experimental: 0.019<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Back pain, Grade 3-4","Control: 0.013<br />Experimental: 0.026<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Bronchitis, Grade 3-4","Control: 0.007<br />Experimental: 0.039<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Diarrhea, Grade 3-4","Control: 0.026<br />Experimental: 0.039<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Dyspnea, Grade 3-4","Control: 0.080<br />Experimental: 0.110<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Fatigue/Asthenia, Grade 3-4","Control: 0.130<br />Experimental: 0.180<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Hypertension, Grade 3-4","Control: 0.050<br />Experimental: 0.120<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Infusion-related reaction, Grade 3-4","Control: 0.020<br />Experimental: 0.039<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Insomnia, Grade 3-4","Control: 0.090<br />Experimental: 0.130<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Pneumonia, Grade 3-4","Control: 0.007<br />Experimental: 0.019<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Pyrexia, Grade 3-4","Control: 0.033<br />Experimental: 0.070<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Respiratory infection, Grade 3-4","Control: 0.160<br />Experimental: 0.250<br />greater: experi<br />event: carfilzomib + daratumumab + dexamethasone, Thrombocytopenia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Edema, Grade 3-4","Control: 0.018<br />Experimental: 0.030<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Fatigue/Asthenia, Grade 3-4","Control: 0.130<br />Experimental: 0.210<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Hepatotoxicity, Grade 3-4","Control: 0.070<br />Experimental: 0.100<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Hyperthyroidism, Grade 3-4","Control: 0.010<br />Experimental: 0.026<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Infusion-related reaction, Grade 3-4","Control: 0.032<br />Experimental: 0.043<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Musculoskeletal pain, Grade 3-4","Control: 0.010<br />Experimental: 0.013<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Pneumonitis, Grade 3-4","Control: 0.230<br />Experimental: 0.270<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Rash, Grade 3-4","Control: 0.010<br />Experimental: 0.013<br />greater: experi<br />event: atezolizumab +  cobimetinib + vemurafenib, Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: avelumab, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: avelumab, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: avelumab, Cough, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />event: avelumab, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: avelumab, Hypothyroidism, Grade 3-4","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />event: avelumab, Infusion-related reaction, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: avelumab, Pruritus, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: avelumab, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />event: avelumab, Rash, Grade 3-4","Control: 0.038<br />Experimental: 0.060<br />greater: experi<br />event: avelumab, Urinary tract infection, Grade 3-4","Control: 0.006<br />Experimental: 0.012<br />greater: experi<br />event: avelumab, Vomiting, Grade 3-4","Control: 0.020<br />Experimental: 0.030<br />greater: experi<br />event: pembrolizumab, Alanine aminotransferase increased, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Arthralgia, Grade ≥3","Control: 0.020<br />Experimental: 0.030<br />greater: experi<br />event: pembrolizumab, Aspartate aminotransferase increased, Grade ≥3","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: pembrolizumab, Blood alkaline phosphatase increase, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Dyspnea, Grade ≥3","Control: 0.050<br />Experimental: 0.070<br />greater: experi<br />event: pembrolizumab, Hypertension, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Pyrexia, Grade ≥3","Control: 0.014<br />Experimental: 0.019<br />greater: experi<br />event: nivolumab, Diarrhea, Grade 3-4","Control: 0.010<br />Experimental: 0.019<br />greater: experi<br />event: nivolumab, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: nivolumab, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Pneumonitis, Grade 4","Control: 0.010<br />Experimental: 0.070<br />greater: experi<br />event: ramucirumab + erlotinib, Diarrhea, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: ramucirumab + erlotinib, Headache, Grade ≥ 3","Control: 0.050<br />Experimental: 0.240<br />greater: experi<br />event: ramucirumab + erlotinib, Hypertension, Grade ≥ 3","Control: 0.070<br />Experimental: 0.170<br />greater: experi<br />event: ramucirumab + erlotinib, Infections, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: ramucirumab + erlotinib, Peripheral edema, Grade ≥ 3","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />event: ramucirumab + erlotinib, Proteinuria, Grade ≥ 3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: ramucirumab + erlotinib, Stomatitis, Grade ≥ 3","Control: 0.120<br />Experimental: 0.150<br />greater: experi<br />event: atezolizumab + bevacizumab, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.024<br />greater: experi<br />event: atezolizumab + bevacizumab, Infusion-related reaction, Grade 3-4","Control: 0.006<br />Experimental: 0.030<br />greater: experi<br />event: atezolizumab + bevacizumab, Proteinuria, Grade 3-4","Control: 0.006<br />Experimental: 0.008<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Alopecia, Grade 3-4","Control: 0.017<br />Experimental: 0.020<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Decreased appetite, Grade 3-4","Control: 0.017<br />Experimental: 0.060<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Dizziness, Grade 3-4","Control: 0.032<br />Experimental: 0.047<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Dyspnea, Grade 3-4","Control: 0.049<br />Experimental: 0.050<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Hypothyroidism, Grade 3-4","Control: 0.020<br />Experimental: 0.045<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Musculoskeletal pain, Grade 3-4","Control: 0.009<br />Experimental: 0.017<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Pruritus, Grade 3-4","Control: 0.003<br />Experimental: 0.047<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Rash, Grade 3-4","Control: 0.014<br />Experimental: 0.020<br />greater: experi<br />event: nivolumab + ipilimumab + chemotherapy, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: brigatinib, Bradycardia, Grade 3-4","Control: 0.000<br />Experimental: 0.022<br />greater: experi<br />event: brigatinib, Headache, Grade 3-4","Control: 0.029<br />Experimental: 0.130<br />greater: experi<br />event: brigatinib, Hypertension, Grade 3-4","Control: 0.007<br />Experimental: 0.029<br />greater: experi<br />event: brigatinib, ILD/Pneumonitis, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: brigatinib, Peripheral neuropathy, Grade 3-4","Control: 0.029<br />Experimental: 0.051<br />greater: experi<br />event: brigatinib, Pneumonia, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: brigatinib, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.029<br />greater: experi<br />event: brigatinib, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: brigatinib, Stomatitis, Grade 3-4","Control: 0.050<br />Experimental: 0.210<br />greater: experi<br />event: olaparib, Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: olaparib, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: olaparib, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: olaparib, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.040<br />greater: experi<br />event: olaparib, Thrombocytopenia, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: olaparib, Vomiting, Grade 3-4","Control: 0.008<br />Experimental: 0.010<br />greater: experi<br />event: atezolizumab, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: atezolizumab, Cough, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: atezolizumab, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: atezolizumab, Dyspnea, Grade 3-4","Control: 0.047<br />Experimental: 0.070<br />greater: experi<br />event: ripretinib, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />event: ripretinib, Constipation, Grade 3-4","Control: 0.023<br />Experimental: 0.035<br />greater: experi<br />event: ripretinib, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />event: ripretinib, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />event: ripretinib, Myalgia, Grade 3-4","Control: 0.000<br />Experimental: 0.035<br />greater: experi<br />event: ripretinib, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />event: ripretinib, Peripheral edema, Grade 3-4","Control: 0.000<br />Experimental: 0.035<br />greater: experi<br />event: ripretinib, Vomiting, Grade 3-4","Control: 0.002<br />Experimental: 0.009<br />greater: experi<br />event: nivolumab + ipilimumab, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: nivolumab + ipilimumab, Cough, Grade 3-4","Control: 0.014<br />Experimental: 0.023<br />greater: experi<br />event: nivolumab + ipilimumab, Decreased appetite, Grade 3-4","Control: 0.009<br />Experimental: 0.036<br />greater: experi<br />event: nivolumab + ipilimumab, Diarrhea/colitis, Grade 3-4","Control: 0.021<br />Experimental: 0.043<br />greater: experi<br />event: nivolumab + ipilimumab, Dyspnea, Grade 3-4","Control: 0.044<br />Experimental: 0.060<br />greater: experi<br />event: nivolumab + ipilimumab, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: nivolumab + ipilimumab, Headache, Grade 3-4","Control: 0.012<br />Experimental: 0.090<br />greater: experi<br />event: nivolumab + ipilimumab, Hepatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: nivolumab + ipilimumab, Hypothyroidism, Grade 3-4","Control: 0.007<br />Experimental: 0.019<br />greater: experi<br />event: nivolumab + ipilimumab, Musculoskeletal pain, Grade 3-4","Control: 0.040<br />Experimental: 0.070<br />greater: experi<br />event: nivolumab + ipilimumab, Pneumonia, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: nivolumab + ipilimumab, Pruritus, Grade 3-4","Control: 0.004<br />Experimental: 0.005<br />greater: experi<br />event: nivolumab + ipilimumab, Pyrexia, Grade 3-4","Control: 0.004<br />Experimental: 0.047<br />greater: experi<br />event: nivolumab + ipilimumab, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: zanubrutinib, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: zanubrutinib, Dizziness, Grade 3-4","Control: 0.004<br />Experimental: 0.040<br />greater: experi<br />event: zanubrutinib, Hemorrhage, Grade 3-4","Control: 0.026<br />Experimental: 0.070<br />greater: experi<br />event: zanubrutinib, Hypertension, Grade 3-4","Control: 0.004<br />Experimental: 0.017<br />greater: experi<br />event: zanubrutinib, Musculoskeletal pain, Grade 3-4","Control: 0.040<br />Experimental: 0.050<br />greater: experi<br />event: zanubrutinib, Pneumonia, Grade 3-4","Control: 0.004<br />Experimental: 0.060<br />greater: experi<br />event: zanubrutinib, Second primary malignancyl, Grade 3-4","Control: 0.009<br />Experimental: 0.013<br />greater: experi<br />event: zanubrutinib, Upper respiratory tract infection, Grade 3-4","Control: 0.046<br />Experimental: 0.070<br />greater: experi<br />event: zanubrutinib, COVID-19, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: zanubrutinib, Cough, Grade 3-4","Control: 0.009<br />Experimental: 0.015<br />greater: experi<br />event: zanubrutinib, Diarrhea, Grade 3-4","Control: 0.009<br />Experimental: 0.012<br />greater: experi<br />event: zanubrutinib, Rash, Grade 3-4","Control: 0.004<br />Experimental: 0.170<br />greater: experi<br />event: olaparib + bevacizumab, Anemia, TYPO","Control: 0.015<br />Experimental: 0.050<br />greater: experi<br />event: olaparib + bevacizumab, Fatigue/Asthenia, TYPO","Control: 0.015<br />Experimental: 0.019<br />greater: experi<br />event: olaparib + bevacizumab, Leukopenia, TYPO","Control: 0.011<br />Experimental: 0.070<br />greater: experi<br />event: olaparib + bevacizumab, Lymphopenia, TYPO","Control: 0.007<br />Experimental: 0.024<br />greater: experi<br />event: olaparib + bevacizumab, Nausea, TYPO","Control: 0.008<br />Experimental: 0.030<br />greater: experi<br />event: niraparib, AST/ALT elevation, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: niraparib, Acute kidney injury, Grade 3-4","Control: 0.020<br />Experimental: 0.310<br />greater: experi<br />event: niraparib, Anemia, Grade 3-4","Control: 0.004<br />Experimental: 0.010<br />greater: experi<br />event: niraparib, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: niraparib, Decreased appetite, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: niraparib, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: niraparib, Headache, Grade 3-4","Control: 0.010<br />Experimental: 0.060<br />greater: experi<br />event: niraparib, Hypertension, Grade 3-4","Control: 0.004<br />Experimental: 0.010<br />greater: experi<br />event: niraparib, Insomnia, Grade 3-4","Control: 0.004<br />Experimental: 0.050<br />greater: experi<br />event: niraparib, Leukopenia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: niraparib, Musculoskeletal pain, Grade 3-4","Control: 0.010<br />Experimental: 0.210<br />greater: experi<br />event: niraparib, Neutropenia, Grade 3-4","Control: 0.004<br />Experimental: 0.390<br />greater: experi<br />event: niraparib, Thrombocytopenia, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: ibrutinib + rituximab, Abdominal pain, Grade ≥ 3","Control: 0.010<br />Experimental: 0.050<br />greater: experi<br />event: ibrutinib + rituximab, Arthralgia, Grade ≥ 3","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />event: ibrutinib + rituximab, Diarrhea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: ibrutinib + rituximab, Dyspnea, Grade ≥ 3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: ibrutinib + rituximab, Hemorrhage, Grade ≥ 3","Control: 0.060<br />Experimental: 0.190<br />greater: experi<br />event: ibrutinib + rituximab, Hypertension, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: ibrutinib + rituximab, Hyperuricemia, Grade ≥ 3","Control: 0.020<br />Experimental: 0.050<br />greater: experi<br />event: ibrutinib + rituximab, Musculoskeletal pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: ibrutinib + rituximab, Pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: ibrutinib + rituximab, Peripheral edema, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: ibrutinib + rituximab, Vomiting, Grade ≥ 3","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: tucatinib + trastuzumab + capecitabine, Diarrhea, Grade 4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: tucatinib + trastuzumab + capecitabine, Hepatotoxicity, Grade 4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: encorafenib + cetuximab, Arthralgia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: encorafenib + cetuximab, Hemorrhage, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: encorafenib + cetuximab, Myopathy, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: encorafenib + cetuximab, Peripheral neuropathy, Grade ≥ 3","Control: 0.008<br />Experimental: 0.011<br />greater: experi<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Alopecia, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Cough/Productive Cough, Grade 3-4","Control: 0.023<br />Experimental: 0.034<br />greater: experi<br />event: durvalumab + Etoposide + either Carboplatin or Cisplatin , Fatigue/Asthenia, Grade 3-4","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />event: isatuximab-irfc + pomalidomide + dexamethasone, Febrile neutropenia, Grade 4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />event: isatuximab-irfc + pomalidomide + dexamethasone, Infusion-related reaction, Grade 4","Control: 0.027<br />Experimental: 0.033<br />greater: experi<br />event: isatuximab-irfc + pomalidomide + dexamethasone, Pneumonia, Grade 4","Control: 0.012<br />Experimental: 0.015<br />greater: experi<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Decreased appetite, Grade 3-4","Control: 0.045<br />Experimental: 0.050<br />greater: experi<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.042<br />Experimental: 0.080<br />greater: experi<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Pneumonia, Grade 3-4","Control: 0.006<br />Experimental: 0.024<br />greater: experi<br />event: tremelimumab + durvalumab + platinum-based chemotherapy, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Diarrhea, Grade 3-4","Control: 0.007<br />Experimental: 0.022<br />greater: experi<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Dyspnea, Grade 3-4","Control: 0.020<br />Experimental: 0.038<br />greater: experi<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.016<br />greater: experi<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />event: cemiplimab-rwlc + platinum-based chemotherapy, Weight decreased , Grade 3-4","Control: 0.033<br />Experimental: 0.160<br />greater: experi<br />event: olaparib + abiraterone + prednisone (or prednisolone), Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: olaparib + abiraterone + prednisone (or prednisolone), Decreased appetite, Grade 3-4","Control: 0.003<br />Experimental: 0.010<br />greater: experi<br />event: olaparib + abiraterone + prednisone (or prednisolone), Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: olaparib + abiraterone + prednisone (or prednisolone), Dizziness, Grade 3-4","Control: 0.015<br />Experimental: 0.023<br />greater: experi<br />event: olaparib + abiraterone + prednisone (or prednisolone), Fatigue/Asthenia, Grade 3-4","Control: 0.018<br />Experimental: 0.050<br />greater: experi<br />event: olaparib + abiraterone + prednisone (or prednisolone), Lymphopenia, Grade 3-4","Control: 0.008<br />Experimental: 0.013<br />greater: experi<br />event: tremelimumab + durvalumab, Decreased appetite, Grade 3-4","Control: 0.043<br />Experimental: 0.060<br />greater: experi<br />event: tremelimumab + durvalumab, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: tremelimumab + durvalumab, Insomnia, Grade 3-4","Control: 0.008<br />Experimental: 0.026<br />greater: experi<br />event: tremelimumab + durvalumab, Musculoskeletal pain, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />event: durvalumab + gemcitabine + cisplatin, Constipation, Grade 3-4","Control: 0.009<br />Experimental: 0.021<br />greater: experi<br />event: durvalumab + gemcitabine + cisplatin, Decreased appetite, Grade 3-4","Control: 0.006<br />Experimental: 0.015<br />greater: experi<br />event: durvalumab + gemcitabine + cisplatin, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />event: durvalumab + gemcitabine + cisplatin, Rash, Grade 3-4","Control: 0.037<br />Experimental: 0.070<br />greater: experi<br />event: darolutamide + docetaxel, Hypertension, Grade 3-4","Control: 0.002<br />Experimental: 0.018<br />greater: experi<br />event: darolutamide + docetaxel, Rash, Grade 3-4","Control: 0.012<br />Experimental: 0.021<br />greater: experi<br />event: darolutamide + docetaxel, Weight Increased, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Abdominal pain, Grade 3-4","Control: 0.050<br />Experimental: 0.100<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Constipation, Grade 3-4","Control: 0.012<br />Experimental: 0.024<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Dizziness, Grade 3-4","Control: 0.012<br />Experimental: 0.013<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Dyspnea, Grade 3-4","Control: 0.047<br />Experimental: 0.090<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.013<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Interstitial lung disease, Grade 3-4","Control: 0.006<br />Experimental: 0.013<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.046<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Upper respiratory tract infection, Grade 3-4","Control: 0.000<br />Experimental: 0.016<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Weight decreased , Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: lisocabtagene maraleucel, Abdominal pain, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: lisocabtagene maraleucel, Asthenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: lisocabtagene maraleucel, Constipation, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: lisocabtagene maraleucel, Cytokine release syndrome, Grade ≥ 3","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />event: lisocabtagene maraleucel, Headache, Grade ≥ 3","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />event: lisocabtagene maraleucel, Hypertension, Grade ≥ 3","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />event: lisocabtagene maraleucel, Hypotension, Grade ≥ 3","Control: 0.120<br />Experimental: 0.150<br />greater: experi<br />event: lisocabtagene maraleucel, Leukopenia, Grade ≥ 3","Control: 0.090<br />Experimental: 0.250<br />greater: experi<br />event: lisocabtagene maraleucel, Lymphopenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: lisocabtagene maraleucel, Myalgia, Grade ≥ 3","Control: 0.510<br />Experimental: 0.800<br />greater: experi<br />event: lisocabtagene maraleucel, Neutropenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: lisocabtagene maraleucel, Peripheral edema, Grade ≥ 3","Control: 0.030<br />Experimental: 0.430<br />greater: experi<br />event: lisocabtagene maraleucel, Prolonged cytopeniat, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: lisocabtagene maraleucel, Tremor, Grade ≥ 3","Control: 0.007<br />Experimental: 0.019<br />greater: experi<br />event: nivolumab + chemotherapy, Abdominal pain, Grade 3-4","Control: 0.060<br />Experimental: 0.070<br />greater: experi<br />event: nivolumab + chemotherapy, Decreased appetite, Grade 3-4","Control: 0.020<br />Experimental: 0.029<br />greater: experi<br />event: nivolumab + chemotherapy, Diarrhea, Grade 3-4","Control: 0.049<br />Experimental: 0.070<br />greater: experi<br />event: nivolumab + chemotherapy, Dysphagia, Grade 3-4","Control: 0.026<br />Experimental: 0.042<br />greater: experi<br />event: nivolumab + chemotherapy, Nausea, Grade 3-4","Control: 0.010<br />Experimental: 0.013<br />greater: experi<br />event: nivolumab + chemotherapy, Peripheral neuropathy, Grade 3-4","Control: 0.026<br />Experimental: 0.050<br />greater: experi<br />event: nivolumab + chemotherapy, Pneumonia, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: nivolumab + chemotherapy, Rash, Grade 3-4","Control: 0.030<br />Experimental: 0.090<br />greater: experi<br />event: nivolumab + chemotherapy, Stomatitis, Grade 3-4","Control: 0.007<br />Experimental: 0.009<br />greater: experi<br />event: nivolumab + ipilimumab, Abdominal pain, Grade 3-4","Control: 0.049<br />Experimental: 0.050<br />greater: experi<br />event: nivolumab + ipilimumab, Dysphagia, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />event: nivolumab + ipilimumab, Musculoskeletal pain, Grade 3-4","Control: 0.026<br />Experimental: 0.080<br />greater: experi<br />event: nivolumab + ipilimumab, Pneumonia, Grade 3-4","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />event: nivolumab + ipilimumab, Pruritus, Grade 3-4","Control: 0.003<br />Experimental: 0.009<br />greater: experi<br />event: nivolumab + ipilimumab, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.031<br />greater: experi<br />event: nivolumab + ipilimumab, Rash, Grade 3-4","Control: 0.010<br />Experimental: 0.019<br />greater: experi<br />event: nivolumab + ipilimumab, Weight decreased , Grade 3-4","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />event: ivosidenib + azacitidine, Arthralgia, Grade ≥ 3","Control: 0.080<br />Experimental: 0.100<br />greater: experi<br />event: ivosidenib + azacitidine, Differentiation Syndrome, Grade ≥ 3","Control: 0.030<br />Experimental: 0.100<br />greater: experi<br />event: ivosidenib + azacitidine, Electrocardiogram QT prolonged, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: ivosidenib + azacitidine, Insomnia, Grade ≥ 3","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Alopecia, Grade 3-4","Control: 0.060<br />Experimental: 0.070<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Cough, Grade 3-4","Control: 0.004<br />Experimental: 0.016<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Decreased appetite, Grade 3-4","Control: 0.004<br />Experimental: 0.012<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Dizziness, Grade 3-4","Control: 0.008<br />Experimental: 0.060<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Headache, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Interstitial lung disease, Grade 3-4","Control: 0.004<br />Experimental: 0.012<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Musculoskeletal pain, Grade 3-4","Control: 0.004<br />Experimental: 0.070<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Stomatitis, Grade 3-4","Control: 0.008<br />Experimental: 0.016<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Vomiting, Grade 3-4","Control: 0.004<br />Experimental: 0.012<br />greater: experi<br />event: fam-trastuzumab deruxtecan-nxki, Weight decreased , Grade 3-4","Control: 0.005<br />Experimental: 0.014<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Alanine aminotransferase increased, Grade 3-4","Control: 0.110<br />Experimental: 0.140<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Anemia, Grade 3-4","Control: 0.002<br />Experimental: 0.011<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Constipation, Grade 3-4","Control: 0.007<br />Experimental: 0.011<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Decreased appetite, Grade 3-4","Control: 0.018<br />Experimental: 0.039<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Diarrhea, Grade 3-4","Control: 0.002<br />Experimental: 0.005<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Edema, Grade 3-4","Control: 0.090<br />Experimental: 0.150<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Febrile neutropenia, Grade 3-4","Control: 0.005<br />Experimental: 0.014<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Mucositis, Grade 3-4","Control: 0.005<br />Experimental: 0.011<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Nausea, Grade 3-4","Control: 0.011<br />Experimental: 0.016<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Peripheral neuropathy, Grade 3-4","Control: 0.000<br />Experimental: 0.014<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Rash, Grade 3-4","Control: 0.060<br />Experimental: 0.080<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Thrombocytopenia, Grade 3-4","Control: 0.160<br />Experimental: 0.180<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Uric acid increased, Grade 3-4","Control: 0.007<br />Experimental: 0.011<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Vomiting, Grade 3-4","Control: 0.002<br />Experimental: 0.009<br />greater: experi<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />event: axicabtagene ciloleucel, Aphasia, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: axicabtagene ciloleucel, Chills, Grade ≥3","Control: 0.000<br />Experimental: 0.050<br />greater: experi<br />event: axicabtagene ciloleucel, Confusional state, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: axicabtagene ciloleucel, Cough, Grade ≥3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: axicabtagene ciloleucel, Delirium, Grade ≥3","Control: 0.000<br />Experimental: 0.120<br />greater: experi<br />event: axicabtagene ciloleucel, Encephalopathy, Grade ≥3","Control: 0.020<br />Experimental: 0.060<br />greater: experi<br />event: axicabtagene ciloleucel, Fatigue/Asthenia, Grade ≥3","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: axicabtagene ciloleucel, Headache, Grade ≥3","Control: 0.120<br />Experimental: 0.180<br />greater: experi<br />event: axicabtagene ciloleucel, Hypophosphatemia, Grade ≥3","Control: 0.030<br />Experimental: 0.110<br />greater: experi<br />event: axicabtagene ciloleucel, Hypotension, Grade ≥3","Control: 0.040<br />Experimental: 0.090<br />greater: experi<br />event: axicabtagene ciloleucel, Hypoxia, Grade ≥3","Control: 0.220<br />Experimental: 0.290<br />greater: experi<br />event: axicabtagene ciloleucel, Leukopenia, Grade ≥3","Control: 0.410<br />Experimental: 0.690<br />greater: experi<br />event: axicabtagene ciloleucel, Neutropenia, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: axicabtagene ciloleucel, Paresthesia, Grade ≥3","Control: 0.010<br />Experimental: 0.090<br />greater: experi<br />event: axicabtagene ciloleucel, Pyrexia, Grade ≥3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: axicabtagene ciloleucel, Sinus tachycardia, Grade ≥3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: axicabtagene ciloleucel, Tremor, Grade ≥3","Control: 0.005<br />Experimental: 0.011<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Abdominal pain, Grade 3-4","Control: 0.029<br />Experimental: 0.032<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Acute kidney injury, Grade 3-4","Control: 0.049<br />Experimental: 0.130<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Anemia, Grade 3-4","Control: 0.005<br />Experimental: 0.011<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Constipation, Grade 3-4","Control: 0.005<br />Experimental: 0.019<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Decreased appetite, Grade 3-4","Control: 0.005<br />Experimental: 0.008<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Dizziness, Grade 3-4","Control: 0.015<br />Experimental: 0.060<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Headache, Grade 3-4","Control: 0.005<br />Experimental: 0.013<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Pyrexia, Grade 3-4","Control: 0.010<br />Experimental: 0.080<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Thrombocytopenia, Grade 3-4","Control: 0.005<br />Experimental: 0.038<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Urinary tract infection, Grade 3-4","Control: 0.005<br />Experimental: 0.009<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: lutetium Lu 177 vipivotide tetraxetan + standard of care, Weight decreased , Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: relatlimab-rmbw +nivolumab, Cough, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />event: relatlimab-rmbw +nivolumab, Decreased appetite, Grade 3-4","Control: 0.014<br />Experimental: 0.020<br />greater: experi<br />event: relatlimab-rmbw +nivolumab, Diarrhea, Grade 3-4","Control: 0.006<br />Experimental: 0.020<br />greater: experi<br />event: relatlimab-rmbw +nivolumab, Fatigue/Asthenia, Grade 3-4","Control: 0.017<br />Experimental: 0.042<br />greater: experi<br />event: relatlimab-rmbw +nivolumab, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: relatlimab-rmbw +nivolumab, Nausea, Grade 3-4","Control: 0.003<br />Experimental: 0.090<br />greater: experi<br />event: olaparib, Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: olaparib, Decreased appetite, Grade 3-4","Control: 0.007<br />Experimental: 0.018<br />greater: experi<br />event: olaparib, Fatigue/Asthenia, Grade 3-4","Control: 0.001<br />Experimental: 0.002<br />greater: experi<br />event: olaparib, Headache, Grade 3-4","Control: 0.003<br />Experimental: 0.030<br />greater: experi<br />event: olaparib, Leukopenia, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: olaparib, Nausea, Grade 3-4","Control: 0.008<br />Experimental: 0.050<br />greater: experi<br />event: olaparib, Neutropenia, Grade 3-4","Control: 0.000<br />Experimental: 0.001<br />greater: experi<br />event: olaparib, Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.007<br />greater: experi<br />event: olaparib, Vomiting, Grade 3-4","Control: 0.011<br />Experimental: 0.023<br />greater: experi<br />event: nivolumab + platinum-doublet chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.023<br />greater: experi<br />event: nivolumab + platinum-doublet chemotherapy, Rash, Grade 3-4","Control: 0.006<br />Experimental: 0.011<br />greater: experi<br />event: nivolumab + platinum-doublet chemotherapy, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: tebentafusp-tebn, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: tebentafusp-tebn, Chills, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: tebentafusp-tebn, Cytokine release syndrome, Grade 3-4","Control: 0.009<br />Experimental: 0.060<br />greater: experi<br />event: tebentafusp-tebn, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.033<br />greater: experi<br />event: tebentafusp-tebn, Hypotension, Grade 3-4","Control: 0.009<br />Experimental: 0.020<br />greater: experi<br />event: tebentafusp-tebn, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.045<br />greater: experi<br />event: tebentafusp-tebn, Pruritus, Grade 3-4","Control: 0.009<br />Experimental: 0.037<br />greater: experi<br />event: tebentafusp-tebn, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.180<br />greater: experi<br />event: tebentafusp-tebn, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />event: tebentafusp-tebn, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Arthralgia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Asthenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Fatigue/Asthenia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Hyperthyroidism, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Myalgia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Pruritus, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: pembrolizumab, Rash maculopapular, Grade ≥ 3","Control: 0.002<br />Experimental: 0.004<br />greater: experi<br />event: pembrolizumab, Abdominal pain, Grade 3-4","Control: 0.002<br />Experimental: 0.012<br />greater: experi<br />event: pembrolizumab, Acute kidney injury, Grade 3-4","Control: 0.002<br />Experimental: 0.027<br />greater: experi<br />event: pembrolizumab, Diarrhea, Grade 3-4","Control: 0.002<br />Experimental: 0.012<br />greater: experi<br />event: pembrolizumab, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: pembrolizumab, Headache, Grade 3-4","Control: 0.006<br />Experimental: 0.037<br />greater: experi<br />event: pembrolizumab, Hepatotoxicity, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: pembrolizumab, Hyperthyroidism , Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: pembrolizumab, Hypothyroidism, Grade 3-4","Control: 0.006<br />Experimental: 0.012<br />greater: experi<br />event: pembrolizumab, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: pembrolizumab, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: pembrolizumab, Pruritus, Grade 3-4","Control: 0.004<br />Experimental: 0.014<br />greater: experi<br />event: pembrolizumab, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.019<br />greater: experi<br />event: asciminib, Headache, Grade 3-4","Control: 0.039<br />Experimental: 0.060<br />greater: experi<br />event: asciminib, Hypertension, Grade 3-4","Control: 0.013<br />Experimental: 0.026<br />greater: experi<br />event: asciminib, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: asciminib, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: atezolizumab, Arthralgia, Grade 3-4","Control: 0.002<br />Experimental: 0.006<br />greater: experi<br />event: atezolizumab, Fatigue/Asthenia, Grade 3-4","Control: 0.002<br />Experimental: 0.008<br />greater: experi<br />event: atezolizumab, Musculoskeletal pain, Grade 3-4","Control: 0.002<br />Experimental: 0.004<br />greater: experi<br />event: atezolizumab, Peripheral neuropathy, Grade 3-4","Control: 0.002<br />Experimental: 0.008<br />greater: experi<br />event: atezolizumab, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.012<br />greater: experi<br />event: atezolizumab, Rash, Grade 3-4","Control: 0.060<br />Experimental: 0.070<br />greater: experi<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Fatigue/Asthenia, Grade 3-4","Control: 0.016<br />Experimental: 0.020<br />greater: experi<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Nausea, Grade 3-4","Control: 0.003<br />Experimental: 0.036<br />greater: experi<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Rash, Grade 3-4","Control: 0.080<br />Experimental: 0.090<br />greater: experi<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Urinary tract infection, Grade 3-4","Control: 0.019<br />Experimental: 0.026<br />greater: experi<br />event: pembrolizumab + chemotherapy + (bevacizumab?), Vomiting, Grade 3-4","Control: 0.001<br />Experimental: 0.006<br />greater: experi<br />event: abemaciclib + endocrine therapy, Infections, Grade 4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: ruxolitinib, Musculoskeletal pain, Grade ≥ 3","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: ruxolitinib, Pyrexia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />event: cabozantinib, Decreased appetite, Grade 3-4","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />event: cabozantinib, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: cabozantinib, Dry mouth, Grade 3-4","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />event: cabozantinib, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: cabozantinib, Headache, Grade 3-4","Control: 0.030<br />Experimental: 0.100<br />greater: experi<br />event: cabozantinib, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.030<br />greater: experi<br />event: cabozantinib, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.100<br />greater: experi<br />event: cabozantinib, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: cabozantinib, Proteinuria, Grade 3-4","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: cabozantinib, Pulmonary embolism, Grade 3-4","Control: 0.000<br />Experimental: 0.050<br />greater: experi<br />event: cabozantinib, Stomatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: cabozantinib, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: cabozantinib, Weight decreased , Grade 3-4","Control: 0.020<br />Experimental: 0.030<br />greater: experi<br />event: zanubrutinib, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: zanubrutinib, Dizziness, Grade 3-4","Control: 0.010<br />Experimental: 0.090<br />greater: experi<br />event: zanubrutinib, Musculoskeletal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: zanubrutinib, Pruritus, Grade 3-4","Control: 0.020<br />Experimental: 0.040<br />greater: experi<br />event: zanubrutinib, Pyrexia, Grade 3-4","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />event: ivosidenib, Anemia, Grade ≥ 3","Control: 0.070<br />Experimental: 0.090<br />greater: experi<br />event: ivosidenib, Ascites, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: ivosidenib, Decreased appetite, Grade ≥ 3","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: ivosidenib, Rash, Grade ≥ 3","Control: 0.000<br />Experimental: 0.020<br />greater: experi<br />event: ivosidenib, Vomiting, Grade ≥ 3","Control: 0.006<br />Experimental: 0.009<br />greater: experi<br />event: nivolumab, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: nivolumab, Arthralgia, Grade 3-4","Control: 0.003<br />Experimental: 0.009<br />greater: experi<br />event: nivolumab, Decreased appetite, Grade 3-4","Control: 0.017<br />Experimental: 0.028<br />greater: experi<br />event: nivolumab, Diarrhea, Grade 3-4","Control: 0.000<br />Experimental: 0.003<br />greater: experi<br />event: nivolumab, Dizziness, Grade 3-4","Control: 0.003<br />Experimental: 0.011<br />greater: experi<br />event: nivolumab, Fatigue/Asthenia, Grade 3-4","Control: 0.006<br />Experimental: 0.040<br />greater: experi<br />event: nivolumab, Hepatitis, Grade 3-4","Control: 0.000<br />Experimental: 0.006<br />greater: experi<br />event: nivolumab, Nausea, Grade 3-4","Control: 0.003<br />Experimental: 0.017<br />greater: experi<br />event: nivolumab, Rash, Grade 3-4","Control: 0.009<br />Experimental: 0.017<br />greater: experi<br />event: nivolumab, Renal dysfunction, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: lenvatinib + pembrolizumab, Abdominal pain, Grade 3-4","Control: 0.020<br />Experimental: 0.050<br />greater: experi<br />event: lenvatinib + pembrolizumab, Acute kidney injury, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: lenvatinib + pembrolizumab, Constipation, Grade 3-4","Control: 0.010<br />Experimental: 0.040<br />greater: experi<br />event: lenvatinib + pembrolizumab, Decreased appetite, Grade 3-4","Control: 0.060<br />Experimental: 0.100<br />greater: experi<br />event: lenvatinib + pembrolizumab, Diarrhea, Grade 3-4","Control: 0.080<br />Experimental: 0.090<br />greater: experi<br />event: lenvatinib + pembrolizumab, Fatigue/Asthenia, Grade 3-4","Control: 0.040<br />Experimental: 0.050<br />greater: experi<br />event: lenvatinib + pembrolizumab, Hemorrhagic events, Grade 3-4","Control: 0.050<br />Experimental: 0.090<br />greater: experi<br />event: lenvatinib + pembrolizumab, Hepatotoxicity, Grade 3-4","Control: 0.200<br />Experimental: 0.290<br />greater: experi<br />event: lenvatinib + pembrolizumab, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.010<br />greater: experi<br />event: lenvatinib + pembrolizumab, Hypothyroidism, Grade 3-4","Control: 0.030<br />Experimental: 0.040<br />greater: experi<br />event: lenvatinib + pembrolizumab, Musculoskeletal pain, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: lenvatinib + pembrolizumab, Nausea, Grade 3-4","Control: 0.030<br />Experimental: 0.080<br />greater: experi<br />event: lenvatinib + pembrolizumab, Proteinuria, Grade 3-4","Control: 0.010<br />Experimental: 0.050<br />greater: experi<br />event: lenvatinib + pembrolizumab, Rash, Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: lenvatinib + pembrolizumab, Vomiting, Grade 3-4","Control: 0.000<br />Experimental: 0.080<br />greater: experi<br />event: lenvatinib + pembrolizumab, Weight decreased , Grade 3-4","Control: 0.003<br />Experimental: 0.005<br />greater: experi<br />event: pembrolizumab + chemotherapy, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.001<br />greater: experi<br />event: pembrolizumab + chemotherapy, Cough, Grade 3-4","Control: 0.003<br />Experimental: 0.009<br />greater: experi<br />event: pembrolizumab + chemotherapy, Decreased appetite , Grade 3-4","Control: 0.018<br />Experimental: 0.032<br />greater: experi<br />event: pembrolizumab + chemotherapy, Diarrhea, Grade 3-4","Control: 0.039<br />Experimental: 0.080<br />greater: experi<br />event: pembrolizumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: pembrolizumab + chemotherapy, Insomnia, Grade 3-4","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: pembrolizumab + chemotherapy, Myalgia, Grade 3-4","Control: 0.018<br />Experimental: 0.037<br />greater: experi<br />event: pembrolizumab + chemotherapy, Nausea, Grade 3-4","Control: 0.023<br />Experimental: 0.033<br />greater: experi<br />event: pembrolizumab + chemotherapy, Peripheral neuropathy, Grade 3-4","Control: 0.003<br />Experimental: 0.013<br />greater: experi<br />event: pembrolizumab + chemotherapy, Pyrexia, Grade 3-4","Control: 0.005<br />Experimental: 0.050<br />greater: experi<br />event: pembrolizumab + chemotherapy, Rash, Grade 3-4","Control: 0.010<br />Experimental: 0.027<br />greater: experi<br />event: pembrolizumab + chemotherapy, Stomatitis, Grade 3-4","Control: 0.015<br />Experimental: 0.027<br />greater: experi<br />event: pembrolizumab + chemotherapy, Vomiting, Grade 3-4","Control: 0.012<br />Experimental: 0.026<br />greater: experi<br />event: pembrolizumab + lenvatinib, Abdominal pain, Grade 3-4","Control: 0.000<br />Experimental: 0.070<br />greater: experi<br />event: pembrolizumab + lenvatinib, Decreased appetite, Grade 3-4","Control: 0.028<br />Experimental: 0.080<br />greater: experi<br />event: pembrolizumab + lenvatinib, Diarrhea, Grade 3-4","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />event: pembrolizumab + lenvatinib, Fatigue/Asthenia, Grade 3-4","Control: 0.003<br />Experimental: 0.006<br />greater: experi<br />event: pembrolizumab + lenvatinib, Headache, Grade 3-4","Control: 0.009<br />Experimental: 0.026<br />greater: experi<br />event: pembrolizumab + lenvatinib, Hemorrhagic events, Grade 3-4","Control: 0.025<br />Experimental: 0.390<br />greater: experi<br />event: pembrolizumab + lenvatinib, Hypertension, Grade 3-4","Control: 0.000<br />Experimental: 0.009<br />greater: experi<br />event: pembrolizumab + lenvatinib, Hypothyroidism, Grade 3-4","Control: 0.006<br />Experimental: 0.050<br />greater: experi<br />event: pembrolizumab + lenvatinib, Musculoskeletal disorders, Grade 3-4","Control: 0.015<br />Experimental: 0.029<br />greater: experi<br />event: pembrolizumab + lenvatinib, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.029<br />greater: experi<br />event: pembrolizumab + lenvatinib, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.003<br />Experimental: 0.060<br />greater: experi<br />event: pembrolizumab + lenvatinib, Proteinuria, Grade 3-4","Control: 0.000<br />Experimental: 0.023<br />greater: experi<br />event: pembrolizumab + lenvatinib, Rash, Grade 3-4","Control: 0.012<br />Experimental: 0.026<br />greater: experi<br />event: pembrolizumab + lenvatinib, Stomatitis, Grade 3-4","Control: 0.012<br />Experimental: 0.050<br />greater: experi<br />event: pembrolizumab + lenvatinib, Urinary tract infection, Grade 3-4","Control: 0.022<br />Experimental: 0.023<br />greater: experi<br />event: pembrolizumab + lenvatinib, Vomiting, Grade 3-4","Control: 0.003<br />Experimental: 0.100<br />greater: experi<br />event: pembrolizumab + lenvatinib, Weight decreased , Grade 3-4","Control: 0.010<br />Experimental: 0.050<br />greater: experi<br />event: daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Diarrhea, Grade ≥ 3","Control: 0.050<br />Experimental: 0.130<br />greater: experi<br />event: daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Fatigue/Asthenia, Grade ≥ 3","Control: 0.170<br />Experimental: 0.230<br />greater: experi<br />event: daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Pneumonia, Grade ≥ 3","Control: 0.000<br />Experimental: 0.002<br />greater: experi<br />event: nivolumab, Arthralgia, Grade 3-4","Control: 0.008<br />Experimental: 0.009<br />greater: experi<br />event: nivolumab, Decreased appetite, Grade 3-4","Control: 0.008<br />Experimental: 0.009<br />greater: experi<br />event: nivolumab, Diarrhea, Grade 3-4","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />event: nivolumab, Dyspnea, Grade 3-4","Control: 0.000<br />Experimental: 0.008<br />greater: experi<br />event: nivolumab, Nausea, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: nivolumab, Pruritus, Grade 3-4","Control: 0.004<br />Experimental: 0.009<br />greater: experi<br />event: nivolumab, Rash, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: nivolumab, Weight decreased , Grade 3-4","Control: 0.005<br />Experimental: 0.014<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, Blood bilirubin increased, Grade 3-5","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, Constipation, Grade 3-5","Control: 0.028<br />Experimental: 0.041<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, Fatigue/Asthenia, Grade 3-5","Control: 0.009<br />Experimental: 0.018<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, Infusion-related reaction, Grade 3-5","Control: 0.014<br />Experimental: 0.028<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, Peripheral sensory neuropathy, Grade 3-5","Control: 0.069<br />Experimental: 0.078<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, Platelet count decreased, Grade 3-5","Control: 0.009<br />Experimental: 0.032<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, Thrombocytopenia, Grade 3-5","Control: 0.019<br />Experimental: 0.046<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, Vomiting, Grade 3-5","Control: 0.005<br />Experimental: 0.009<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, Weight decreased , Grade 3-5","Control: 0.000<br />Experimental: 0.005<br />greater: experi<br />event: pembrolizumab + trastuzumab + chemotherapy, pyrexia, Grade 3-5","Control: 0.026<br />Experimental: 0.028<br />greater: experi<br />event: nivolumab + chemotherapy, Abdominal pain, Grade 3-4","Control: 0.004<br />Experimental: 0.006<br />greater: experi<br />event: nivolumab + chemotherapy, Constipation, Grade 3-4","Control: 0.000<br />Experimental: 0.001<br />greater: experi<br />event: nivolumab + chemotherapy, Cough, Grade 3-4","Control: 0.025<br />Experimental: 0.036<br />greater: experi<br />event: nivolumab + chemotherapy, Decreased appetite, Grade 3-4","Control: 0.037<br />Experimental: 0.050<br />greater: experi<br />event: nivolumab + chemotherapy, Diarrhea, Grade 3-4","Control: 0.001<br />Experimental: 0.005<br />greater: experi<br />event: nivolumab + chemotherapy, Edema, Grade 3-4","Control: 0.050<br />Experimental: 0.070<br />greater: experi<br />event: nivolumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","Control: 0.003<br />Experimental: 0.008<br />greater: experi<br />event: nivolumab + chemotherapy, Headache, Grade 3-4","Control: 0.004<br />Experimental: 0.031<br />greater: experi<br />event: nivolumab + chemotherapy, Increased amylase, Grade 3-4","Control: 0.037<br />Experimental: 0.070<br />greater: experi<br />event: nivolumab + chemotherapy, Increased lipase, Grade 3-4","Control: 0.008<br />Experimental: 0.015<br />greater: experi<br />event: nivolumab + chemotherapy, Palmar-plantar erythrodysesthesia, Grade 3-4","Control: 0.048<br />Experimental: 0.070<br />greater: experi<br />event: nivolumab + chemotherapy, Peripheral neuropathy, Grade 3-4","Control: 0.004<br />Experimental: 0.010<br />greater: experi<br />event: nivolumab + chemotherapy, Pyrexia, Grade 3-4","Control: 0.001<br />Experimental: 0.017<br />greater: experi<br />event: nivolumab + chemotherapy, Rash, Grade 3-4","Control: 0.008<br />Experimental: 0.018<br />greater: experi<br />event: nivolumab + chemotherapy, Stomatitis, Grade 3-4","Control: 0.007<br />Experimental: 0.013<br />greater: experi<br />event: nivolumab + chemotherapy, Weight decreased , Grade 3-4","Control: 0.010<br />Experimental: 0.030<br />greater: experi<br />event: sacituzumab govitecan, Abdominal Pain, Grade 3-4","Control: 0.060<br />Experimental: 0.090<br />greater: experi<br />event: sacituzumab govitecan, Anemia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: sacituzumab govitecan, Arthralgia, Grade 3-4","Control: 0.000<br />Experimental: 0.004<br />greater: experi<br />event: sacituzumab govitecan, Constipation, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: sacituzumab govitecan, Decreased appetite, Grade 3-4","Control: 0.010<br />Experimental: 0.110<br />greater: experi<br />event: sacituzumab govitecan, Diarrhea, Grade 3-4","Control: 0.004<br />Experimental: 0.008<br />greater: experi<br />event: sacituzumab govitecan, Headache, Grade 3-4","Control: 0.004<br />Experimental: 0.030<br />greater: experi<br />event: sacituzumab govitecan, Hypokalemia, Grade 3-4","Control: 0.060<br />Experimental: 0.110<br />greater: experi<br />event: sacituzumab govitecan, Leukopenia, Grade 3-4","Control: 0.004<br />Experimental: 0.030<br />greater: experi<br />event: sacituzumab govitecan, Nausea, Grade 3-4","Control: 0.340<br />Experimental: 0.520<br />greater: experi<br />event: sacituzumab govitecan, Neutropenia, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: sacituzumab govitecan, Stomatitis, Grade 3-4","Control: 0.010<br />Experimental: 0.020<br />greater: experi<br />event: sacituzumab govitecan, Vomiting, Grade 3-4"],"key":["isatuximab-irfc + Carfilzomib + Dexamethasone, Pneumonia, Grade 4","pembrolizumab + chemotherapy, Diarrhea, Grade 3-4","pembrolizumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","pembrolizumab + chemotherapy, Stomatitis, Grade 3-4","pembrolizumab + chemotherapy, Vomiting, Grade 3-4","tivozanib, Bleeding, Grade 3-4","tivozanib, Decreased appetite, Grade 3-4","tivozanib, Dysphonia, Grade 3-4","tivozanib, Dyspnea, Grade 3-4","tivozanib, Fatigue/Asthenia, Grade 3-4","tivozanib, Hypertension, Grade 3-4","tivozanib, Hypothyroidism, Grade 3-4","lorlatinib, Arthralgia, Grade 3-4","lorlatinib, Back pain, Grade 3-4","lorlatinib, Bronchitis, Grade 3-4","lorlatinib, Chest pain, Grade 3-4","lorlatinib, Cognitive effects, Grade 3-4","lorlatinib, Diarrhea, Grade 3-4","lorlatinib, Dyspnea, Grade 3-4","lorlatinib, Edema, Grade 3-4","lorlatinib, Hypertension, Grade 3-4","lorlatinib, Mood effects, Grade 3-4","lorlatinib, Myalgia, Grade 3-4","lorlatinib, Peripheral neuropathy, Grade 3-4","lorlatinib, Respiratory failure, Grade 3-4","lorlatinib, Sleep effects, Grade 3-4","lorlatinib, Weight Increased, Grade 3-4","cemiplimab-rwlc, Decreased appetite, Grade 3-4","cemiplimab-rwlc, Rash, Grade 3-4","nivolumab + cabozantinib, Abdominal pain, Grade 3-4","nivolumab + cabozantinib, Cough, Grade 3-4","nivolumab + cabozantinib, Decreased appetite, Grade 3-4","nivolumab + cabozantinib, Diarrhea, Grade 3-4","nivolumab + cabozantinib, Dysphonia , Grade 3-4","nivolumab + cabozantinib, Hepatotoxicity, Grade 3-4","nivolumab + cabozantinib, Musculoskeletal pain, Grade 3-4","nivolumab + cabozantinib, Nausea, Grade 3-4","nivolumab + cabozantinib, Pruritus, Grade 3-4","nivolumab + cabozantinib, Rash, Grade 3-4","nivolumab + cabozantinib, Vomiting, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Arrhythmia, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Back pain, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Constipation, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Cough, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Diarrhea, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Muscle spasms, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Peripheral sensory neuropathy, Grade 3-4","D-VCd (daratumumab + hyaluronidase + bortezomib + cyclophosphamide + dexamethasone), Pneumonia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Anemia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Decreased appetite, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Dehydration, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Diarrhea, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Fatigue/Asthenia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Febrile neutropenia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Hepatic function abnormal, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Interstitial lung disease, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Nausea, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Stomatitis, Grade 3-4","osimertinib, Abdominal Pain, Grade ≥ 3","osimertinib, Decreased appetite, Grade ≥ 3","osimertinib, Diarrhea, Grade ≥ 3","osimertinib, Dry skin, Grade ≥ 3","osimertinib, Fatigue/Asthenia, Grade ≥ 3","osimertinib, Nail toxicity, Grade ≥ 3","osimertinib, Rash, Grade ≥ 3","osimertinib, Stomatitis, Grade ≥ 3","osimertinib, Upper respiratory tract infection, Grade ≥ 3","osimertinib, Urinary Tract Infection, Grade ≥ 3","relugolix, Diarrhea, Grade 3-4","relugolix, Fatigue/Asthenia, Grade 3-4","relugolix, Hot flush, Grade 3-4","selinexor + bortezomib + dexamethasone, Appetite decrease, Grade 3-4","selinexor + bortezomib + dexamethasone, Cataract, Grade 3-4","selinexor + bortezomib + dexamethasone, Diarrhea, Grade 3-4","selinexor + bortezomib + dexamethasone, Dizziness, Grade 3-4","selinexor + bortezomib + dexamethasone, Fatigue/Asthenia, Grade 3-4","selinexor + bortezomib + dexamethasone, Nausea, Grade 3-4","selinexor + bortezomib + dexamethasone, Pyrexia, Grade 3-4","selinexor + bortezomib + dexamethasone, Upper respiratory tract infection, Grade 3-4","selinexor + bortezomib + dexamethasone, Vision blurred, Grade 3-4","selinexor + bortezomib + dexamethasone, Vomiting, Grade 3-4","selinexor + bortezomib + dexamethasone, Weight decreased , Grade 3-4","sacituzumab govitecan-hziy, Constipation, Grade 3-4","sacituzumab govitecan-hziy, Decreased appetite, Grade 3-4","sacituzumab govitecan-hziy, Diarrhea, Grade 3-4","sacituzumab govitecan-hziy, Fatigue/Asthenia, Grade 3-4","sacituzumab govitecan-hziy, Hypokalemia, Grade 3-4","margetuximab + chemotherapy, Cough, Grade 3-4","margetuximab + chemotherapy, Fatigue/Asthenia, Grade 3-4","margetuximab + chemotherapy, Infusion-related reaction, Grade 3-4","margetuximab + chemotherapy, Nausea, Grade 3-4","margetuximab + chemotherapy, Pain in extremity, Grade 3-4","pembrolizumab + chemotherapy, Constipation, Grade 3-4","pembrolizumab + chemotherapy, Decreased appetite, Grade 3-4","pembrolizumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","pembrolizumab + chemotherapy, Rash, Grade 3-4","venetoclax + azacitidine, Abdominal pain, Grade 3-4","venetoclax + azacitidine, Decreased appetite, Grade 3-4","venetoclax + azacitidine, Diarrhea, Grade 3-4","venetoclax + azacitidine, Dyspnea, Grade 3-4","venetoclax + azacitidine, Edema, Grade 3-4","venetoclax + azacitidine, Fatigue/Asthenia, Grade 3-4","venetoclax + azacitidine, Febrile neutropenia, Grade 3-4","venetoclax + azacitidine, Hemorrhage, Grade 3-4","venetoclax + azacitidine, Hypotension, Grade 3-4","venetoclax + azacitidine, Musculoskeletal pain, Grade 3-4","venetoclax + azacitidine, Nausea, Grade 3-4","venetoclax + azacitidine, Rash, Grade 3-4","venetoclax + azacitidine, Sepsis (excluding fungal), Grade 3-4","venetoclax + azacitidine, Stomatitis, Grade 3-4","venetoclax + azacitidine, Vomiting, Grade 3-4","pembrolizumab, Diarrhea, Grade 3-4","pembrolizumab, Pneumonitis, Grade 3-4","pembrolizumab, Upper respiratory tract infection, Grade 3-4","pembrolizumab, Vomiting, Grade 3-4","nivolumab + ipilimumab, Abdominal pain, Grade 3-4","nivolumab + ipilimumab, Arthralgia, Grade 3-4","nivolumab + ipilimumab, Cough, Grade 3-4","nivolumab + ipilimumab, Diarrhea, Grade 3-4","nivolumab + ipilimumab, Musculoskeletal pain, Grade 3-4","nivolumab + ipilimumab, Pneumonia, Grade 3-4","nivolumab + ipilimumab, Pruritus, Grade 3-4","nivolumab + ipilimumab, Pyrexia, Grade 3-4","nivolumab + ipilimumab, Rash, Grade 3-4","nivolumab + ipilimumab, Upper respiratory tract infection, Grade 3-4","elacestrant, Abdominal pain, Grade 3-4","elacestrant, Decreased appetite , Grade 3-4","elacestrant, Fatigue/Asthenia, Grade 3-4","elacestrant, Headache, Grade 3-4","elacestrant, Musculoskeletal pain, Grade 3-4","elacestrant, Nausea, Grade 3-4","elacestrant, Vomiting, Grade 3-4","azacitidine, Abdominal pain, TYPO","azacitidine, Constipation, TYPO","azacitidine, Diarrhea, TYPO","azacitidine, Fatigue/Asthenia, TYPO","azacitidine, Febrile neutropenia, TYPO","azacitidine, Nausea, TYPO","azacitidine, Pain in extremity, TYPO","azacitidine, Pneumonia, TYPO","azacitidine, Vomiting, TYPO","carfilzomib + daratumumab + dexamethasone, Anemia, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Back pain, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Bronchitis, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Diarrhea, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Dyspnea, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Fatigue/Asthenia, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Hypertension, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Infusion-related reaction, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Insomnia, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Pneumonia, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Pyrexia, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Respiratory infection, Grade 3-4","carfilzomib + daratumumab + dexamethasone, Thrombocytopenia, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Edema, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Fatigue/Asthenia, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Hepatotoxicity, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Hypertension, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Hyperthyroidism, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Infusion-related reaction, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Musculoskeletal pain, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Pneumonitis, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Rash, Grade 3-4","atezolizumab +  cobimetinib + vemurafenib, Stomatitis, Grade 3-4","avelumab, Arthralgia, Grade 3-4","avelumab, Constipation, Grade 3-4","avelumab, Cough, Grade 3-4","avelumab, Diarrhea, Grade 3-4","avelumab, Hypothyroidism, Grade 3-4","avelumab, Infusion-related reaction, Grade 3-4","avelumab, Pruritus, Grade 3-4","avelumab, Pyrexia, Grade 3-4","avelumab, Rash, Grade 3-4","avelumab, Urinary tract infection, Grade 3-4","avelumab, Vomiting, Grade 3-4","pembrolizumab, Alanine aminotransferase increased, Grade ≥3","pembrolizumab, Arthralgia, Grade ≥3","pembrolizumab, Aspartate aminotransferase increased, Grade ≥3","pembrolizumab, Blood alkaline phosphatase increase, Grade ≥3","pembrolizumab, Dyspnea, Grade ≥3","pembrolizumab, Hypertension, Grade ≥3","pembrolizumab, Pyrexia, Grade ≥3","nivolumab, Diarrhea, Grade 3-4","nivolumab, Rash, Grade 3-4","nivolumab, Upper respiratory tract infection, Grade 3-4","pembrolizumab, Pneumonitis, Grade 4","ramucirumab + erlotinib, Diarrhea, Grade ≥ 3","ramucirumab + erlotinib, Headache, Grade ≥ 3","ramucirumab + erlotinib, Hypertension, Grade ≥ 3","ramucirumab + erlotinib, Infections, Grade ≥ 3","ramucirumab + erlotinib, Peripheral edema, Grade ≥ 3","ramucirumab + erlotinib, Proteinuria, Grade ≥ 3","ramucirumab + erlotinib, Stomatitis, Grade ≥ 3","atezolizumab + bevacizumab, Hypertension, Grade 3-4","atezolizumab + bevacizumab, Infusion-related reaction, Grade 3-4","atezolizumab + bevacizumab, Proteinuria, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Alopecia, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Decreased appetite, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Diarrhea, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Dizziness, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Dyspnea, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Headache, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Hypothyroidism, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Musculoskeletal pain, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Nausea, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Pruritus, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Rash, Grade 3-4","nivolumab + ipilimumab + chemotherapy, Vomiting, Grade 3-4","brigatinib, Bradycardia, Grade 3-4","brigatinib, Headache, Grade 3-4","brigatinib, Hypertension, Grade 3-4","brigatinib, ILD/Pneumonitis, Grade 3-4","brigatinib, Peripheral neuropathy, Grade 3-4","brigatinib, Pneumonia, Grade 3-4","brigatinib, Pyrexia, Grade 3-4","brigatinib, Rash, Grade 3-4","brigatinib, Stomatitis, Grade 3-4","olaparib, Anemia, Grade 3-4","olaparib, Diarrhea, Grade 3-4","olaparib, Dyspnea, Grade 3-4","olaparib, Nausea, Grade 3-4","olaparib, Thrombocytopenia, Grade 3-4","olaparib, Vomiting, Grade 3-4","atezolizumab, Constipation, Grade 3-4","atezolizumab, Cough, Grade 3-4","atezolizumab, Decreased appetite, Grade 3-4","atezolizumab, Dyspnea, Grade 3-4","ripretinib, Abdominal pain, Grade 3-4","ripretinib, Constipation, Grade 3-4","ripretinib, Fatigue/Asthenia, Grade 3-4","ripretinib, Hypertension, Grade 3-4","ripretinib, Myalgia, Grade 3-4","ripretinib, Nausea, Grade 3-4","ripretinib, Peripheral edema, Grade 3-4","ripretinib, Vomiting, Grade 3-4","nivolumab + ipilimumab, Arthralgia, Grade 3-4","nivolumab + ipilimumab, Cough, Grade 3-4","nivolumab + ipilimumab, Decreased appetite, Grade 3-4","nivolumab + ipilimumab, Diarrhea/colitis, Grade 3-4","nivolumab + ipilimumab, Dyspnea, Grade 3-4","nivolumab + ipilimumab, Fatigue/Asthenia, Grade 3-4","nivolumab + ipilimumab, Headache, Grade 3-4","nivolumab + ipilimumab, Hepatitis, Grade 3-4","nivolumab + ipilimumab, Hypothyroidism, Grade 3-4","nivolumab + ipilimumab, Musculoskeletal pain, Grade 3-4","nivolumab + ipilimumab, Pneumonia, Grade 3-4","nivolumab + ipilimumab, Pruritus, Grade 3-4","nivolumab + ipilimumab, Pyrexia, Grade 3-4","nivolumab + ipilimumab, Rash, Grade 3-4","zanubrutinib, Constipation, Grade 3-4","zanubrutinib, Dizziness, Grade 3-4","zanubrutinib, Hemorrhage, Grade 3-4","zanubrutinib, Hypertension, Grade 3-4","zanubrutinib, Musculoskeletal pain, Grade 3-4","zanubrutinib, Pneumonia, Grade 3-4","zanubrutinib, Second primary malignancyl, Grade 3-4","zanubrutinib, Upper respiratory tract infection, Grade 3-4","zanubrutinib, COVID-19, Grade 3-4","zanubrutinib, Cough, Grade 3-4","zanubrutinib, Diarrhea, Grade 3-4","zanubrutinib, Rash, Grade 3-4","olaparib + bevacizumab, Anemia, TYPO","olaparib + bevacizumab, Fatigue/Asthenia, TYPO","olaparib + bevacizumab, Leukopenia, TYPO","olaparib + bevacizumab, Lymphopenia, TYPO","olaparib + bevacizumab, Nausea, TYPO","niraparib, AST/ALT elevation, Grade 3-4","niraparib, Acute kidney injury, Grade 3-4","niraparib, Anemia, Grade 3-4","niraparib, Constipation, Grade 3-4","niraparib, Decreased appetite, Grade 3-4","niraparib, Fatigue/Asthenia, Grade 3-4","niraparib, Headache, Grade 3-4","niraparib, Hypertension, Grade 3-4","niraparib, Insomnia, Grade 3-4","niraparib, Leukopenia, Grade 3-4","niraparib, Musculoskeletal pain, Grade 3-4","niraparib, Neutropenia, Grade 3-4","niraparib, Thrombocytopenia, Grade 3-4","ibrutinib + rituximab, Abdominal pain, Grade ≥ 3","ibrutinib + rituximab, Arthralgia, Grade ≥ 3","ibrutinib + rituximab, Diarrhea, Grade ≥ 3","ibrutinib + rituximab, Dyspnea, Grade ≥ 3","ibrutinib + rituximab, Hemorrhage, Grade ≥ 3","ibrutinib + rituximab, Hypertension, Grade ≥ 3","ibrutinib + rituximab, Hyperuricemia, Grade ≥ 3","ibrutinib + rituximab, Musculoskeletal pain, Grade ≥ 3","ibrutinib + rituximab, Pain, Grade ≥ 3","ibrutinib + rituximab, Peripheral edema, Grade ≥ 3","ibrutinib + rituximab, Vomiting, Grade ≥ 3","tucatinib + trastuzumab + capecitabine, Diarrhea, Grade 4","tucatinib + trastuzumab + capecitabine, Hepatotoxicity, Grade 4","encorafenib + cetuximab, Arthralgia, Grade ≥ 3","encorafenib + cetuximab, Hemorrhage, Grade ≥ 3","encorafenib + cetuximab, Myopathy, Grade ≥ 3","encorafenib + cetuximab, Peripheral neuropathy, Grade ≥ 3","durvalumab + Etoposide + either Carboplatin or Cisplatin , Alopecia, Grade 3-4","durvalumab + Etoposide + either Carboplatin or Cisplatin , Constipation, Grade 3-4","durvalumab + Etoposide + either Carboplatin or Cisplatin , Cough/Productive Cough, Grade 3-4","durvalumab + Etoposide + either Carboplatin or Cisplatin , Fatigue/Asthenia, Grade 3-4","isatuximab-irfc + pomalidomide + dexamethasone, Febrile neutropenia, Grade 4","isatuximab-irfc + pomalidomide + dexamethasone, Infusion-related reaction, Grade 4","isatuximab-irfc + pomalidomide + dexamethasone, Pneumonia, Grade 4","tremelimumab + durvalumab + platinum-based chemotherapy, Decreased appetite, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Fatigue/Asthenia, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Pneumonia, Grade 3-4","tremelimumab + durvalumab + platinum-based chemotherapy, Rash, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Constipation, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Decreased appetite, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Diarrhea, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Dyspnea, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Fatigue/Asthenia, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Musculoskeletal pain, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Rash, Grade 3-4","cemiplimab-rwlc + platinum-based chemotherapy, Weight decreased , Grade 3-4","olaparib + abiraterone + prednisone (or prednisolone), Anemia, Grade 3-4","olaparib + abiraterone + prednisone (or prednisolone), Decreased appetite, Grade 3-4","olaparib + abiraterone + prednisone (or prednisolone), Diarrhea, Grade 3-4","olaparib + abiraterone + prednisone (or prednisolone), Dizziness, Grade 3-4","olaparib + abiraterone + prednisone (or prednisolone), Fatigue/Asthenia, Grade 3-4","olaparib + abiraterone + prednisone (or prednisolone), Lymphopenia, Grade 3-4","tremelimumab + durvalumab, Decreased appetite, Grade 3-4","tremelimumab + durvalumab, Diarrhea, Grade 3-4","tremelimumab + durvalumab, Insomnia, Grade 3-4","tremelimumab + durvalumab, Musculoskeletal pain, Grade 3-4","durvalumab + gemcitabine + cisplatin, Constipation, Grade 3-4","durvalumab + gemcitabine + cisplatin, Decreased appetite, Grade 3-4","durvalumab + gemcitabine + cisplatin, Pyrexia, Grade 3-4","durvalumab + gemcitabine + cisplatin, Rash, Grade 3-4","darolutamide + docetaxel, Hypertension, Grade 3-4","darolutamide + docetaxel, Rash, Grade 3-4","darolutamide + docetaxel, Weight Increased, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Abdominal pain, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Anemia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Constipation, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Decreased appetite, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Dizziness, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Dyspnea, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Fatigue/Asthenia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Headache, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Interstitial lung disease, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Musculoskeletal pain, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Nausea, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Pyrexia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Upper respiratory tract infection, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Vomiting, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Weight decreased , Grade 3-4","lisocabtagene maraleucel, Abdominal pain, Grade ≥ 3","lisocabtagene maraleucel, Asthenia, Grade ≥ 3","lisocabtagene maraleucel, Constipation, Grade ≥ 3","lisocabtagene maraleucel, Cytokine release syndrome, Grade ≥ 3","lisocabtagene maraleucel, Headache, Grade ≥ 3","lisocabtagene maraleucel, Hypertension, Grade ≥ 3","lisocabtagene maraleucel, Hypotension, Grade ≥ 3","lisocabtagene maraleucel, Leukopenia, Grade ≥ 3","lisocabtagene maraleucel, Lymphopenia, Grade ≥ 3","lisocabtagene maraleucel, Myalgia, Grade ≥ 3","lisocabtagene maraleucel, Neutropenia, Grade ≥ 3","lisocabtagene maraleucel, Peripheral edema, Grade ≥ 3","lisocabtagene maraleucel, Prolonged cytopeniat, Grade ≥ 3","lisocabtagene maraleucel, Tremor, Grade ≥ 3","nivolumab + chemotherapy, Abdominal pain, Grade 3-4","nivolumab + chemotherapy, Decreased appetite, Grade 3-4","nivolumab + chemotherapy, Diarrhea, Grade 3-4","nivolumab + chemotherapy, Dysphagia, Grade 3-4","nivolumab + chemotherapy, Nausea, Grade 3-4","nivolumab + chemotherapy, Peripheral neuropathy, Grade 3-4","nivolumab + chemotherapy, Pneumonia, Grade 3-4","nivolumab + chemotherapy, Rash, Grade 3-4","nivolumab + chemotherapy, Stomatitis, Grade 3-4","nivolumab + ipilimumab, Abdominal pain, Grade 3-4","nivolumab + ipilimumab, Dysphagia, Grade 3-4","nivolumab + ipilimumab, Musculoskeletal pain, Grade 3-4","nivolumab + ipilimumab, Pneumonia, Grade 3-4","nivolumab + ipilimumab, Pruritus, Grade 3-4","nivolumab + ipilimumab, Pyrexia, Grade 3-4","nivolumab + ipilimumab, Rash, Grade 3-4","nivolumab + ipilimumab, Weight decreased , Grade 3-4","ivosidenib + azacitidine, Arthralgia, Grade ≥ 3","ivosidenib + azacitidine, Differentiation Syndrome, Grade ≥ 3","ivosidenib + azacitidine, Electrocardiogram QT prolonged, Grade ≥ 3","ivosidenib + azacitidine, Insomnia, Grade ≥ 3","fam-trastuzumab deruxtecan-nxki, Abdominal pain, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Alopecia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Anemia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Cough, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Decreased appetite, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Diarrhea, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Dizziness, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Fatigue/Asthenia, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Headache, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Interstitial lung disease, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Musculoskeletal pain, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Nausea, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Stomatitis, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Vomiting, Grade 3-4","fam-trastuzumab deruxtecan-nxki, Weight decreased , Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Alanine aminotransferase increased, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Anemia, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Constipation, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Decreased appetite, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Diarrhea, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Edema, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Febrile neutropenia, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Mucositis, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Nausea, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Peripheral neuropathy, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Pyrexia, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Rash, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Thrombocytopenia, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Uric acid increased, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Vomiting, Grade 3-4","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Weight decreased , Grade 3-4","axicabtagene ciloleucel, Aphasia, Grade ≥3","axicabtagene ciloleucel, Chills, Grade ≥3","axicabtagene ciloleucel, Confusional state, Grade ≥3","axicabtagene ciloleucel, Cough, Grade ≥3","axicabtagene ciloleucel, Delirium, Grade ≥3","axicabtagene ciloleucel, Encephalopathy, Grade ≥3","axicabtagene ciloleucel, Fatigue/Asthenia, Grade ≥3","axicabtagene ciloleucel, Headache, Grade ≥3","axicabtagene ciloleucel, Hypophosphatemia, Grade ≥3","axicabtagene ciloleucel, Hypotension, Grade ≥3","axicabtagene ciloleucel, Hypoxia, Grade ≥3","axicabtagene ciloleucel, Leukopenia, Grade ≥3","axicabtagene ciloleucel, Neutropenia, Grade ≥3","axicabtagene ciloleucel, Paresthesia, Grade ≥3","axicabtagene ciloleucel, Pyrexia, Grade ≥3","axicabtagene ciloleucel, Sinus tachycardia, Grade ≥3","axicabtagene ciloleucel, Tremor, Grade ≥3","lutetium Lu 177 vipivotide tetraxetan + standard of care, Abdominal pain, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Acute kidney injury, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Anemia, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Constipation, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Decreased appetite, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Diarrhea, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Dizziness, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Fatigue/Asthenia, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Headache, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Nausea, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Pyrexia, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Thrombocytopenia, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Urinary tract infection, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Vomiting, Grade 3-4","lutetium Lu 177 vipivotide tetraxetan + standard of care, Weight decreased , Grade 3-4","relatlimab-rmbw +nivolumab, Cough, Grade 3-4","relatlimab-rmbw +nivolumab, Decreased appetite, Grade 3-4","relatlimab-rmbw +nivolumab, Diarrhea, Grade 3-4","relatlimab-rmbw +nivolumab, Fatigue/Asthenia, Grade 3-4","relatlimab-rmbw +nivolumab, Musculoskeletal pain, Grade 3-4","relatlimab-rmbw +nivolumab, Nausea, Grade 3-4","olaparib, Anemia, Grade 3-4","olaparib, Decreased appetite, Grade 3-4","olaparib, Fatigue/Asthenia, Grade 3-4","olaparib, Headache, Grade 3-4","olaparib, Leukopenia, Grade 3-4","olaparib, Nausea, Grade 3-4","olaparib, Neutropenia, Grade 3-4","olaparib, Stomatitis, Grade 3-4","olaparib, Vomiting, Grade 3-4","nivolumab + platinum-doublet chemotherapy, Fatigue/Asthenia, Grade 3-4","nivolumab + platinum-doublet chemotherapy, Rash, Grade 3-4","nivolumab + platinum-doublet chemotherapy, Vomiting, Grade 3-4","tebentafusp-tebn, Arthralgia, Grade 3-4","tebentafusp-tebn, Chills, Grade 3-4","tebentafusp-tebn, Cytokine release syndrome, Grade 3-4","tebentafusp-tebn, Fatigue/Asthenia, Grade 3-4","tebentafusp-tebn, Hypotension, Grade 3-4","tebentafusp-tebn, Nausea, Grade 3-4","tebentafusp-tebn, Pruritus, Grade 3-4","tebentafusp-tebn, Pyrexia, Grade 3-4","tebentafusp-tebn, Rash, Grade 3-4","tebentafusp-tebn, Vomiting, Grade 3-4","pembrolizumab, Arthralgia, Grade ≥ 3","pembrolizumab, Asthenia, Grade ≥ 3","pembrolizumab, Fatigue/Asthenia, Grade ≥ 3","pembrolizumab, Hyperthyroidism, Grade ≥ 3","pembrolizumab, Myalgia, Grade ≥ 3","pembrolizumab, Pruritus, Grade ≥ 3","pembrolizumab, Rash maculopapular, Grade ≥ 3","pembrolizumab, Abdominal pain, Grade 3-4","pembrolizumab, Acute kidney injury, Grade 3-4","pembrolizumab, Diarrhea, Grade 3-4","pembrolizumab, Fatigue/Asthenia, Grade 3-4","pembrolizumab, Headache, Grade 3-4","pembrolizumab, Hepatotoxicity, Grade 3-4","pembrolizumab, Hyperthyroidism , Grade 3-4","pembrolizumab, Hypothyroidism, Grade 3-4","pembrolizumab, Musculoskeletal pain, Grade 3-4","pembrolizumab, Nausea, Grade 3-4","pembrolizumab, Pruritus, Grade 3-4","pembrolizumab, Rash, Grade 3-4","asciminib, Headache, Grade 3-4","asciminib, Hypertension, Grade 3-4","asciminib, Musculoskeletal pain, Grade 3-4","asciminib, Nausea, Grade 3-4","atezolizumab, Arthralgia, Grade 3-4","atezolizumab, Fatigue/Asthenia, Grade 3-4","atezolizumab, Musculoskeletal pain, Grade 3-4","atezolizumab, Peripheral neuropathy, Grade 3-4","atezolizumab, Pyrexia, Grade 3-4","atezolizumab, Rash, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Fatigue/Asthenia, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Nausea, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Rash, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Urinary tract infection, Grade 3-4","pembrolizumab + chemotherapy + (bevacizumab?), Vomiting, Grade 3-4","abemaciclib + endocrine therapy, Infections, Grade 4","ruxolitinib, Musculoskeletal pain, Grade ≥ 3","ruxolitinib, Pyrexia, Grade ≥ 3","cabozantinib, Decreased appetite, Grade 3-4","cabozantinib, Diarrhea, Grade 3-4","cabozantinib, Dry mouth, Grade 3-4","cabozantinib, Fatigue/Asthenia, Grade 3-4","cabozantinib, Headache, Grade 3-4","cabozantinib, Hypertension, Grade 3-4","cabozantinib, Nausea, Grade 3-4","cabozantinib, Palmar-plantar erythrodysesthesia, Grade 3-4","cabozantinib, Proteinuria, Grade 3-4","cabozantinib, Pulmonary embolism, Grade 3-4","cabozantinib, Stomatitis, Grade 3-4","cabozantinib, Vomiting, Grade 3-4","cabozantinib, Weight decreased , Grade 3-4","zanubrutinib, Diarrhea, Grade 3-4","zanubrutinib, Dizziness, Grade 3-4","zanubrutinib, Musculoskeletal pain, Grade 3-4","zanubrutinib, Pruritus, Grade 3-4","zanubrutinib, Pyrexia, Grade 3-4","ivosidenib, Anemia, Grade ≥ 3","ivosidenib, Ascites, Grade ≥ 3","ivosidenib, Decreased appetite, Grade ≥ 3","ivosidenib, Rash, Grade ≥ 3","ivosidenib, Vomiting, Grade ≥ 3","nivolumab, Abdominal pain, Grade 3-4","nivolumab, Arthralgia, Grade 3-4","nivolumab, Decreased appetite, Grade 3-4","nivolumab, Diarrhea, Grade 3-4","nivolumab, Dizziness, Grade 3-4","nivolumab, Fatigue/Asthenia, Grade 3-4","nivolumab, Hepatitis, Grade 3-4","nivolumab, Nausea, Grade 3-4","nivolumab, Rash, Grade 3-4","nivolumab, Renal dysfunction, Grade 3-4","lenvatinib + pembrolizumab, Abdominal pain, Grade 3-4","lenvatinib + pembrolizumab, Acute kidney injury, Grade 3-4","lenvatinib + pembrolizumab, Constipation, Grade 3-4","lenvatinib + pembrolizumab, Decreased appetite, Grade 3-4","lenvatinib + pembrolizumab, Diarrhea, Grade 3-4","lenvatinib + pembrolizumab, Fatigue/Asthenia, Grade 3-4","lenvatinib + pembrolizumab, Hemorrhagic events, Grade 3-4","lenvatinib + pembrolizumab, Hepatotoxicity, Grade 3-4","lenvatinib + pembrolizumab, Hypertension, Grade 3-4","lenvatinib + pembrolizumab, Hypothyroidism, Grade 3-4","lenvatinib + pembrolizumab, Musculoskeletal pain, Grade 3-4","lenvatinib + pembrolizumab, Nausea, Grade 3-4","lenvatinib + pembrolizumab, Proteinuria, Grade 3-4","lenvatinib + pembrolizumab, Rash, Grade 3-4","lenvatinib + pembrolizumab, Vomiting, Grade 3-4","lenvatinib + pembrolizumab, Weight decreased , Grade 3-4","pembrolizumab + chemotherapy, Arthralgia, Grade 3-4","pembrolizumab + chemotherapy, Cough, Grade 3-4","pembrolizumab + chemotherapy, Decreased appetite , Grade 3-4","pembrolizumab + chemotherapy, Diarrhea, Grade 3-4","pembrolizumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","pembrolizumab + chemotherapy, Insomnia, Grade 3-4","pembrolizumab + chemotherapy, Myalgia, Grade 3-4","pembrolizumab + chemotherapy, Nausea, Grade 3-4","pembrolizumab + chemotherapy, Peripheral neuropathy, Grade 3-4","pembrolizumab + chemotherapy, Pyrexia, Grade 3-4","pembrolizumab + chemotherapy, Rash, Grade 3-4","pembrolizumab + chemotherapy, Stomatitis, Grade 3-4","pembrolizumab + chemotherapy, Vomiting, Grade 3-4","pembrolizumab + lenvatinib, Abdominal pain, Grade 3-4","pembrolizumab + lenvatinib, Decreased appetite, Grade 3-4","pembrolizumab + lenvatinib, Diarrhea, Grade 3-4","pembrolizumab + lenvatinib, Fatigue/Asthenia, Grade 3-4","pembrolizumab + lenvatinib, Headache, Grade 3-4","pembrolizumab + lenvatinib, Hemorrhagic events, Grade 3-4","pembrolizumab + lenvatinib, Hypertension, Grade 3-4","pembrolizumab + lenvatinib, Hypothyroidism, Grade 3-4","pembrolizumab + lenvatinib, Musculoskeletal disorders, Grade 3-4","pembrolizumab + lenvatinib, Nausea, Grade 3-4","pembrolizumab + lenvatinib, Palmar-plantar erythrodysesthesia, Grade 3-4","pembrolizumab + lenvatinib, Proteinuria, Grade 3-4","pembrolizumab + lenvatinib, Rash, Grade 3-4","pembrolizumab + lenvatinib, Stomatitis, Grade 3-4","pembrolizumab + lenvatinib, Urinary tract infection, Grade 3-4","pembrolizumab + lenvatinib, Vomiting, Grade 3-4","pembrolizumab + lenvatinib, Weight decreased , Grade 3-4","daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Diarrhea, Grade ≥ 3","daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Fatigue/Asthenia, Grade ≥ 3","daratumumab + hyaluronidase-fihj + pomalidomide + dexamethasone, Pneumonia, Grade ≥ 3","nivolumab, Arthralgia, Grade 3-4","nivolumab, Decreased appetite, Grade 3-4","nivolumab, Diarrhea, Grade 3-4","nivolumab, Dyspnea, Grade 3-4","nivolumab, Nausea, Grade 3-4","nivolumab, Pruritus, Grade 3-4","nivolumab, Rash, Grade 3-4","nivolumab, Weight decreased , Grade 3-4","pembrolizumab + trastuzumab + chemotherapy, Blood bilirubin increased, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Constipation, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Fatigue/Asthenia, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Infusion-related reaction, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Peripheral sensory neuropathy, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Platelet count decreased, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Thrombocytopenia, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Vomiting, Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, Weight decreased , Grade 3-5","pembrolizumab + trastuzumab + chemotherapy, pyrexia, Grade 3-5","nivolumab + chemotherapy, Abdominal pain, Grade 3-4","nivolumab + chemotherapy, Constipation, Grade 3-4","nivolumab + chemotherapy, Cough, Grade 3-4","nivolumab + chemotherapy, Decreased appetite, Grade 3-4","nivolumab + chemotherapy, Diarrhea, Grade 3-4","nivolumab + chemotherapy, Edema, Grade 3-4","nivolumab + chemotherapy, Fatigue/Asthenia, Grade 3-4","nivolumab + chemotherapy, Headache, Grade 3-4","nivolumab + chemotherapy, Increased amylase, Grade 3-4","nivolumab + chemotherapy, Increased lipase, Grade 3-4","nivolumab + chemotherapy, Palmar-plantar erythrodysesthesia, Grade 3-4","nivolumab + chemotherapy, Peripheral neuropathy, Grade 3-4","nivolumab + chemotherapy, Pyrexia, Grade 3-4","nivolumab + chemotherapy, Rash, Grade 3-4","nivolumab + chemotherapy, Stomatitis, Grade 3-4","nivolumab + chemotherapy, Weight decreased , Grade 3-4","sacituzumab govitecan, Abdominal Pain, Grade 3-4","sacituzumab govitecan, Anemia, Grade 3-4","sacituzumab govitecan, Arthralgia, Grade 3-4","sacituzumab govitecan, Constipation, Grade 3-4","sacituzumab govitecan, Decreased appetite, Grade 3-4","sacituzumab govitecan, Diarrhea, Grade 3-4","sacituzumab govitecan, Headache, Grade 3-4","sacituzumab govitecan, Hypokalemia, Grade 3-4","sacituzumab govitecan, Leukopenia, Grade 3-4","sacituzumab govitecan, Nausea, Grade 3-4","sacituzumab govitecan, Neutropenia, Grade 3-4","sacituzumab govitecan, Stomatitis, Grade 3-4","sacituzumab govitecan, Vomiting, Grade 3-4"],"type":"scatter","mode":"markers","marker":{"autocolorscale":false,"color":"rgba(109,177,191,1)","opacity":0.55,"size":5.66929133858268,"symbol":"circle","line":{"width":1.88976377952756,"color":"rgba(109,177,191,1)"}},"hoveron":"points","name":"experi","legendgroup":"experi","showlegend":true,"xaxis":"x","yaxis":"y","hoverinfo":"text","_isNestedKey":false,"frame":null},{"x":[null,0.13,0.1,null,null,null],"y":[0.2,null,null,0.06,null,null],"text":["Control:    NA<br />Experimental: 0.200<br />greater: NA<br />event: pembrolizumab, Pyrexia, All Grades","Control: 0.130<br />Experimental:    NA<br />greater: NA<br />event: pembrolizumab, pyrexia, All Grades","Control: 0.100<br />Experimental:    NA<br />greater: NA<br />event: polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Dyspnea, All grades","Control:    NA<br />Experimental: 0.060<br />greater: NA<br />event: axicabtagene ciloleucel, Cytokine release syndrome, Grade ≥3","Control:    NA<br />Experimental:    NA<br />greater: NA<br />event: tebentafusp-tebn, Hair color changes, Grade 3-4","Control:    NA<br />Experimental:    NA<br />greater: NA<br />event: tebentafusp-tebn, Skin Hypopigmentation, Grade 3-4"],"key":["pembrolizumab, Pyrexia, All Grades","pembrolizumab, pyrexia, All Grades","polatuzumab vedotin-piiq + R-CHP (rituximab + cyclophosphamide + doxorubicin + prednisone), Dyspnea, All grades","axicabtagene ciloleucel, Cytokine release syndrome, Grade ≥3","tebentafusp-tebn, Hair color changes, Grade 3-4","tebentafusp-tebn, Skin Hypopigmentation, Grade 3-4"],"type":"scatter","mode":"markers","marker":{"autocolorscale":false,"color":"rgba(127,127,127,1)","opacity":0.55,"size":5.66929133858268,"symbol":"circle","line":{"width":1.88976377952756,"color":"rgba(127,127,127,1)"}},"hoveron":"points","name":"NA","legendgroup":"NA","showlegend":true,"xaxis":"x","yaxis":"y","hoverinfo":"text","_isNestedKey":false,"frame":null}],"layout":{"margin":{"t":48.1461187214612,"r":7.30593607305936,"b":44.5662100456621,"l":48.9497716894977},"font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":14.6118721461187},"title":{"text":"Adverse Events, highest grade reported","font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":17.5342465753425},"x":0,"xref":"paper"},"xaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[-0.01,1.01],"tickmode":"array","ticktext":["0%","25%","50%","75%","100%"],"tickvals":[0,0.25,0.5,0.75,1],"categoryorder":"array","categoryarray":["0%","25%","50%","75%","100%"],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.65296803652968,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"Roboto Condensed","size":11.689497716895},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176,"zeroline":false,"anchor":"y","title":{"text":"Control","font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":14.6118721461187}},"hoverformat":".2f"},"yaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[-0.01,1.01],"tickmode":"array","ticktext":["0%","25%","50%","75%","100%"],"tickvals":[0,0.25,0.5,0.75,1],"categoryorder":"array","categoryarray":["0%","25%","50%","75%","100%"],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.65296803652968,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"Roboto Condensed","size":11.689497716895},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176,"zeroline":false,"anchor":"x","title":{"text":"Experimental","font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":14.6118721461187}},"hoverformat":".2f"},"shapes":[{"type":"rect","fillcolor":null,"line":{"color":null,"width":0,"linetype":[]},"yref":"paper","xref":"paper","x0":0,"x1":1,"y0":0,"y1":1}],"showlegend":false,"legend":{"bgcolor":null,"bordercolor":null,"borderwidth":0,"font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":11.689497716895}},"hovermode":"closest","barmode":"relative"},"config":{"doubleClick":"reset","modeBarButtonsToAdd":["hoverclosest","hovercompare"],"showSendToCloud":false},"source":"A","attrs":{"2ee034fb60cd":{"intercept":{},"slope":{},"type":"scatter"},"2ee0755f35df":{"x":{},"y":{},"colour":{},"key":{}}},"cur_data":"2ee034fb60cd","visdat":{"2ee034fb60cd":["function (y) ","x"],"2ee0755f35df":["function (y) ","x"]},"highlight":{"on":"plotly_click","persistent":false,"dynamic":false,"selectize":false,"opacityDim":0.2,"selected":{"opacity":1},"debounce":0},"shinyEvents":["plotly_hover","plotly_click","plotly_selected","plotly_relayout","plotly_brushed","plotly_brushing","plotly_clickannotation","plotly_doubleclick","plotly_deselect","plotly_afterplot","plotly_sunburstclick"],"base_url":"https://plot.ly"},"evals":[],"jsHooks":[]}</script>
</div>
</div>
</section>
<section id="relationship-1" class="level6">
<h6 class="anchored" data-anchor-id="relationship-1">|- Relationship</h6>
<p>This is the same but added a linear regression (green line)</p>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-9-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<p>Full linear model:</p>
<div class="cell">
<div class="cell-output cell-output-stdout">
<pre><code>
Call:
lm(formula = Experimental ~ Control, data = .)

Residuals:
     Min       1Q   Median       3Q      Max 
-0.39225 -0.00915 -0.00785  0.00223  0.39280 

Coefficients:
            Estimate Std. Error t value Pr(&gt;|t|)    
(Intercept) 0.009146   0.001156   7.911 5.41e-15 ***
Control     0.935273   0.020764  45.044  &lt; 2e-16 ***
---
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1

Residual standard error: 0.03919 on 1309 degrees of freedom
  (6 observations deleted due to missingness)
Multiple R-squared:  0.6078,    Adjusted R-squared:  0.6075 
F-statistic:  2029 on 1 and 1309 DF,  p-value: &lt; 2.2e-16</code></pre>
</div>
</div>
</section>
<section id="placebo-vs.-active-control-1" class="level6">
<h6 class="anchored" data-anchor-id="placebo-vs.-active-control-1">|- Placebo vs.&nbsp;Active Control</h6>
<p>Compares placebo vs.&nbsp;active controls</p>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-11-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<p>Full models</p>
<div class="cell">
<div class="cell-output cell-output-stdout">
<pre><code>$`Active-control`

Call:
lm(formula = Experimental ~ Control, data = .)

Residuals:
     Min       1Q   Median       3Q      Max 
-0.36908 -0.01007 -0.00636  0.00364  0.39569 

Coefficients:
            Estimate Std. Error t value Pr(&gt;|t|)    
(Intercept) 0.007382   0.001720    4.29 2.03e-05 ***
Control     0.897708   0.024465   36.69  &lt; 2e-16 ***
---
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1

Residual standard error: 0.04333 on 722 degrees of freedom
  (6 observations deleted due to missingness)
Multiple R-squared:  0.6509,    Adjusted R-squared:  0.6505 
F-statistic:  1346 on 1 and 722 DF,  p-value: &lt; 2.2e-16


$`Placebo-control`

Call:
lm(formula = Experimental ~ Control, data = .)

Residuals:
     Min       1Q   Median       3Q      Max 
-0.07887 -0.00791 -0.00661  0.00239  0.37718 

Coefficients:
            Estimate Std. Error t value Pr(&gt;|t|)    
(Intercept) 0.007610   0.001472    5.17 3.23e-07 ***
Control     1.302910   0.051256   25.42  &lt; 2e-16 ***
---
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1

Residual standard error: 0.03167 on 585 degrees of freedom
Multiple R-squared:  0.5248,    Adjusted R-squared:  0.524 
F-statistic: 646.2 on 1 and 585 DF,  p-value: &lt; 2.2e-16</code></pre>
</div>
</div>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-13-1.png" class="img-fluid" width="960"></p>
</div>
</div>
</section>
</section>
<section id="body-system" class="level4">
<h4 class="anchored" data-anchor-id="body-system">Body system</h4>
<p>Maybe do by body system next?</p>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-14-1.png" class="img-fluid" width="960"></p>
</div>
</div>
</section>
<section id="distrubtion" class="level4">
<h4 class="anchored" data-anchor-id="distrubtion">Distrubtion</h4>
<p>This is the adverse events mapped as distributions. Only evaluated for highest grades reported. Only show trials with significant difference (p-value &lt; 0.05) between the experimental and control arms (otherwise the distrubution would be the same).</p>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-15-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<div class="cell">

</div>
<div class="cell">

</div>
<div class="cell">

</div>
</section>
<section id="summary-difference-between-arms" class="level3">
<h3 class="anchored" data-anchor-id="summary-difference-between-arms">Summary Difference between arms</h3>
<div class="cell">

</div>
<div class="cell">
<div class="cell-output-display">
<div class="plotly html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-7b4945a08359899a76d9" style="width:100%;height:520px;"></div>
<script type="application/json" data-for="htmlwidget-7b4945a08359899a76d9">{"x":{"data":[{"x":[0.7,0.7,2,0.6,2,-0.7,1.65066870739523e-17,0.6,-3.23258498502889e-17,0.6,2.6,-1.5,-0.7,10,2,0.7,-1.4,-1.48662086692209e-18,1.3,-1.5,-0.0999999999999997,9.66430064230437e-18,2,1.3,-0.7,-0.7,-0.7,14.9,2,7.76274273635047e-18,2,2,1,2,-2.96651871174628e-17,-2.30528685654873e-17,1,1,5,-2.50973856978849e-17,-2.4,2.30291140476053e-17,15,-9.13063007746719e-18,4,0.8,0.8,-4.19190082656638e-17,4.2,1.6,1.6,2.4,3.2,1.01173546395915e-17,1.6,7.57567211850885e-18,3.6,7.5,5,1,23,8,-4.4,0.5,2.1,1,4.1,1.1,1,3,2,1.0491696052983e-17,2,1,4,23,4,2,1,1,1,8,1,-3.02822298573041e-17,1,1,-4.20057646433491e-17,1,3.91414421027785e-17,4,1.35986615210522e-17,3,3,2,1,4,3,3,0.6,1.3,4.21571910352996e-17,3.2,1.3,3,5,7,1.9,-0.7,4,1.2,3.7,9,1,1.2,8,3,1,-8.85187899983082e-18,1.6,1.1,-1.5,-2.2,0.3,1.48128042345133e-18,-0.4,4,0.3,-3.55139891368075e-17,6,8.75199927765027e-18,-1.57381826422278e-17,2.77811587610115e-17,1,19,10,1,3,3.00769922439002e-19,1,16,-4.24041232665056e-17,-8.18956342429349e-18,1,2,-2,1,4,1,16.6,3.5,0.4,5.9,1.7,-0.2,2.2,0.2,29,0.6,-0.4,1,-0.4,-0.6,2,0.4,5,0.6,4.6,1,3.72353504405667e-17,20,38.6,3.62324633069405e-17,3.01007083392428e-18,0.3,1,1.3,1.5,1.8,-3.76332317184711e-18,1.6,-3.7145266956342e-17,3.36228510389142e-18,1.3,4.05850675897056e-17,1.3,-0.5,12.7,1,0.7,0.3,0.8,3.2,4.03276144689681e-17,-9,7,1,5,-1.49991515035887e-17,1,null,-8.85051361415271e-18,1,-2,2.57176173223853e-17,12,4,-25,2,-1,6,8,5,7,-3,28,1,8,1,-42,1,-1,-0.700000000000001,0.8,0.4,0.8,-1.5,-3.02297812711533e-17,-1.98164752429861e-17,-1.20550692925441e-17,5.1,null,-0.5,3.3,1.1,4.5,2.8,18,null,1.2,1,1.4788887982142e-17,1,-9.53944298143638e-18,1,1,3.28603063194261e-17,-2.55898454628602e-17,1,-4.62178018646429e-18,1,3.67720140505981e-17,1,3,7,1,-3.54977504026507e-18,1.87858226754058e-17,10,2,7,3,10,1,2,5,1,1,1,3,1,3,4,3.53106586917035e-18,1,-1.98802160645897e-17,1,4,9,1,1,2,-4.09372787163864e-17,5,4,2.9101124799547e-17,2,8,1.4,-0.6,7,5.2,-3.01965088202325e-17,5,0.3,1.7,36.5,0.9,4.4,1.4,2.9,5.7,2.3,1.4,3.8,0.0999999999999997,9.7],"y":[1.13124558038544,0.892596594756469,0.856782687362283,1.02480042609386,0.85780050244648,1.12458481849171,0.99496777926106,1.0195279592881,1.19174674979877,0.927008700673468,1.00336546904873,1.21161463402677,1.04596491856501,1.24007308506407,1.1085710626794,0.859294443507679,0.867334206937812,1.09057159163058,0.819393615005538,0.77216152404435,1.06687274435535,0.851799158728682,1.07850917300675,1.20107688393909,1.13291829824448,0.755849958281033,1.0134962706361,1.09671260393225,11.943676108378,11.8246828306001,11.7959866871824,12.0711472111288,12.1479324013926,12.1273880680092,11.8443835005164,11.7732441601111,11.9512868099846,11.9023995376192,11.8382818328682,11.8566221591318,12.9702406241558,12.7513262630673,12.7890007673996,13.0265975862276,13.1375272811856,13.2054204131709,12.9051153089385,13.2333894441836,13.190807509236,12.9982388312928,12.8884508748306,13.1464349369053,13.1640893690055,13.0306446182076,12.7924363292987,13.1009053527378,19.0625462892931,18.8560667638667,18.7595866807969,19.0326210119529,18.9261371586472,19.0051232420374,18.9399343864061,19.0188189415494,19.2323598082876,18.9983613920631,18.856932069757,19.1910535552306,10.9034943751758,10.784684705548,11.036609676783,10.8983996902825,10.7881502084201,11.225663845893,11.162768802722,11.0905480614165,11.201448845095,10.9913805321557,10.8912828816101,11.090107864351,10.9820791209349,10.9642083912622,10.79178480478,10.8511865840992,10.9059216827154,14.8283810628345,15.1321126322728,14.9756872518919,14.948435825645,15.2451864767354,14.9772613398964,14.9285774944583,15.1926681003533,14.7554925364675,15.0511919412529,15.1760569423204,15.2378675369546,20.178221338545,20.2345525271958,19.8021422612946,19.7913452052744,20.011620975798,19.7509801222477,19.8886044346727,20.2143500159727,19.9663864946924,19.9318563572597,19.8798552287044,19.9769490193576,19.8176220929017,19.8748650004854,20.0427313501714,9.96340721391607,10.1224245637422,10.1659565251321,10.0074094535084,10.0731255430728,10.0743320989423,9.77871785627212,9.82364207366481,10.0544494031928,9.80970151524525,10.1334575568326,9.82780433620792,10.2154546037782,10.0370168620721,9.9460368551081,9.17821880010888,8.90954872500151,8.97665664355736,9.04061847506091,8.79327926516999,9.24454468244221,9.01351717661601,8.92728278273717,8.89238296519034,9.13321172725409,8.84298130078241,8.96244479145389,8.08297628629953,7.83294685010333,7.96864952519536,8.00040492229164,7.88968386279885,7.7615049504675,7.92703789961524,8.15403501526453,7.7921199107077,18.1314841402927,17.7714944069739,17.8960715621943,17.8308939241106,18.0211842408171,18.0992737843189,3.96498966577929,3.85767866345122,3.84295649593696,3.98716452752706,3.96433087601326,3.83852500969078,3.81110406771768,3.88622329104692,4.16092175408266,4.00651366706006,3.91231154429261,3.82449504220858,3.83990634407382,4.04232108022552,4.0442184136482,4.09078134712763,3.95333308330737,3.88078105123714,7.14268654049374,7.08697809721343,6.87858692009468,7.20527861895971,7.19691130169667,6.81760574690998,6.81491751526482,6.84556241356768,6.75828475377057,6.77405074005947,7.12943949329201,6.90685940801632,6.93236488418188,1.89082240778953,2.15970342070796,1.79579437361099,1.81842459586915,1.82148484967183,1.93407359346747,1.86463587440085,2.22286845918279,5.7546832334483,5.75780291727278,6.08926771045662,6.18635696580168,5.97915384732187,6.23514262854587,6.10961653443519,6.23735446156934,6.24284687370528,6.00141744629946,6.22608226188459,5.95141199557111,5.76164244138636,6.14616587851197,5.82179568824358,5.83645626646467,5.9332514788257,5.91029207373504,5.8334382356843,6.16100068751257,5.96709306316916,6.20991414866876,5.89506052283105,5.99816310277674,6.23343847296201,6.07197961164638,5.79048459196929,6.10650789656211,3.0069919875823,3.03554172348231,2.95306158310268,3.02017578051891,3.09313575201668,2.8592121185502,2.77992276102304,3.13952764496207,3.10631307994481,2.77503865968902,3.15075705607887,3.24223469162825,3.00899508025032,3.04547953419387,3.12301005958579,2.75699423078913,3.1562922532903,2.75988219492137,5.11735876719467,4.99937866278924,5.21875409409404,4.88587031746283,5.0349843678996,4.8927839192329,5.20692183542997,5.05184984707739,4.80512639891822,4.85829022410326,5.0606170243118,4.837405547034,5.17758880474139,16.1208284761524,16.12719028024,16.0033019538969,16.1919729465153,16.0848080748692,15.9308827838395,16.1284167193808,16.1081239809282,15.8840679115383,15.928700805176,16.1216394484509,15.8953479822958,15.8079180202913,16.116440444719,16.239514097455,13.8942822142271,14.1457075738581,13.7507001727354,13.8803209412144,13.7941315630451,14.0394676787546,13.7878367495723,13.8694805218838,14.0517736949259,14.0927850741427,14.0684224436991,13.8711282981094,14.1273157326505,14.2313275478082,13.8219119239366,13.9911464846227,13.9196038014488,13.7803725044942,14.1071276476141,13.8049352036323,16.9177103379043,16.8887885143049,16.7522801834857,17.2087360862643,16.8506180859404,16.8712081486592,16.8834532634355,16.9569083461538,17.2466775381472,16.7723971295636,17.2270654994063,17.0617503811372,16.9828756694915,17.1213950891979,17.128801172832,16.8359590381151,17.0120867198566,16.8453790029744,16.9920182147762],"text":["diff:   0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Arthralgia, Grade 3-4","diff:   0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Back pain, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Bronchitis, Grade 3-4","diff:   0.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Chest pain, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Cognitive effects, Grade 3-4","diff:  -0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Constipation, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Cough, Grade 3-4","diff:   0.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Diarrhea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Dizziness, Grade 3-4","diff:   0.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Dyspnea, Grade 3-4","diff:   2.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Edema, Grade 3-4","diff:  -1.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Fatigue/Asthenia, Grade 3-4","diff:  -0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Headache, Grade 3-4","diff:  10.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Hypertension, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Mood effects, Grade 3-4","diff:   0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Myalgia, Grade 3-4","diff:  -1.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Nausea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Pain in extremity, Grade 3-4","diff:   1.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Peripheral neuropathy, Grade 3-4","diff:  -1.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Pneumonia, Grade 3-4","diff:  -0.1<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Pyrexia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Rash, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Respiratory failure, Grade 3-4","diff:   1.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Sleep effects, Grade 3-4","diff:  -0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Upper respiratory tract infection, Grade 3-4","diff:  -0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Vision disorder, Grade 3-4","diff:  -0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Vomiting, Grade 3-4","diff:  14.9<br />fct_reorder(factor(id), -as.numeric(id_long)): 106<br />keyz: Study B7461006, Weight Increased, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Arrhythmia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Arthralgia, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Back pain, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Constipation, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Cough, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Diarrhea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Dyspnea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Injection site reactions, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Muscle spasms, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Peripheral sensory neuropathy, Grade 3-4","diff:   5.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Pneumonia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 114<br />keyz: ANDROMEDA, Upper respiratory tract infection, Grade 3-4","diff:  -2.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Abdominal pain, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Alopecia, Grade 3-4","diff:  15.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Anemia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Constipation, Grade 3-4","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Decreased appetite, Grade 3-4","diff:   0.8<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Dehydration, Grade 3-4","diff:   0.8<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Diarrhea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Edema peripheral, Grade 3-4","diff:   4.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Fatigue/Asthenia, Grade 3-4","diff:   1.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Febrile neutropenia, Grade 3-4","diff:   1.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Hepatic function abnormal, Grade 3-4","diff:   2.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Interstitial lung disease, Grade 3-4","diff:   3.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Nausea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Pyrexia, Grade 3-4","diff:   1.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Stomatitis, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 115<br />keyz: DESTINY-Gastric01, Vomiting, Grade 3-4","diff:   3.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Appetite decrease, Grade 3-4","diff:   7.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Cataract, Grade 3-4","diff:   5.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Diarrhea, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Dizziness, Grade 3-4","diff:  23.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Fatigue/Asthenia, Grade 3-4","diff:   8.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Nausea, Grade 3-4","diff:  -4.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Peripheral neuropathy, Grade 3-4","diff:   0.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Pyrexia, Grade 3-4","diff:   2.1<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Upper respiratory tract infection, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Vision blurred, Grade 3-4","diff:   4.1<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Vomiting, Grade 3-4","diff:   1.1<br />fct_reorder(factor(id), -as.numeric(id_long)): 119<br />keyz: BOSTON, Weight decreased , Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Abdominal pain, Grade 3-4","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Decreased appetite, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Diarrhea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Dizziness, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Dyspnea, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Edema, Grade 3-4","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Fatigue/Asthenia, Grade 3-4","diff:  23.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Febrile neutropenia, Grade 3-4","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Hemorrhage, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Hypotension, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Musculoskeletal pain, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Nausea, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Rash, Grade 3-4","diff:   8.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Sepsis (excluding fungal), Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Stomatitis, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Urinary tract infection, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 127<br />keyz: VIALE-A , Vomiting, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Abdominal pain, TYPO","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Arthralgia, TYPO","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Constipation, TYPO","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Decreased appetite, TYPO","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Diarrhea, TYPO","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Dizziness, TYPO","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Fatigue/Asthenia, TYPO","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Febrile neutropenia, TYPO","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Nausea, TYPO","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Pain in extremity, TYPO","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Pneumonia, TYPO","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 132<br />keyz: QUAZAR, Vomiting, TYPO","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Anemia, Grade 3-4","diff:   0.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Back pain, Grade 3-4","diff:   1.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Bronchitis, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Cough, Grade 3-4","diff:   3.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Diarrhea, Grade 3-4","diff:   1.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Dyspnea, Grade 3-4","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Fatigue/Asthenia, Grade 3-4","diff:   5.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Hypertension, Grade 3-4","diff:   7.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Infusion-related reaction, Grade 3-4","diff:   1.9<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Insomnia, Grade 3-4","diff:  -0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Nausea, Grade 3-4","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Pneumonia, Grade 3-4","diff:   1.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Pyrexia, Grade 3-4","diff:   3.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Respiratory infection, Grade 3-4","diff:   9.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 134<br />keyz: CANDOR, Thrombocytopenia, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Edema, Grade 3-4","diff:   1.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Fatigue/Asthenia, Grade 3-4","diff:   8.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Hepatotoxicity, Grade 3-4","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Hypertension, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Hyperthyroidism, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Hypothyroidism, Grade 3-4","diff:   1.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Infusion-related reaction, Grade 3-4","diff:   1.1<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Musculoskeletal pain, Grade 3-4","diff:  -1.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Nausea, Grade 3-4","diff:  -2.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Photosensitivity reaction, Grade 3-4","diff:   0.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Pneumonitis, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Pruritus, Grade 3-4","diff:  -0.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Pyrexia, Grade 3-4","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Rash, Grade 3-4","diff:   0.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 137<br />keyz: IMspire150, Stomatitis, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Alopecia, Grade ≥ 3","diff:   6.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Diarrhea, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Epistaxis, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Gastrointestinal hemorrhage, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Gingival bleeding, Grade ≥ 3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Headache, Grade ≥ 3","diff:  19.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Hypertension, Grade ≥ 3","diff:  10.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Infections, Grade ≥ 3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Peripheral edema, Grade ≥ 3","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Proteinuria, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Pulmonary hemorrhage, Grade ≥ 3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 150<br />keyz: RELAY, Stomatitis, Grade ≥ 3","diff:  16.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 154<br />keyz: PROfound, Anemia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 154<br />keyz: PROfound, Cough, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 154<br />keyz: PROfound, Decreased appetite, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 154<br />keyz: PROfound, Diarrhea, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 154<br />keyz: PROfound, Dyspnea, Grade 3-4","diff:  -2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 154<br />keyz: PROfound, Fatigue/Asthenia, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 154<br />keyz: PROfound, Nausea, Grade 3-4","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 154<br />keyz: PROfound, Thrombocytopenia, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 154<br />keyz: PROfound, Vomiting, Grade 3-4","diff:  16.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 160<br />keyz: PAOLA-1, Anemia, TYPO","diff:   3.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 160<br />keyz: PAOLA-1, Fatigue/Asthenia, TYPO","diff:   0.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 160<br />keyz: PAOLA-1, Leukopenia, TYPO","diff:   5.9<br />fct_reorder(factor(id), -as.numeric(id_long)): 160<br />keyz: PAOLA-1, Lymphopenia, TYPO","diff:   1.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 160<br />keyz: PAOLA-1, Nausea, TYPO","diff:  -0.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 160<br />keyz: PAOLA-1, Vomiting, TYPO","diff:   2.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, AST/ALT elevation, Grade 3-4","diff:   0.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Acute kidney injury, Grade 3-4","diff:  29.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Anemia, Grade 3-4","diff:   0.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Constipation, Grade 3-4","diff:  -0.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Cough, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Decreased appetite, Grade 3-4","diff:  -0.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Dizziness, Grade 3-4","diff:  -0.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Dyspnea, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Fatigue/Asthenia, Grade 3-4","diff:   0.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Headache, Grade 3-4","diff:   5.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Hypertension, Grade 3-4","diff:   0.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Insomnia, Grade 3-4","diff:   4.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Leukopenia, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Musculoskeletal pain, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Nausea, Grade 3-4","diff:  20.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Neutropenia, Grade 3-4","diff:  38.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Thrombocytopenia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 164<br />keyz: PRIMA, Vomiting, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Alopecia, Grade 3-4","diff:   0.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Constipation, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Decreased appetite, Grade 3-4","diff:   1.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Diarrhea, Grade 3-4","diff:   1.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Dyspnea, Grade 3-4","diff:   1.8<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Fatigue/Asthenia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Insomnia, Grade 3-4","diff:   1.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Musculoskeletal pain, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Nausea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Peripheral neuropathy, Grade 3-4","diff:   1.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Rash, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Vomiting, Grade 3-4","diff:   1.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 28<br />keyz: Study 16113, Weight decreased , Grade 3-4","diff:  -0.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 3<br />keyz: PROpel, Abdominal pain, Grade 3-4","diff:  12.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 3<br />keyz: PROpel, Anemia, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 3<br />keyz: PROpel, Decreased appetite, Grade 3-4","diff:   0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 3<br />keyz: PROpel, Diarrhea, Grade 3-4","diff:   0.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 3<br />keyz: PROpel, Dizziness, Grade 3-4","diff:   0.8<br />fct_reorder(factor(id), -as.numeric(id_long)): 3<br />keyz: PROpel, Fatigue/Asthenia, Grade 3-4","diff:   3.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 3<br />keyz: PROpel, Lymphopenia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 3<br />keyz: PROpel, Nausea, Grade 3-4","diff:  -9.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Anemia, Grade ≥3","diff:   7.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Aphasia, Grade ≥3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Chills, Grade ≥3","diff:   5.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Confusional state, Grade ≥3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Constipation, Grade ≥3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Cough, Grade ≥3","diff:    NA<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Cytokine release syndrome, Grade ≥3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Decreased appetite, Grade ≥3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Delirium, Grade ≥3","diff:  -2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Diarrhea, Grade ≥3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Dizziness, Grade ≥3","diff:  12.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Encephalopathy, Grade ≥3","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Fatigue/Asthenia, Grade ≥3","diff: -25.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Febrile neutropenia, Grade ≥3","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Headache, Grade ≥3","diff:  -1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Hypokalemia, Grade ≥3","diff:   6.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Hypophosphatemia, Grade ≥3","diff:   8.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Hypotension, Grade ≥3","diff:   5.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Hypoxia, Grade ≥3","diff:   7.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Leukopenia, Grade ≥3","diff:  -3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Nausea, Grade ≥3","diff:  28.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Neutropenia, Grade ≥3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Paresthesia, Grade ≥3","diff:   8.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Pyrexia, Grade ≥3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Sinus tachycardia, Grade ≥3","diff: -42.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Thrombocytopenia, Grade ≥3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Tremor, Grade ≥3","diff:  -1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 51<br />keyz: ZUMA-7, Vomiting, Grade ≥3","diff:  -0.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Abdominal pain, Grade 3-4","diff:   0.8<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Arthralgia, Grade 3-4","diff:   0.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Chills, Grade 3-4","diff:   0.8<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Cytokine release syndrome, Grade 3-4","diff:  -1.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Diarrhea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Dry skin, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Edema, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Erythema, Grade 3-4","diff:   5.1<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Fatigue/Asthenia, Grade 3-4","diff:    NA<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Hair color changes, Grade 3-4","diff:  -0.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Headache, Grade 3-4","diff:   3.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Hypotension, Grade 3-4","diff:   1.1<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Nausea, Grade 3-4","diff:   4.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Pruritus, Grade 3-4","diff:   2.8<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Pyrexia, Grade 3-4","diff:  18.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Rash, Grade 3-4","diff:    NA<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Skin Hypopigmentation, Grade 3-4","diff:   1.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 58<br />keyz: IMCgp100-202, Vomiting, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Arthralgia, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Aspartate aminotransferase increased, Grade ≥ 3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Asthenia, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Diarrhea, Grade ≥ 3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Fatigue/Asthenia, Grade ≥ 3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Hyperthyroidism, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Hypothyroidism, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Increased alanine aminotransferase, Grade ≥ 3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Myalgia, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Nausea, Grade ≥ 3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Pruritus, Grade ≥ 3","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Rash, Grade ≥ 3","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 60<br />keyz: KEYNOTE-716, Rash maculopapular, Grade ≥ 3","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Decreased appetite, Grade 3-4","diff:   7.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Diarrhea, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Dry mouth, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Dysgeusia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Dysphonia, Grade 3-4","diff:  10.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Fatigue/Asthenia, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Headache, Grade 3-4","diff:   7.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Hypertension, Grade 3-4","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Nausea, Grade 3-4","diff:  10.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Palmar-plantar erythrodysesthesia, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Proteinuria, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Pulmonary embolism, Grade 3-4","diff:   5.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Stomatitis, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Vomiting, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 74<br />keyz: COSMIC-311, Weight decreased , Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Abdominal pain, Grade 3-4","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Acute kidney injury, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Constipation, Grade 3-4","diff:   3.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Decreased appetite, Grade 3-4","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Diarrhea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Dysphonia, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Fatigue/Asthenia, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Headache, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Hemorrhagic events, Grade 3-4","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Hepatotoxicity, Grade 3-4","diff:   9.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Hypertension, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Hypothyroidism, Grade 3-4","diff:   1.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Musculoskeletal pain, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Nausea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Palmar-plantar erythrodysesthesia, Grade 3-4","diff:   5.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Proteinuria, Grade 3-4","diff:   4.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Rash, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Stomatitis, Grade 3-4","diff:   2.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Vomiting, Grade 3-4","diff:   8.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 82<br />keyz: CLEAR, Weight decreased , Grade 3-4","diff:   1.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Abdominal pain, Grade 3-4","diff:  -0.6<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Constipation, Grade 3-4","diff:   7.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Decreased appetite, Grade 3-4","diff:   5.2<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Diarrhea, Grade 3-4","diff:   0.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Dysphonia, Grade 3-4","diff:   5.0<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Fatigue/Asthenia, Grade 3-4","diff:   0.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Headache, Grade 3-4","diff:   1.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Hemorrhagic events, Grade 3-4","diff:  36.5<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Hypertension, Grade 3-4","diff:   0.9<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Hypothyroidism, Grade 3-4","diff:   4.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Musculoskeletal disorders, Grade 3-4","diff:   1.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Nausea, Grade 3-4","diff:   2.9<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Palmar-plantar erythrodysesthesia, Grade 3-4","diff:   5.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Proteinuria, Grade 3-4","diff:   2.3<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Rash, Grade 3-4","diff:   1.4<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Stomatitis, Grade 3-4","diff:   3.8<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Urinary tract infection, Grade 3-4","diff:   0.1<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Vomiting, Grade 3-4","diff:   9.7<br />fct_reorder(factor(id), -as.numeric(id_long)): 84<br />keyz: Study 309, Weight decreased , Grade 3-4"],"key":["Study B7461006, Arthralgia, Grade 3-4","Study B7461006, Back pain, Grade 3-4","Study B7461006, Bronchitis, Grade 3-4","Study B7461006, Chest pain, Grade 3-4","Study B7461006, Cognitive effects, Grade 3-4","Study B7461006, Constipation, Grade 3-4","Study B7461006, Cough, Grade 3-4","Study B7461006, Diarrhea, Grade 3-4","Study B7461006, Dizziness, Grade 3-4","Study B7461006, Dyspnea, Grade 3-4","Study B7461006, Edema, Grade 3-4","Study B7461006, Fatigue/Asthenia, Grade 3-4","Study B7461006, Headache, Grade 3-4","Study B7461006, Hypertension, Grade 3-4","Study B7461006, Mood effects, Grade 3-4","Study B7461006, Myalgia, Grade 3-4","Study B7461006, Nausea, Grade 3-4","Study B7461006, Pain in extremity, Grade 3-4","Study B7461006, Peripheral neuropathy, Grade 3-4","Study B7461006, Pneumonia, Grade 3-4","Study B7461006, Pyrexia, Grade 3-4","Study B7461006, Rash, Grade 3-4","Study B7461006, Respiratory failure, Grade 3-4","Study B7461006, Sleep effects, Grade 3-4","Study B7461006, Upper respiratory tract infection, Grade 3-4","Study B7461006, Vision disorder, Grade 3-4","Study B7461006, Vomiting, Grade 3-4","Study B7461006, Weight Increased, Grade 3-4","ANDROMEDA, Arrhythmia, Grade 3-4","ANDROMEDA, Arthralgia, Grade 3-4","ANDROMEDA, Back pain, Grade 3-4","ANDROMEDA, Constipation, Grade 3-4","ANDROMEDA, Cough, Grade 3-4","ANDROMEDA, Diarrhea, Grade 3-4","ANDROMEDA, Dyspnea, Grade 3-4","ANDROMEDA, Injection site reactions, Grade 3-4","ANDROMEDA, Muscle spasms, Grade 3-4","ANDROMEDA, Peripheral sensory neuropathy, Grade 3-4","ANDROMEDA, Pneumonia, Grade 3-4","ANDROMEDA, Upper respiratory tract infection, Grade 3-4","DESTINY-Gastric01, Abdominal pain, Grade 3-4","DESTINY-Gastric01, Alopecia, Grade 3-4","DESTINY-Gastric01, Anemia, Grade 3-4","DESTINY-Gastric01, Constipation, Grade 3-4","DESTINY-Gastric01, Decreased appetite, Grade 3-4","DESTINY-Gastric01, Dehydration, Grade 3-4","DESTINY-Gastric01, Diarrhea, Grade 3-4","DESTINY-Gastric01, Edema peripheral, Grade 3-4","DESTINY-Gastric01, Fatigue/Asthenia, Grade 3-4","DESTINY-Gastric01, Febrile neutropenia, Grade 3-4","DESTINY-Gastric01, Hepatic function abnormal, Grade 3-4","DESTINY-Gastric01, Interstitial lung disease, Grade 3-4","DESTINY-Gastric01, Nausea, Grade 3-4","DESTINY-Gastric01, Pyrexia, Grade 3-4","DESTINY-Gastric01, Stomatitis, Grade 3-4","DESTINY-Gastric01, Vomiting, Grade 3-4","BOSTON, Appetite decrease, Grade 3-4","BOSTON, Cataract, Grade 3-4","BOSTON, Diarrhea, Grade 3-4","BOSTON, Dizziness, Grade 3-4","BOSTON, Fatigue/Asthenia, Grade 3-4","BOSTON, Nausea, Grade 3-4","BOSTON, Peripheral neuropathy, Grade 3-4","BOSTON, Pyrexia, Grade 3-4","BOSTON, Upper respiratory tract infection, Grade 3-4","BOSTON, Vision blurred, Grade 3-4","BOSTON, Vomiting, Grade 3-4","BOSTON, Weight decreased , Grade 3-4","VIALE-A , Abdominal pain, Grade 3-4","VIALE-A , Decreased appetite, Grade 3-4","VIALE-A , Diarrhea, Grade 3-4","VIALE-A , Dizziness, Grade 3-4","VIALE-A , Dyspnea, Grade 3-4","VIALE-A , Edema, Grade 3-4","VIALE-A , Fatigue/Asthenia, Grade 3-4","VIALE-A , Febrile neutropenia, Grade 3-4","VIALE-A , Hemorrhage, Grade 3-4","VIALE-A , Hypotension, Grade 3-4","VIALE-A , Musculoskeletal pain, Grade 3-4","VIALE-A , Nausea, Grade 3-4","VIALE-A , Rash, Grade 3-4","VIALE-A , Sepsis (excluding fungal), Grade 3-4","VIALE-A , Stomatitis, Grade 3-4","VIALE-A , Urinary tract infection, Grade 3-4","VIALE-A , Vomiting, Grade 3-4","QUAZAR, Abdominal pain, TYPO","QUAZAR, Arthralgia, TYPO","QUAZAR, Constipation, TYPO","QUAZAR, Decreased appetite, TYPO","QUAZAR, Diarrhea, TYPO","QUAZAR, Dizziness, TYPO","QUAZAR, Fatigue/Asthenia, TYPO","QUAZAR, Febrile neutropenia, TYPO","QUAZAR, Nausea, TYPO","QUAZAR, Pain in extremity, TYPO","QUAZAR, Pneumonia, TYPO","QUAZAR, Vomiting, TYPO","CANDOR, Anemia, Grade 3-4","CANDOR, Back pain, Grade 3-4","CANDOR, Bronchitis, Grade 3-4","CANDOR, Cough, Grade 3-4","CANDOR, Diarrhea, Grade 3-4","CANDOR, Dyspnea, Grade 3-4","CANDOR, Fatigue/Asthenia, Grade 3-4","CANDOR, Hypertension, Grade 3-4","CANDOR, Infusion-related reaction, Grade 3-4","CANDOR, Insomnia, Grade 3-4","CANDOR, Nausea, Grade 3-4","CANDOR, Pneumonia, Grade 3-4","CANDOR, Pyrexia, Grade 3-4","CANDOR, Respiratory infection, Grade 3-4","CANDOR, Thrombocytopenia, Grade 3-4","IMspire150, Edema, Grade 3-4","IMspire150, Fatigue/Asthenia, Grade 3-4","IMspire150, Hepatotoxicity, Grade 3-4","IMspire150, Hypertension, Grade 3-4","IMspire150, Hyperthyroidism, Grade 3-4","IMspire150, Hypothyroidism, Grade 3-4","IMspire150, Infusion-related reaction, Grade 3-4","IMspire150, Musculoskeletal pain, Grade 3-4","IMspire150, Nausea, Grade 3-4","IMspire150, Photosensitivity reaction, Grade 3-4","IMspire150, Pneumonitis, Grade 3-4","IMspire150, Pruritus, Grade 3-4","IMspire150, Pyrexia, Grade 3-4","IMspire150, Rash, Grade 3-4","IMspire150, Stomatitis, Grade 3-4","RELAY, Alopecia, Grade ≥ 3","RELAY, Diarrhea, Grade ≥ 3","RELAY, Epistaxis, Grade ≥ 3","RELAY, Gastrointestinal hemorrhage, Grade ≥ 3","RELAY, Gingival bleeding, Grade ≥ 3","RELAY, Headache, Grade ≥ 3","RELAY, Hypertension, Grade ≥ 3","RELAY, Infections, Grade ≥ 3","RELAY, Peripheral edema, Grade ≥ 3","RELAY, Proteinuria, Grade ≥ 3","RELAY, Pulmonary hemorrhage, Grade ≥ 3","RELAY, Stomatitis, Grade ≥ 3","PROfound, Anemia, Grade 3-4","PROfound, Cough, Grade 3-4","PROfound, Decreased appetite, Grade 3-4","PROfound, Diarrhea, Grade 3-4","PROfound, Dyspnea, Grade 3-4","PROfound, Fatigue/Asthenia, Grade 3-4","PROfound, Nausea, Grade 3-4","PROfound, Thrombocytopenia, Grade 3-4","PROfound, Vomiting, Grade 3-4","PAOLA-1, Anemia, TYPO","PAOLA-1, Fatigue/Asthenia, TYPO","PAOLA-1, Leukopenia, TYPO","PAOLA-1, Lymphopenia, TYPO","PAOLA-1, Nausea, TYPO","PAOLA-1, Vomiting, TYPO","PRIMA, AST/ALT elevation, Grade 3-4","PRIMA, Acute kidney injury, Grade 3-4","PRIMA, Anemia, Grade 3-4","PRIMA, Constipation, Grade 3-4","PRIMA, Cough, Grade 3-4","PRIMA, Decreased appetite, Grade 3-4","PRIMA, Dizziness, Grade 3-4","PRIMA, Dyspnea, Grade 3-4","PRIMA, Fatigue/Asthenia, Grade 3-4","PRIMA, Headache, Grade 3-4","PRIMA, Hypertension, Grade 3-4","PRIMA, Insomnia, Grade 3-4","PRIMA, Leukopenia, Grade 3-4","PRIMA, Musculoskeletal pain, Grade 3-4","PRIMA, Nausea, Grade 3-4","PRIMA, Neutropenia, Grade 3-4","PRIMA, Thrombocytopenia, Grade 3-4","PRIMA, Vomiting, Grade 3-4","Study 16113, Alopecia, Grade 3-4","Study 16113, Constipation, Grade 3-4","Study 16113, Decreased appetite, Grade 3-4","Study 16113, Diarrhea, Grade 3-4","Study 16113, Dyspnea, Grade 3-4","Study 16113, Fatigue/Asthenia, Grade 3-4","Study 16113, Insomnia, Grade 3-4","Study 16113, Musculoskeletal pain, Grade 3-4","Study 16113, Nausea, Grade 3-4","Study 16113, Peripheral neuropathy, Grade 3-4","Study 16113, Rash, Grade 3-4","Study 16113, Vomiting, Grade 3-4","Study 16113, Weight decreased , Grade 3-4","PROpel, Abdominal pain, Grade 3-4","PROpel, Anemia, Grade 3-4","PROpel, Decreased appetite, Grade 3-4","PROpel, Diarrhea, Grade 3-4","PROpel, Dizziness, Grade 3-4","PROpel, Fatigue/Asthenia, Grade 3-4","PROpel, Lymphopenia, Grade 3-4","PROpel, Nausea, Grade 3-4","ZUMA-7, Anemia, Grade ≥3","ZUMA-7, Aphasia, Grade ≥3","ZUMA-7, Chills, Grade ≥3","ZUMA-7, Confusional state, Grade ≥3","ZUMA-7, Constipation, Grade ≥3","ZUMA-7, Cough, Grade ≥3","ZUMA-7, Cytokine release syndrome, Grade ≥3","ZUMA-7, Decreased appetite, Grade ≥3","ZUMA-7, Delirium, Grade ≥3","ZUMA-7, Diarrhea, Grade ≥3","ZUMA-7, Dizziness, Grade ≥3","ZUMA-7, Encephalopathy, Grade ≥3","ZUMA-7, Fatigue/Asthenia, Grade ≥3","ZUMA-7, Febrile neutropenia, Grade ≥3","ZUMA-7, Headache, Grade ≥3","ZUMA-7, Hypokalemia, Grade ≥3","ZUMA-7, Hypophosphatemia, Grade ≥3","ZUMA-7, Hypotension, Grade ≥3","ZUMA-7, Hypoxia, Grade ≥3","ZUMA-7, Leukopenia, Grade ≥3","ZUMA-7, Nausea, Grade ≥3","ZUMA-7, Neutropenia, Grade ≥3","ZUMA-7, Paresthesia, Grade ≥3","ZUMA-7, Pyrexia, Grade ≥3","ZUMA-7, Sinus tachycardia, Grade ≥3","ZUMA-7, Thrombocytopenia, Grade ≥3","ZUMA-7, Tremor, Grade ≥3","ZUMA-7, Vomiting, Grade ≥3","IMCgp100-202, Abdominal pain, Grade 3-4","IMCgp100-202, Arthralgia, Grade 3-4","IMCgp100-202, Chills, Grade 3-4","IMCgp100-202, Cytokine release syndrome, Grade 3-4","IMCgp100-202, Diarrhea, Grade 3-4","IMCgp100-202, Dry skin, Grade 3-4","IMCgp100-202, Edema, Grade 3-4","IMCgp100-202, Erythema, Grade 3-4","IMCgp100-202, Fatigue/Asthenia, Grade 3-4","IMCgp100-202, Hair color changes, Grade 3-4","IMCgp100-202, Headache, Grade 3-4","IMCgp100-202, Hypotension, Grade 3-4","IMCgp100-202, Nausea, Grade 3-4","IMCgp100-202, Pruritus, Grade 3-4","IMCgp100-202, Pyrexia, Grade 3-4","IMCgp100-202, Rash, Grade 3-4","IMCgp100-202, Skin Hypopigmentation, Grade 3-4","IMCgp100-202, Vomiting, Grade 3-4","KEYNOTE-716, Arthralgia, Grade ≥ 3","KEYNOTE-716, Aspartate aminotransferase increased, Grade ≥ 3","KEYNOTE-716, Asthenia, Grade ≥ 3","KEYNOTE-716, Diarrhea, Grade ≥ 3","KEYNOTE-716, Fatigue/Asthenia, Grade ≥ 3","KEYNOTE-716, Hyperthyroidism, Grade ≥ 3","KEYNOTE-716, Hypothyroidism, Grade ≥ 3","KEYNOTE-716, Increased alanine aminotransferase, Grade ≥ 3","KEYNOTE-716, Myalgia, Grade ≥ 3","KEYNOTE-716, Nausea, Grade ≥ 3","KEYNOTE-716, Pruritus, Grade ≥ 3","KEYNOTE-716, Rash, Grade ≥ 3","KEYNOTE-716, Rash maculopapular, Grade ≥ 3","COSMIC-311, Decreased appetite, Grade 3-4","COSMIC-311, Diarrhea, Grade 3-4","COSMIC-311, Dry mouth, Grade 3-4","COSMIC-311, Dysgeusia, Grade 3-4","COSMIC-311, Dysphonia, Grade 3-4","COSMIC-311, Fatigue/Asthenia, Grade 3-4","COSMIC-311, Headache, Grade 3-4","COSMIC-311, Hypertension, Grade 3-4","COSMIC-311, Nausea, Grade 3-4","COSMIC-311, Palmar-plantar erythrodysesthesia, Grade 3-4","COSMIC-311, Proteinuria, Grade 3-4","COSMIC-311, Pulmonary embolism, Grade 3-4","COSMIC-311, Stomatitis, Grade 3-4","COSMIC-311, Vomiting, Grade 3-4","COSMIC-311, Weight decreased , Grade 3-4","CLEAR, Abdominal pain, Grade 3-4","CLEAR, Acute kidney injury, Grade 3-4","CLEAR, Constipation, Grade 3-4","CLEAR, Decreased appetite, Grade 3-4","CLEAR, Diarrhea, Grade 3-4","CLEAR, Dysphonia, Grade 3-4","CLEAR, Fatigue/Asthenia, Grade 3-4","CLEAR, Headache, Grade 3-4","CLEAR, Hemorrhagic events, Grade 3-4","CLEAR, Hepatotoxicity, Grade 3-4","CLEAR, Hypertension, Grade 3-4","CLEAR, Hypothyroidism, Grade 3-4","CLEAR, Musculoskeletal pain, Grade 3-4","CLEAR, Nausea, Grade 3-4","CLEAR, Palmar-plantar erythrodysesthesia, Grade 3-4","CLEAR, Proteinuria, Grade 3-4","CLEAR, Rash, Grade 3-4","CLEAR, Stomatitis, Grade 3-4","CLEAR, Vomiting, Grade 3-4","CLEAR, Weight decreased , Grade 3-4","Study 309, Abdominal pain, Grade 3-4","Study 309, Constipation, Grade 3-4","Study 309, Decreased appetite, Grade 3-4","Study 309, Diarrhea, Grade 3-4","Study 309, Dysphonia, Grade 3-4","Study 309, Fatigue/Asthenia, Grade 3-4","Study 309, Headache, Grade 3-4","Study 309, Hemorrhagic events, Grade 3-4","Study 309, Hypertension, Grade 3-4","Study 309, Hypothyroidism, Grade 3-4","Study 309, Musculoskeletal disorders, Grade 3-4","Study 309, Nausea, Grade 3-4","Study 309, Palmar-plantar erythrodysesthesia, Grade 3-4","Study 309, Proteinuria, Grade 3-4","Study 309, Rash, Grade 3-4","Study 309, Stomatitis, Grade 3-4","Study 309, Urinary tract infection, Grade 3-4","Study 309, Vomiting, Grade 3-4","Study 309, Weight decreased , Grade 3-4"],"type":"scatter","mode":"markers","marker":{"autocolorscale":false,"color":"rgba(0,0,0,1)","opacity":0.5,"size":5.66929133858268,"symbol":"circle","line":{"width":1.88976377952756,"color":"rgba(0,0,0,1)"}},"hoveron":"points","showlegend":false,"xaxis":"x","yaxis":"y","hoverinfo":"text","_isNestedKey":false,"frame":null}],"layout":{"margin":{"t":42.6666666666667,"r":7.30593607305936,"b":39.0867579908676,"l":463.92694063927},"font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":14.6118721461187},"title":{"text":"Top 20 Medians for difference bewteen arms, highest grade only","font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":17.5342465753425},"x":0,"xref":"paper"},"xaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[-46.03,42.63],"tickmode":"array","ticktext":["-40","-20","0","20","40"],"tickvals":[-40,-20,0,20,40],"categoryorder":"array","categoryarray":["-40","-20","0","20","40"],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.65296803652968,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"Roboto Condensed","size":11.689497716895},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176,"zeroline":false,"anchor":"y","title":{"text":"Point difference between arms","font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":14.6118721461187}},"hoverformat":".2f"},"yaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[0.4,20.6],"tickmode":"array","ticktext":["<b>lorlatinib<\/b> vs. crizotinib","olaparib","<b>tebentafusp-tebn<\/b> vs. Investigator’s Choice","niraparib","pembrolizumab","<b>axicabtagene ciloleucel<\/b> vs. SOC","cemiplimab-rwlc","<b>olaparib<\/b> vs. enzalutamide or abiraterone","ramucirumab","atezolizumab","venetoclax","daratumumab + hyaluronidase","<b>fam-trastuzumab deruxtecan-nxki<\/b> vs. Chemo (Irinotecan or Paclitaxel)","<b>lenvatinib + pembrolizumab<\/b> vs. sunitinib","azacitidine","cabozantinib","<b>pembrolizumab + lenvatinib<\/b> vs. chemo","olaparib","selinexor","daratumumab"],"tickvals":[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20],"categoryorder":"array","categoryarray":["<b>lorlatinib<\/b> vs. crizotinib","olaparib","<b>tebentafusp-tebn<\/b> vs. Investigator’s Choice","niraparib","pembrolizumab","<b>axicabtagene ciloleucel<\/b> vs. SOC","cemiplimab-rwlc","<b>olaparib<\/b> vs. enzalutamide or abiraterone","ramucirumab","atezolizumab","venetoclax","daratumumab + hyaluronidase","<b>fam-trastuzumab deruxtecan-nxki<\/b> vs. Chemo (Irinotecan or Paclitaxel)","<b>lenvatinib + pembrolizumab<\/b> vs. sunitinib","azacitidine","cabozantinib","<b>pembrolizumab + lenvatinib<\/b> vs. chemo","olaparib","selinexor","daratumumab"],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.65296803652968,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"Roboto Condensed","size":11.689497716895},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176,"zeroline":false,"anchor":"x","title":{"text":"Isolated effects measured","font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":14.6118721461187}},"hoverformat":".2f"},"shapes":[{"type":"rect","fillcolor":null,"line":{"color":null,"width":0,"linetype":[]},"yref":"paper","xref":"paper","x0":0,"x1":1,"y0":0,"y1":1}],"showlegend":false,"legend":{"bgcolor":null,"bordercolor":null,"borderwidth":0,"font":{"color":"rgba(0,0,0,1)","family":"Roboto Condensed","size":11.689497716895}},"hovermode":"closest","barmode":"relative"},"config":{"doubleClick":"reset","modeBarButtonsToAdd":["hoverclosest","hovercompare"],"showSendToCloud":false},"source":"A","attrs":{"2ee02241606d":{"x":{},"y":{},"key":{},"type":"scatter"}},"cur_data":"2ee02241606d","visdat":{"2ee02241606d":["function (y) ","x"]},"highlight":{"on":"plotly_click","persistent":false,"dynamic":false,"selectize":false,"opacityDim":0.2,"selected":{"opacity":1},"debounce":0},"shinyEvents":["plotly_hover","plotly_click","plotly_selected","plotly_relayout","plotly_brushed","plotly_brushing","plotly_clickannotation","plotly_doubleclick","plotly_deselect","plotly_afterplot","plotly_sunburstclick"],"base_url":"https://plot.ly"},"evals":[],"jsHooks":[]}</script>
</div>
</div>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-21-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<div class="cell">
<div class="cell-output cell-output-stdout">
<pre><code>[1] 0.007877956</code></pre>
</div>
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-22-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<p>Maybe like a heat map of the rankings, best efficacy vs.&nbsp;most toxic</p>
</section>
<section id="mechanism-of-action" class="level3">
<h3 class="anchored" data-anchor-id="mechanism-of-action">Mechanism of action</h3>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-23-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<div class="cell">

</div>
</section>
<section id="discountination" class="level3">
<h3 class="anchored" data-anchor-id="discountination">Discountination</h3>
<div class="cell">

</div>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-26-1.png" class="img-fluid" width="960"></p>
</div>
</div>
</section>
<section id="fatal" class="level3">
<h3 class="anchored" data-anchor-id="fatal">Fatal</h3>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-27-1.png" class="img-fluid" width="960"></p>
</div>
</div>
</section>
</section>
<section id="efficacy" class="level2">
<h2 class="anchored" data-anchor-id="efficacy">Efficacy</h2>
<section id="overall-survival" class="level4">
<h4 class="anchored" data-anchor-id="overall-survival">Overall Survival</h4>
<div class="cell">

</div>
<p>All OS reported/found</p>
<p>Drugs are the drugs measured in trial design. Bolded is the intervention arm. If not bolded, it was compared against placebo or same regime without the intervention drug</p>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-29-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<p>Not novel but interesting to see which trials used OS as primary endpoint</p>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-30-1.png" class="img-fluid" width="960"></p>
</div>
</div>
</section>
<section id="pfs-others" class="level4">
<h4 class="anchored" data-anchor-id="pfs-others">PFS + Others</h4>
<div class="cell">
<div class="cell-output-display">
<p><img src="OncologSideEffects_quarto_files/figure-html/unnamed-chunk-31-1.png" class="img-fluid" width="960"></p>
</div>
</div>
<div class="cell">

</div>
</section>
</section>

</main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>